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Abstract 
In coeliac disease (CD), dietary gluten - a ubiquitous protein in wheat, rye and barley derived foods 
- degrades intestinal absorptive function. Untreated C D involves a cascade of autoimmune modulated 
health effects in genetically predisposed individuals, with a worldwide C D prevalence in European 
origin populations of about 0.3% to 1%. Resultant physical problems in undetected or sub-optimally 
treated cases include anaemia and reduced bone density, with the risk of intestinal lymphoma and 
overall mortality increased. Depression and reduced life quality are also commonly reported pre- and 
post-diagnosis. Gut restitution and general health restoration is incumbent upon strict, lifelong avoid-
ance of gluten ingestion and maintaining the diet is a challenge in itself. At any time only around 
one in five to ten probable C D cases are actually diagnosed, owing to an insidious onset in minimal-
symptomatic cases and a kaleidoscopic clinical presentation. Studies ofthe psychological ramifications 
of C D comprise a small proportion of burgeoning international research into the pathogenesis and 
genetic underpinnings. The goal ofthe thesis was to investigate psychological functioning in C D at 
different stages of treatment with the gluten-free diet (GFD), both cross-sectional ly and longitudinally. 
Study 1 involved a clinically heterogeneous biopsy-confirmed Australian C D group aged 16 to 84 
(mean 41 years; n = 110; 6 0 % female). Mean age at diagnosis was 36.9 years (range 1-84, S D = 15.4), 
occurring after the age of 19 years in 8 7 % of cases. Participants with C D undertook 5-6 hours of clinical 
interviewing and assessment. They were compared with two age-, sex-, education-, socioeconomic 
status-and IQ-matched comparison groups; 69 healthy volunteers, termed normal controls (NCs) and 53 
people with diabetes mellitus (DM; Type-1 = 36; Type-2 = 17). The normal and chronic illness 
comparison groups were recruited in an analogous way to the C D group and subject to identical assess-
ment procedures. Individual evaluation across key demographic, health-related, affective, cognitive and 
behavioural domains involved use oi the Beck Depression Inventory, 2nd Edition (BDI-II; 1996), the 
full Wechsler Adult Intelligence Scale, 3rd Edition (WAIS-1II; 1997), Spielberger '$ State-Trait Anxiety 
(1983) and State-Trait Anger Expression (1988) Inventories and the Quality of Life Questionnaire 
(QLQ; Evans & Cope, 1989). Results: In neuropsychological (WAIS-IH) testing, the C D sample had 
reduced working memory ( W M ) and processing speed (PS) compared to NCs. These differences held 
when the C D sample was subdivided into low, medium or high subgroups, based on total IQ, age at 
study entry, age or number of symptoms at C D diagnosis and time on or compliance with the GFD. The 
results were also significant irrespective of gender, although the clear processing speed difference was 
accentuated in male, compared to female, participants with CD. A subgroup of two thirds ofthe C D 
sample, retrospectively assessed at study commencement as clinically multisymptomatic at the time of 
C D diagnosis, had significantly higher BDI-II depression (of somatic-affective origin), trait anxiety and 
state anger, as well as reduced quality of life (QOL), compared to the healthy (but not chronic illness) 
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comparison groups. State anxiety was higher in the multisymptomatic C D subgroup vis-a-vis both 
comparison groups, regardless of gender. Across the full C D sample, retrospective self-reported health 
status was markedly lower prior to diagnosis in relation to each comparison group. Unlike participants 
with D M , whose self-rated health status declined slightly pre- to post-diagnosis, a significant increase in 
subjective health status was reported in the C D group following diagnosis. Nevertheless, the multisymp-
tomatic subgroup still rated their health status following diagnosis (i.e., at study enrolment) as below 
healthy control levels. U p o n gender partitioning, statistical significance only held for females. The lack 
of perceived health improvement in the chronic illness comparison group pre- to post-diagnosis was 
attributed to the almost inevitable, eventual deterioration of health associated with D M , as distinct from , 
C D , in which a remission of health problems is generally observed following consistent adherence to thej 
G F D . Nevertheless, almost one in three participants w h o were multisymptomatic at C D diagnosis were 
at least mildly depressed at study entry. Discriminant function analysis, using equally weighted static 
and dynamic diagnostic, dietary and temporal correlates, was undertaken to determine if a combination 
of readily available or obtainable clinical information was useful in predicting psychological function-
ing. This process correctly predicted group membership of three in four C D participants, each classified 
beforehand as either non-depressed or above the minimum cut-score conferring BDI-II depression at 
study entry. O f major clinical relevance was the high reliability and reasonable specificity of this 
straightforward procedure. Seven out often non-depressed C D participants were correctly classified, 
with identification of more than eight out often w h o were depressed. Since only easily procurable 
clinical information was utilised and false positives could be screened via psychometric assessment or 
clinical interviewing, this accurate, brief, cost-effective analysis would appear to have significant 
practical utility as an adjunct in mental health intervention considerations in the care of C D patients. 
Study 2 involved the reassessment, one year later (i.e., at T2), of one quarter ofthe full cross-
sectional C D sample (n = 27; 14 females, 13 males) w h o had been diagnosed with C D for less than nine 
weeks at initial assessment (Ti) in Study 1. These participants were reassessed using an identical 
protocol. A subgroup often healthy volunteers was also reassessed, principally to monitor inherent 
retesting effects in the WAIS-III and test-retest stability of other measures used. In general, the 
longitudinal C D group reported initial G F D compliance, which had been sustained at T2. 
Results: Perceived health status pre-to post-diagnosis increased, verifying the same finding at study 
entry. State anxiety decreased between Ti and T2 and a trend towards a decrease in mean BDI-II scores 
(underpinned by change in the somatic, as opposed to the cognitive, dimension of self-reported 
depression) was observed, in addition to slight decreases in trait anxiety, state and trait anger. 
The Profile of Mood States ( P O M S ; McNair, Lorr, & Droppleman, 1971) was administered to the 
longitudinal C D group at Ti and T2, to corroborate any shifts in affect identified by the primary 
Psychological Sequelae in C D M\ 
aforementioned measures. Changes between Ti and T2, in order of descending strength of significance, 
were decreases in fatigue-inertia (which held across gender), confusion-bewilderment and anger-hostility 
A total mood disturbance score, based on the summation of all six P O M S subscales, was also found to 
significantly decrease, although depression-dejection did not significantly change. One year on the 
G F D was not associated with a significant improvement in Q O L and one third still exhibited low Q O L . 
A 3-point rise in full IQ, not above a level that could be accounted for by a practice effect, occurred 
within the C D group, with residual index-specific weaknesses in W M and P S compared to NCs. 
Summary: Each study detailed in the thesis highlighted that the psychological sequelae observed in 
C D are typically juxtaposed with markers of clinical severity at diagnosis and physical symptomatology I 
post-diagnosis. For many - but not all - of those newly diagnosed, mood state ameliorates in concert 
with recession of physical symptoms in response to a strict G F D sustained over the passage of time. 
However, the specific neuropsychological deficits may be relatively refractory to dietary change. 
Increased symptomatic duration prior to diagnosis significantly impacted on the degree of impairment, 
underlining the essence of early detection. Furthermore, self-reported depression affected about one 
third of multisymptomatic C D participants at study enrolment and remained elevated in almost one-
quarter of all newly diagnosed C D study entrants at one year follow-up. Multisymptomatic members 
of this longitudinal group did not quite attain, on average, the same Q O L as N C participants, with a 
significantly greater proportion reporting low Q O L . These results suggest that, following C D diagnosis, 
psychological intervention should be considered in conjunction with ongoing specialist medical advice 
and expert dietary assistance. 
Chapter 1: Introduction to Coeliac Disease 
The National Heart Foundation of Australia, state anti-cancer councils and various government 
bodies have advised the public ofthe dangers of contemporary Western eating habits (Craig, 1988). 
These include excessively high saturated fat, salt and refined sugar consumption and inadequate fibre 
intake (Stanton, 1995). Australians in at-risk groups, including people with hypertension, raised low-
density lipoprotein (LDL) cholesterol and diabetes mellitus, have also been alerted to the benefits of 
modified nutritional regimens (Lester, 1994). Campaigns financed by the business sector have 
advocated the inclusion of particular foods. For example, women have been encouraged by the beef 
industry to eat more red meat in advertisements highlighting purported links between a wide range of 
frequently experienced, everyday symptoms (e.g., tiredness), anaemia and low dietary iron (e.g., 
"Red Meat, Feel Good"; Gardiner, 2001). 
Similarly, osteoporosis has been coupled with inadequate dietary calcium by the Australian 
Dairy Corporation (2001). This link contrasts with current medical opinion that "the long-term 
effect of a high dietary calcium intake on bone health is unclear" (Delmas, 2002, p. 2022). Evidence 
exists that, in adults, increased calcium ingestion per se, whether from milk or other foods, does not 
actually reduce the incidence of hip fracture and may even be counterproductive (Feskanich, Willett, 
Stampfer, & Colditz, 1997). The reality may sound extraordinary, against the powerful resonance of 
pro-dairy messages to the contrary, which saturate advertising space, seduce and profoundly 
influence consumer choice (Schelling, 1996). These campaigns include; "Milk. Are you getting 
enough?" (1994-98) and "Milk, Legendary Stuff' (1998-99), both highly successful Australian 
marketing promotions (Davey, 2000). 
At the base ofthe food guide pyramid advocated by health educators and nutritionists (Baron, 
2002, p. 1269), are breads and cereals, with 6-11 daily servings recommended, ahead of even fruit or 
vegetables (2-4 and 3-5 servings respectively). Bread, whether in a loaf or sliced, in rolls, buns, 
muffins, pastries and even rusks for babies, remains the venerated "staff of life". This is attributable 
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to historic, economic and social - as well as health - considerations. Naturally low in fat, high in 
complex carbohydrates if unrefined, and full of, or fortified with, fibre, wheat-based breads are 
especially inexpensive to mass-produce. They are palatable, readily available, versatile and 
convenient, having been embraced by European culture since Biblical times. Pasta was a homemade, 
mostly ceremonial food in Middle Ages Europe (Greco, 1991), but, like bread, became gluten-
enriched after the Renaissance (Greco, 1997) and more widely available after the Industrial 
Revolution (Feldman & Sears, 1981). 
Vegetarianism's mid-late twentieth century resurgence (Waerland, 1979; Whorton, 1994), 
underpinned by ecological, ethical, religious and health concerns (Worsley & Skrzpiec, 1998), was 
contemporaneous with the Pritikin-inspired diet, based on grains, pasta and plant-based foods. Each 
movement was buoyed by associations between saturated fat and elevated cholesterol, weight gain 
and atherosclerosis (Hetzel & McMichael, 1989). A lynchpin ofthe low glycaemic index (G.I.) 
solution for blood sugar control, weight loss, diabetes and heart disease management, pasta was again 
popularised during the preceding decade as a ".. .fabulous low G.I. food...to eat more of (Miller, 
Foster-Powell, Colagiuri, & Leeds, 1996, pp. 143-144). Miller et al.'s international best-selling book, 
based on sixty research papers addressing the glycaemic index of foods, was strongly endorsed by 
Zimmet (1996), director of Melbourne's International Diabetes Institute. These influences have 
heralded the revived promotion of pasta, cereal and bread, as part of a low G.I., cholesterol-free, 
environmentally friendly and low-cost panacea for many ofthe Western world's major health 
problems associated with dietary imbalances and excesses. 
Maintaining the bread group as a foundation stone of healthy eating has been an overwhelming 
success. It would therefore surprise many health-conscious people that, over time, "as people put 
more pasta and bread in their diets, they increased their risk of diabetes by two-and-a half times" 
(Fuhrman, 1998, p. 123). Furthermore, the ingestion of these foods is immediately and acutely toxic 
for a significant minority of people. Affecting 0.3% to 1.1% of European origin populations (Greco, 
1997; Meloni, Dore, Fanciulli, Tanda, & Bottazo, 1999) is a disease often overlooked as a possible 
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cause of gastronomic distress, anaemia, skin inflammation, osteoporosis, depression, infertility and 
even neurological disorders, lymphoma, and increased mortality if undetected (Nielsen et al., 1985; 
Club del Tenue Study Group, 2001; Catassi et al., 2002). 
This readily treatable illness has largely escaped the glare of public health campaigns, and a 
degree of scrutiny in general medical practice commensurate with its prevalence and seriousness. 
While reliable testing exists, at least six out of seven people in the developed world and a higher 
proportion in non-Western nations probably escape diagnosis (Catassi et al., 1996). For all of these 
reasons, coeliac disease (CD) qualifies as a major identifiable worldwide health problem. It remains 
"hard to imagine that the single most common food intolerance to the single most common staple 
food in our environment might provoke such a variety of adverse immuno-mediated reactions in any 
part ofthe human body" as those medically documented in CD (Greco, 1997, p. 19). 
Given the dearth of research in Australia investigating the psychological impact of CD in the 
small proportion of detected cases and the aforesaid social forces and culinary conventions that 
exacerbate the problem, CD is the consummate challenge for health educators and uncharted terrain 
for clinical/ health psychology. At an annual state meeting for health psychologists1, lack of CD 
awareness in these circles was apparent. The author observed that few people amongst those present 
had actually heard of CD. Only one person later identified herself as being familiar with the 
condition in any detail. Her older sister had, quite coincidentally, been diagnosed just a week earlier. 
Public and professional nescience may both contribute to the likelihood of missed or mis-
diagnosis, but, combined with increased awareness, has also lead to the significant percentage of CD 
cases identified in recent times in adulthood, often following long periods of unspecified ill health 
throughout life (Sollid & Lundin, 2001). The old adage that "doctors do not diagnose diseases they do 
not know" is often applicable to CD. For those affected, a delay or absence of an accurate diagnosis 
and treatment may be catastrophic in health terms. This chapter briefly reviews the historical 
Victorian Section ofthe Australian Psychological Society College of Health Psychologists, AGM, Melbourne; 
Australia, September, 1998 
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aspects, aetiological underpinnings, pathogenesis and worldwide epidemiology of C D , its 
heterogeneous clinical presentation, current diagnosis and treatment guidelines, contemporary 
research trends, food labelling practice standards, diagnostic screening and other micro- and macro-
level issues pertaining to the interface with clinical and health psychology. 
History 
References to gastrointestinal (GI) maladies were written in Sanskrit as long ago as 1500 BC 
(Hunter, 1987). The earliest known description of a CD-like malabsorption condition was made by a 
second century AD physician, Aretaeus (Adams, trans. 1856; cited in Thomas, 1948). Aretaeus was 
from Cappadocia, an eastern department ofthe Roman Empire and today part of Turkey, where the 
first traces of wild wheat and barley were originally cultivated (Greco, 1997). Within Adams' 
translation (Thomas, 1948), signs of "atony" throughout the GI tract - familiar nowadays in classic 
CD cases - were noted, including "eructations" (belching) and flatulent "evacuations", as well as 
observations ofthe patient [as] emaciated and atrophied, pale [and] feeble" (p. 600). The illness 
itself was described as "very protracted and intractable", being found in children, older people and in 
"women rather than to men" (p. 601). The accompanying diarrhoea in children was attributed to an 
"ephemeral [i.e., transitory] intemperance to food" (p. 601). Aretaeus has also been credited with 
coining the term coeliac, from the Greek word koilia (meaning "belly"), to denote the abdominal 
distension and diarrhoea experienced by those afflicted (Ciclitira & Ellis, 1997). Further descriptions 
of GI syndromes consistent with CD symptomatology ensued, with various unsavoury or chimerical 
remedies offered, including one recorded by Oxford's Robert Lovel, quoting Pliny in 1661 
(Rawcliffe & James, 1985): "The hee-goot spleen rosteth, helpeth the coeliak" (p. 17). 
The Dutch physician Vincent Katelaer described the ailment "Stomatitus Aphthous" in a 1669 
treatise on "spruw" [sic], noting small ulcers in the intestines and mouths of diarrhoea sufferers 
(Hunter, 1987). Sprue came to refer to chronic enteritis encountered in the tropics, with CD sometimes 
designated "non-tropical sprue". It was more than two hundred years later, in his 1888 paper "On the 
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Coeliac Affection", that Samuel Gee of London provided the first clear description of C D as a specific 
condition, as documented by Walker-Smith (1988) at the 5th Coeliac Meeting in London: 
There is a kind of chronic indigestion, which is met with in persons of all ages, yet is especially 
apt to affect children between 1 and 5 years old ... Signs ofthe disease are yielded by the 
faeces, being loose, but not watery, bulky and pale. The onset ofthe disease is usually gradual 
...Cachexia2 is a constant symptom. The belly is mostly soft, often distended (p. 1). 
Gibbons (1889) described the characteristic emotional symptoms of a child with C D a year later 
(cited in Gardiner, Porteous, & Walker-Smith, 1971, p. 39): "The temper ofthe child seems variable, 
most frequently he is extremely irritable, fretful, capricious or peevish. Nothing seems to please him 
and altogether he is unlike himself. Despite Gee's unmistakable description and an archetypal limn 
illustrated by Gibbons, the cause of what became known as chronic intestinal infection, or recurrent 
diarrhoea in childhood (see Still, 1918), remained obscure. The most prominent cases usually 
appeared in infancy and typically succumbed to acute infantile diarrhoea (Visakorpi, 1997). 
Dutch paediatrician Willem Dicke made a curious observation half a century after Gee's initial 
description of C D . Dicke (1950) found that children with chronic intestinal infection in Nazi-occupied 
Holland improved under conditions of near starvation, when Dutch wheat was sent to Germany, but 
deteriorated again after World W a r II, as wheat became readily available. Suggesting that grains 
might be a causative factor, Dicke (1950) became the first person to show that flour from wheat and 
other grains produced C D symptoms in children with the illness, generalising his finding to all ages. 
This was to prove the aggiornamento of C D research and patient care. The hybrid term "coeliac 
sprue", synonymous with gluten intolerance, thus emerged. 
With a team of researchers at the University of Birmingham, the late Australian pioneer Charlotte 
Anderson, described variously by peers as the "mother" (Myers, 2002, p.l) and "grandmother of 
paediatric gastroenterology"; Walker-Smith, p. 589), subsequently isolated gluten as the noxious 
component of wheat flour in those susceptible. Anderson et al. (1952) had their results verified by van 
Cachexia is a condition of extreme malnutrition, with chronic disability of body or mind 
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de Kamer, Weijers and Dicke (1953), w h o established that the gliadin fraction of gluten in wheat 
protein was especially toxic for people with CD. Paulley (1954) noted atrophy ofthe villi in the 
intestines of untreated CD cases. Anderson shared the new CD results with sceptical paediatricians 
on a tour of hospital centres in the United States, during which she found gastroenterologists working 
with adults more easily persuaded by the Dutch and English results (Allen, 1996). On her return to 
Australia, Anderson instigated small intestinal bioptic testing for CD and prescribed diets free of 
wheat gluten to CD patients at the Royal Children's Hospital in Melbourne (Anderson, Townley, 
Messer, & Hubbard, 1962). With various commercial millers and bread makers, she pioneered the 
development of local gluten-free breads suitable for CD sufferers (Allen, 1996), 
Prior to the introduction ofthe gluten-free diet (GFD), published mortality rates in CD ranged 
from 10-30% (Hardwick, 1939; Ciclitira, 2001). Sakula and Shiner (1957) were the first to demon-
strate, via histological examination of an upper intestinal biopsy, proof of mucosal atrophy in a child 
with CD similar to that found in "thirteen adult cases of ideopathic steathorrhoea", which these 
authors said "may be one and the same disease" (p. 877). "For many decades" - until this finding -
"anatomical lesions ofthe small intestine in children with coeliac disease [had] been suggested by 
some authors and denied by others" (p. 876). Margot Shiner's pioneering work (Hancock & Shiner, 
1958; Shiner, 1956, 1959) consequently opened the way for modern diagnostic techniques. 
Definition, Aetiology, Heredity and Pathogenesis 
In CD, also known as gluten-sensitive enteropathy, and still referred to as celiac sprue in most 
North American medical texts, the intestinal absorptive surface in susceptible individuals is damaged 
by dietary gluten, a ubiquitous protein in foods derived from wheat, rye, barley and various 
combinations of these grains (e.g., triticale/ spelt; Farrell & Kelly, 2002). The intolerance to ingested 
gluten is permanent (Troncone, Greco, & Auricchio, 1996), appearing classically in infancy upon 
exposure to gluten after weaning, or in early childhood. However, CD may manifest clinically at any 
age. Breast feeding duration, age at which gluten is introduced into the infant diet, length of period 
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during which both breast milk and gluten are given, amount of gluten consumed and infectious agents 
(e.g., adenovirus type 12) are all early environmental factors of apparent importance in disease onset 
(Ascher, Krantz, Rydberg, Nordin, & Kristiansson, 1997; Falth-Magnusson, Franzen, Jansson, Laurin, 
& Stenhammar, 1996; Sollid, 2002). Pre-diagnostically silent (i.e., symptomless), latent or mild cases 
often emerge insidiously - or recur in many instances of undiagnosed childhood CD - after 
adolescence and throughout adulthood (Duggan, 1997; Gracey & Anderson, 1969). Adult-detected 
cases may have been preceded by months, years or decades of very subtle to severe CD-related 
symptoms or unspecified ill-health, with non-specific or atypical (non-GI) coeliac features. 
Untreated CD involves a cascade of autoimmune modulated health effects in genetically 
predisposed individuals, with a subtle interplay between genes and environment (Sollid et al, 2001). 
An "... inappropriate T-cell mediated immune response against ingested gluten" that jeopardises the 
tight, intercellular junctions in the intestinal epithelium, characteristically increases gut permeability 
in the "early phase of CD" and "may be responsible for the increased incidence of autoimmune 
disorders reported in untreated CD...", as elucidated by Allesio Fasano (2000, p. 769), Professor of 
Pediatrics, Medicine, and Physiology and Director ofthe Center for Celiac Research, Baltimore, 
Maryland (see also Fasano et al., 2000). 
A genetic predisposition to CD has long been recognised (Ebbs, 1950). Concordance between 
identical twins, believed to be at least 70% (Susi, Holopainen, Mustalahti, Maki, & Partenen, 2001; 
Trier, 1991), is probably higher, given that some discordant individuals later diagnosed appear to 
have had latent (i.e., clinically quiescent) CD (Maki & Collin, 1997). Recent Italian research in fact 
revealed concordance rates between (genetically identical) monozygotic twins of 0.86 proband 
wise and 0.75 pair wise, versus dizygotic rates of 0.20 proband wise and 0.11 pair wise (Greco et 
al., 2002). Since dizygotic twins are not more alike genetically than other siblings, but share a 
common environmental background, these authors noted that their research design afforded a 
"powerful means of assessing the weight of genetic and environmental factors... with substantial 
evidence for a very strong genetic component in CD" (p. 624). Approximately one third of siblings 
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and 10%o of first degree relatives of people with C D are usually affected (Partanen, 1997). 
At least nine out often CD patients carry a combination of two human leukocyte antigen 
(HLA) alleles on chromosome 6 (HLA-DQA1*0501 and HLA-DQB1 *02), but so do about 20% of 
healthy European controls (Pena, Garrote, & Crusius, 1998). Based on the familial clustering of CD, 
non-HLA genes may collectively have more influence upon who develops CD (Sollid 
& Lundin, 2001). Although individual contributions from each single, hypothesised, predisposing 
non-HLA gene are relatively small (Zhong et al., 1996), evidence is accumulating for the role of 
CTLA4 on chromosome 2, a regulator of T-cell function, in susceptibility to CD (Djilali-Saiah et al., 
1998; Holopainen et al., 2000, 2001; King et al., 2002; Popat, Hearle, Bevan et al., 2002). 
Small bowel villous atrophy, crypt hyperplasia and decreased villous height-to-crypt depth 
ratio are morphological changes observed at the small intestinal mucosal surface, in the duodenum and 
proximal jejunum, at CD diagnosis (Fasano & Catassi, 2001). There is also a proliferation of 
intraepithelial lymphocytes (Selby, 2001). Figure 1 overleaf shows images of villi pre- (top) and post-
diagnosis (bottom) sourced from www.gesa.org.au publications - professional CD guidelines. The 
severity of mucosal inflammation, damage at pathologic sites, length of intestine and extent of 
intestinal surface involved are highly variable (Barr & Grehan, 1998). Mucosal changes range from 
minor villous blunting or partial atrophy (with patients often presenting clinically as oligo3symptomatic 
or asymptomatic), to subtotal or total villous atrophy, in classic and multisymptomatic cases (see 
Fasano & Catassi, 2001, p. 645, for a pictorial display ofthe range of histological grades of atrophy). 
Cells constituting normal, frond-like functional villi (microscopic intestinal projections) are 
involved in the digestion and absorption of all nutrients, including vitamins, minerals, proteins, fats 
and simple carbohydrates. In CD, widespread or even patchy damage to the absorptive surface ofthe 
intestines thus results in various degrees of malabsorption of most nutrients. Impaired assimilation of 
lipids significantly limits uptake ofthe fat-soluble vitamins (A, D, E, and K), also forcing the body to 
3 
General (Greek-derived) medical prefix; useful in describing CD cases with few or slight symptoms of illness 
(from Gk. oligos: small, oligios: few); used by Aldao del Rosario (1992) and other CD researchers 
Figure 1: Images sourced from www.gesa.org.au publications - professional C D guidelines; 
Damaged mucosal surface (appearing flattened) shown above; Functional villi below 
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utilise essential amino acids as an energy source. Given that protein metabolism in the gut contributes 
about one third of whole-body protein turnover (van der Schoor et al, 2002), impaired mucosal 
activation may unduly compromise extra-visceral amino acid requirements. Degraded uptake, 
utilisation or retention ofthe major electrolytes (including potassium, magnesium and calcium) and 
micronutrients (e.g., vitamin B6, copper and iron; all precursors of haemoglobin formation and 
neurotransmitter production; Hallert, 1987) may also impact on bone metabolism and many other 
physiological processes (Selby & Faulkner-Hogg, 1998). In severe CD cases, "the absorptive surface 
ofthe small intestine may shrink from the size of a tennis court4 to that of a household door" (Ryan, 
2000, p. 835). Intake of nutrients in the upper intestinal area (e.g., iron and folate) is most affected 
Reduced intellectual performance and behavioural alterations are both associated with iron deficiency 
alone (Lozoff, 1989). Sideropenic anaemia accompanies most CD diagnoses (Barr & Grehan, 1998). 
Secondary metabolic problems, arising from nutritional deficiencies and immunological 
reactions caused by or associated with CD, exert stress on digestion-related, ancillary and remote 
body organs. Systemic effects and perturbations ensue (Howdle, 1997). Ramifications for an affected 
person's general health and well-being may be substantial, cumulative and even life-threatening, 
with the risk of intestinal lymphoma and overall mortality increased (Club del Tenue Study Group, 
2001), especially in untreated or sub-optimally managed CD patients. 
Gut restitution and restoration of general health are incumbent upon strict, lifelong avoidance of 
gluten ingestion. Following gluten withdrawal, clinical improvement occurs within weeks in just over 
two thirds of cases (Pink & Creamer, 1967; Selby & Faulkner-Hogg, 1998). An almost immediate 
remission of nettling symptoms of chronic ill-health or acute GI pain is often described (see Greco, 
1997; Lohiniemi, 2001). Internally, complete healing ofthe intestinal mucosa may take six to twelve 
months in children (Mulder, Wahab, Moshaver, & Meijer, 2000) and up to a year or longer in 
adults and the elderly (Grefte, Bouman, Grond, Jansen, & Kleibeuker, 1988; O'Mahony, Howdle, & 
Total area of adult mucosal epithelial surface = 400m2 or ~ 200 times entire skin surface area (Brandtzaeg, 1997) 
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Losowsky, 1996). Ongoing nutritional deficiencies, especially early in treatment, are not uncommon. 
For example, magnesium depletion, which may contribute to osteoporosis, has been noted in clinically 
asymptomatic CD patients on the GFD (Rude & Olerich, 1996). Full histological restitution is com-
promised by incomplete removal of gluten, with subsequent dietary lapses causing re-inflammation 
Numerous, often related, aetiologies have been proposed for the pathogenic changes observed, 
including enzymopathic theories, membrane glycoprotein- and mucosal permeability-defect hypotheses 
(Cornell, 1996). Increasingly, unequivocal support and evidence supporting immunological pathways 
(Fasano, 2000; Schuppan, 2000; Sollid, Lundin, Sjostrom, Molberg, & Thorsby, 1997) has emerged. 
Gluten proteins form complexes with an enzyme in the small bowel architecture known as tissue trans-
glutimase (tTG), instigating "an antigenic response from the mucosal T cells" (Ryan, 2000, p. 835). 
The "resultant antitransglutimase autoantibody damages [the] intestinal mucosa" (p. 835). 
Redefinition of CD as an auto-immunological reaction to gluten has occurred within the last 
decade (Pena et al., 1998). In acute or active CD, intestinal damage is almost always demonstrable, 
however slight, and GI symptomatology is a common, but not exclusive, physical indicator of illness 
(Mulder, Rostami, & Marsh, 1998). Indeed, in the preceding generation, close to half of all new CD 
cases worldwide have presented with non-GI symptoms at diagnosis, as noted by Fasano and Catassi 
(2001) in an overview of present day diagnosis-treatment protocols in CD (see also Catassi & 
Fasano, 2002, or Hallert, 1984, for an earlier overview of all clinical aspects). 
Extra-intestinal manifestations, which may present with or without obvious mucosal atrophy, 
include dermatitis herpetiformis (see Fry, 1997/ 2002), a blistering skin disorder and the "classical 
non-GI disorder associated with CD" (Selby & Falkner-Hogg, 1998, p. 32) and dental enamel 
hypoplasia (Aine, 1996), each of which often receive treatments unrelated to CD recognition. In fact, 
without an active case-finding strategy in risk groups, most people with CD are unlikely to be 
detected (Hin, Bird, Fisher, Mahy, & Jewell, 1999; Mustalahti et al., 2002; Sanders, Hurlstone et al., 
2002), owing to a preponderance of unapparent or unheeded symptomatology. On the basis of CD 
identified via screening data versus actual clinical diagnosis, Fasano and Catasasi (2001) remarked 
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that, "worldwide, C D out ofthe intestine is 15 times more frequent than C D in the intestine" (p. 641) 
Even at the symptomatic level, the Norwegians Sollid and Lundin (2001) noted that many ofthe 
likeliest signs of C D "including anaemia, fatigue, osteoporosis, depression, and infertility.. are not 
especially suggestive of a disorder ofthe gut" (p. sl3). 
Classic versus Atypical Presentation 
The classic presentation of CD involves a failure to thrive and significant weight loss, or failure 
to gain weight, in infancy or early childhood, as well as lassitude, pallor (due to anaemia) and GI 
distress, signs of which include bloating (resulting in abdominal distension), diarrhoea, flatulence 
or constipation and steatorrhoea (fat malabsorption), with increased faecal fat traditionally the 
barometer (Trier, 1991). Nevertheless, these clinical features are highly variable and characteristic 
ofthe acute phase or more severe cases of C D , now widely recognised as not confined to early life 
(Tursi et al., 2001). Moreover, none of these features are pathognomic to C D (Pham & Barr, 1996). 
Iron-deficiency anaemia is perhaps the most frequent concomitant or antecedent symptom, extra-
intestinal manifestation or atypical feature (in absence of GI symptoms) of C D at diagnosis. This 
often manifests as a loss of vitality or pallor in children (Abdullah, 1994). Menstrual irregularity or 
amenorrhea during the child-bearing years, especially if refractory to supplementation of iron and 
folic acid, may also indicate C D (Barr et al., 1993). Various skeletal pathologies (e.g., osteoporosis5, 
osteopaenia5, and osteomalacia5; Basu, Elmer, Babu, & Kelly, 2000; Marsh, 1994, and dental 
enamel defects/ mineralisation disturbances of permanent teeth; Rasmusson & Eriksson, 2001) are 
common, with significant osteopaenia usually accompanying adult C D diagnosis (Selby & 
Faulkner-Hogg, 1998). Recurrent oral aphthous ulceration is not rare and cutaneous disorders (e.g., 
psoriasis, dermatitis herpetiformis) are seen in one quarter of C D patients (Fry, 1997). 
Osteoporosis: Defined as hip bone mineral density (BMD) T score 2.5 standard deviations (SDs) or more < young 
adult female mean using Dual Energy X-ray Absorptiometry (DEXA); Osteopaenia: B M D T score < -1, > -2.5 SD on 
DEXA; Osteomalacia: Adult version of rickets (vitamin D/ Ca |). 
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Professor Claes Hallert and his colleagues, ofthe Coeliac Centre at Linkoping University, Sweden, 
have found depression to be the most common psychological problem in people with CD pre- and post-
diagnosis (Hallert & Astrom, 1982; Hallert & Derefeldt, 1982; see Hallert, 1984, 1987, and 1997, for 
comprehensive reviews). Pyridoxine (vitamin Be) deficiency, then supplemental repletion, was linked 
to a decrement, followed by a significant amelioration of mood state (Hallert, Astrom, & Walan, 1983) 
Increased depressive symptoms in CD were also identified by Ciacci, Iavarone, Mazzacca, and De Rosa 
(1998) and dysthymia was the most frequent psychological symptom post-diagnosis in a small CD 
series, affecting 23% (Rebaudengo et al., 1997). Most recently, Carta et al. (2002) found a high 
prevalence of major depressive and panic disorder in adult CD patients compared to healthy controls. 
Headaches and migraine are often reported (Perniola et al., 1997; Roche Herrero et al., 2001), 
sometimes with bioccipital calcification and epilepsy (Piattella et al., 1997). Subtle neuropsychological 
deficits have also been identified (Grech, Richards, McLaren, & Winkelman, 2000). Serological 
evidence of CD was found in just over half of a cohort of patients with cryptic neurological dysfunc-
tion (Hadjivassiliou et al., 1996) and neurological complications occurred in 7% of another newly 
diagnosed CD series (Luostarinen, Pirttila, & Collin, 1999). These include polyneuropathy, ataxia and 
epilepsy (Gobbi, Andermann, Naccarato, & Banchini, 1997). Suggestions CD "can be associated with 
severe neurological symptoms" (Bruzelius, Liedholm, & Hellblom, 2001, p. 3538) prompted those 
authors to call for CD screening "in suspected cases" (p. 3538). "Atypical neurological involvement 
associated with CD" (Hanagasi Gurol, Sahin, & Emre, 2001, p. 67) may sometimes result from a long-
term deficiency of nutrients essential to neural function (see also Holmes, 1997), but is chiefly 
understood to have an immunological basis (Alaedini et al., 2002; Burk et al., 2001, Williamson et al., 
2000), independent of malabsorption in CD (Fasano & Catassi, 2001; Hadjivassiliou et al., 1998). 
Thyroid conditions are often synchronous with CD (Hakanen, et al., 2001) and subclinical thyroid 
disease may be an underlying factor in the increased risk of psychiatric morbidity in CD patients 
(Carta et al., 2002). Other atypical CD symptoms or complications are alopecia (Corraza et al., 1995) 
and arthritis. Onset occurs as early as adolescence (Maki et al., 1988). Rickets and short stature, 
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linked to malabsorption and once a primary manifestation of C D (Groll, Candy, Preece, Tanner, & 
Harries, 1980), is not as common nowadays (Visakorpi, 1992), but less severe or subclinical signs of 
physical underdevelopment are reported (Visakorpi, 1997). Children with untreated CD typically fail 
to grow satisfactorily, appearing thin or wasted, with undulating symptoms and subtle progression in 
milder cases (Anderson, 1969). George et al. (1997) detailed the clinical picture at the time of CD 
diagnosis in 193 Dutch children, identified in 1993-4. Growth failure6 was the most common 
presenting symptom. In Australia, "plotting of growth percentiles is [deemed] mandatory in the 
assessment of suspected coeliac disease [in conjunction with other investigations] and is very helpful 
in the differentiation of this condition from other diarrhoeal diseases" (Barr et al., 1993, p. 4) 
Adult-detected patients routinely present as weak and listless. Anaemia and low bone mineral 
density (BMD) occurs in at least two thirds of those newly diagnosed (Barr & Grehan, 1998). 
Retrospective histories of persistent, long-standing ill health, often accepted as normal by the 
unsuspecting patient, or intermittent symptoms intensifying prior to diagnosis, rather than true 
clinical silence, are usually readily uncovered (Johnston, Watson, McMillan, Sloan, & Love, 1998). 
Many adult patients realise after diagnosis that they "have been unwell all their lives" (Barr et al., 
1993, p. 10) and may have been "shopping around trying to understand what is wrong with them, 
not knowing they are celiac" (Fasano, 1998, p. 3). Emotionally, this realisation may evoke relief at 
the possibility or novel experience of vigorous health, despair or embitterment at newly discovered 
ill-health (e.g., osteoporosis) or lost physical condition (e.g., infertility), fear of future complications, 
or various combinations and intensities of these and other sentiments, at different times (Lohiniemi, 
2001). All reactions, whether negative or positive, pessimistic, optimistic or realistic, mirror the 
clinical heterogeneity of CD and other illnesses with delayed recognition and an uncertain course, 
such as type-2 diabetes (see Edelwich & Brodsky, 1986) or Huntington's disease (HD). In HD, 
lowered mood often precedes the definitive choreic movements, with "signs of a mental disorder 
among the first manifestations of a systemic or cerebral disease" (American Psychiatric Association 
Defined as a decrease of > two SDs below their growth line, either in height, weight or both. 
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[APA], 1994, p. 167). That psychiatric treatment may be attempted prior to awareness ofthe presence 
of Huntington's disease (Grech, 1993) is reminiscent of clinical judgments about and treatment of 
depressive illness in unrecognised CD, noted decades ago (see Hallert & Derefeldt, 1982). 
Initial CD diagnosis is correlated with lowered body mass index (e.g., Capristo et al., 1997), 
partly attributable to nutrient malabsorption, especially lipids. Increasingly though, CD patients may 
be overweight at diagnosis (Franzese et al., 2001). Those authors reported atypical cases presenting 
with obesity-related liver dysfunction. Smallness ofthe liver in young children with CD was noted 
long ago by Still (1918), with mild liver abnormalities common at diagnosis (Davison, 2002; 
Sjoberg, Lindgren, & Eriksson, 1997). The GFD may, however, reverse hepatic failure (Kaukinen et 
al., 2002). Slight, albeit clinically relevant neuropsychological impairment is, in turn, prevalent in 
liver disease (Elass, Lund, & Ranek, 1978; Watanabe, Tuchida, Yata, & Kuwabara, 1995). This 
relationship's pert- inence to neuropsychiatric functioning in CD is not yet established. It is known 
that the severity ofthe aforementioned neurological complications may be associated with a later age 
of diagnosis (Hadjivassiliou et al, 1998), but CD is also widespread among children with 
neurological dysfunction (Salur et al., 2000). The atypical aetiology or inadequate response (pre-CD 
diagnosis) of these conditions to standard medical interventions may lead to further investigations 
that uncover underlying gluten sensitivity. At different centres in a small number of countries, 
including Sweden, Finland, Italy and Ireland, routine screening for CD in high-risk paediatric and 
adult groups is increasingly occurring. 
The "experience [of] miscarriage or an unfavourable outcome of pregnancy" occurs in up to half 
of untreated women with CD, but "no excess of unfavourable outcomes are observed" after 6-12 
months ofthe GFD (Martinelli et al, 2000, p. 332). These authors showed CD is more common than 
most diseases for which pregnant women are routinely screened, affecting 1.4% of their group. They 
demonstrated that many ofthe avoidable outcomes of untreated CD in pregnancy (including a 
nine-fold increased risk of miscarriage and low birth weight) are reversible following timely diagnosis 
and GFD treatment, supporting suggestions of CD screening during pregnancy (Greco, 2001). 
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Associated Health Problems 
The list of physical health problems often comorbid, or significantly associated, with CD is 
extensive (James & Scott, 2001). These may result from the chronic or acute effects of malnutrition 
due to malabsorption in CD, covalent genetic underpinnings, or the direct and remote immunological 
sequelae cognate to gluten ingestion (see Maki, Collin, & Visakorpi, 1997). Patent or implicit 
haematological, osteological, endocrinological or dermatological signs are commonplace. 
Hyposplenism, indicated by Howell-Jolly bodies on a blood film, is not uncommon in CD (Duggan, 
1997; Selby, 2001) and frequently persists despite gluten withdrawal" (Barr et al., 1993). Conditions 
that Fasano and Catassi (2001) noted as possibly gluten-dependent include autoimmune hepatitis 
(Sjoberg et al., 1997), Addison's disease (in case reports; e.g., Collin & Maki, 1994) and Sjogren's 
syndrome, which affects 3-5% of adult CD patients in Tampere, Finland (Collin & Kaukinen, 1998) 
Immunoglobulin A (IgA) deficiency, not in itself harmful, is a gluten independent association that 
affects about one in thirty people with CD (Cataldo, Marino, Ventura, Bottaro, & Corrazza, 1998) and 
invalidates serological testing using IgA antigliadin (AGA) and antiendomysium antibodies (EMAs) 
as markers for CD, generating false negatives (Prasad, Thomas, Nicholas, Sharer, & Snook, 2001). 
An increased duration of gluten exposure is connected with a correspondingly enhanced risk 
of other autoimmune diseases in CD (Ventura, Magazzu, & Greco, 1999). It has been proposed that 
increased age at CD diagnosis, as well as gluten exposure per se, may partly explain this observation 
(Sategna Guidetti, Solerio, Scaglione, Aimo, & Mengozzi, 2001). Ebbs et al. (1950) noticed an 
increased incidence of diabetes mellitus in CD - a finding since confirmed (Cronin & Shanahan, 
1997). Recently, people with insulin-dependent diabetes mellitus were found to be about twenty 
times more likely to have or develop CD, with a 6.2% overall prevalence of biopsy-confirmed CD 
in a northern Italian cohort of children and adolescents with type-1 diabetes (Barera et al., 2002). 
The major gluten independent condition associated with CD - or vice versa - is Down's syndrome 
(Zubillaga, Vitoria, Arrieta, Echaniz, & Garcia-Masdevall, 1993), but the reasons "remain 
unexplained" (Hill, Fasano, Schwartz, Counts, Glock, & Horvarth, 2000, p. 89). In an Australian 
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institutionalised Down's syndrome adult group, C D prevalence was increased more than one hundred-
fold (Gale, Wimalaratna, Brotodiharjo, & Duggan, 1997; see also Carlsson et al., 1998). Book et al 
(2001) recently recommended that children with Down's syndrome be screened for CD, after also 
finding an increased prevalence in a Utah-based, United States Caucasian population. 
An interesting question is the overall association, if any, between CD and cardiovascular health. 
Correlates of potential atherosclerosis have been investigated in CD (e.g., elevated homocysteine; 
Hallert, Lilliecreutz, Fridell, & Grant, 1999). Banco (2000) noted that "heart disease (10.83%) was 
twice as prevalent as [in] the general population" (p. S28) in an international survey of 835 people 
with CD. Prati et al. (2002), who investigated "a possible link between CD and dilated cardio-
myopathy" found that end-stage heart failure patients "are at increased risk for CD as compared to 
the general population" (p. 39). Conversely, in a longitudinal study of dermatitis herpetiformis 
patients, "mortality from ischaemic heart disease was significantly below national rates.. and was 
similar in patients who had followed a [GFD] and those who had not" (Swerdlow, Whittaker, 
Carpenter, & English, 1993, p. 140). West et al. (2002) actually found "a favourable cardiovascular 
profile which is likely to afford substantial protection from ischaemic heart disease and stroke" (p. 
A18), in middle-aged English people with undetected CD identified via serological screening. These 
authors highlighted a common finding of hypocholesterolemia in newly identified CD. Could it be 
that a malabsorption of lipids and iron, in untreated CD, guards against an inordinately high intake 
of saturated (and trans) fat, as previously alluded (Whorwell, Alderson, Foster, & Wright, 
1976), and, perhaps, a tendency towards iron overload in the modern diet? 
One ofthe most disturbing complications of undetected or poorly managed CD, regardless of 
other symptoms or presenting features, is an increased risk of intestinal lymphoma, which is partly 
responsible for a two-fold overall increase in mortality in CD (Logan, Rifkind, Turner, & 
Ferguson, 1989). This outcome was essentially replicated by the Club del Tenue Study Group 
(2001), but - in terms of pattern of clinical presentation - only found to apply to CD patients with 
GI symptomatology at diagnosis, as opposed to those detected with minor symptoms or via 
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antibody screening. Whilst malignancies have been previously reported in at least one in ten adult 
CD patients (Harris, Cooke, Thompson, & Waterhouse, 1967), strict GFD adherence sustained 
from childhood reduces risk to a level comparable with the general population (Logan et al., 
1989). Poor compliance and delay in diagnosis significantly increases mortality, with non-
Hodgkin lymphoma the main cause of death (Club del Tenue Study Group, 2001). 
In patients adhering to the dietary restrictions, BMD may eventually reach the level of 
healthy controls, with significant increases in the first year of treatment (see Valdimarsson, Toss, 
Ross, Lofrnan, & Strom, 1994), but this not a universal finding (McFarlane, Bhalla, Reeves, Morgan, 
& Robertson, 1995). Half of McFarlane et al.'s (1995) treated adult patients had osteoporosis (see also 
Scott, Gaywood, & Scott, 2000, for a detailed review of guidelines for osteoporosis in CD). Indeed, 
GFD treatment was insufficient to resolve osteopaenia in Turkish children with CD one year post-
diagnosis (Kalayci, Kansu, Girgin, Kucuk, & Aras, 2001), or bone size in asymptomatic Hungarian 
children and adolescents many years after commencement of a GFD (Szathmari et al, 2001). Adult-
detected patients have even less of an opportunity to overcome low peak bone mass. 
A problem in symptomless CD detected via screening protocols is that the likelihood of 
compliance "with a very restricted lifelong diet in the hope of avoiding a distant complication defies 
logic" (Duggan, 1997, p. 315). Similar observations of adherence to treatment being centred on the 
existence of current symptoms or regimen difficulty, rather than long-term benefits, have been noted 
in diabetes (Jacobsen, de Groot, & Samson, 1995). In many serious and sometimes irreversible CD-
related complications, such as osteoporosis or lymphoma, there may be few, if any, noticeable 
symptoms of these diseases until the advanced stages. 
Diagnosis and Screening for Coeliac Disease 
None ofthe clinical features, archetypal abnormalities ofthe duodenojejunal junction ofthe 
small bowel or problems of malabsorption in CD are unique to this illness (Pham & Barr, 1996; 
Ryan, 2000), as alluded earlier. Other clinical conditions sharing the histological changes seen in CD 
include eosinophilic enteritis, Crohn's disease, cow's milk protein intolerance, tropical sprue, bacterial 
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overgrowth, infection with Giardia lamblia and kwashiorkor (Barr et al., 1993; Troncone, Maurano, 
Iovine, Petrone, & Paparo, 1998). Furthermore, "one form of intestinal malabsorption does not rule 
out another" (Hallert, 1984, p. 98). Clear evidence of gluten intolerance, with documentation of a 
clinical response to gluten withdrawal, has therefore remained a primary consideration following 
Dicke's (1950) observations (Anderson, 1953; Barr et al., 1993; Walker-Smith, 1997). 
A 1969 meeting ofthe European Society of Paediatric Gastroenterology, Hepatology, and 
Nutrition (ESPGHAN) in Interlaken, Switzerland, universally established the criteria required for 
the definition and diagnosis of CD (Meeuwisse, 1970), A series of small intestinal biopsies7 
to establish evidence of gluten-induced damage in the presence of GI elimination and mucosal re-
injury after a gluten "challenge" (and reappearance of CD symptoms) represented the exhaustive 
(and invasive) process of CD identification. At the first international CD conference in London 
that year, only the first two steps were deemed essential (Walker-Smith, 1997). The third phase 
involving the gluten challenge was questioned, given the increasing acceptance of CD as a 
permanent condition, and practical considerations regarding tracking patients and implementing 
the gluten challenge. Nevertheless, the three-stage ESPGHAN or Interlaken criteria, for definitive 
CD confirmation, changed little for the next two decades (Marsh, 1995). 
The gluten-dependant mucosal damage, resolution upon dietary exclusion and, preferably, 
demonstration of disease permanence via histological relapse after gluten exposure, were accepted 
as key steps in diagnosis. Although diagnoses continued to be precipitated by the recognition of 
classic CD signs and symptoms observed to resolve after dietary treatment, the clinical criteria 
became vestigial or even redundant in many cases, as the proportion of identified subclinical or 
oligosymptomatic cases rose with advances in screening technology and interpretation. 
Use of increasingly reliable and accurate serological (blood) testing techniques resulted in greater 
detection of CD, as well as influencing assessment protocols, with a progressive simplification ofthe 
7
 The biopsy involves taking a sample of tissue from the lining ofthe small intestine, normally the duodenum, 
using a gastroscope, fed mechanically from the mouth into the bowel of a conscious or sedated patient The bioptic 
procedure may be called a "gastroscopy", "upper GI endoscopy" (UGIE) or "esophagogastroduodenoscopy" (EGD) 
Psychological Sequelae in C D 19 
diagnostic guidelines in the preceding decade (see Walker-Smith, 1997). In 1990 the E S P G H A N 
criteria were revised, with a good clinical response to the GFD confirmatory given a clinical 
presentation, serological screening profile and histological findings compatible with CD from the 
outset (Walker-Smith et al., 1990). A repeat, control biopsy, to confirm histological resolution after 
dietary intervention, was determined to be requisite only in the event of an equivocal clinical 
response to the GFD or in patients symptom-free at diagnosis, often the case in identification via 
screening (Fasano & Catassi, 2001). Various grades of intestinal lesions were acknowledged as 
possibly indicative of CD, from patchy and partial epithelial damage to total villous atrophy. The 
gluten challenge, with bioptic evidence of histological relapse - also no longer considered mandatory 
- was reserved for cases involving doubt about the initial diagnosis. These include instances in which 
an initial biopsy specimen is atypical of CD, otherwise inadequate or was not performed at the time 
of diagnosis (Troncone et al., 1998). Other circumstances in which a gluten challenge is 
recommended include diagnoses made prior to the age of two years, or when the possibility, or 
suspicion, of a differential diagnosis may be heightened (e.g., in communities with a high incidence 
of other causes of enteropathy; Troncone et al., 1998). A planned gluten challenge may also be 
useful in the event that an adolescent intends to depart from the GFD (Walker-Smith, 1997). 
The present day gold standard of CD diagnosis "remains histologic confirmation ofthe intestinal 
damage in serologically positive individuals" (Fasano & Catassi, 2001, p. 636). Even so, serological 
screening devices available to the general practitioner are becoming very reliable in identifying 
clinically suspected CD and diagnostic tests are imminent (e.g., Baldas et al.'s (2000) highly accurate 
dot blot assay). With each passing year, the zero biopsy goal envisaged by Schmitz (1997) inevitably 
moves closer to reality. For the time being, use of combinations of assays, including the highly 
specific AGA IgA and very sensitive AGA IgG, plus the antiendomysium antibody (AEA, or its 
antigen tTG) results in excellent positive and negative predictive value for identifying CD, particularly 
in high risk groups, but is in reality limited by a range of clinical, practical, interpretative and cost 
considerations, outlined in detail by Fasano & Catassi (2001). Those authors reviewed current 
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diagnostic protocols and outlined an "algorithm for the definitive diagnosis of C D " (p. 644) in 
reference to ESPAGHN criteria (Walker-Smith, et al., 1990). In biopsy-proven cases, serological 
testing may provide useful collateral information in monitoring compliance with the GFD (Valletta & 
Mastella, 1990) and, of course, "is often crucial for how far an investigation [of CD] is pursued" in 
the first place (Ludvigsson, Falth-Magnusson, & Ludvigsson, 2001, p. 1279). 
Since strict, lifetime avoidance of all gluten containing foods represents a lifestyle alteration 
involving considerable sacrifice for the patient, false-positive CD diagnoses, albeit uncommon, must 
be minimised via bioptic confirmation of intestinal damage in serologically positive cases. 
Conversely, a serious consequence of under diagnosing a genuine case of CD by forgoing bioptic 
testing is that the level of GFD compliance is likely to be diminished. Realistically, "the picture of a 
damaged intestine" (Fasano, 1997, p. 7) is likely to project a greater impression on a CD patient of 
the seriousness of their illness, and importance of following the GFD, than a less-invasive serological 
procedure, especially in people who are relatively asymptomatic. 
People suspected of having a gluten intolerance, but who have not been definitively assessed, are 
strongly advised against self-trialling a GFD (Barr et al. 1993; Kaukinen et al., 2000; Selby, 2001), as 
suggested in some otherwise useful books advocating rotation or elimination diets (e.g., Buist, 1990; 
Savill & Hamilton, 2001). Transitory or ongoing wheat sensitivities and other cereal or otherwise 
dietary-related intolerances may exist (Selby & Faulkner-Hogg, 1998; Kaukinen et al., 2000), as do 
alternative reasons for reducing or avoiding gluten-containing foodstuffs (e.g., CD-like, or irritable 
bowel, symptoms, due to wheat starch fermentation in the gut). A food additive commonly used as a 
mould inhibitor in bread (calcium propionate) has also recently been linked to irritability in Australian 
children, most of whom had attention-deficit hyperactivity disorder (ADHD)-type behaviours (Dengate, 
2002). However, the GFD is an absolute medical necessity for people after confirmation of CD. As 
noted in a Gluten-Free Living guide (1999), "gluten sensitivity is not a casual diagnosis". Serological 
tests for CD may be invalidated by pre-test avoidance of gluten (Selby, 2001). Murray (1999) noted 
that "both the general public and practitioners of alternative medicine commonly ascribe a vast 
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collection of ill effects to dietary gluten and prescribe wheat-free or gluten-free diets for many 
complaints without any attempt to confirm the existence of celiac disease or even without an awareness 
ofthe disease", which "can lead to diagnostic difficulties" (p. 356). Given the lifelong implications 
of CD and following the GFD, it is crucial to determine whether CD or another condition is the 
underlying health problem and, by corollary, to be certain that strict adoption ofthe GFD is necessary. 
In Australia, Victorian Coeliac Society support centre staff are periodically contacted by 
confused, ostensibly newly diagnosed CD patients who have, "on their own initiative" (Ryan, 2000, 
p. 836), or encouraged by health care professionals - sometimes their general, or alternative, health 
practitioner - to "trial" a "low or no gluten diet" (without a preceding biopsy; Ryan, p. 836) and 
judge for themselves if they feel better. Referral to a gastroenterologist for upper GI endoscopy or 
even serologic testing may not have occurred, a fear also expressed elsewhere (Green, 1998). Parents 
of children with CD have also reported receiving medical opinion that their children will probably 
"grow out of it [CD]" by adolescence or adulthood, based on previous observations of spontaneous 
clinical remission prior to the use ofthe GFD (Sheldon, 1959) and histological recovery upon a 
gluten challenge (e.g., Schmitz, Jos, & Rey, 1978; see also McNeish, 1980). 
A very small percentage of health care professionals may even doubt that CD is a legitimate 
medical condition, with some still expressing scepticism that certain foodstuffs are a legitimate and 
documented etiological factor in physical illnesses in the absence of classic allergic mechanisms. 
Others perhaps regard the GFD as a fad, still perceive the illness due to CD as a "transient" food 
intolerance (see Berg & Lindberg, 1979), or rely on outdated medical information, which in past 
decades has catalogued genuine cases of CD to be a rare intestinal disease confined to childhood, as 
reported by Visakorpi (1992, 1997). Poor knowledge of CD among family doctors has also been noted 
previously in Italy (Catassi, 1997), where CD awareness is relatively high. Certainly, the "limited 
expertise of health care professionals regarding the celiac diet and absence of federal regulations [in 
the United States and other countries] for accurate food and drug labelling both represent significant 
challenges for patients with newly diagnosed CD" (Fasano & Catassi, 2001, p. 647). 
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A 1995 survey of 1,887 Australian Coeliac Society members (out of a total national membership 
at that time of about 5,000), declaring themselves to have medically diagnosed CD (Stuart, 1997a 
and 1997b; see also Stuart, Faulkner-Hogg, Selby, & Loblay, 1997), revealed that 92% of 
respondents had been referred for and undertaken at least one small bowel biopsy to confirm the 
diagnosis, but 8% had not. Of those having a small bowel biopsy, 58% had only one biopsy (which, 
as mentioned, is now often regarded as adequate), 31% had two and 11% had three (or more) over 
time. Ofthe 8% (i.e., 151 people) surveyed who were not biopsy-confirmed only 39% had actually 
undertaken serologic testing. It is conceivable that people who are proactive about their illness - in 
becoming members of self-help or support associations (such as the Coeliac Society) - might be 
over-representative ofthe proportion of people with CD community-wide who have been diagnosed 
according to the gold standard, inclusive at least one biopsy. 
Given that nearly 90% of Australians see a general practitioner at least once a year (Harris & 
Penrose-Wall, 2001), a unique opportunity for early intervention exists in general practice to facilitate 
investigation of many common, under-recognized conditions, including CD, a point stressed by 
Ventura et al. (2001). The high prevalence of CD now verified in an Australian population-based 
study (Hovell et al., 2001) and the frequent non-specificity of symptoms in CD detected locally, akin 
to the worldwide experience, presents a persuading case for wider screening of CD. 
In a Melbourne-based study, Ryan (2001) demonstrated that about 5% (5 in 97) of patients 
undergoing gastroscopy had CD, but none ofthe patients presenting with diarrhoea and only one of six 
with anaemia had CD, showing that restricting biopsy to this group would have missed most patients 
with CD. He recently suggested that "people presenting for gastroscopy represent a high-yield group 
for histological screening for CD in Australia" (Ryan, 2002, p. 298), arguing the case for routine 
duodenal biopsy at the time of gastroscopy, regardless ofthe indication. Differential diagnoses to CD, 
not mentioned earlier, also include lactase deficiency or cystic fibrosis in children and irritable bowel 
syndrome, pancreatic insufficiency or GI blood loss in adults (Selby & Faulkner-Hogg, 1998). 
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Epidemiology of Coeliac Disease Since 1950 
Many health care professionals in Australia and North America may be unfamiliar with CD, but 
the illness is now recognized as the "second most common chronic disorder of children" in Sweden 
(Popat et al., 2002b, p. 28) and "one ofthe commonest lifelong disorders in Italy" (Catassi et al., 
1996; Parnell & Ciclitira, 1999, p. 2), if not the Western world, in adults and children (Catassi et al, 
2002; Catassi & Fasano, 2002). However, this has been a relatively recent acknowledgement. Prior 
to the identification of gluten as the causative environmental factor in CD, few paediatric cases 
survived infancy, often succumbing in early childhood due to a combination of nutritive factors (i.e., 
uncorrected malabsorption plus general under-nutrition as a result of poverty) and reduced 
resistance to a variety of other illnesses, including concomitant GI infections (Greco, 1997). 
Contemporaneous with Dicke's identification ofthe toxicity of certain farinaceous elements in 
CD, the cumulative incidence of "sprue syndrome" was estimated to range from one in four to 
eight thousand in the United Kingdom (Davidson & Fountain, 1950). Despite the advent of simple 
devices enabling intestinal biopsy soon afterwards, CD was regarded as a relatively rare condition 
originating in infancy or early childhood for the best part ofthe succeeding two decades, with 
detection based on classic GI symptoms. Green and Wollaeger (1960) noted that only 4% of new 
CD diagnoses in the United States at that time were made in patients aged over sixty years. 
During the 1960s in Finland, around eight or nine out of each ten new CD cases were diagnosed 
in infants below the age two years, with a mean age often months (Maki, 1998). Gluten had, on 
average, been introduced just over four months before the onset of symptoms. The development of 
more sophisticated diagnostic techniques in that period was accompanied by increased awareness 
of CD among gastroenterologists, as well as paediatricians. A study reporting a relatively high CD 
incidence of one in six hundred people in Ireland (Mylotte, Egan-Mitchell, McCarthy, & 
McNicholl, 1973) three decades ago sparked an explosion of interest in the true incidence and 
prevalence of CD throughout Europe, which was found to be higher than previously believed. 
Paradoxically, increased CD awareness, contributing to the practice of delaying gluten exposure 
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after weaning in the belief that sensitivity to gluten may not develop, was sequelled by a real decrease 
in the incidence of childhood CD. This trend was documented in Britain (Littlewood, Crollick, & 
Richards, 1980) and Ireland over a twenty year period, beginning in the early-mid 1970s (Gumaa, 
McNicholl, Egan-Mitchell, Connolly, & Loftus, 1997). On the other hand, the childhood CD 
incidence remained constant, then increased in the Netherlands (George et al, 1997) and Sweden 
(Hallert, 1998) in the 1980s. This phenomenon was attributed to a slight postponement of gluten 
introduction (Cavell, 1992), with reduced onset of illness in infancy, offset by a minor drift upwards 
in age at diagnosis. Greater awareness of CD by paediatricians and general practitioners and the 
advent of more sensitive serological screening were other contributing factors, increasing the 
likelihood of diagnosis at any time in childhood (Hallert, 1998). 
Compared to neighbouring Nordic countries, the incidence of CD recorded in Danish children 
has been very low, at about one in 10,000 between 1962 and 1987 (Weile & Krasilnikoff, 1992, 
1993). Although retrospective reviews of clinical diagnoses, as well as the national diagnostic 
register were used, these figures were still much lower than Europe in general. Of significance, 
Danish children are introduced gradually and comparatively late in infancy to much smaller amounts 
of gluten than Swedish children. At the age of nine months Swedish children were reported to have 
an intake of 50.6 g wheat/ day compared to only 7.9 g wheat/ day for Danish infants (Michaelsen, 
Weile, Larsen, Samuelsson, & Krasilnikoff, 1993). Interestingly, the adult prevalence of CD in 
Denmark of about 0.2% approaches that seen in neighbouring countries (Sjoberg & Eriksson, 1999). 
Modified infant feeding practices, as well as a greater appreciation and detection of clinically 
silent, oligosymptomatic or atypical cases (Tursi et al, 2001), especially in later life, has led to a much 
higher estimate ofthe overall prevalence of CD in the preceding decade or so. Catassi (1997) noted 
that the first reported community screening study of CD (undertaken by Hed et al., 1986) was 
apparently overlooked for several years. This investigation showed a 1 in 256 prevalence of un-
diagnosed CD, based on serological markers, among Swedish blood donors. Other population-based 
screening studies in the preceding two decades verified that the overall CD prevalence was at least one 
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in several hundred in Scotland (Logan, Rifkind, Busutti, Gilmour, & Ferguson, 1989), Denmark 
(Weile et al, 1996) and Norway (Hovdenak et al, 1996, 1999), and as high as 1:130 in Finland 
(Kolho, Farkkila, & Savilahti, 1998). The prevalence of CD in a large, recent series of healthy 2.5 
year old Swedish children was 1.3%, but if the already known cases of symptomatic, biopsy-verified 
CD in that birth cohort were added, the prevalence reached 2% (i.e., 1 in 50). Following a large scale 
multi-centre collaborative study, CD prevalence in Italy was determined to be 1 in 184 (Catassi, 1997), 
with a ratio of known to undiagnosed CD cases of 1 to 7. This determination, and others according 
similar estimates, are based on comparisons between the number of actual CD diagnoses in given 
geographic areas versus research-based screening data pertaining to the general local population. 
The iceberg model (Logan, 1992; see also Catassi et al, 1994; Fasano & Catassi, 2001, and 
Figure 2; a representation courtesy of Maki & Collin, 1997, reprinted on next page) is a useful way 
of conceptualising the varying CD prevalence rates temporally and geographically, obtained by a 
variety of methodologies. In this model, the total coeliac population may be conceptualised as a 
floating iceberg, in which the visible portion represents the known or detected CD cases at any given 
time point, The submerged part depicts unrecognised CD, with the undiagnosed cases (typically 
silent or asymptomatic) just below the surface. Latent or potential cases complete the iceberg 
(Ferguson, Arranz, & O'Mahoney, 1993). Latent CD refers to either "existing but not manifest" 
illness (Holm, 1998, p. 19), including a pre-biopsy CD history or ".. .the situation where serology is 
positive but biopsy [is] negative" (Ryan, 2000, p. 836), in which case "some but probably not all of 
these individuals will develop clinical [CD]" (p. 836). Potential CD may be considered either 
synonymous with CD latency, or inclusive of a larger population pool with any abeyant markers or 
even correlates of illness. At one extreme this may extend to all people with predisposing genotypes, 
involving up to one in five people of European heritage, most of whom will never develop CD 
(Holmes, 2001). The overall size ofthe iceberg is dependent primarily on genetic susceptibility (not 
unknown in Mongoloid/Negroid races, but consistently higher in Caucasians; Pham & Barr, 1996), 
and the definitional threshold of CD, given the enormous continuum of histologic, immunologic 
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Figure 2: The coeliac iceberg and spectrum of gluten sensitivity 
(representation courtesy of Maki and Collin, 1997) 
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and clinical heterogeneity and severity observed. 
At what point the CD iceberg floats above or lies below the waterline is influenced by 
numerous factors. These include average gluten intake (which is highest, with wheat intake, in 
latitudes remote from the equator), CD awareness (public and professional) and the quality and 
accessibility of medical care generally and CD diagnostic facilities in particular, including the 
sensitivity of serological markers, assay methods, cut-off values and interpretation (Catassi, 1997). 
In Western countries the visible part ofthe iceberg (i.e., clinically diagnosed cases) is by and large 
five to ten times smaller than the submerged portion (Fasano & Catassi, 2001), as revealed by 
prevalence studies entailing current diagnostic procedures and representative samples from the 
general population. In incidence studies, the age sampled and historical and regional context are 
also highly relevant, as demonstrated by the Nordic experience. 
Finally, the population sampling method utilised is germane to the evident prevalence. 
For instance, the use of blood donors is a convenient way to mass screen for CD with sensitive 
serological markers. However, blood donors actually represent a selected, relatively healthy subgroup 
from the general population, from which people with a range of symptoms of ill health, deficiency 
states or CD-related conditions (e.g., anaemia, very common in untreated CD) are not permitted to 
give blood (Australian Red Cross Blood Service, 2002). In Australia, an increasingly restrictive 
screening protocol, involving detailed interviewing, pre-donation finger-prick haemoglobin testing 
(entailing strict cut-criteria) and post-donation testing, is used in selection. Although one's exclusion 
as a blood donor may not be indefinite, records of volunteers are kept and the resolution of health 
issues, with medical clearances, is a pre-condition of future donating. A net result is that many people, 
for the sake their own - as well as blood recipients' - health, are discouraged or barred from ongoing 
blood donation. It is conceivable that people with untreated CD, who are more likely to have a range 
of health problems, may be less likely to initially present to make blood donations. 
Of people already diagnosed with CD (some of whom may be detected as a direct consequence 
of being initially barred from donating due to anaemia), serological testing for CD becomes negative 
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with strict adherence to the G F D . In addition, only 3 % ofthe Australian population are regular donors 
(Australian Red Cross Blood Service, 2002) and a higher proportion of males donate blood, but a 
greater proportion of women usually have CD (Sjoberg & Eriksson, 1999). Overall, notwithstanding 
the imposition of stricter exclusionary criteria in recent years and variations in restrictions pertaining 
to different countries, it appears prevalence rates based on blood donors, whilst useful, are likely to 
significantly underestimate CD prevalence, or yield minimal to lower limits. 
In Australia, a reported CD prevalence of one in 2,900 (Porter & Duggan, 1990), based on 
clinical diagnosis, has been superseded by a recent study which retrospectively analysed stored serum 
samples from 3,011 participants from the Busselton health study (Hovell et al, 2001), then tracked 
serologically positive individuals. Seven (out often) participants who were IgA and AEA positive 
had bioptic results compatible with CD, with three not tested (one subject had died, another could not 
be traced and a third refused small-bowel biopsy). Two other participants already had a CD diagnosis, 
resulting in a prevalence of 1 in 251 if all ten AEA-positive participants are included. 
Used as a rough guide, this prevalence figure, if extrapolated to the Australian population of 19.5 
million (ABS, 2002), would suggest that there are in the order of 80,000 Australians with CD. The 
latter, hypothetical number is obviously greatly in excess of approximately 8,000 current members of 
the Australian Coeliac Society who are medically diagnosed CD patients (G. Price, personal 
communication, July 9, 2002), even acknowledging that about one third of members fail to renew their 
annual membership. Propinquity regarding national CD association membership numbers in relation 
to the total population and the estimated prevalence of CD, are observed elsewhere in the world, 
including New Zealand8 (with analogous circumstances and food labelling laws to Australia), and, to 
a lesser degree, the United Kingdom9. 
Coeliac Society membership in New Zealand, a country in which gluten-free food is partly government subsidised, 
numbers approximately 2,000 (C. Chambers, personal communication, May 21, 2002) in a population of just under 4 
million 03runner, 2002), an equivalent membership rate to neighbour, Australia, on a per capita basis. 
The United Kingdom national membership of just over 50,000 (J. Willis, personal communication, June 5,2002), in 
a nation of about 60 million people QBrunner, 2002), is somewhat higher per head of population. 
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Australian Coeliac Society membership has grown more than five-fold since 1990, with steady 
increases recently replacing the rapid growth previously observed. A plateau in new monthly 
membership figures, presently hovering at around 200 nationally (D. Baker, personal communication, 
May 20, 2002), has been counterbalanced by slightly increased annual retention, perhaps reflective of 
an ever-increasing and up-to-date range of resources provided by local state coeliac Societies. 
Future medical screening for CD, as part ofthe management of very common, but often 
obstinate, health problems associated with the illness (e.g., reduced bone density, depression, 
reproductive disorders and type-1 diabetes mellitus), would involve millions of Australians (Wall, 
Wood, & Holman, 1999), but probably lead to vastly improved health in at least tens of thousands, if 
the Australian CD prevalence is comparable to Europe's, as appears likely. There is also an 
increasing recognition and prioritisation, by the Australian federal and state governments, of disease 
entities associated with the greatest overall community morbidity (e.g., diabetes, musculoskeletal 
problems and depression), and calls to identify underlying causes and associations (Wall, Wood, & 
Holman, 1999). Clearly, CD - as one potential underlying factor or condition associated with all of 
these common health problems - appears to be a prime candidate for future inclusion. 
Recent estimates ofthe true CD prevalence have converged on an upper figure of about 1% of 
the general population (Cook, Burt, Collett, Whitehead, Frampton, & Chapman, 2000; see also Fasano 
& Catassi, 2001; Greco, 1997). Prevalence rates of this magnitude, let alone smaller ones, require large 
population samples to give stable and reliable results (Catassi, 1997; Karvonen, 2000). However, firm 
evidence in support of this figure is accumulating. In two separate Italian studies, biopsy-proven CD 
prevalence in Sardinian children was ascertained. For 6-14 year olds, this figure was determined to be 
at least 1.1% (Meloni et al, 1999) and, in those aged 11-15 years, 0.86-0.91%, if a repeatedly AEA-
positive subject with normal mucosal architecture was included (Catassi et al, 2000). The prevalence 
of CD in the United States, where the disorder was previously believed to be rare, has been found to 
be as high as in the Caucasian European general population, at 0.9% in adults and 0.6% in children, 
with the CD prevalence in various risk groups also similar (Gerarduzzi et al, 2000). 
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In Northern Ireland, serological screening of a randomly selected adult population of 1,823 (not 
blood donors) led to a biopsy-proven prevalence of at least 0.8%, of which only two of fifteen detected 
CD cases had been previously diagnosed (Johnston, Watson, McMillan, Sloan, & Love, 1997). Sanders 
et al. (2002) found 12 new biopsy-proven cases in a sample of 1200 volunteers from five general 
practices in South Yorkshire, the "first study to establish the prevalence of undiagnosed CD in 
a general population from England" (p. A18). Prevalence rates close to 0.8% in Finland and 1-2% in 
Sweden (as noted), 0.6% and 1.2% respectively in Argentina (Gomez et al, 2001) and New Zealand 
(Cook et al, 2000) have also been documented. Applied to the Australian population, a 1% CD 
prevalence would increase the aforementioned estimate of 80,000 people to almost 200,000. 
A prevailing belief that CD was rare in the United States was questioned in the preceding decade 
(Fasano, 1996). In fact, CD "... may be as common as in Europe" (Hill et al, 2000, p. 86), as 
demonstrated by ongoing, multi-centre, epidemiological US research. Gerarduzzi et al. (2000) found 
a CD prevalence of 1:167 and 1:111 in healthy children and adults respectively and 1:30/ 
40 in symptomatic children/ adults. 
Of major significance, the prevalence of IgA-AEA positivity found in 989 Arab Saharawi children 
in Northern Africa is at least five-fold higher than in European populations (Catassi et al, 1999). 
These authors also found that serum IgA-AEA positivity appeared to be a very reliable marker of 
biopsy-confirmed CD in this group. Further evidence of its specificity in children with chronic 
malnutrition and diarrhoea has been demonstrated (Gandolfi et al, 2001). Catassi (2001) proposed 
that the high prevalence of CD in the Saharawi children may be due to a protective role ofthe coeliac 
enteropathy against intestinal infections in the context of both low gluten intake and poor sanitary 
conditions in that region. This possibility is reminiscent of West et al's (2002) favourable 
cardiovascular profile in screening-detected, untreated CD. The notion of CD conferring one or more 
selective advantages in certain environments may help to explain its persistence in European 
populations, given the conjoint circumstances of limited control of sanitation and a much lower 
comparative gluten intake relatively recently in human history. 
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Demographic Findings: A g e and Gender 
The median age at CD diagnosis is rising worldwide as CD awareness increases, screening 
methods become more accurate and widely used and minimal-symptomatic CD cases are recognised, 
especially later in life (Barr & Grehan, 1998; Beaumont & Mian, 1998). Previous researchers have 
demonstrated a bimodal peak for age at diagnosis in adults, with the first crest in the fourth decade 
(mainly in women) and a later one in the sixth and seventh decades, principally in males (Swinson & 
Levi, 1980). Although these trends may not be universal, middle-aged adults in the 45 to 54 age 
bracket were the highest-prevalence subgroup in a comprehensive Swedish series aged greater than 
15 years, with one quarter detected due to coexisting dermatitis herpetiformis and over one third 
having a history of childhood CD symptoms (Hallert, Gotthard, Norrby, & Walan, 1981). Similarly, 
in Hovell et al's (2001) Australian epidemiological study there was significant clustering of CD 
cases in the 30 to 50 year age range. 
Where CD awareness is relatively high and active case finding is increasingly applied (e.g., Italy, 
Sweden, Finland, Norway and Britain/ Ireland), CD detection is generally amplified across most age 
groups, irrespective of disease severity. Therefore, the age at diagnosis for a person having CD in 
these countries may be expected to be lower than elsewhere. However, a lower anticipated mean age 
at diagnosis in the overall population is counterpoised by the soaring rate of middle-aged to elderly 
adult cases systematically unearthed, many of whom are oligosymptomatic, or unresponsive to 
treatment for any ofthe wide range of related illnesses aforementioned. Many researchers have 
touched on or explored these trends (see Ascher, 1997; Catassi, 1997, Ciclitira, 2001; Cooke & 
Holmes, 1984; Hallert, 1998; Kelly, Phillips, Elliot, Dias, & Walker-Smith, 1989, Maki et al, 
1998, Maki & Collin, 1997, and Visakorpi, 1997). 
No gender-related genetic differences in people diagnosed with CD have been identified to date, 
but women typically make up a greater percentage of identified CD cases in adult series (e.g., Corrao 
et al., 1996). In children, the ratio is usually closer to unity (McConnell, 1981; cited in Logan, Tucker, 
Psychological Sequelae in C D 
Rifkind, & Heading, 1983). T w o of three C D patients in a population-based Spanish study were 
female, which the authors ascribed "to a greater genetic risk of immunologic disease" in women 
(Riestra, Fernandez, Rodrigo, Garcia, & Ocio, 2000, p. 401). The consistent inter-study finding is that 
about two (and up to three) times as many females as males are diagnosed with CD in adulthood 
(Beaumont & Mian, 1998; Collin, Reunala, et al, 1997), with the ratio ranging from IT to 2.8:1 (Bode 
& Gudmand-Fteyer, 1996). These findings are mostly attributable to women being more susceptible 
to, or likely to be investigated for, a number of medical conditions that are CD-related, such as 
anaemia (with amenorrhoea uniquely affecting women), osteoporosis and mood disorders (including 
depression), as well as the increased frequency of females visiting doctors (Wright, 1995). Ciacci, 
Cirillo, Sollazzo, Savino, Sabbatini, and Mazzacca (1995) examined the relationship between gender 
and clinical presentation in adult celiac disease. Unsurprisingly, females outnumber males in Coeliac 
Society membership figures worldwide, with a ratio of 2:1 noted in the United Kingdom (McConnell, 
1981; cited in Logan et al, 1983). Females comprised three quarters of respondents in Stuart's (1997) 
survey of 1,887 Australian Coeliac Society members and the mean age overall was 48 years (range: 
3 to 89 years), with the ages of children responding via a parent included in that calculation. 
A potentially gender-related selection advantage that has been surmised to be associated with 
CD, and may partially explain the prevalence and stability of CD in modern populations, is a low 
male sex ratio in the offspring of women with CD (see Hozyasz, 2002; James, 2001). Hozyasz (2002) 
made intriguing observations of historical mechanisms that may have counterbalanced an increased 
overall morbidity and mortality in CD. These partly related to a higher proportion of female births to 
women with CD, based on the finding by Norgard, Fonager, Sorenson and Olsen (1999) that the 
male sex was proportionately lower than an expected value in a Danish cohort. 
Anecdotal observations among general practitioners, gastroenterologists and Coeliac Society 
staff in Victoria suggest that more males than females who are referred to the state support centre 
(for CD and GFD information) fail to make initial contact, or quickly lose touch with their local 
support group. Furthermore, the author's direct observations, accrued during years of involvement 
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as a Victorian Coeliac Society committee member and reinforced during the extensive interviewing 
of 110 CD patients involved in the present study, are that adult female CD patients often report 
having brothers and sons with a range of unexplained health problems, depressive symptoms or 
even classic features of CD. The males in these women's lives often refuse to be tested for CD or, 
even if diagnosed, regard the GFD as effeminate. These males are unlikely to persevere with the 
GFD consistently, if at all. This problem may be somewhat exacerbated in countries like Australia, 
where relatively high wheat and beer consumption is interwoven within the local social milieu. 
Australian males are also typically discouraged from expressing concerns about ill-health, 
contextual to a macho undercurrent which permeates an otherwise laid-back local culture that may 
not be conducive to inquisitiveness about one's health, or a resolve to follow dietary restrictions, 
Relevance of Gender to Depression in CD 
Periodically, initial calls are received at the local Coeliac Society support centre from newly 
diagnosed patients who present as severely depressed and sometimes acknowledging suicidal ideation, 
Despite the fact "psychiatric morbidity is a leading cause of disability among adult celiacs" (Hallert, 
1987, p. 127), suicidality in CD patients is only occasionally reported (e.g., Pellergrmo, 1995). Even 
so, eight cases of self-poisoning (equating to 2.1% ofthe sample) were recorded in a large British CD 
series (Holmes, 1997) and suicide was the cause of mortality in three out of twenty-three (i.e., 13% 
of) deaths recorded among 98 Danish non-tropical sprue patients diagnosed in the two decades (1964-
1982), before they were traced via the national Central Person Registrar (Nielsen et al, 1985). The 
three reasons cited were depression, severe abdominal pain and osteoporosis (due to chronic back pain/ 
steroid treatment), with various health complications noted in other surviving and deceased patients. 
In Australia, the first-time callers to the Victorian support centre mentioned above are not 
uncommonly young men who rarely call back and typically do not wish to (and cannot) be traced. 
Given that; (a) young men per se are in a very high risk category for completed suicide in Australia 
(de Looper & Bhatia, 2001) and elsewhere (Clark & Fawcett, 1992); (b) the physically ill, in general, 
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are at greater risk of suicide (Peruzzi & Bongar, 1999); (c) the baseline risk of experiencing depression 
appears to be specifically increased in CD (see Hallert, 1984, 1997); and (d) depression is possibly the 
single greatest indicator or predictor of suicide (Isometsa, Aro, Henriksson, Heikkinen, & Lonnqvist, 
1994), early psychological assessment, and intervention if required, might be especially indicated in 
some newly identified CD subgroups. These include patients expressing suicidal ideation, those 
exhibiting questionable self-care behaviours or simply low motivation, due to accompanying 
depression, or patients with reduced support and lower socio-economic status, who presumably also 
comprise a significant proportion of those least inclined to either make contact with their local CD 
support group or able to comply with the GFD. 
In people with a history of depression, the lifetime risk of suicide in untreated mood disorder 
may reach 19% (Montano, 1994). The lifetime risk in the general population for developing various 
mood disorders range from 10-25% for women and 5-10% for men (for Major Depressive Disorder; 
APA, 1994) and about 6% overall for Dysthymic Disorder (APA, 1994). As noted, there is an 
increased prevalence of both Major Depressive and Dysthymic Disorder in CD (Carta et al, 2002), 
with subclinical thyroid disease touted as "a significant risk factor" in the possibility of their 
development (p. 789). A major differential diagnosis for these two mood disorders is Mood Disorder 
Due to a General Medical Condition (APA, 1994), an entity which, intuitively, may be highly 
applicable in CD and requires closer inquiry. 
An overlap between various categories of psychiatric diagnoses is not uncommon, nor is an 
increased prevalence of other mental disorders if a mood disorder already exists (APA, 1994; Fawcett 
& Kravitz, 1983). Certainly, the issues involved in assisting people with CD to recognise, accept and/ 
or embrace their illness, and managing the emotional, technical, practical and social implications of 
the GFD, are of direct relevance to health professionals involved in their care. The extent of 
compliance with the GFD may also be pivotal upon the recognition, by gastroenterologists, general 
practitioners and dietitians, that patients require encouragement and validation of their experiences of 
the GFD, as well as factual information, clear advice and medical follow-up and monitoring. 
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Gluten-Free Dietary Treatment and Compliance 
Anderson (1960) proved that the mucosal damage in CD is reversible by adopting a GFD, 
without which "a regression of intestinal damage... is a very rare event" (Carroccio et al., 2001, 
p. 1105). Strict, lifelong GFD adherence, although challenging, is indeed the only recognised and 
effective treatment for people diagnosed with CD (Howdle, 1994). Described as "easy to prescribe 
but hard to follow" (Lohiniemi, 2001, si 4), the exclusion of gluten "induces remission but not cure" 
(Ryan, 2000, p. 835). Nutritional deficiency correction, management of decreased bone density, 
ongoing assessment for related disorders and annual follow-up (by a gastroenterologist) are other 
"mainstays of treatment" (Ryan, 2000, p. 838; see also Ciclitira, 2001). Membership of a coeliac 
association or support group is also highly recommended (Selby & Faulkner-Hogg, 1998; Fasano & 
Catassi, 2001; Ryan, 2000), since supported patients cope better and adhere more consistently with 
the dietary and lifestyle adjustments (Lohiniemi, 2001). 
The intestinal damage in CD is caused by the alcohol-soluble prolamin fraction of gluten; that is, 
gliadin in wheat, secalin in rye and hordein in barley (Wieser, 1998), with "potency proportional to 
their nitrogen content" (wheat > rye > barley; Duggan, 1997, p. 312) and the effects probably dose-
dependant (McNeish, 1980). Besides being widespread in bread, pasta and pastry products, gluten is 
undisclosed or hidden in many food additives, modified starches, stocks, thickeners, malt extracts, 
sauces and alcoholic beverages (Price, 1997; Selby & Faulkner-Hogg, 1998). Gluten may also be an 
inactive excipient in medications (Fasano & Catassi, 2001; Pham & Barr, 1996). At the lower end of 
the consumption continuum, "the relationship between the quantity of gluten ingested and the 
severity ofthe histological and clinical abnormalities in CD patients is still unclear" (Catassi et al, 
1998, p. 97). The effect of trace amounts of gluten on CD patients is subject to ongoing research 
(Selby & Faulkner-Hogg, 1998). 
In Italy, where the cost of gluten-free food for CD patients is partially covered by the national 
health care system, unintentional gluten ingestion was reported in correspondence by Ciacci and 
Mazzacca (1998). These authors noted that a single dose of 100 mg of gliadin, or even smaller 
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amounts ingested continually over a prolonged period, may damage the intestinal mucosa. They 
analysed the gliadin content of common, putatively gluten-free foods in key food groups, finding that 
6.4% of "gluten-free" foods could be potentially toxic, exceeding 30 mg of gliadin per 100 grams. 
Gluten-free flours were found to be the most suspect. 
Oats have been determined to be relatively safe for adolescents and adults with CD in the 
preceding decade (Hallert, Kilander, et al, 1999; Janatuinen et al, 2002; Lohiniemi, Maki, Kaukinen, 
Laippala, & Collin, 2000). Studies in children are lacking, but Holm, Vuolteenaho, and Maki (2000) 
reported an absence of antibody responses in 10 out of 14 children aged over seven years during a 24 
month challenge. Two children had symptoms of vomiting and diarrhoea within hours of oat 
ingestion, albeit without gut inflammation. 
St0rsrud and Lenner (2000) showed that the addition of oats to the GFD increased nutritional status 
over two years in another small, adult Swedish series, members of whom subjectively experienced a 
"tastier and more varied diet" (S19) and also improved symptomatically. However, cross-contamination 
with gluten between the harvesting and final production stage is believed to be a principal reason 
apparent sensitivities are often reported (Fasano & Catassi, 2001; Hallert, Kilander, et al, 1999). 
Unfortunately, unadulterated sources of oats are not yet available in Australia (Ryan, 2000), and have 
therefore been explicitly excluded from the local GFD by leading dietitians (Selby & Faulkner-Hogg, 
1998). Contamination, as well as secondary food intolerances, may account for the adverse effects CD 
patients sometimes report in relation to other gluten-free grains, such as quinoa and amaranth, which, 
if sourced and produced unadulterated by gliadin, are otherwise suitable, nutrient-dense options. 
Other alternatives to gluten containing grains include rice, maize (i.e., corn, or as polenta), soy, 
millet, sorghum and soba (buckwheat), chickpea, lentil (e.g., dhal), faba (or fava) bean; popular in 
the Mediterranean/ Middle and Near East, arrowroot (tapioca/ cassava), breadfruit (Artocarpus 
incisa), sago or taro flours (used throughout Oceania), and potato, almond meal, lupin, psyllium, and 
rapeseed (see also Selby & Faulkner-Hogg, 1998). Indeed, there are plentiful leguminous plants, 
pulses, starchy vegetable or tubers and grass varieties in the plant kingdom available to, or 
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potentially suitable for, people with C D . Several ofthe latter, lesser known choices, which are 
dietary staples in some Asian and Pacific regions, are gradually becoming more accessible to people 
with CD, as commercial food manufacturers worldwide recognize the specific dietary needs in CD 
A gluten-free "grainaissance", lead by Italy and the Nordic countries (see Lohiniemi, 2001) is 
increasingly palpable in Australia, where a prodigious increase in the importation and local 
production of suitable grains has been witnessed, coeliac-friendly corner store merchants are no 
longer a rarity and commercially viable gluten-free bakeries now exist. From a health perspective, 
many ofthe abovementioned foods offer the advantage of being relatively unprocessed compared to 
the more widely available gluten-containing products, an additional consideration in the event of 
CD-associated illness (e.g., diabetes mellitus). 
Furthermore, notwithstanding the inconvenience, substitutions required and restrictions involved, 
"homemade gluten-free pasta is as well or better digested than gluten-containing pasta" (Clemente et 
al. 2001, p. 110). Certainly, the GFD has generally been believed to be at least adequate nutritionally. 
However, the latter assumption has been questioned, especially in relation to the B-group vitamins 
(Thompson, 1999), which occur naturally in unrefined grains. Homocysteine, a metabolic marker of 
vitamin B6, folic acid and B12 status, was elevated in 41% of a Swedish cohort of biopsy-normalised 
CD patients treated for ten years, indicating the likelihood of inadequate vitamin intake (Hallert, 
Lilliecreutz, et al., 1999; see also Hallert, Grant, Grehn, et al, 2002). 
Raised homocysteine, like LDL cholesterol, appears to be a significant risk factor associated with 
cardiovascular disease mortality (Alfthan, Aro, & Gey, 1997), although the level of risk remains 
unresolved (Wilson, 2002). However, since many treated CD patients also consume higher levels of 
dietary fat than untreated patients and controls (Capristo et al, 1997), and homocysteine is carried by 
LDL cholesterol (McCully, 1999), raised homocysteine in two out five CD patients warrants further 
analysis ofthe GFD, as formulated by CD patients with and without dietetic advice. 
Neurotoxicity has also been linked to increased homocysteine levels (Lipton et al, 1997). 
Homocysteinemia is associated with neurological and psychiatric disorders, including Alzheimer's 
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disease (Clarke et al, 1998) and schizophrenia (Regland, Johansson, Grenfeldt, Hjelmgren, & 
Medhus, 1995). Vitamin B6, Bn and folic acid (the latter being reduced in 85% of new CD patients 
in one series; Hallert, Tobiasson, & Walan, 1981) each have an integral protective role in reducing 
homocysteine levels (McCully, 1999), as well as their direct involvement in neurotransmitter 
production (Sauberlich, 1991). Unrefined grains, whole meal bread, fortified breakfast cereals, 
wheat germ and malt - among the items most difficult to replace in a GFD - are major sources of 
vitamin B6 and folic acid. 
The modern way of life makes it awkward to maintain a diet free from gluten, let alone a 
nutritionally complete and balanced one, with compliance waning over time (see McCrae, Eastwood, 
Martin, & Sircus, 1975). More than one third of Quebecers with CD recently reported difficulty in 
adhering to the GFD (Lamontagne, West, & Galibois, 2001). Travelling, dining out, fast food and 
convenience eating are particular challenges. Apart from the scarcity of gluten-free items in certain 
settings (e.g., sandwich bars), additional problems include undeclared ingredients, incomplete, unclear 
or inaccurate food labelling and cross-contamination in the process of cooking (e.g., the use of cooking 
surfaces or implements exposed to gluten). Undoubtedly, "more stringent regulations and more precise 
identification of ingredients in processed foods would make it easier for those affected to obtain a safe 
and varied diet in our culture of heavily processed food" (Murray, 2002, p. 362). Unsurprisingly, lack 
of awareness about CD among health care professionals extends throughout the hospitality industry, 
where a waiter's failure to communicate a gluten-free requirement request or a chefs inadvertent use 
of gluten, oversight or misunderstanding may result in days of acute GI distress for a CD patient. 
Moreover, accidental gluten exposure entails more than a short-term, painful or uncomfortable 
experience. Delayed reactions involving significant histological damage, with villi taking weeks to 
normalise, may occur following a single gluten challenge. Those experiencing severe reactions upon 
exposure may decide eating out is simply not an option. Giving, receiving and sharing food, attending 
work luncheons and dining with family or friends is a normal part of most people's lives, but constant 
uncertainty about whether a given meal is gluten-free accompanies every outing for someone with CD 
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Since radically compromising one's way of life by entirely avoiding eating in public is hardly 
appealing, many people with CD get into the habit of pre-preparing their own food. Although the 
alternatives to wheat flour are relatively limited in variety, less palatable and more expensive (Barr et 
al. 1993) than their gluten-containing counterparts, CD patients are often sufficiently amazed at the 
improvement in their general health and well-being to at least attempt to follow the prescribed diet. 
For the long-suffering, newly identified person with CD, feeling healthy is frequently a novel 
experience. This was portrayed by Greco (1997), in recounting the words of an apparently 
oligosymptomatic CD sufferer, who was struck by the sheer "pleasantness]" of his existence on the 
GFD, having previously been "convinced life required tolerance, hardship, patience, sometimes 
misery..." (p. 13). This newfound vitality and exuberant outlook following dietary change 
encapsulates the experience of many people first detected with CD in middle or later life. In a large 
scale survey in the United States, improved quality of life after diagnosis was reported by 77% of 
respondents (Green et al, 2001). 
Despite the relief of diagnosis and experience of radically improved health, rigorous 
compliance with the specified diet is difficult to sustain. For a range of practical, social, cultural 
and psychological reasons (Becker, Maiman, Kirscht, Haefner, & Drachman, 1977; Buckfield, 1997) 
this is especially the case for children and adolescents (Booth, 1991; Cinquetti, Micelli, & Zoppi, 
1997; Cinquetti et al, 1999; Delia Morte et al, 1992; Ljungman & Mydral, 1993; McNeish, 1980), 
people diagnosed late in life (Hankey & Holmes, 1994), people with intellectual limitations (e.g., 
Down's syndrome), symptomless patients (Catassi, Ratsch, Fabiani, D'Angelo et al, 1998), patients 
from minority groups (Butterworth, Banfield, Iqbal, & Cooper, 2002) and adolescent males 
compared to females with CD (Greco, Mayer, Ciccarelli, Troncone, & Auricchio, 1997). 
In contrast to the findings regarding dietary compliance, women prepare the family meal more 
often than men, possibly influencing observations of reduced female, compared to male, life quality 
(Hallert et al., 1998) and increased perceptions of burden of illness among women with CD (Hallert 
et al., 2002). Reviews of follow-up studies indicate that only 17-65% of adolescent and adult CD 
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patients sustain a strict G F D (Kaukinen et al, 1999) and 30-50% of patients have dietary transgressions 
later in life (Maki & Collin, 1997). Poor compliance is the main reason for an unsatisfactory response 
to the GFD and health complications. 
Buckfield (1997), at the Centre of Applied Psychology, University of Canberra, investigated 
whether a wide range of biomedical and attitudinal factors influenced GFD compliance. She surveyed 
one hundred Australian Capital Territory members ofthe Coeliac Society of New South Wales. A 
multiple linear regression analysis showed that the perceived utility ofthe GFD by patients and, to a 
lesser degree, time on the GFD, accounted for the greatest amount of variance in dietary compliance 
Greater non-compliance was associated with low perceived benefits, high perceived costs, low self-
efficacy and a longer time on the GFD. There also appeared to be a lack of knowledge about the long-
term consequences of non-compliance among people with CD and ofthe presence of gluten in certain 
ingredients and food products. Interestingly, health belief models predicting that many ofthe factors 
examined by Buckfield would underpin significant variance in dietary adherence (e.g., Becker et al, 
1977) were not verified, with 80% of variance in compliance unexplained. 
Poor compliance in children with CD was "correlated with poor knowledge ofthe disease" among 
their parents, which was "in turn related to the family's social status (Jackson, Glasgow & Thorn, 1985, 
p. 672). The level of knowledge about CD has also been assessed by Ciacci, et al. (1998) in their 
study of depressive symptoms in adult CD. An inverse "trend towards correlation" (p. 249) was found 
between depressive symptomatology and CD knowledge. The latter entity was in turn significantly 
correlated with higher socioeconomic levels (itself based on educational attainment and work status). 
No interactions with compliance were reported. 
Buckfield (1997) suggested the strong need for interventions involving education programmes and 
greater assistance for people who do not join support groups. However, at the present time, broader-
based health campaigns are unlikely to be inclusive of coeliac content, or sensitive to the specific needs 
of people with CD, who are therefore strongly "encouraged to join their state Coeliac Society" (Ryan, 
2000, p. 835) by Australian gastroenterologists. Recent evidence found membership of a Coeliac 
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Society correlated most strongly with self-rated compliance with the G F D in English C D patients of 
Caucasian extraction (Butterworth et al, 2002). Other factors correlating with GFD compliance in 
Butterworth et al's study, in descending order of strength of significance, were a detailed explanation 
of CD by a physician, regular dietetic follow-up and the affordability of gluten-free products, 
understanding food labelling, getting sufficient prescription gluten-free products, having a follow-up 
small-bowel biopsy, and obtaining gluten-free products on prescription. Compared to Caucasians, 
compliance was poor among South Asian CD patients, who reported feeling relatively dissatisfied 
with information provided by doctors and dietitians, and "were less likely to attend dietetic clinics.. 
or be members ofthe Coeliac Society" (A18). 
Certainly, membership with a local coeliac association enables personal contact with other CD 
sufferers, invaluable both after initial diagnosis and following the honeymoon period of improved 
health described by many CD patients (e.g., Lohiniemi, 2001), after which medical follow-up, 
ongoing interpersonal support and sustained dietary compliance, are essential to health maintenance, 
but incumbent on the patient. The GFD remains the cornerstone of treatment, notwithstanding the 
wish expressed by many CD patients that "one day a pill, vaccine, or preventative measure might 
perhaps be available to save them from a lifelong restricted diet (Lohiniemi, 2001, sl4). 
In relation to this hope, double blind clinical trials are underway in Melbourne, Australia, to 
assess the effectiveness of an enzyme supplement protective against gluten challenge in 
diagnosed adult patients (Macrae, Cornell, Stelmasiak, & Bhatal, 2002). This enzyme is capable 
of digesting (in vitro) the proteins of wheat, barley, rye and other cereals that damage the small 
bowel in CD. Its preliminary usefulness in human CD patients, if proven, may be limited to 
reducing health risks associated with inadvertent ingestion of small amounts of gluten in people 
with relatively mild enteropathy. A "possible enzyme therapy strategy" has also been proposed by 
others, stemming from independent research simultaneously underway at Stanford University 
(Hausch, Shan, Santiago, Gray, & Khosla, 2002, p. G996; see also Shan et al, 2002). 
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Macro-level Issues and Food Labelling 
Australia's national coeliac society recommends a strict GFD treatment regimen and only endorses 
food products that are 100% gluten-free. This absolute standard of no detectable gluten ("in practice, 
less than 0.003% gluten"; Ryan, 2000, p. 836) is also favoured in New Zealand, whose food authority 
is aligned with Australia's, Canada, the United States, Italy, Spain and Austria. It is more stringent 
than the contentious international protocol currently approved by most government bodies or dietetic 
associations elsewhere throughout Europe, which permit 10 mg of gliadin per day for CD patients, 
generally in the form of wheat starch based gluten-free products (Ryan, 2000; Selby & Faulkner-
Hogg, 1998). This was also the case in Australia prior to 1994. 
In accordance with the Codex Alimentarius Commission ofthe Food and Agricultural 
Organization ofthe United Nations and the World Health Organization, this more permissive protocol 
translates as a definition of gluten-free food that permits up to 0.02% gluten (Ryan, 2000), or 0.3% 
protein from gluten-containing grains in foods labelled gluten-free (Faulkner-Hogg, Selby, & Loblay, 
1999). Such products are more economically viable and readily available than the totally gluten-free 
alternatives, and appear to be well tolerated by many people with CD (Lohiniemi et al, 2000). On the 
other hand, "the consumption of trace amounts of gluten, traditionally allowed in a Codex-GFD, 
could be responsible for the continuing symptoms seen in some patients with CD" (Faulkner-Hogg et 
al, 1999, p. 784; see also Chartrand, Russo, Duhaime, & Seidman, 1997). Zarkadas and Molloy 
(1996) reported that Italian doctors have declared it".. .unethical for medical doctors to prescribe 
foods containing any amount of gluten in diets for CD, when they know that even small amounts of 
gluten can increase the risk of osteoporosis, malignancies and other complications" (p. 3). Pre-
diagnosis, though, many patients' daily life will have revolved around the convenience of readily 
available, commercially made, processed foods (i.e., cereal, sandwiches and pasta). 
Not infrequently, lactase deficiency coexists with untreated CD. If associated with the intestinal 
damage preceding CD diagnosis, lactase activity recommences in many Caucasian patients following 
adherence to the GFD. Since a continuation of diarrhoea after gluten withdrawal may be secondary to 
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a lactase insufficiency that is associated with GI infections or imbalances predating C D diagnosis 
(e.g., bacterial overgrowth; Hallert, 1984), or is co-dependant with or exacerbated by CD, a lactose-
free, as well as GFD may be necessary "until there is substantial histological improvement" (Barr et 
al, 1993, p. 9), or indefinitely if a lactase-deficiency is substantive to CD. Fortunately, it appears that 
"lactose intolerance does not affect the severity of osteopenia" in CD (Lanzarotto et al, 2000, p. S22), 
with 26 out of 42 lactose intolerant patients in an Italian series osteopaenic or osteoporotic, compared 
to 13 out of 30 who were lactose tolerant, a statistically insignificant result. Furthermore, many 
dairy products, such as yoghurt, cottage and hard cheeses, in which lactose is pre-digested, absent 
or minimal, are well tolerated by people who are lactose intolerant. The lactobacilli in fermented 
products may supplant, support or even stimulate the body's capacity or ability to produce its own 
lactase, aiding the synthesis and absorption of many micronutrients, including calcium (Lee, 1988). 
Importantly, these foods, combined with gradual and/ or limited increments in lactose ingestion, may 
therefore have a dietary role in the treatment of osteoporosis (Lee & Krasinski, 1998; Tamm, 1994), 
so prevalent in CD pre- and post-diagnosis (McFarlane et al, 1995). Concern about the development 
of osteopathy, and prevention of other long-term complications of CD, as well as the sensitivity of 
many patients to marginal or even trace amounts of gluten, have contributed to the formal adoption 
zero tolerance to gluten by the medical establishment and dietetic fraternities in Australia. 
Following intense lobbying by CD sufferers, the Coeliac Society, the Dietitians Association of 
Australia, general practitioners, paediatricians and gastroenterologists, changes to the Australian Food 
Standards Code were foreshadowed in 1994. From March, 1995, the Australian National Food 
Authority required that foods labelled as gluten-free cannot contain any detectable gluten, while low 
gluten products must not have more than 0.02% gluten (Faulkner-Hogg et al, 1999). A clearly 
displayed panel providing nutritional information is now required if a food is described as being 
either gluten-free or low gluten. The accuracy and reliability of detecting gluten in food diminishes at 
very low levels (Price, 1997) and was a major impetus behind the adoption of no detectable gluten as 
the local GFD standard. These changes put Australians and New Zealanders with CD in the position 
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of being able to make highly informed choices when formulating their G F D . A counter argument is 
that this unconditional benchmark is not proven to be absolutely necessary in the majority of people 
with CD. It has also been regarded as excessively restrictive from a patient's standpoint and a 
deterrent to the provision of gluten-free foods, from a cost and convenience viewpoint, and even the 
legal perspective. The latter issue has been observed in the case of a major Australian airline, whose 
temporary response to a complaint about the addition of a bread roll to an otherwise gluten-free meal 
was to remove the gluten-free option from the menu. 
Whilst evidence exists that very small amounts of daily gluten (as contained in thickeners or even 
wheat starch) may not adversely affect health in many CD cases, an essentially zero default setting 
regarding gluten intake nevertheless confers several advantages at an individual and population level. 
A flow on effect subsequent to rigorous food labelling in Australia has been the accelerated 
emergence of exclusively gluten-free products, available in supermarkets, and menu items in 
restaurants, that are indeed far more likely to be genuinely gluten-free. In addition to increased safety 
for CD patients who are highly gluten-sensitive, all CD patients may enjoy greater peace of mind, as 
well as enhanced choice, when shopping or dining out. Another benefit of strict, medically endorsed 
GFD restrictions and highly regulated food labelling laws is a reduction of confusion about the GFD 
among medical staff and key allied health care professionals, including dietitians, who may only see 
a small number of CD patients annually, among CD patients themselves about what is permissible in 
the GFD, and among food industry personnel who are responsible for manufacturing, preparing and 
distributing gluten-free food, or relaying information regarding the GFD requirements. 
At a population level, the mere principle of zero tolerance towards gliadin is also more likely to 
raise thresholds regarding the degree of reduction, if not elimination, of both obvious and hidden 
sources of gluten by CD patients (and food providers). At this time, a source of oats guaranteed to 
be free from contamination with gluten is becoming commercially available in Australia, as a direct 
result of sustained demand by local CD patients based on expectations of zero gluten content (and 
increased awareness of CD). The vast majority of local patients who previously avoided oats -
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perhaps unnecessarily - may be more likely to add this nutritious food to their diet, also improving 
variety, as aforementioned (St0rsrud & Lenner, 2000). 
Worldwide, different nations may be assisted or disadvantaged by idiosyncratic conditions that 
impact on endeavours to meet local GFD standards. In the United States, for example, maize -
compared with wheat in Australia - is a predominant grain, so thickeners, starch and flour mixes, 
sauces and additives in many foods are more likely to be gluten-free. On the other hand, the 
development of, agreement to, and enforcement of food regulations becomes even more challenging 
in a much larger comparative population, with a higher number of regulatory authorities and greater 
dissemination of powers across many more states and sub-jurisdictions. 
Although Australian food labelling laws have been found to be contravened in the case of many 
new and pre-existing food products, the various state Coeliac Societies, which are well coordinated 
nationally, keep a close watch on all edible commodities marked "gluten-free" and are in a position 
to provide regularly updated information to Society members, including those newly and distantly 
diagnosed. The compilation of a commercial gluten-free food directory is no longer undertaken, 
given that information may be "out of date even before printing" (Price, 1997, p. 5), but the national 
society endorses foods that are tested and found to have no detectable gluten via the use of a gluten-
free logo. Australian CD patients and their families benefit considerably - in many other ways -
from membership of their state Coeliac Society and local support groups. "Dietary support and 
information is critically important for the maintenance of diet restrictions in coeliac disease" (Ryan, 
2000, p. 838) and local websites are increasingly helpful (e.g., www.coeliac.org.au - the Australian 
Coeliac Society). Practical aids include the national Coeliac Society's extensive, annually updated, 
ingredient list, which can be used in conjunction with current information on the gluten-content of 
most commercial foods (available from each state office), and identity-information cards, designed to 
assist in conveying clear, specific information when dining out (see Appendix A). These cards 
declare "I have been medically diagnosed a 'coeliac'" and are available in many European and Asian 
languages. 
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Overview of Coeliac Disease 
Coeliac disease is an autoimmune enteropathy with multifactorial genetic underpinnings. 
It is caused by gluten ingestion, in up to approximately 1% of ethnically Caucasian populations, 
fewer than 20% of whom are clinically diagnosed, even where high CD awareness exists. Prior to 
universal treatment with the GFD, provoked by Dicke's (1950) World War II observations, the 
outlook for people with acute CD was bleak. Today, though, sound health is attainable via the 
meticulous, sustained exclusion of dietary gluten and the spryly identification and decisive 
management of concomitant sequelae. Complying with the GFD is very challenging from a 
practical and psychological viewpoint. Gluten is ubiquitous in processed foodstuffs, food labelling 
cannot be taken fore granted as exacting, and an element of risk always accompanies assumptions that 
foods prepared by others are gluten-free. Confidence in accepting and embracing, rather than 
concealing one's illness, including communicating one's needs assertively, is indispensable when 
eating out socially. These personal qualities often take time to develop, especially in younger patients. 
Extra attention is also imperative to ensure the GFD is nutritionally complete (Hallert, Lilliecreutz 
et al, 1999). On a positive note, "its emphasis on fresh fruits and vegetables" (Ryan, 2000, p. 838) 
and the necessity of querying or avoiding almost all processed foods, may motivate and facilitate the 
adoption of exceptionally healthy dietary habits. The opposite consequence - of substituting high fat 
foods to compensate for lowered caloric intake (due to a diminished choice of carbohydrates in the 
GFD) - has been observed after diagnosis (Capristo et al, 1997) and may be detrimental to health. 
There is a great breadth of clinical presentations in CD (Fasano, Guandalini, & Kagnoff, 2000). 
These range from acute illness in infancy, following weaning, to asymptomatic screening-detected 
cases in adulthood. In some high-risk groups (e.g., relatives of people with CD) the proportion of 
symptomatic to asymptomatic cases may be surprisingly greater in adulthood (e.g., Berti et al, 
2000), in contrast to an increasingly higher ratio of atypical to typical symptoms at diagnosis at 
many centres (e.g., Sanders et al., 2002). Although clinically apparent loss of vitality is often 
precipitous just before diagnosis, the erosion of health is frequently insidious, even in childhood-
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detected cases (Anderson, 1969), and, eight decades on from Still's (1918) observations, it remains 
"by no means easy to be sure ofthe date of onset" (p. 163). In spite of doughty resistance in the face 
of long-term, unexplained loss of well-being pre-diagnosis, a dramatic denouement of health in 
untreated sufferers classically precedes - and unfortunately remains crucial in ultimately ensuring, 
let alone expediting - clinical diagnosis, in many people found to have CD (e.g., Lohiniemi, 2001) 
Seemingly mild presentations, in which CD has been previously unsuspected, make up a 
proportionately greater percentage of total diagnoses, if, when and where CD awareness is 
increased. In most diagnoses designated as silent or oligosymtomatic, there is actually a history of 
chronic or recurrent ill-health, typically dating back years or decades. At least one serious, and not 
uncommonly inveterate, health complication (e.g., skeleton pathology) usually accompanies 
diagnosis, with an increased duration of gluten exposure pre-diagnosis possibly heightening the risk 
of developing other autoimmune disorders (Ventura et al, 1999). 
Clinical depression, a common observation prior to treatment, may antedate CD diagnosis by 
many years (Goldberg, 1970; Hallert & Astrom, 1982). Although salient psychological amelioration 
is evident upon intervention with the GFD in numerous cases, and many ofthe physical markers of 
illness improve, above-average depressive symptomatology is still witnessed post-diagnosis in a 
significant proportion of patients (e.g., Addolorato et al, 2001.). These authors, like Hallert, Astrom, 
and Walan (1983), observed that lowered mood may initially be intractable post-treatment, at least 
without intervention additional to the GFD (Hallert, Astrom, et al, 1983). Conversely, "psychological 
issues [whilst a legitimate consequence of CD] can often divert diagnosis" (Marziani & Pianaroli, 
2000, S14), and, if GI symptoms coexist, may "simulate a functional10 abdominal pain". This is a 
serious issue previously noted by Hallert (1984) that may lead to incorrect diagnoses and prolonged, 
unnecessary suffering. In younger CD patients, irritability, restlessness, hyperkinesis or inattention 
"Functional gastiointestinal disorders (FGD) are the result of disordered GI function in the absence of known 
pathology of structure. FGD are among the commonest medical conditions" (Jones et al., 2000 p. ii2) 
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may be misinterpreted pre-CD diagnosis as having a behavioural aetiology. In adult patients, apathy 
and lassitude parallel the lack of concentration, distractibility and peevishness described in coeliac 
children, or irascibility seen in adolescents with CD, but may also "mimic psychiatric disturbance" 
(Hallert, et al, 1998, p. 936), notwithstanding the existence of genuine depressive illness or 
symptomatology at higher than expected levels (Goldberg, 1970; Hallert, & Astrom, 1982). 
Tentative impressions of a constellation of symptoms resembling DSM-IV dysthymic disorder 
or ICD-10 neurasthenia (WHO, 1993) may be titrated from the literature. In a modified version ofthe 
Zung Self-Rating Depression Scale, "psychologic" and "biologic" items made equivalent contributions 
to increased depressive symptoms in a large, Italian CD group (Ciacci et al, 1998), and "a tendency 
for greater impairment to occur in the mental domains ofthe SF-36 than the physical ones" (p. 936) 
was noted by Hallert et al. (1998) among treated female CD patients. 
The hypothesis that somatic-affective (rather than cognitive) elements - which may represent the 
somatic features of mental or physical illness, or both - preponderate among a substantial number of 
mildly depressed or apparently dysthymic CD patients, will be investigated in the current thesis 
Anger is a clinical dimension in psychiatry that often overlaps with depression (Fava & Rosenbaum, 
1999; Glenmullen, 2000), but anger levels are a relatively unknown quantity in CD and will be 
investigated in the cross-sectional and longitudinal studies of this thesis. Elevated anxiety in CD 
recedes after diagnosis (Addolorato et al, 2001) and the qualify of life subsequently improves 
(Mustalahti et al, 2000), but does not quite reach usual community levels, particularly in women 
(Hallert et al, 1998). 
Results ostensibly suggesting otherwise (Lohiniemi, Mustalahti, Collin, & Maki, 1998) have 
been partly interpreted by those authors in terms of a sense of relief upon diagnosis "at getting an 
answer to unexplained complaints", that was conceded to be an overly optimistic "impression of 
perfect health" (p. 76). General psychological well-being may indeed noticeably improve after 
implementation ofthe GFD in relation to a CD patient's former emotional state and general expect-
ations, but - abstrusely - ebb after many years of following the GFD, compared to the general 
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population (Lohiniemi et al, 1998; see also Hallert et al, 1998). 
Intellectual ability remains intact in adults with longstanding CD, even prior to GFD treatment 
(Hallert & Astrom, 1983), but the question of fine gradations in cognitive functioning after dietary 
treatment has not been the subject of large, case control studies (Collin, Eerola, & Pirttila, 1997), in 
spite ofthe not infrequent finding of neurologic complications in CD, especially in men, despite the 
greater female incidence of CD (Hadjivassiliou et al, 1998), also noted by Ciclitira (2001). 
Neuropsychological status, quality of life and mood/ affective state are three key, interconnected, but 
somewhat neglected, areas of coeliac research addressed in the cross-sectional and longitudinal 
studies comprising this thesis. The next chapter will review previous biopsychosocial, physiological 
and neuropsychiatric research in CD, framing the current project. 
Chapter 2: Psychophysiology of Coeliac Disease 
The physical effects of CD, by encroaching upon multiple metabolic processes (Howdle, 1997), 
not infrequently involving the endocrine and nervous system (Gobbi et al, 1997), influence the 
psychological functioning of those affected. Numerous underlying mechanisms are proposed (Hallert, 
Astrom, & Sedval, 1982; Holmes, 1997; Luostarinen, Collin, Peraaho, Maki, & Pirttila, 2001; Wills, 
2000), with depression the predominant psychiatric problem encountered (Addolorato et al, 2001; 
Goldberg, 1970; Hallert & Astrom, 1982; Carta et al, 2002). Secondary psychological reactions in 
CD also originate from several sources. These include the realisation that CD is a complex, lifelong 
health issue involving permanent dietary and lifestyle restrictions (Cinquetti et al, 1999; Gasbarrini 
& Addolorato, 1997). The sense of self may be affected. Perceptions of inferiority and vulnerability 
in response to delayed, interrupted or less than optimal physical development were noted by Hallert 
(1987). A disruption in early relationships and family dynamics has also been observed (Gardiner, 
Porteous, & Walker-Smith, 1971; Marziani & Pianaroli, 2000; Prugh, 1951). Adolescence, a key 
period of identity formation, may be especially challenging in CD (Fabiani et al, 2000). 
Quality of life in CD is significantly affected in children (Kolsterman et al, 2001) and adults 
(Grech et al, 2000; Lohiniemi et al, 1988), with the GFD failing to restore life quality to healthy 
community levels (Hallert et al, 1998). This issue is pronounced in women (Hallert et al, 1998), 
who perceive the burden of their illness as greater than their male counterparts (Hallert et al, 2002). 
Based on those authors' inferences, an underlying reason may be the greater responsibility placed on 
women, compared with men, to prepare their own gluten-free meals, which is consistent with local 
Australian observations ofthe preponderance of female attendees at regular cooking demonstrations 
provided by the Coeliac Society. Conversely, "an overview of neurologic complications [in CD] 
reveals a mainly male predominance" (Ciclitira, 2001, p. 1536; see also Hadjivassiliou et al, 1998) 
- an observation mirrored in neuropsychological findings of male cognitive processing speed 
inferiority in CD (Grech et al, 2000) - despite a higher incidence of CD in women. 
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M o o d state, cognitive functioning and perceived quality of life in C D are inter-related entities, 
each partly a function of having a chronic illness per se (Wells, Golding, & Burnam, 1988) and many 
CD-specific variables (Hallert, 1987; see also Hallert et al, 2002). These include the severity of CD, 
ranging from quiescent to debilitating, and one indication of which is the magnitude of steatorrhoea 
(i.e., fat malabsorption) at diagnosis. This key symptom significantly correlated pre-treatment with 
the level of depression in CD (Hallert & Astrom, 1983). Other hypothetical variables include the 
symptomatic period (pre- and post diagnosis), duration of gluten exposure (see Ventura et al, 1999), 
degree of dietary compliance in CD (see Buckfield, 1997; Mayer et al, 1991), and interaction of 
various other inherent and exogenous psychosocial factors, such as spousal or family support. Direct 
research primarily focussing on these interactions is lacking. 
Prior studies have generally failed to find clear-cut associations between GI symptomatology and 
mental state in CD (Goldberg, 1970; Hallert, Astrom, 1982) or, for that matter, other physical and 
psychological factors, except for the correlation between fat malabsorption and depression 
mentioned and a cause/ effect relationship linking nutritional (vitamin Be) status and depression (see 
Hallert, 1997), to be discussed shortly. In the present thesis, such considerations were of interest, 
with key measurable health-related indices documented in all participants. 
Historical References to Neuropsychiatric Disorders in CD 
Although evidence of neurological, psychiatric and psychological complications of CD have 
accumulated during the preceding century, the exact prevalence and nature of these sequelae are 
difficult to catalogue accurately for numerous reasons. Firstly, different researchers have included (or 
omitted) various conditions under many umbrellas such as neuropathy, neurological disturbances and 
psychiatric disorders. In some studies, only severe or diagnosed psychiatric disorders were considered, 
whereas others included subtle signs of disorders, mild or transient affective symptomatology, or a prior 
history of psychiatric disturbance in their prevalence estimates. Secondly, information from referral 
centres such as coeliac societies or gastroenterology clinics may be unreliable because patients are 
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drawn from selected groups. Although the most severely ill patients in the clinical spectrum are often 
observed in a consecutive series of hospital-based clinical diagnoses, the opposite may be true in other 
circumstances (e.g., screening studies). Thirdly, the duration of undetected CD and stage of GFD 
treatment profoundly influences both prevalence estimates and the apparent severity of complications, 
A succession of CD patients assessed at diagnosis or in the early stage of treatment with the GFD may 
display higher levels of psychological disturbance than long-term patients compliant with the GFD. 
The literature abounds with adjectives pertaining to the breadth of psychological sequelae 
encountered in CD. Affected children have been portrayed as "irritable, fretful, capricious or peevish" 
(Gibbons, 1889; cited in Gardiner et al, 1971, p. 39) and "characteristically unhappy" prior to gluten 
restriction (Challacombe & Wheeler, 1987, p. 145). Daynes (1956) reported "naughtiness, depression 
and fits due to wheat sensitivity" in the context of a "pre-coeliac syndrome" in young children, marked 
by "irritable, negativistic and spiteful" behaviour and disturbed sleep remitting upon gluten exclusion 
(p. 391). Reference was made to a "headache/ insomnia/ depression (H.I.D.) syndrome" in adults with 
CD (p. 392). The demeanour of gluten-intolerant people has also been described as "turned inward", 
"rigid" and "schizoid" (Hunter, 1987, p. 13), which relate to supposed associations of CD with schizo-
phrenia and autism (Dohan, 1970, 1980, 1983; Rudin, 1981; see also Bersani, De Palma, Sandri, & di 
Pietralata, 1997; Coleman, 1997; and Marson, Michetti, & Volterra, 1997; in Gobbi et al, 1997). 
Purported connections between CD and schizophrenia stemmed from an improvement and earlier 
hospital discharge in psychotic patients on cereal and milk-free diets (Dohan, 1973), positive 
worldwide correlations between major mental illness diagnoses and gluten consumption, histories of 
CD in the childhood of some schizophrenia patients and isolated case studies (see Dohan, 1983; 
Pfeiffer, 1984), not all of which found an improvement on the GFD (e.g., Storms, Clopton, Wright, 
1982). Suggestive reports still appear (e.g., De Santis, 1997), but no cases of schizophrenia were found 
in a large Swedish epidemiological CD study (Hallert, 1982). Also, "no evidence was found to link 
schizophrenia with CD" in an MMPI profile of CD patients compared to surgical controls (Hallert, 
1987, p. 129), nor was CD detected in two separate groups of autistic children displaying GI symptoms 
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(McCarthy & Coleman, 1979; Walker-Smith, 1973). Table 1 provides an overview ofthe current status 
of a selection of neuropsychiatric and neurological entities with CD, with the strength of association 
denoted by the number of plus (+) signs, on the balance of empirical evidence. 
Table 1 
Current Status of Association of a Selection of Neuropsychiatric and Neurological Entities with CD; 
Entities under Direct Investigation in Present Thesis are Underlined 
Entity Status Association 
A D H D 
Anger 
Asperger's syndrome 
Ataxia 
Anxiety 
Autism 
Cerebellar syndrome 
Cognition (specific skills) 
Dementia 
Depression 
Depressive symptomatology: 
[MMPI] 
[Zung SRDS] 
Dysthymia 
Down's syndrome 
Epilepsy/ seizures 
Intellectual capacity (overall) 
Migraine 
Neurological disorders 
[of unknown cause] 
Peripheral neuropathy 
Quality of life 
Schizophrenia 
Spinal cord degeneration 
Substance-related disorders 
6.8% of G F D treated C D patients had A D H D characteritiscs1 
N o prior studies; state/ trait anger assessed in present thesis 
Reported by Asperger2 40 years ago; unsubstantiated 
Atypical symptom reported as part of cerebellar syndrome 
State-anxiety elevated pre-GFD4; normal levels post-GFD4 
Isolated case reports; Unconfirmed5 
Many case reports6 
Visual discrimination and short-term memory reduction 
Uncommon8; refractory where identified9 
10 Common at diagnosis ; significant incidence post-GFD 11, 12 
Elevated pre-/ post-diagnosis12 (psycho-vegetative 
and subjective depression components prominent) 
About half of C D patients affected pre-/ 1 year post GFD 1 4 
Very common; 2 3 % of small Italian C D series15 
Definite association16; gluten-independent 
Association in two geographic areas (e.g., Italy ; Ireland ) 
N o consistent signs of impairment in Swedish series19 
Often reported anecdotally; some evidence20 
C D not uncommon21; screening recommended22 
Case reports in middle-aged coeliac men23; otherwise rare24 
.25 Slightly but significantly reduced, especially in women 
Popular theory in 1970s26; epidemiologic evidence lacking 
Several case reports ; infrequent finding 
Unknown; reduced incidence of cigarette smoking 
27 
29 
+ 
-/ + 
-H-+ 
-H-+ 
+ 
++ 
-/ + 
++ 
-/ + 
Strength of Association Key: (strong); ++ (moderate); + (weak or inconsistently replicated) 
- / + (ambiguous/ unknown) - (Doubtful) 
Note: References in Table 1 (1-29) are listed in numerical order in Appendix B. 
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Wills, Turner, Lock, Johnston, Unsworth and Fry (2002) recently noted that "neuropsychiatric 
complications have been reported in up to 26% of [CD] patients" (p. 259). Indeed, it is not 
uncommon in the CD literature to find high rates of reported neuropsychiatric symptomatology (e.g., 
Kozlowska, 1991) or disorders (e.g., Carta et al, 2002) among CD patient groups, but negligible 
increases above expected levels ofthe prevalence of CD if screening is undertaken in psychiatric 
patient groups. Admittedly, the latter effect is susceptible to the unreliability of identifying relatively 
low incidence entities (i.e., CD) in already highly selected groups. For instance, Pynnonen, Isometsa, 
Aalberg, Verkasalo, and Savilahti (2002) found only one case of CD in a screen of 140 new 
adolescent psychiatric outpatients, but clearly the absence of this sole CD patient, or addition of just 
one or two extra CD patients (by chance selection), would have dramatically altered this result. 
It may be further argued that, due to high CD awareness in Finland, potential CD patients would 
be relatively likely to be identified prior to the development of neuropsychiatric complications 
attributable to or associated with CD. Conversely, Kozlowska (1991), in an "evaluation of mental 
status of [41] children with malabsorption syndrome after long-term [GFD] treatment" (p. 130) found 
"various psychiatric symptoms...in 48.8%, and EEG abnormalities in 70,7%" (p. 130). 
Proposed associations between CD and psychiatric disorders other than depression, and neurologic 
conditions except for Down's syndrome, epilepsy, cerebellar syndrome and perhaps migraine, have 
generally been unsustained. Nevertheless, "tangential references" (Prugh, 1951, p. 220), "impression-
istic" portrayals (Hallert, 1987, p. 128) and pejorative sounding connotations and extrapolations 
attached to the descriptions of psychological sequelae in CD are historically widespread. 
Prugh noted that the "secondary nature" of reactions arising "from the stresses imposed by 
protracted illness and difficult management" (p. 220) had traditionally been acknowledged in children 
with CD, as well as their mothers, and within the mother-child relationship. That author's observations 
of a series of 14 children with CD indicated to him the evolution "of a consistent though non-specific 
personality" structure (p. 226), via psychodynamic mechanisms, stemming from the onset and 
aggravations of illness. According to Prugh, his group of children appeared "to be passive, often 
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withdrawn, definitely inhibited personalities, commonly exhibiting certain aspects ofthe obsessive-
compulsive trends seen in their mothers" (p. 227). He also observed "intensification" of "irritability 
and constant crying... during episodes of illness in infants". The "expression of aggressive or 
angry feelings" in periods of "freedom from exacerbations" (p. 227) was evident in older children. 
More recently, Carlsson et al. (2001) listed "proneness to nightmares" (p. 45) with two GI symptoms 
as characterising the symptomatic, screening detected 2.5 year old infants with CD in a Swedish series 
Personality was evaluated in CD from a clinical perspective (see Hallert and Astrom, 1982), with 
only depressive features prominent. Therefore, from the viewpoint of Hippocrates' conceptualisation 
of four fundamental personality dimensions (see Davison & Neale, 1990) - as represented by essential 
bodily fluids (blood, yellow bile, black bile and phlegm) - surfeit black bile, producing a pessimistic 
persona or "melancholic" temperament, may be conjured to depict a "coeliac personality". Abundance 
of blood results in an optimistic attitude and extraverted behaviour, with the converse - introversion -
not infrequently seen in CD, although an inhibited, withdrawn or gloomy outlook may also reasonably 
reflect the reality of poor ongoing health, or indeed clinical depression, rather than true personality 
traits. Moreover, the relative optimism, calmness and relief observed in patients after diagnosis (e.g., 
Lohiniemi et al, 1998) is preferentially suggestive of Hippocrates' "sanguine" dimension. 
In his view, excess lymph resulted in a stoic and apathetic (or "phlegmatic") disposition -
evocative of Greco's portrayal ofthe long-suffering, but indomitable adult sufferer who soldiers on in 
the face of wretched health prior to CD diagnosis. Finally, anger and irritability, pointing towards the 
"choleric" disposition, was represented by the yellow bile; vividly reflected in Prugh's younger 
coeliac patients, who are perhaps less equipped to cope emotionally and socially with fluctuating ill-
health preceding identification of CD, and who may also suffer from the effects of clinical depression, 
albeit expressed differently. The irascibility and turmoil observed in children often recedes post-
diagnosis, further supporting the likelihood that peculiarities of affective functioning observed may be 
ascribed to depressed mood directly attributable to biological mechanisms stemming from untreated 
illness (Hallert & Sedvall, 1983; Hernanz and Polanco, 1991), and reflecting a "reactive condition", 
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as opposed to enduring "personality traits" or typologies (Gasbarrini & Addolorato, 1997, p. 350). 
Described behaviours and suggested underlying dynamics in Prugh's series of coeliac children 
(and their mothers) were presumably potentiated by many uncertainties owing to a lack of awareness 
ofthe primary cause CD at that time, with universal dissemination of Dicke's findings imminent but 
not yet embraced by paediatricians in the United States (Allen, 1996). Nevertheless, Prugh's detailed 
observations, including those of largely repressed, but at times increased, "resentment, hostility and 
anger" (p. 227), have contemporary implications. Since present day CD diagnoses are often delayed 
until adulthood in a substantial proportion of cases, aspects ofthe psychodynamic processes and 
perturbations inferred by Prugh, if considered valid, are still likely to operate. After diagnosis, 
adolescent patients may also be "angry at society for pitying them" (Ashkenzai & Barash, 1992, 240) 
Glenmullen (2000) has noted that core psychological symptoms of depression (i.e., feeling helpless, 
hopeless and worthless) "represent...stifled anger and sadness turned against oneself (p. 271). In 
undetected CD, uncertainty about the cause of feeling physically and emotionally unwell may fuel 
resentment against others (e.g., health care practitioners), but ultimately revert to anger at oneself and 
consequently depression. After diagnosis, the rigours of a restricted lifestyle, including 
the ubiquitous infiltration of gluten into everyday foods, can also lead to futile bitterness towards 
the external world that is eventually turned inward, sustaining depression in some cases. 
Behavioural Disturbance Prior to Diagnosis: Case Reports 
Hernanz and Polanco (1991) noted that nine out of fifteen children exhibited signs of behavioural 
disturbance pre-CD diagnosis that improved after GFD institution. They reported that untreated, 
symptomatic children "can be irritable, querulous, depressive, apathetic, or negate, and they also may 
present with stereotyped movements" (p. 1480). Contained within patients' perspectives of CD 
compiled by Bennet (1998), diagnosed herself in 1995, are the poignant personal stories of 7 men and 
14 women who grappled with elusive symptoms, often underlying troubled behaviours, throughout 
various life stages. One elderly patient frequently admonished and spanked for eating dirt and stealing 
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food from garbage cans recalled that "her father had mistakenly thought she was just being a naughty 
child. She reflects, 'This was very cruel as I was getting no nutrients from my food and that was reason 
I was always starving'" (p. 9). Another patient reported "constant nightmares" in childhood (p. 61), 
concentration problems throughout life and losing track of conversations midstream, but managed to 
graduate from college late in life, muddling "through with sheer determination and persistence" (p. 63) 
Recently, Pynnonen, Isometsa, Verkasalo, Savilahti and Aalberg (2002) retrospectively detailed the 
effect of untreated CD on the "development of mental disorders in children and adolescents" (p. 331). 
In two compelling case studies, those authors described how one patient "had serious problems 
controlling her temper and problems with explosive anger" (p. 332), while another met the criteria for 
"intermittent explosive disorder" (p. 333) pre-CD diagnosis. In each case, clinical levels of depression 
and aggression, as measured by the Beck Depression Inventory (BDI) and Child Behavior Checklist 
(CBCL) receded significantly post-CD diagnosis, "without psychiatric treatment or known 
psychosocial factors to explain the remission" (p. 333). 
In the subject ofthe first case study "anorexia nervosa was suspected" and criteria for "eating 
disorder not otherwise specified" were met "on the basis of an interview with the Schedule for 
Affective disorders and Schizophrenia for School-Age Children - Present and Lifetime Version" 
(p. 332). In hindsight (post CD-diagnosis), this diagnosis appeared inappropriate. The latter case report 
noted "autistic-like" behaviours, "disruptive restlessness", "difficulties concentrating and studying" 
and "obsessive aggression" for years prior to the identification of CD and "severe and increasing 
tiredness" (p. 332-333) leading up to the diagnosis. That young patient had also been "shunned by his 
schoolmates" (p. 332) as a result of his behaviour, compromising his self-esteem to such an extent 
that he remained withdrawn after CD diagnosis, but was able to successfully return to his studies at 
the age of 17 and was apparently "coping better with his chronic loneliness" (p. 333). 
As reported in Chapter One, behavioural reactions emanating from these early, secondary psychol-
ogical processes may also deflect investigations of true underlying aetiology (i.e., the existence of CD; 
Marziani & Pianaroli, 2000). The restlessness, inattention and unruliness of undiagnosed children 
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(later responding favourably to the G F D ) may mimic many ofthe symptoms of unrelated disorders such 
as ADHD. As part of a doctorate thesis at the University of Madrid, Martmez-Bermejo (1998) found 
that 6.8% of GFD treated CD patients had characteristics of ADHD, using DSM-IV criteria. This figure 
did not differ greatly from rates reported in the general population, ranging from 2.2% to 10.1%, 
depending on studies cited by Martinez-Bermejo and Polanco (2002). Those authors recently 
summarised the neuropsychological changes in coeliac disease, in a detailed overview translated from 
Spanish by a colleague ofthe author (M. Alvarenga, personal communication, Jan. 2003). 
Certain components ofthe psychological sequelae, even in known CD, remain largely unexplored 
psychometrically. The true levels of state and trait anger in CD are good examples, and subject to 
inquiry in adult patients in this thesis. In one ofthe few reviews even alluding to anger (Goldberg, 
1970), that author found "most" idiopathic steatorrhea (i.e., probable CD) patients "can show anger 
(74%)", in stark contrast to Paulley's (1949) sample, whose personality profile was summarised by 
Goldberg ("in the interests of brevity", p. 463) as, conversely, being unable to "show anger" (see Table 
VIII, p.462). Such contrasting results may be interpreted as cancelling each other regarding overall 
levels of anger in CD. Alternatively, they could point to either normal or elevated - but repressed -
angry feelings, either when chronically unwell pre-diagnosis, during perturbations of CD, or as part of a 
passive/ aggressive mechanism of anger expression, shaped by fluctuating ill-health and related factors 
from an early age. More recently, Ashkenzai and Barash (1992) noted that in Jewish teenagers with CD, 
anger may be directed "at society for pitying them and considering them as having a disease" (p. 240). 
Subjective feelings, tendencies towards or objective manifestations of irritability, "contrariness" 
(as noted by Sheldon, 1959, p. 137) or overt anger may be connected in several ways to the develop-
ment of individuality and temperament in relation to coping with having a chronic, but in Paulley's 
time, undefined illness (still relevant today), and, in the GFD era (from the decade post-WWII), 
managing a restricted diet, disease exacerbations related to deviations from the GFD and primary CD-
related psychological processes akin to the aetiologies proposed in relation to depression, 
Recently, Ciacci, Iavarone, Siniscalchi, Romano and De Rosa (2002) noted that "anger was the 
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predominant emotion that induced patients to transgress" from the G F D , being "inversely correlated 
with actual compliance" (p. 2082). People with CD, especially those moderately to severely affected 
or noncompliant with the GFD, may also be less resilient to extraneous stressors, and more susceptible 
to developing psychiatric disorders or clusters of symptoms across the mood and affective spectrum 
In his review of previous surveys, Goldberg (1970) concurred with findings of an above-
average existence of depressive and obsessional traits, emotional reactivity and sensitivity, and 
introspection/ introversion in relation to his sample, with the depressive aspects most pronounced. 
Against the backdrop of Dohan's and others' hypotheses of links with psychotic and developmental 
disorders (discounted by Hallert, 1984), other researchers have further pondered the existence of a 
distinct coeliac personality, most often associated with depression and anxiety in CD. These include 
Gasbarrini and Addolorato (1997), who found no evidence for trait anxiety in CD, but indications of 
reactive (state) anxiety and depression in a small CD group, compared to healthy controls. 
More recently, Carta et al. (2002) reported that "compared to controls, a significantly higher 
number of CD patients met criteria for lifetime and 6-month major depressive disorder (MDD) and 
lifetime panic disorder" (p. 789). Addolorato et al (2001) noted a significant elevation of state anxiety 
at diagnosis compared to healthy controls, which decreased one-year post-GFD to control levels, but 
above-average depressive symptomatology that did not remit. 
Previously, Hallert and Astrom (1982) reported that the Minnesota Multiphasic Personality 
Inventory (MMPI; Hathaway & McKinley, 1951) depression subscale was the only scale clinically 
elevated in 12 consecutive adult CD patients (mean [M] T score = 70.3, SD = 12.5) compared to 12 
matched surgical controls (M = 59.2, SD = 9.3), selected from patients awaiting elective cholecystect-
omy. Further delineation using the Harris subscales revealed that subjective depression (Dl), 
psychomotor retardation (D2) and Physical Malfunctioning (D3) were significant elements in the 
elevation observed by Hallert and Astrom (1982) in Scale 2 (compared to controls), which remained 
clinically significant after institution ofthe GFD and folate supplementation, but normalised following 
additional treatment with pyridoxine (i.e., vitamin B6; Hallert, Astrom, & Walan, 1983). 
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Neurological Complications in C D : Underlying Mechanisms 
Relationships between enteric diseases, GI and neurological functioning have been well described 
a propos possible gut-brain effects (e.g., malabsorption) and vice versa (e.g., defects of gut innervation) 
in detailed reviews (Perkin & Murray-Lyon, 1998; Willis & Hovell, 1996). The preceding chapter 
demonstrated that as CD awareness increases and screening programs expand, the subclinical part of 
the coeliac iceberg is exposed. In tum, the proportion of minimal-symptomatic cases increases. It may 
be expected that "the complications of malabsorption will become rare" (Collin, Eerola, & Pirtilla, 
1997, p. 285), but more subtle signs of long-term ill health, including neurological manifestations, 
such as dementia, will be detected. The apparent prevalence of psychopathologic processes in CD 
populations at any time is probably balanced by the marriage of both truths, in that a diminishing 
frequency of severe CD-related malnutrition as a primary cause of psychopathology is being 
counterpoised by an increased identification of cases involving neuropathy stemming from circuitous 
and protracted immune-mediated pathogenic mechanisms, either operating concurrently and indep-
endently of CD (e.g., common genetic linkage; Luostarinen et al, 2001) or indirectly (e.g., extra-
intestinal immunologic pathways; Gobbi et al, 1992), via gliadin-related or auto-antigen activation 
due to CD (Howdle, 1997). The multiple genetic underpinnings involved in susceptibility to CD, 
combined with great individual variation in vulnerability to the neuropathic changes potentially 
associated with CD, make the task of pinpointing related pathways very challenging. 
In a significant number of cases, CD is being diagnosed after the detection of neurological 
disorders (Luostarinen et al, 1999). A re-emerging recognition and interest in cerebral dysfunction 
and the clinico-neuroradiological aspects of CD has been precipitated by new structural and functional 
imaging technologies (see Gobbi, Andermann, Naccarato, & Banchini, 1997), further influencing the 
apparent strength of association between CD and various neuropathologies (Wills, 2000). 
Where detected, brain atrophy in CD is most often found in the cerebellar regions, the deep grey and 
brain stem nuclei, and the spinal cord tracts (see Collin, Eerola, & Pirtilla, 1997 for a review). The 
cerebellar damage is marked by Purkinje cell loss and the "deep grey matter structures affected include 
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the thalamus, caudate nucleus, globus pallidus, putamen, amygdala, anterior hypothalamic nuclei, 
periaqueductal grey matter, corpora quadrigemina, the substantia nigra, and the red nuclei" (Perkin & 
Murray-Lyon, 1998, p. 296). These structures are involved in mood attenuation, memory and fine 
motor function (Kolb & Whishaw, 1990). The resultant clinical syndrome - typically ataxia and 
peripheral neuropathy in adult cases - is frequently resistant to the effects of GFD intervention and/ 
or supplementary nutrition (e.g., folic acid, Bi2 and/ or vitamin E therapy). However, Pellecchia et al 
(1999) reported "a clear improvement of clinical and electrophysiologic abnormalities and resolution 
of villous atrophy" (p. 1607) after two years ofthe GFD in 34-year-old man with a seven year history 
of slowly progressive ataxia. White-matter lesions have also been found in one in five GFD treated 
children with CD (Kieslich, Errazuriz, Posselt, Moeller-Hartmann, Zanella, & Boehles, 2001). 
A proliferation of case studies emerging in the preceding decade (Collin et al, 1997) has illustrated 
a significant incidence of neuropathy in newly diagnosed CD patients (Luostarinen et al, 1999) and, 
conversely, a greater than expected prevalence of CD in people with occult or cryptic neurological 
dysfunction (Hadjivassiliou et al, 1996), which is often identified prior to CD (Cooke & Thomas-
Smith, 1966; Hadjivassiliou et al, 1998). In cases of "gluten ataxia", about 80% of patients have the 
same HLA DQ2 (=70%) or DQ8 (=10%) genetic profile ordinarily observed in CD, but "20% have 
the HLA DQ1... not yet reported in association with CD" (Hadjivassiliou et al, 2002, p. 1226). 
A modest but significant association between epilepsy and CD, with or without evidence of 
concomitant cerebral calcification, has also been reported worldwide, in Ireland (Cronin et al, 1998), 
Finland (Luostarinen et al, 2001) and Italy, where the combination of CD, epilepsy and intracranial 
posterior calcification is widely reported (see Gobbi et al, 1997). Immunological mechanisms, 
probably independent of malabsorption in CD (Fasano & Catassi, 2001), may underlie this correlation, 
but the aetiology remains speculative. Although some case reports have demonstrated improvements 
in intractable epilepsy following CD diagnosis and adherence to the GFD (see Cronin et al, 1998), 
the consequences of untreated CD in concomitant cases are yet to be fully elaborated. 
The Down's syndrome/ CD association is gluten-independent (Fasano & Catassi, 2001). Specific 
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genetic underpinnings are possible (Salur et al, 2000), but, with the exception of Down's syndrome, 
"the mechanism of links between neurological diseases and CD... cannot be simple, because a 
substantive number of factors (nutritional, immunological, neuroendocrine, etc.) may be involved" (p 
709). Salur et al. (2000) ruled out the "induction of cross-reactive immunological reactions against brain 
tissue" (p. 710) in the development of neurological diseases in their study, which found a "high 
frequency of CD among children with neurological disorders" (p. 707). Kieslich et al (2001) found brain 
white-matter lesions in 15 (20%) of 75 young, diet-treated CD patients ranging in age from 2.8 to 24.2 
years (mean of 11.6 years). They held the view abnormalities "may be ischemic in origin as a result of a 
vasculitis or caused by inflammatory demyelination" (p. e21). Salur et al's (2000) and Kieslich et al's 
(2001) results indicate "CD should be suggested as a differential diagnosis in children with unclear 
white-matter lesions" (Salur et al, p. e21), or in any neurological irregularities of uncertain aetiology 
Luostarinen et al. (2001) reported a 16.1% CD frequency in patients with ataxia of unknown origin 
when cases of alcohol abuse were omitted, suggesting the possibility of a "shared and immunologically 
mediated mechanism contributing to the mucosal and neural tissue damage" (p. 447). Pratesi et al 
(1998) observed that "sera from patients with active CD contain IgA antibodies that react with human 
brain vessel structures" (p. 817), while Alaedini et al. (2002) identified serum anti-ganglioside anti-
bodies "reactive against brain gangliosides" in 6/ 27 CD patients (p. 145), proposing that "the neuro-
pathy of celiac disease may be autoimmune and associated with anti-ganglioside antibodies" (p. 145). 
In a review of neurology and neuropathy in CD, Wills (2000) noted the predominance of "case 
reports... small, uncontrolled studies" and "idiosyncratic definitions of gluten sensitivity" (p. 445), 
upon which several etiological theories are speculated, commenting that "separating the wheat from the 
chaff in the neurology of gluten sensitivity is not straightforward (Wills & Unsworth, 2002, p. 519). 
Wills (2000) isolated immunological dysfunction, citing potential pathogenic mechanisms, and 
"disordered metabolism secondary to trace vitamin deficiency" (p. 445) as likely causes of neurological 
complications in CD. For other useful contributions in this area, see Piattella et al. (1997), Pengiran 
Tengah, Wills and Holmes (2002) and Hadjivassiliou et al. (2003). 
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Orthomolecular Psychiatry: Nutritional Deficiency in C D 
Collin, Eerola, and Pirtilla (1997) have noted that "in earlier [CD] series, many neurological 
symptoms have been the consequence of severe malabsorption" (p. 285). The existence of 
sustained nutritional deficiencies during the untreated phase of illness may indeed contribute to, or 
specifically underpin, several ofthe mental abnormalities observed in CD, especially changes in 
mood state (Hallert, Astrom, & Sedval, 1982; Hallert & Astrom, 1983; Holmes, 1997; Morris, 
Ajdukiewicz, & Read, 1970; see also Hallert, Martensson, & Allgen, 1982), some aspects of which 
may improve on the GFD (Hallert & Sedvall, 1983), or additional supplementation with pyridoxine 
(Hallert, Astrom, & Walan, 1983). 
In the case of pyridoxine, Morris et al. (1970) "confirmed that pyridoxine deficiency occurs in 
adult celiac disease and that the restriction of gluten from the diet appeared to affect pyridoxal 
levels favourably" (p. 549). Those authors noted that CD patients in another series (Cooke & 
Smith, 1966) had previously "appeared to respond to parenteral pyridoxine therapy", as well as the 
"similarity between the neurological disorder of adult celiac disease and that seen in mood states of 
disturbed pyridoxine metabolism" (p. 549) observed by Cooke and Smith (1966). Delayed and 
reduced uptake has also been noticed upon oral loading in the untreated phase of CD in young 
children, compatible with a shifting ofthe site of absorption away from damaged areas, as well as 
reduced overall absorption (Reinken & Zieglauer, 1978). These results were in agreement with 
earlier data (Reinken, Zieglauer, & Berger, 1976). 
Tryptophan metabolism and serotonin production are certainly dependent on pyridoxine and 
other micronutrients (which function as coenzymes in key steps; Hallert, 1987), with a disruption in 
these processes related to mood disorder in children with CD (Challacombe & Wheeler, 1987; 
Hemanz & Polanco, 1991), even after GFD treatment, and in adults (Hallert, Astrom, & Sedval, 
1982). As noted earlier, clinically significant depression observed in the MMPI profiles of newly 
detected CD patients was refractory to GFD treatment and concomitant folate supplementation, but 
remitted in response to vitamin B6, supplied over a six-month period prior to re-assessment 
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(Hallert, Astrom, & Walan, 1983). A dose of 80mg, at least forty times above the Australian 
recommended daily intake (of l-2mg, depending on age, gender and other factors; Truswell, 1990), 
was used in this study. Hallert (1987) subsequently concluded that "there is good evidence to 
implicate metabolic effects from vitamin B6 deficiency in the pathogenesis of depression in adult 
celiacs" (p. 133). 
It could also be surmised that the body's own production of niacin (partly supplied in the diet), 
which is dependent on adequate tryptophan and vitamins Bi, B2 and B6, may also be compromised 
in CD, increasing the risk of marginal or deficient status, a known factor in the depressive aspects of 
pellagra. Interestingly, dementia is part ofthe "classic triad of pellagra: dermatitis, diarrhea, and 
dementia" (Baron, 2002, p. 1282), the latter beginning "with insomnia, irritability, and apathy", 
progressing to "confusion, memory loss, hallucinations, and psychosis. The diarrhea can be severe 
and may result in malabsorption due to atrophy ofthe intestinal villi" (p. 1282). Although non-
specific, these universally documented effects of niacin deficiency are remarkably inclusive and 
descriptive of those observed in undiagnosed CD, and possibly not incidental in some cases. 
Holmes (1997) also noted that pathological lesions located in the brains of some CD patients may 
be reminiscent of particular deficiency states, including pellagra, the classic niacin (B3) deficiency 
disease (also inclusive of pyridoxine and tryptophan insufficiencies; Pfeifer, 1975), Wernicke's 
encephalopathy, which is primarily caused by a vitamin Bi deficit in alcoholics (Kolb & Whishaw, 
1990), and the generalised avitaminosis status of malnourished prisoners of war. 
Folic acid deficiency has been found in CD (e.g., Hallert, Tobiasson, & Walan, 1981). Although 
low folate has been separately linked to psychiatric disorders, especially depression (Young, 1989, 
1991) and neurological disease (Reynolds, Rothfeld, & Pincus, 1973), it is possibly less crucial in the 
potential development of neural atrophy than other nutritional inadequacies in CD (Collin, Eerola, & 
Pirttila, 1997; Hallert, 1987). The aforementioned finding of raised homocysteine in treated CD cases 
(Hallert et al, 1999) may be symptomatic of decrements in the intake, absorption or metabolism of 
vitamin Be and B12, as well as folic acid, in CD, as indicated by those authors. Cyanocobalamin (B12) 
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status has generally been found to be adequate in the majority of C D patients, or only marginally 
reduced (Holmes, 1997), but was deficient in four out often newly diagnosed patients in a recent 
Scottish series (Dahele & Ghosh, 2001), with levels normalising on the GFD. 
Reduced absorption of iron is usually involved in any of a range of anaemic conditions in CD, 
which together account for one ofthe most common observations at - and principal reasons leading 
to - initial diagnosis. Iron deficiency, also "the most common nutritional deficiency worldwide, has 
negative effects on.. .motor and mental development in infants, children and adolescents" (Looker, 
Cogswell, & Gunter, 2002, p. 2114) and has been implicated in behavioural lability (Lozoff, 1989). 
Its role in mental health in CD requires further investigation. 
Deficiencies of vitamin E have been implicated in neurologic degeneration associated with a 
range of diseases involving chronic fat malabsorption. These include abetalipoproteinaemia (Muller, 
Lloyd, & Wolff, 1983), small bowel resection (see Federico, Battisti, & Dotti, 1997) and cystic 
fibrosis (Sung, Park, Mastri, & Warwick, 1980). Low serum concentrations of vitamin E, secondary 
to impaired fat absorption (which also impacts on vitamin A, D, K and essential fatty acid 
assimilation), have also been found in CD patients, including those with neurological disorders 
(Harding, Muller, Thomas, & Willison, 1982; Muller et al, 1983; see also Holmes, 1997) and may 
be significantly involved aetiologically (Ackerman, 1989; Trabert et al, 1992). In addition, vitamin 
E functions synergistically, as an antioxidant, with the trace mineral selenium (Mindell, 1982). 
Selenium is of considerable importance to human health (Rayman, 2000). Its deficient or 
marginal status has been implicated in lowered mood state during a double-blind crossover trial on 
the standard Profile of Mood States (POMS) inventory (Benton & Cook, 1991) and in a double-blind 
study using the POMS Bipolar form (Hawkes & Hornbostel, 1996), while supplementation has 
reduced intractable seizures in children (Ramaekers, Calomme, Vanden Berghe, & Makropoulos, 
1994; Weber, Maertens, Meng, & Pippenger, 1991). Selenium has also been found to be deficient in 
patients noncompliant with the GFD or in the early stages of GFD therapy (Kalita et al, 2002). It was 
even suppressed in clinically well people on the GFD, compared to healthy controls (Hinks, Inwards, 
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Lloyd, & Clayton, 1984), and in treated Scottish children with C D , in relation to the standard 
reference range for whole blood selenium content (Ward, Arthur, Russell, & Aggett, 1984). 
The fact that lower levels of selenium have been found in CD patients on both a gluten-free and 
unrestricted diet, compared to healthy controls (Cortigiani, Nutini, Caiulo, Ughi, & Ceccarelli, 
1989), suggests that the GFD itself, as well as primary malabsorption, may play a role in reduced 
levels in some patients. Selenium's additional roles in immunocompetence, thyroid functioning 
(which may impact on mood, behaviour and cognitive function; Sher, 2001) and cancer mortality 
(reviewed by Rayman, 2000) underline the range of potential implications of malabsorption, 
deficiencies and under-nutrition in CD on physical and mental health. 
In the case of many micronutrients that may be reduced in CD, such as selenium and vitamin D, 
there is often a narrow range between a marginal or overt deficiency, adequate dietary levels, 
therapeutic doses and potential toxicity, as well as intricate interrelationships and synergy between 
different nutritional co-factors, so any supplementation addition to the GFD needs to be carefully 
medically assessed and monitored. 
Multiple nutritional deficiencies associated with CD pre-diagnosis, especially ofthe B 
vitamins (including, but unlikely to be limited to, B3, Be, Bn, folic acid and B12) and tocopherols 
(vitamin E), major electrolytes (e.g., magnesium and potassium) and other less-studied micronutrients 
such as selenium, may presumably aggravate or even instigate neuropsychiatric problems in some 
CD patients. It is also plausible that the effects may resemble, either clinically or at a neuro-imaging 
level, processes in other types of nutrient malabsorption (e.g., cystic fibrosis), depletion (e.g., 
alcoholism) and deficiency states (e.g., starvation), that lead to protracted avitaminosis. 
The current consensus is that any sustained orthomolecular insufficiencies in CD appear more 
likely to be involved in neurotransmitter dysregulation, in turn associated with decrements in mood 
state (Hallert, 1997), than overt "cell degeneration in brain tissues" (p. 213). In addition to reduced 
uptake or assimilation of vitamin Be, these nutritional shortfalls include "enhanced enteric protein 
loss" pre-diagnosis (Hallert, 1987, p. 131), expressly involving degradation of tryptophan - a 
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marginally available, essential amino acid even under optimal physiological conditions (Chaitow, 
1991) - by gut bacteria (Cluysenaer & Van Tongeren, cited in Hallert, 1987), probable mineral 
deficiencies other than selenium and iron and the likelihood of marginal status in relation to many 
vitamins. Use of therapies additional to the GFD, including supplementary dietary regimes, were 
noted in the interviews of all CD participants and their healthy and disease control counterparts in 
the present thesis, in view of their potential effect on health and mood state and the previously 
identified therapeutic role of pyridoxine in CD (Hallert, Astrom, & Walan, 1983). 
In the preceding decade in Australia, it was estimated from community samples that 25.8% of 
Australians (30.3% of women and 21.3% of men) used vitamin or mineral supplements in the 
fortnight prior to interview (National Health Survey, 1995), compared to about 40% of United States 
citizens in similar surveys (Ervin, Wright, & Kennedy-Stephenson, 1999). In another representative 
survey of South Australian residents in 1993 (MacLennan, Wilson, & Taylor, 1996), 48.5% of 
respondents reported using at least one non-medically prescribed alternative medicine in the 
preceding year, with non-prescribed vitamin use most commonly reported (41.2% of females and 
33.8%o of males). Given moderately and possibly increasing use of vitamin use in Australia 
(Australian Institute of Health and Welfare, 2000) and potential roles for vitamin supplementation as 
an adjunct to GFD treatment in CD patients with refractory depression, the incidental level of 
supplement use among local CD patients, compared to healthy controls, was considered especially 
noteworthy, and was monitored in the present thesis. 
It should be noted that not all CD researchers perceive nutritional deficiencies to be a key factor 
in observed neuropsychiatric complications. For example, Magauddu et al (1997) remarked that "no 
correlation between the neurologic disorder and a nutritional deficiency could be established" (p. 
127) in a number of reports and studies (e.g., Cook, 1976; Collin et al, 1991). These authors 
favoured "the hypothesis of a common genetic origin for CD" (p. 128) and neurological disorders, 
ahead of nutritional and other causes. However, aetiological models and evidence for other 
pathways leading to neural dysfunction in CD are relatively scarce at present. 
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Federico, Battista, and Dotti (1997) made reference to a multi-faceted model of neuroaxonal 
degeneration in psuedoglutaric aciduria II, inclusive of concepts of nutrient malabsorption, as well as 
immunological abnormalities, toxins, environmental stress and genetic background, which may have 
some utility in discerning the range of potential pathologic mechanism in CD-related neurological 
impairment, where this occurs. It is possible that each of these mechanisms may play a role in 
isolation or in coalition, with the emphasis of one or several accentuated in individual cases. 
Depressive Symptomatology, Mood and Anxiety Spectrum Disorders 
Four decades ago, Sheldon (1959) noted that there was "little to add to [Gee's 1888] clinical 
account" (p. 132) in the diagnosis of CD over the "passage of 70 years", except greater awareness "of 
the psychologic disturbances that may accompany physical disease; certainly the unhappiness ofthe 
celiac child is a very typical feature ofthe fully developed disease" (p. 132). Most recently, and two 
decades after confirmation of Goldberg's (1970) observation of depression as the key psychological 
complaint in CD (Hallert & Astrom, 1982), Hallert et al. (2002) concluded that "depressiveness 
appears to be by far the most common neuropsychiatric complication among treated adults" (p. 42), 
in line with Holmes' (1997) and Carta et al's (2002) findings. 
Nevertheless, unravelling genuine causality and underlying associations between mood or 
mental state, potential neuro-radiological or -functional (e.g., neurotransmitter level) correlates, 
nutritional status, GI symptomatology and other possible indices of pathogenesis or physical markers 
of CD, remains a complex task. As noted by Goldberg (1970), in the case of diarrhoea - which is 
common in CD pre-diagnosis - a "well-known psychophysiological relationship" with mood exists, 
but "what causes what" (p. 462) is unclear. A finer grained analysis by that author in 46 patients with 
idiopathic steatorrhoea, 23 patients with Crohn's disease and 11 patients with alactasia demonstrated 
that "diarrhoea is neither sufficient nor necessary for psychiatric illness" (p. 462). 
Furthermore, Hallert and Astrom (1982) found "no distinct relationship between abdominal 
complaints - mostly diarrhoea... and pain..." (p. 23) and depression in their aforementioned study of 
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12 newly diagnosed C D patients (8 w o m e n and 4 men), although a positive correlation was found 
between the degree of steatorrhoea and depression, as noted. Significantly, "early signs of mental 
depression" have also been observed in malabsorption syndromes other than CD, including those 
involving fructose (Ledochowski, Sperner-Unterweger, Widner, & Fuchs, 1998) and lactose in 
females (Ledochowski, Sperner-Unterweger, & Fuchs, 1998). Regarding fructose malabsorption, 
Ledochowski, Widner, Bair, Probst, and Fuchs (2000) reported that depression scores (using Beck's 
Depression Inventory; BDI) decreased by 65.2%) on a fructose- and sorbitol-reduced diet after four 
weeks, with the majority of 53 adults showing mild to moderate mood disturbance (BDI score > 11) 
prior to dietary intervention, which those authors associated with decreased serum tryptophan 
concentrations. Their results highlight both the possible impact on mood of malabsorption of 
nutrients concomitant with disordered digestion in a general sense and the considerable potential 
difference in mood pre- and post-dietary intervention. 
During the preceding decade, the existence of depression in CD was corroborated, irrespective 
of aetiology, as a significant issue at several centres throughout Europe, including Germany, the 
United Kingdom and Italy. In a large scale Italian project specifically investigating neuropsychiatric 
symptoms in the clinical pattern of CD (Bottaro et al, 1997), data from 550 children with CD (age 
range 7 months to 17 years) were collected. These authors found that behavioural disturbances 
frequently presented as an associated symptom at diagnosis. Children less than two years of age 
often presented with irritability and muscular hypotonia, simulating a peripheral neuropathy, while 
obsessional neuroses, apathy, epileptic seizures and cerebral calcifications occurred in older children 
at levels greater than chance. 
Vaitl and Stouthamer-Geisel (1992; cited in Hallert, 1997) posted the Hopkins Symptom Check 
List (SCL-90R) to 182 adult members (mean age 45 years) ofthe German Coeliac Society. Hallert 
reported that in the experience of one in two members of that series, their pre-existing CD symptoms 
(before diagnosis) had been attributed to psychological causes, leading to pharmacological treatment 
in 32% ofthe sample and psychotherapy in 14%. These observations are clearly acutely relevant to 
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clinical and health psychologists, mental health care professionals in psychiatry, and general medical 
practitioners, who are all likely to come into contact with undiagnosed CD cases in hospital settings, 
community outpatient settings, and general or private practice. Hallert reported Vaitl and Stouthamer-
Geisel's (1992) precis that "coeliacs are apt to show a distinct "psychovegetative" state of exhaustion 
featuring a depressive component", and "found that patients who had gone unrecognized" as having 
CD "for many years, or were unable to maintain a strict GFD" once identified, "were particularly at 
risk of showing symptoms of mental ill-health and to report more pronounced psychological 
complaints" (p. 212). 
Holmes (1997) noted that, in the United Kingdom, depression (at 10.1%), epilepsy (3.6%), 
migraine (3.1%), anxiety (2.3%), self-poisoning and carpal tunnel syndrome (each 2.1%) were the six 
most common psychiatric or neurological disturbances among 388 patients with CD attending the 
Derbyshire Royal Infirmary. In recent Italian research, 92 consecutive adult CD patients (M age = 29 
years, 76% female) on the GFD for an average of 7.9 years and 48 Hepatitis C patients (serving as 
"chronic condition controls") were compared with each other, and 100 normal subjects, on a modified 
version ofthe Zung Self-Rating Depression Scale (Ciacci et al, 1998). Three items "evaluating 
gastroenteric symptoms of depression" (p. 247; i.e., decreased appetite, weight loss and constipation) 
on the Zung were omitted to avoid bias due to CD. Results indicated a strong group effect on 
depression, with mean scores differentiating CD patients (M = 31.81, SD = 7.84) from normal 
controls (M = 27.14, SD = 5.26) upon post hoc analysis (p. < .0001), and CD scores also significantly 
lower (p = .038) than those of Hepatitis C patients (M = 28.73, SD = 7.09). 
Notwithstanding these statistical differences, it is evident that the greatest mean group score 
difference of 4.67 (between the CD and normal control groups) represents an average item score 
difference of 0.27 (i.e., 4.67 divided by 17 items), in relation to possible item scores of 1 to 4 for 
each item, with a higher score corresponding to a greater experience ofthe particular symptom of 
depression described by each item. From a clinical perspective, it is arguable that the differences 
identified by Ciacci et al. are relatively small (with the mean normal control score equal to 85% of 
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the C D score). Differences in the proportions of C D patients above a certain threshold of depressive 
symptomatology (compared to the control groups) are perhaps more meaningful. Indeed, while cut 
scores using the Zung were not provided by Ciacci et al, they reported that depression affected "at 
different levels, about one-third of coeliacs, in contrast to 1 in 10 [Hepatitis C] patients", suggesting 
"that depressive symptoms are better related to the characteristics of CD than to a general chronic 
disease condition" (p. 249). Age at diagnosis, duration of and compliance with the GFD did not 
correlate with depression in the CD patients. A trend towards an inverse correlation was reported 
between depression and the CD patients' level of knowledge about CD, prompting those authors to 
tentatively remark that "depressive symptoms may prevent patients from reaching a high level of 
knowledge ofthe disease or, conversely, that a good level of knowledge about the disease could play 
a role in reducing the depression level" (p. 249-250). 
Ciacci et al reported that "both 'psychologic' and 'biologic' scores were able to distinguish CD 
patients well" (p. 249) from normal controls (p < .00001 and p < 0.0002 respectively), but "within 
the CD group the analysis failed to show a significant difference [between psychologic and biologic 
scores]" (p. 249). Ciacci et al's conclusion that the psychologic - compared to the co-occurring 
biologic - mechanisms underlying depressive symptomatology were "probably. ..in our sample, 
predominant" (p. 250) appeared to be an over-interpretation ofthe results in relation to the evidence 
provided. However, their depth of analysis drew attention to the important question ofthe degree to 
which either somatic/ affective or cognitive factors, or an equal combination of both, underlie the 
increased prevalence of depression and heightened intensity of depressive symptomatology 
frequently reported in CD, 
As noted earlier, Hallert and Astrom (1982) had previously reported a slight relative increase in 
the Harris subscales Dl to D3 (i.e., Psychomotor Retardation, Physical Functioning and to a lesser 
degree Subjective Depression), more so than Mental Dullness or Brooding, compared to controls 
and Psychomotor Retardation over Subjective Depression within the CD group, using the MMPI. It 
appeared that somatic, rather than cognitive, indications of depression were possibly of slightly 
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greater clinical significance in that sample, although neither the Harris subscales nor the M M P I was 
designed to make these distinctions. 
In a smaller study, Gasbarrini and Addolorato (1998) compared anxiety and depression in ten CD 
patients with the same number of inflammatory bowel disease (IBD) patients and healthy volunteers 
The tests used were the State-Trait Anxiety Inventory and IP AT Depression Scale Questionnaire and 
chi-square analyses were undertaken. A large number of physiological functions were also measured 
(e.g., serum electrolyte levels). Unfortunately, it was not reported for how long the CD or IBD 
patients had been treated. Gasbarrini and Addolorato (1998) noted a trend, although not a statistically 
significant difference in anxiety levels across groups. Participants in the CD group were significantly 
more depressed than healthy controls but not statistically more depressed than IBD patients, 
notwithstanding another reported trend. 
Gasbarrini and Addolorato (1998) concluded that "the anxiety and depression found in coeliac 
patients could be secondary to a reduced neuronal production of monoaminergic substances, a 
mechanism currently implicated in the pathogenesis of behavioural disturbances, and to the 
emotional reaction to the symptoms of disease which often determine a reduction in the quality of 
life.. .It would therefore always be advisable to evaluate not only clinical, laboratory and biopsy 
parameters in these patients but also carry out a psychometric evaluation to determine the level of 
anxiety and depression and to distinguish between 'reactive' and 'trait' forms" (p.352-353). In a 
study reported earlier (Addolorato et al, 1996), using the same measures but a higher number of 
participants from the same three groups of patients (n = 16), state but not trait anxiety was more 
common in CD and IBD patients compared to healthy controls and depression was present in a 
greater percentage of CD patients, compared to healthy controls. 
Recent, longitudinal findings at the same centre showed that almost half of a newly diagnosed 
Italian adult CD group (14 males, 21 females; M age = 29.8 years, SD = 7.4) remained depressed 
after one year on the GFD, compared to only one in ten healthy controls (Addolorato et al, 2001). 
Those authors used a cut-score of 37 on a modified version ofthe Zung Self-Rating Depression Scale 
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(used by Ciacci et al, 1998, as mentioned above), which corresponded to a point score of 49 on the 
full Zung Scale, considered high and conferring a positive predictive value of a diagnosis of 
depression in about nine out often people (Magruder, Norquist, Feil, Kopans, & Jacobs, 1995). 
Addolorato et al's findings suggest that depression may, like anaemia, be very common in CD 
pre-diagnosis but, analogous to the aforementioned finding of refractory osteopenia in a significant 
percentage of cases (Kalayci et al, 2001), resistant to early GFD treatment in the absence of additional 
dietetic, psychiatric or psychological therapies. In contrast to results pertaining to depression, the 
percentage of CD patients with high levels of state anxiety (71.4%) decreased significantly, compared 
to controls, after one year on the GFD (to 25.7%), with a cut score of 40 on Spielberger's State-Trait 
Anxiety Inventory used to designate high or low anxiety. No difference between CD patients and 
controls was observed in trait anxiety, and the percentage of CD patients displaying high trait anxiety 
was essentially unchanged after one year ofthe GFD (25.7% versus 17.1%). 
Finally, the most recent research (Carta et al, 2002) has found an increased prevalence of 
several psychiatric disorders in 36 adult CD patients compared to healthy controls, notably Major 
Depressive Disorder, Dysthymic Disorder, Panic Disorder and Adjustment Disorder, using DSM-IV 
criteria and the Italian version ofthe composite international diagnostic interview (Robins, Wing, & 
Wittchen, 1989). Carta et al. (2002) implicated subclinical thyroid disease as a "significant risk 
factor" (p. 789) for psychiatric disorders in CD, in addition to the role of autoimmunity in general, 
"severe dietary deficits", age of onset of CD and "environmental stress" (p. 791). 
In summary, there are many possible causes of depression in CD. These include general 
biological susceptibilities and endogenous mechanisms related to nutritional deficiencies and/ or 
immunological factors, primary psychiatric symptomatology associated with aspects of concomitant 
physical illness specific to CD and secondary psychological reactions connected with uncertainty 
about the cause of physical illness pre-diagnosis and the ramifications of CD, including the personal 
and social implications associated with sustaining the GFD post-diagnosis. 
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Substance U s e in Coeliac Disease 
Vaifl and Stouthamer-Geisel (1992; cited in Hallert, 1997) found that in half of a large series of 
182 adult German Coeliac Society members, symptoms of ill-health prior to CD diagnosis were 
assessed as having a psychological cause, leading to pharmacological treatment in one in three of 
these respondents. Since depression is generally more common in CD and antidepressant 
medication is typically the treatment of choice by general practitioners (Harris & Penrose-Wall, 
2001), the German findings may be pertinent to CD populations locally in Australia and elsewhere. 
Among 388 patients attending a clinic in the U.K., Holmes (1997) noted eight cases (i.e., 2.1%) 
of self-poisoning, a finding congruent with greater medication misuse among most populations in 
which the rate of prescriptions for drugs are increased due to an increased diagnosis of mood 
disorders (Andrews, Hall, Teesson, & Henderson, 1999; Tippett, Elvy, Hardy, & Raphael, 1994) 
Indications in the CD literature that people with CD have an increased likelihood of use or abuse of 
prescribed, or for that matter illicit drugs, or alcohol, are lacking and may be unlikely, outside of 
the context of pharmacological treatment for mood disorders. 
An interesting recent finding in Argentine CD patients was "a positive linear correlation between 
the age at diagnosis and the estimated daily cigarette consumption in active smokers" (Vazquez, 
Maurino, & Bai, 2002, p. 1258). Most ofthe few studies undertaken indicate a lower prevalence of 
smokers among CD patients compared to age- and sex-matched controls or community levels (e.g., 
Snook et al, 1996; Vazquez et al, 2001, West et al, 2002). Perhaps this is related to the fact people 
with CD struggle enough with their health pre-diagnosis without compounding their ill-health by 
smoking, and following diagnosis are more health conscious. In any event, a large scale Australian 
community survey indicates that cigarette smoking - in addition to its relationship with physical ill-
health (AIHW, 1996) - is associated with poorer mental health, including depression (Jorm et al, 
1999), even after controlling for other well known mediating correlates. Therefore, a reduced 
incidence ofthe habit in CD patients is a positive finding. Cigarette, alcohol, prescribed and illicit drug 
use, based on self-report, were recorded in the histories of all participants in the present thesis. 
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Neuropsychological Observations 
Given that neurological complications have been reported in as many as one third of CD patients 
(Banerji & Hurvitz, 1971), there have been few studies investigating the neuropsychological impact 
of CD. Pavone, Mazzone, Incorpora, Drago, and Bottaro (1997) investigated a wide range of 
cognitive abilities in children with CD. They retrospectively compared two groups, one on a strict 
GFD (69 children) and another "not completely compliant" (p. 291) group (51 children). 
Compliance was assessed via blood testing for markers of gluten ingestion. A control group of age-
matched children without clinical signs of GI, nutritional or metabolic disease was also included. 
These authors failed to find evidence in the CD group of neurological or psychiatric problems, but 
found significant relative impairment in the non-compliant CD group in visual discrimination ability 
and short-term memory. There were not significant differences in mean WISC-R intelligence 
quotients between the groups. Given the cross-sectional design, it was not possible to determine 
whether the non-compliant CD group's specific identified deficits were attributable to, or preceded, 
non-compliant dietary behaviour. 
Using the revised Wechsler Intelligence Scale for Children and the Rey-test, Pavone, Mazzone, 
Incorpa, Drago and Bottaro (1997) found visual discrimination and short-term memory deficits 
using the latter instrument in a small subgroup of children with CD, compared to healthy controls, 
"with a slightly more significant occurrence of impairment of these abilities in patients not 
compliant with the [GFD]" (p. 292). Other cognitive skills were unaffected. 
Pavone et al's (1997) results were noteworthy, but the significant results pertained to a sample 
of just nine CD patients, compared to twenty control participants. Therefore, the possibility of a 
chance finding is increased. Dementia is uncommonly associated with CD (Holmes, 1997) and, 
accordingly, there was an absence of distinctive signs of intellectual dysfunction in a detailed study 
of untreated Swedish CD patients (Hallert & Astrom, 1983) and in 25 out of 26 Italian CD patients 
(De Maria, Gorno, Cappa, Guarneri, & Antonini, 1997). 
Hallert and Astrom (1983) studied a consecutive series of 19 untreated, middle-aged Swedish 
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patients ( M = 48 years, S D = 11; 12 females and 7 males), w h o were under investigation and 
later found to have confirmed CD, with a comprehensive psychometric test battery sensitive to 
neurological illness. That study's results were not suggestive of organic brain disease in CD, at 
either a group or individual level, notwithstanding that 4 out of 19 patients (i.e., 21%) had an overall 
pattern of scores falling in the borderline range. The mean scores for all tests fell within one 
standard deviation ofthe general population range, based in most cases on the conversion of scores 
to a stanine scale. In summary, those authors found "no consistent signs of cognitive impairment" 
(p. 87) and "unaffected intellectual ability" (p. 88). The performance ofthe 8 patients "with overt 
illness in their childhood" (p. 88) was indistinguishable from the remaining 11 patients in that series. 
De Maria et al. (1997) used tests geared to the detection of posterior impairment, including 
Benton's Judgment of Line Orientation test and the Rey-Osterrieth Complex Figure (see Spreen & 
Strauss, 1991) in their assessment of 26 Italian CD patients. All except one patient performed at a 
level within expected margins. However, those authors also found that all five of another group of 
patients - having both CD and epilepsy - returned scores in the abnormal range in Benton's test 
and three out of five scored below normal on the Rey. These two tests have previously been found 
to best discriminate between patients with early to mid-stage Huntington's disease, in which 
posterior impairment has emerged, and healthy controls (Grech, 1993). 
In a review of dementia, cognitive impairment and brain atrophy in CD, Collin, Eerola, and 
Pirtilla (1997) published a list of 17 CD patients with known dementia or brain atrophy, noting the 
degree of cognitive impairment (i.e., mild to severe and/ or progressive) associated with each case. 
They noted that peripheral neuropathy was the "most frequent" neurological symptom (p. 285), 
while brain atrophy was often localised in the "cerebellum, deep grey and brain stem nuclei, and 
spinal cord tracts" (p. 286), with "progressive cerebellar disease" also referred to in relation to 
other small series. 
In bilateral cerebellar-damaged patients without CD, various indices of speed of information 
processing, movement time and reaction time have been lowered in several studies (see Botez, Botez, 
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Elie, & Attig, 1989; Botez-Marquard, Botez, Cardu, & Leveille, 1989; Ivry & Keele, 1989), with 
"the role of subcortical structures in speed of information processing" well recognised (Beaumont, 
Kenealy, & Rogers, 1996, p. 202) and higher cortical associations likely (Schahmann, 1991) 
Memory impairment was reported by Luostarinen, Pirttila, and Collin (1999) in their series of 
CD patients with neurological symptoms, while Biirk et al. (2001) found "moderate verbal memory 
and executive dysfunction" (p. 1013) in the subset of sporadic cerebellar ataxia patients with gluten 
sensitivity. In summary, given that "cerebellar damage is commonly reflected in problems of fine 
motor control, coordination, and postural regulation... some aspects of sensory processing, 
perceptual discrimination, motor learning and emotionally toned responses" (Lezak, 1983, p. 46; 
see also Watson, 1978), links appear to emerge regarding the abovementioned psychometric 
findings of decreased visual discrimination ability and short-term memory, and general 
observations of increased depression in CD. Additional effects of damage to the cerebellum include 
"weakness and a tendency to fatigue" (Kolb & Whishaw, 1990) - symptoms often observed post-
diagnosis in CD - which may also be elements of otherwise unaddressed depressive illness in CD 
(Hallert, 1997). Teasing apart respective contributions of neurological damage and clinical 
depression in the neuropsychological sequelae of CD is therefore problematic. 
Considered together, the neuro-imaging, psychiatric, orthomolecular, psychological and case 
study perspectives lead to the conceivable notion of a continuum regarding the potential 
neuropsychological performance or status of CD patients. It appears that global functioning remains 
relatively intact in the majority of patients, but dysfunction ranging from subtle to severe may 
emerge in the event of untreated or more severe cases of CD, with some ofthe changes reflected in 
functional pathology, cerebral atrophy or other structural changes. Collin, Eerola, and Pirtilla (1997) 
acknowledged the likelihood of "multifactorial" aetiologies underlying any "neurological 
complications in CD" (p. 288), further remarking that "a cross-sectional study ofthe intellectual 
ability of new and earlier diagnosed CD patients is needed" and "the impact ofthe GFD on 
intellectual ability must be evaluated" (p. 288). 
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The evaluation of fine gradations in neuropsychological functioning, including abilities in 
distinct areas such as verbal comprehension, perceptual organisation, working memory and 
processing speed, was indeed undertaken in a large adult CD sample, compared to two comparison 
groups, in Study 1 ofthe present thesis. Preliminary results using healthy controls have been 
previously presented (Grech et al, 2000). One year follow-up assessment of a smaller subgroup, 
newly diagnosed with CD at entry into Study 1, is discussed in Study 2. 
Health Status and Quality of Life in Coeliac Disease 
Perceived health status and quality of life (QOL) in chronic illness became the subject of 
increasing research in the preceding decade (Walker & Rosser, 1990), with GI illnesses, including 
inflammatory bowel disease (ulcerative colitis and Crohn's) the subject of considerable interest 
(Kiinsebeck, Korber, & Freyberger, 1990). In Danish inflammatory bowel disease patients, 
perceptions of diminished life quality were reported in relation to disease exacerbation, but not 
everyday life, compared to controls with acute short-term illness (Sorenson, Olson, & Binder, 1987). 
In treated CD patients, subjective health has been found to be slightly decreased, although only in 
females (Hallert et al, 1998), perceived disease burden was increased, albeit again exclusively in 
females (Hallert et al, 2002) and female adolescent CD patients report more physical complaints 
(Kolsterman, Koopman, Schalekamp, & Mearin, 2001). Psychological general well-being was 
reduced in CD patients, regardless of gender, before and well beyond one year after adoption the 
GFD, but not at precisely one year post-diagnosis in Finnish patients (Lohiniemi et al, 1998). 
In their study of QOL in CD, Lohiniemi et al (1998) stated that "the life of a coeliac disease 
patient may be full of contradictions between the difficulty of following the diet and the possibility 
of complications following an incomplete diet" (p.12). They approached the task of generating a 
QOL measure relevant to CD by dividing the concept into two aspects: "objectively measurable 
welfare" (with the concept of health or a disease appearing as signs), and "subjective well-being" 
(symptoms). Specifically, Lohiniemi and colleagues assessed psychological general well-being (via 
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a standardized schedule), GI complaints (via the Gastrointestinal Symptom Rating Scale), self-
expressed quality of life and self-expressed general health in two groups of CD patients, one assessed 
cross-sectionally and the other followed longitudinally for one year. These were 188 adults coded as 
CD patients in the membership register ofthe Finnish Coeliac Society who had followed the GFD 
for 7.6 years on average, and 39 newly diagnosed CD patients at the Department of Medicine in 
Tampere University Hospital. A third, control group consisted of 108 randomly selected, non-coeliac 
Finnish adults. 
The cross-sectional study showed that GI complaints remained common for CD patients on a 
GFD, while the longitudinal subjects initially reported a marked reduction in GI symptoms, with the 
symptoms almost reappearing to pre-diagnosis levels over time. Similarly, psychological well-being 
improved significantly following diagnosis and adoption ofthe GFD (rising from well below to above 
normal levels), but diminished over time (to well below normal levels). One could conclude that 
while the GFD is critical in treating CD, it may not quite be the total cure hoped for. Indications are 
that the psychological outcomes of CD are complex and separating reactive versus intrinsic factors is 
not straightforward. 
In a not unfamiliar tale in Bennett's compilation of patient perspectives touched on earlier, an adult 
patient reported that pre-diagnosis "no one understands that when you are hanging on to your life by 
your fingertips, you either give up or try everything you can to find an answer" (p. 65). Although 
angst, signs of depression, and eroded life quality evident in many of Bennett's narrative case histories 
were accompanied by resilience and spirit in the face of relentless ill health, relief and newfound hope 
just after diagnosis may wane as new realities dawn. These include maintaining a strict diet, managing 
CD-related complications (e.g., osteoporosis) and other fresh challenges (e.g., weight gain), as well as 
the normal everyday pressures of life. Although prevailing in the battle with CD may assist some 
patients to cope better psychologically after the honeymoon period of improved health, the possible 
effects of CD on physical systems (e.g., thyroid and adrenal function) and psychological state (e.g., 
reduced self-worth) may leave a legacy, increasing vulnerability to stress and reducing life quality. 
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In a further study examining psychological general well-being using the Psychological General 
Well-being questionnaire and the Gastrointestinal Symptom Rating Scale, Mustalahti, Lohiniemi, 
Collin, and Maki (2000) found that psychological general well-being improved in 20 silent CD 
patients (M = 105.4 to 115.6; possible score range of 22-132) and in 20 clinically diagnosed patients 
(M= 93.3 to 112) after one year on the GFD, compared to just before GFD intervention. The extent 
of GI symptoms also decreased in both groups in that time. Those authors proposed that screening 
for CD in healthy family members was therefore warranted on the basis of improvements in QOL 
Hallert et al. (1998) assessed subjective health status in 89 adult CD patients (61% female), treated 
with the GFD for 10 years and in clinical remission, using the Short Form 36 Health survey (SF-36; 
Swedish version). Those authors found that CD patients, as a group, scored significantly lower than 
5277 age-matched, gender-balanced Swedish adults comprising a normative group in only two ofthe 
eight scales, General Health and Vitality, each of which "measure both physical and mental aspects of 
health" (p. 934). Three each ofthe remaining six scales (none of which significantly differentiated the 
CD group from normative scores) were indices of either physical or mental health. 
Neither age nor GFD compliance impacted on the results. However, upon gender breakdown, the 
difference between CD patients' and normative scores was actually confined to female CD patients, 
who scored significantly lower within the General Health, Vitality and Role Emotional domains, 
"suggesting poor subjective health and excessive tiredness that tend to interfere with daily activities" 
(p. 934) and most pronounced in middle-aged women. Among male CD patients, the picture was 
reversed across most scales, with scores for Bodily Pain and Social Functioning actually lower and 
higher respectively compared to population norms. 
Although no differences were reported in the mean SF-36 scale scores between CD patients in 
histologic remission compared to those with ongoing, gluten-related mucosal abnormalities, a 
negative correlation was found, regardless of gender, between subjective well-being and GI 
symptoms, using the Gastrointestinal Symptoms Rating Scale. 
The salient finding of reduced subjective health among female, in contrast to male, CD patients 
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was tentatively attributed, at least in part, to contextual social factors, such as the greater likelihood 
of males having "their meals cooked by someone else" (p. 937). Notwithstanding the tendency 
towards equalisation of domestic duties across gender worldwide in western cultures, at least among 
younger age groups, this possibility is intuitively appealing in light ofthe present author's anecdotal 
observations of Australian CD patients. Local patients' eating habits certainly also parallel the 
broader societal mores, in which the responsibility regarding food preparation is typically assumed 
by women, at least in older age groups. This reality is pertinent to the spouses of middle-aged or 
older men with CD and the mothers, in-laws and relatives of younger men with CD, with the men 
perhaps perceiving their coeliac needs as readily accommodated and catered for by others, while 
female patients assume an inordinate responsibility which may be more easily felt as a burden 
With wider, superorder issues in mind, Hallert et al. (2002) further investigated whether women's 
lower level of subjective health "could be explained by differences in the perceived disease burden" 
(p. 39), comparing 34 men with CD and the same number of age-matched women, all diagnosed 8-
12 years earlier, treated with the GDD and in clinical remission. Those authors also used a matched 
group of type-2 DM patients as controls, also treated for 10 years. The Burden of Illness protocol 
utilised is detailed in their paper, with the 9 items "constructed in order to assess relevant non-cost 
aspects ofthe perceived burden of illness" (p. 40). Hallert et al. found that CD patients were 
"convinced to a similar degree that keeping to the gluten-free diet was the key to health" (p. 41), 
regardless of gender, and there were no significant differences between people with CD or type-2 
DM, despite Hallert et al's reasonable assertion that "in clinical terms, diabetes is a more serious 
condition than being coeliac" (p. 41). However, with the CD group, female patients were 
significantly "less satisfied with the outcome at 10 years" (p. 39) than males. This was reflected in 
their significantly higher Burden of Illness sum scores, suggesting "that the subjective poor health in 
otherwise well-treated coeliac women is closely associated with the perceived disease burden" (p. 
41). Notable aspects of reduced satisfaction among women were related to "the need to gain more 
knowledge about the disorder, the interference with socialising with friends at work and at leisure, 
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the demand to have to abstain from important things in life and the possibility that their children 
could get the disorder" (p. 41). 
Specific explanations of disease burden proposed by Hallert et al. to explain the evident 
"perception of restriction" (p. 41) included "an intense feeling of being diverse, this being particularly 
true for coeliac women" (p. 41) and "bitterness at not being diagnosed earlier in life" (p. 41), 
expressed by both male and female CD patients, and partially interpreted by those authors as possibly 
being connected with the likelihood that "early diagnosis implies better outcome" (p. 41) in CD, as is 
true in the case in many medical conditions. The experience of greater GI symptomatology among 
treated female CD patients (Hallert et al, 1998) was also regarded as a key underlying reason for 
higher levels of female dissatisfaction and distress. No gender differences were noted among the 
type-2 DM patients. 
Health status and quality of life, knowledge of CD (clearly regarded by Ciacci et al, 1998, and 
Hallert et al, 2002 as related to QOL) and multidimensional health locus of control were all 
investigated in CD patients in the present thesis, as detailed in Chapter 5 - Study 1. The chapter 
which immediately follows provides an overview ofthe psychological sequelae (cognitive 
functioning, affect and QOL) previously observed in DM patients, selected to provide a chronic 
illness comparison group in relation to the range of assessment undertaken in the cross-sectional 
and longitudinal CD groups (Study 1 and 2). 
Synopsis of Psychological Factors in CD 
Reviewing previous studies relevant to the psychology of CD, depression stands out as the 
most prominent psychiatric disorder associated with the illness. Swedish, Italian and British 
research all converge upon this seemingly universal conclusion. The slight to moderately increased 
prevalence of generalised depressive symptomatology, compared to expected community levels, is 
heightened prior or close to diagnosis, and tends to increase in association with correlates of more 
overt or severe GI illness, but not in any consistent way. Given the relationship and overlap 
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between depression and anxiety, it not surprising that psychometric evidence ofthe reactive form 
ofthe latter may also accompany depression at the time of diagnosis. State anxiety normalised 
after sustained implementation ofthe GFD and regression of physical symptoms of CD, while 
Finnish researchers reported an increase in psychological general well-being - to above-average 
community levels - one year after GFD therapy. This was partly attributed to a sense of relief at 
receiving medical confirmation ofthe genesis of physical ill-health (see also Ciacci et al, 2002), 
which may have temporarily accentuated the level of subjective mental health in a positive direction 
Indeed, the cross-sectional picture was less positive, with psychological general well-being found to 
be reduced after many years on the GFD. In a broader sense, "the medical characteristics of a disease 
may show only a modest correlation with those perceived by patients" (Hallert et al, 1998, p. 41-42, 
in reference to Maes, Leventhal, & DeRidder, 1996), with the inconsistent associations between the 
physical and psychological features of CD perhaps more easily understood in this context. 
Evidence has been presented in this chapter that disabling clinical depression may predate the 
diagnosis of CD by many years (Hallert, 1984; Vaitl and Stouthamer-Geisel, 1992) and two studies 
(Addolorato et al, 2001; Hallert, Astrom, & Walan, 1983) are in agreement that signs of depression 
are, to a significant degree, refractory following diagnosis, at least without additional nutritional 
therapy, over and above the passage of time. 
The question of whether somatic, cognitive or multifactorial dimensions of depression underlie 
the lowered affect in CD remains open. Ciacci et al's (1998) study was inconclusive in this regard, 
while Hallert and Astrom's (1982) findings, although not geared to shed light on this issue, provided 
an indication that somatic factors may be somewhat more prominent. This hypothesis is subject to 
systematic investigation in the present thesis, via the use of psychometric analysis equipped to 
answer this question. 
Empirical support for the hypothesis of a "distinct depressive mood [in CD] that is separated 
from reactions to being medically ill" (Hallert, 1987, p. 129) has been presented using physiological 
evidence (Hallert, Astrom, & Sedval, 1982) indicating reduced central monoamine metabolism in 
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C D in relation to nutrient malabsorption, and by means of studies utilising chronic illness control 
groups (e.g., Ciacci et al, 1998; Gasbarrini and Addolorato, 1998; Hallert & Astrom, 1982). These 
results support suggestions that "depressive symptoms are better related to the characteristics of CD 
that to a consequence of being affected by a chronic disease condition" (p. 505). 
Quality of life, while not studied as extensively as depression in CD, has been observed to be 
slightly lowered among treated patients, compared to community levels, but only amongst females 
(Hallert et al, 1998). The perceived burden of illness was not higher compared to type-2 DM 
patients, but, within the CD group, women were less satisfied with the outcome following sustained 
GFD adherence than males (Hallert et al, 2002). 
A breakdown and verification ofthe specific factors involved in the reduced QOL reported in CD 
is required, in addition to "a cross-sectional study ofthe intellectual ability of new and earlier 
diagnosed CD patients" (Collin, Eerola, and Pirtilla, 1997, p. 288), notwithstanding relatively intact 
intellectual functioning in a small group of untreated CD patients with evidence of lifelong intestinal 
malabsorption (Hallert & Astrom, 1982). Isolated findings of visual discrimination and short-term 
memory deficits (Pavone et al, 1997) suggest the need for further research. Furthermore, the "the 
impact ofthe GFD on intellectual ability" (p. 288) has not been evaluated, but is one ofthe key 
undertakings of this thesis. The relatively newly diagnosed CD patients assessed in Study 1 (Chapter 
4) formed the cross-sectional sub-group re-evaluated in Study 2 (Chapter 5), using standard protocols 
to be outlined. 
Other aspects of psychological functioning in CD, such as health locus of control and anger, have 
not previously been investigated and form part ofthe assessment of CD patients in Studies 1 and 2. 
The predominance of "case reports and small, uncontrolled studies" in this area has been noted 
recently (Wills, 2000) and so the use of two comparison groups, including people with, and without, 
another distinct chronic illness was considered essential in building upon the body of CD research 
reported thus far. The next chapter outlines prior psychological research pertaining to the chronic 
illness comparison group selected for use in the present thesis. 
Psychological Sequelae in C D 
Chapter 3: Psychological Aspects of Diabetes Mellitus 
Selection of a Disease Comparison Group 
Several studies examining health-related perceptions and behaviours in CD have used chronic 
illness comparison groups. These include a 10-year follow-up study ofthe burden of illness in 
CD, which compared 68 people with CD and the same sized sample of people with age- and sex-
matched type-2 diabetes (Hallert et al, 2002), as discussed in the preceding chapter. Another 
study investigated the relationship between cigarette smoking and CD in 87 CD patients, using 
174 age- and sex-matched individuals diagnosed with functional GI disorder (Snook et al, 1996) 
However, "the difficulty in finding a proper control group sharing key features with CD" has been 
conceded (Hallert et al, 2002, p. 42) 
Only a minority of studies investigating psychological functioning in CD have in fact used 
either chronic illness or healthy control groups, and very few have used both. Two reported in the 
literature are a large scale study (Ciacci et al, 1998) which compared the extent of depressive 
symptomatology in people with CD (n = 100), people without a chronic illness (n = 100) and 
Hepatitis C patients (n = 48). A smaller study of anxiety and depression in CD utilised ten 
inflammatory bowel disease subjects (Gasbarrini & Addolorato, 1997). 
In addition to developing a sizeable comparison group of healthy volunteers in this thesis, an 
appropriate chronic illness comparison group was sought to assist in determining whether any 
group differences that may emerge were due to the CD condition, or partly or wholly attributable 
to simply having a chronic illness. Selecting a suitable chronic illness comparison group involved 
the consideration of a number of factors. Medical conditions without predominantly GI 
symptomatology were preferred, since processes related to the disruption of nutrient uptake, 
implicated in the psychological sequelae of CD, also occur in other gut-related disorders. The 
decision to rule out other GI illnesses (e.g., inflammatory bowel disease) - with which CD 
patients may be misdiagnosed - also reduced the need for systematic medical screening for 
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undiagnosed C D in the chronic illness comparison group. 
As CD is a chronic, lifelong but treatable condition, with dietary self-management of 
paramount importance, many diseases with fundamentally dissimilar characteristics were 
overlooked in selecting a comparison group. These included disorders with terminal courses (e.g., 
HIV or Hepatitis C infection and cancer), those requiring entirely pharmacological interventions, 
typically acute, but remitting, or degenerative diseases, and illnesses with mainly neurological or 
psychiatric symptoms (e.g., Alzheimer's, epilepsy, Huntington's disease and schizophrenia). 
Other classes of chronic illness not considered ideal candidates for inclusion as a chronic 
illness comparison group were those generally perceived to be significantly less or more severe, 
in general, than CD (e.g., cystic fibrosis). Illnesses of fluctuating or seasonal intensity, such as 
eczema and hay fever, were regarded as being somewhat less severe, or restrictive, than CD 
overall. Additionally, both are very common illnesses in Australia and were therefore also 
expected to be widespread in the CD sample. Finally, practical restraints dictated that the chronic 
illness comparison participants chosen should be recruited readily within a two year time frame, 
limiting the diseases contemplated to those affecting sufficiently large numbers of people. 
Presently incurable but treatable diseases were preferred, with management leading to 
relatively pain-free living, in accordance with the general parameters of CD. Asthma warranted 
serious thought, having been the subject of a pre-thesis review by the author, but emotional 
factors were considered to precipitate or ameliorate symptomatology in a significant percentage 
of sufferers (Rietveld & Prins, 1998), potentially confounding results. Like eczema and hay fever, 
asthma is another very common illness in Australia, with a significant number of CD patients 
expected to have asthmatic conditions, so a less prevalent disease was sought. 
One class of chronic illness survived the application of all exclusionary criteria and, in 
addition, stood out as sharing many similarities with CD. Diabetes mellitus (DM) is a very 
common "group of metabolic diseases" (American Diabetes Association, 2000, p. 69) partly or 
chiefly subject to dietary control, with cumulative long-term physical complications in untreated 
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or poorly managed cases, not unlike the situation - albeit generally to a less severe degree - in 
CD. Disease onset and development is often insidious in non-autoimmune or type-2 DM (the 
most prevalent form), as in CD, and a "long subclinical prodromal phase" (Serrano-Rios, Goday, 
& Larrard, 1999) is also observed in type-1 DM. Although type-1 and -2 DM arise as a result of 
distinct causes, the symptoms are often comparable. Ongoing self-regulation is a key to health 
maintenance in the case of both major types of DM, which is a major similarity to CD. 
Overview of Diabetes Mellitus 
Characterised by a "dysregulation of glucose homeostasis" (Todd & Farrall, 1997, p. 284), 
resulting in hyperglycaemia (high blood glucose), DM affects about 6% ofthe general population. 
The illness was officially ranked as the seventh highest direct cause of mortality in the United States 
in 1998 (64,751 deaths or 24 per 100,000 ofthe population that year; United States Department of 
Health, 1999). Diseases ofthe heart were the leading cause of mortality, with DM estimated to be an 
underlying factor in a significant proportion of these deaths (Brunner, 2001). The illness is 
associated with an insufficient production, or an inability to utilise, the hormone insulin, which is 
responsible for keeping blood glucose levels within tight parameters. Insulin transports the sugar out 
ofthe blood and into the body's muscles, where it is used to provide energy for the body. 
Type-1, immune-mediated, or insulin-dependent DM, previously called "juvenile diabetes", is 
a "clinically and etiologically heterogenous.. .genetically determined chronic autoimmune 
disorder" (Serrano-Rios et al, 1999, p. 113). It occurs most commonly in children and young 
adults and develops when the immune system attacks the insulin-producing beta (|3) cells ofthe 
pancreas, destroying them. As a result, the pancreas does not produce adequate insulin, with 
insulin injections needed to replace the deficit. Typically, insulin deficiency "manifests only after 
80-90% of endocrine f3-cells have been destroyed" (Schloot, Pozzilla, & Mandrup-Poulsen, 1999, 
p. 141). The "(3 cell destruction is irreversible, and despite insulin replacement by injection, 
patients suffer early mortality, kidney failure and blindness" (Todd & Farrall, 1997, p. 284). As in 
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CD, both genetic and environmental factors are involved in the multifactorial aetiology of type-1 
DM (Buzzetti, Quattrocchio, & Nistico, 1998). Environmental influences may include viral 
infection, psychological stress and early exposure after weaning to cow's milk proteins (Akerblom 
& Knip, 1998). Human leukocyte antigen associated genes at the DR and DQ loci contribute more 
than 40%o ofthe inherited susceptibility, but an increasing number of non-HLA genes are being 
recognized (Buzzetti, Quattrocchio, Nistico, 1998; Serrano-Rios et al, 1999). A 30-70% 
concordance for DM is reported in identical twins (Todd & Farrall, 1997). The peak age of onset 
ranges between 10 to 14 years and a male to female ratio approaching unity is observed in most 
areas (Muntoni & Muntoni, 1997). The greatest incidence of DM occurs in the Nordic countries, 
with the rate highest in Finland (Tuomilehto et al, 1992) and some high-incidence areas situated 
in Mediterranean regions (e.g., Sardinia; Muntoni, Stabilini, Stabilini, Mancousa, & Muntoni, 
1995). The risk of type-1 DM is comparatively low in Negroid populations and the illness is rare 
in Asian and Pacific Islander groups. Slightly fewer than one in ten people with DM are initially 
diagnosed with the insulin-dependent form, which affects about 0.4 to 1% ofthe population, or up 
to 200,000 Australians (ABS, 2001). 
Type-2, insulin-resistant, or non-insulin-dependent DM, was previously called "adult onset 
diabetes" and classically occurs in older adults. However, it is becoming increasingly common in 
younger age groups, where it is accounting for a growing proportion of new diagnoses, due to the 
rise in obesity (Hansen, Fulop, & Hunter, 2000). Type-2 DM stems "from insulin-resistance, 
mainly caused by visceral obesity, with a defect in compensatory insulin secretion" (Masharani & 
Karam, 2002, p. 1203). Typically, sufficient insulin is produced, but the body of type-2 DM 
patients gradually becomes insensitive to its effects, resulting in hyperglycaemia. Most patients are 
overweight, having a body mass index (BMI) greater than 25, with the majority designated as 
obese (BMI > 30). By creating an insulin-resistant state, obesity "abets the development of 
diabetes and, once diabetes manifests itself, accelerates its deterioration" (Pi-Sunyer, 2000, 1451). 
Oral agents or intravenous insulin are often necessary to treat this form of diabetes, which affects 
Psychological Sequelae in C D 88 
more than nine out often D M patients (Zimmet, 1995). This equates to more than one million 
Australians, around half of whom are undiagnosed (ABS, 2001). 
Other forms of diabetes exist. For example, diabetes insipidus is a pituitary disease with 
symptoms of excessive thirst and urination, but is caused by an entirely different mechanism to 
diabetes mellitus. Another example is gestational diabetes, which may occur during pregnancy 
However, it was not planned to include any participants with diabetes insipidus or gestational 
diabetes in the chronic illness comparison sample ofthe present thesis. 
Short-term dangers and complications of diabetes, especially pertinent to type-1 patients, 
include hypoglycaemia (low blood sugar), which is typically of swift onset and may lead to shock 
and unconsciousness if untreated (via repletion of blood glucose). The other main short-term 
danger is ofthe opposite type; ketoacidosis or diabetic coma, which develops slowly and results 
from extremely high levels of blood sugar (Cooke, 2002). Early signs of ketoacidosis include 
flushed dry skin, blurry vision, a dry mouth, excessive thirst and urination, abdominal pain and 
deep, rapid breathing or difficulty breathing, followed by drowsiness and coma (American 
Diabetes Association, 2002). Immediate medical attention is required. 
In both major types of DM, the treatment goal is to achieve euglycaemia, or stable blood 
glucose levels, as consistently as possible. This process involves a sustained combination of 
pharmacological therapy (usually including insulin), dietary and lifestyle modifications (i.e., 
aerobic exercise and weight loss). The first two factors, medication and diet, are of primary 
significance in the case of type-1 DM and the latter two, diet and lifestyle changes, are most 
important in type-2 DM, especially in the earlier stages of treatment. Long-term complications and 
cumulative effects of DM involve multiple organ systems. Various degrees of vascular and 
neurological damage are common (Phillips et al, 1998), including kidney failure, stroke, 
blindness, impotence, peripheral neuropathy and circulatory problems, which may eventually lead 
to amputation of extremities or limbs. There is also an increased prevalence of GI symptoms in 
each major form of DM (Locke, 1995). These are reported more frequently by female patients and 
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have been attributed to diabetic complications, especially peripheral neuropathy, and the effects of 
poor glycaemic control (Bytzer et al, 2002). 
Hyperglycaemia leads to most ofthe specific long-term complications in DM, with all three 
aforementioned treatment factors geared towards reducing glucose levels to or below the non-
diabetic range. However, excessive reductions result in hypoglycaemia (i.e., low blood sugar), 
"the limiting factor in the management of diabetes" (Cryer, 1999, p. 42). Initial symptoms usually 
develop rapidly and include light-headedness, dizziness, weakness, nausea and hunger (Tierney et 
al, 2002) and confused, nervous, excitable or irritable behaviour, shallow breathing and pale, 
moist skin (Cooke, 2002). Shock, convulsions and unconsciousness may ensue if sugar is not 
provided and intravenous glucose is then required. Neural damage and cognitive impairment is 
associated with recurrent, severe episodes (Langan, Deary, Hepburn, & Frier, 19991). From a 
psychological perspective, fear of hypoglycaemic episodes, with consequent weight gain as a 
result of compensatory overeating (coupled with increased insulin use), represent major, but 
under-recognised, problems for many DM patients (Cypress, 1999). 
Ofthe chronic illnesses considered in relation to developing a disease comparison group, DM, 
like CD, was one ofthe most affected by the patient's self-management of his or her condition. A 
DM patient's medical regime compliance, diet, exercise, personal habits, weight control, 
emotional state and self-care behaviours collectively determine his or her immediate, medium and 
long-term physical and psychological health. In view ofthe primary subject matter ofthe thesis -
psychological sequelae in CD - a review of affective and neuropsychological functioning and life 
quality in the chosen chronic illness comparison group was undertaken. 
Review of Mood, Anxiety and Other Psychiatric Disorders in DM 
Moderate-severe levels of depressive and anxiety-related symptomatology are common in both 
major types of DM (Lloyd, Dyer, & Barnett, 2000). Clinical depression is two to three times more 
prevalent in DM than in the general population (Lustman, Clouse, Alrakawi, Rubin, & Gelenberg, 
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1997), with at least one out of every five D M patients experiencing a major episode (Gavard, Lustman, 
& Clouse, 1993). A clinical and epidemiologic review noted that life-time prevalence rates of 
depression in DM "vary between 24% and 29%" in type-1 patients, with "the symptom rofile... similar 
to that in non diabetic psychiatric patients" (Eiber, Berlin, Grimaldi & Bisserbe, 1997, p. 351). As well 
as occurring more frequently in DM, depressive episodes also tend to persist for longer than in 
psychiatric patients (Lustman et al, 1997) and recur earlier (Kovacs, Obrosky, Goldston, & Drash, 
1997; Lustman, Griffith, & Clouse, 1988; Lustman, Griffith, Freedland, & Clouse, 1997). A meta-
analysis of 27 studies (from 1975-1999) also found "a significant and consistent association of 
diabetes complications and depressive symptoms" (de Groot, Anderson, Freedland, Clouse, & 
Lustman, 2001, p. 620), with effect sizes ranging from small to moderate (r = . 17 to .32). 
There are two major, inter-related hypotheses proposed to account for all of these findings (see 
Talbot & Nouwen, 2000). One proposes that depression in DM is a result of biochemical factors 
directly related to the illness or its treatment. The DSM-IV criteria for Mood Disorder Due to a 
General Medical Condition are relevant to this theory. The second hypothesis suggests that depression 
in DM is a secondary consequence of incapacity, stress and psychosocial demands emanating from 
and associated with managing a chronic illness per se. 
In their detailed review, Talbot and Nouwen (2000) found limited exclusive support for either 
hypothesis, instead concluding that major depressive disorder in DM "represents a 
multidimensional phenomenon resulting from interactions between biologic and psychosocial 
factors" (p. 1556). Those authors also questioned the assumed direction of causality (that DM leads 
to depression), by presenting evidence that depression typically precedes the diagnosis of DM by 
many years, at least in type-2 patients (Lustman et al, 1988), and increases the risk of developing 
complications after diagnosis. An exception was noted in the cases of late-onset depressive illness, 
which has been found to be associated with the micro- and macro-vascular changes in DM 
(Alexopoulos et al, 1997; Robinson, Morris, & Fedoroff, 1990). 
Finally, it should not necessarily be assumed that the level of depression is always elevated in 
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groups of D M patients. A case-control Finnish study of people with type-2 D M often years duration, 
using the Zung Self-rating Depression Scale, showed no difference in the level of depression compared 
with non-DM controls (Viinamaki, Niskanen, & Uusitupa, 1995). Also, in Dutch research using the 
Beck Depression Inventory (BDI), newly diagnosed DM patients did not differ from healthy controls 
(Palinkas, Barrett-Connor, & Wingard, 1991). In that study, more distantly diagnosed DM patients had 
higher age-adjusted BDI scores, and affective and somatic BDI subscales, than newly diagnosed 
patients or healthy controls. However, age and number of chronic conditions were independent 
predictors of depressive symptomatology, with the latter perhaps better projected by the "presence or 
severity of complications and comorbid conditions" in DM (Luscombe, 2000, p. 21), rather than the 
existence of diabetes of itself, except where depression precedes the development of diabetes. 
Studies assessing aspects of mood in DM other than depression have investigated the levels of 
state and trait anxiety and anger. These have been found to be higher in diabetes patients than in a 
comparison group of people suffering from "somatic disease", but "clearly below those with 
psychological disturbances" (Laederach-Hofmann, Mussgay, Schill, & Ruddel, 2000, p. 169) in a 
large scale German study. McCrimmon, Ewing, Frier, & Deary (1999) noted a "significant increase 
in feelings of anger" (p. 35) during experimentally induced hypoglycaemic episodes in people with 
both DM and non-diabetic subjects, while Sato et al. (2002) reported increased anxiety in female, 
compared to male, DM patients. In a systematic review of 18 studies, Grisby, Anderson, Freedland, 
Clouse and Lustman (2002) determined that elevated symptoms of anxiety were present in about 
40% of patients with DM (males: 33%; females 55%), whether type-1 or -2, and 14% of DM 
patients have Generalised Anxiety Disorder. 
With regard to other clinical disorders in DM, "disturbed eating behaviour" is more prevalent in 
DM patients than in matched, healthy controls (Engstrom et al, 1999, p. 117), with an eating disorder 
(ED) diagnosis able to "be made in up to 10% of young women" with type-1 diabetes, according to 
an Italian review (Verotti, Catino, De Luca, Morgese, & Chiarellia, 1999, p. 21). Those authors 
attributed weight gain, dietary restraint and food preoccupation as predisposing features of DM in the 
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development of EDs. In a large German multicenter study, "the overall prevalence range of current 
EDs was 5.9 - 8.0% (lifetime prevalence 10.3 - 14%)" (Herpertz et al, 1998, p. 1110), with no 
differences in relation to gender, or between type-1 and -2 DM. Those authors reported "intentional 
insulin undertreatment or omission" (p. 1110) - sometimes referred to as "insulin purging" - in 4 1% 
of their sample. Hoffman's (2001) belief that "the weight gain associated with good glycemic control 
likely increase [female adolescent DM patients'] susceptibility to abnormal eating" (p. 73) has a 
parallel in the tendency towards weight gain following GFD institution in CD, which is perhaps also 
worthy of investigation in relation to EDs. As in CD, "there is no specific personality pattern in 
diabetic patients" (Eiber et al, p. 351). 
Neuropsychological Functioning 
Decrements in neuropsychological functioning are widely reported in both type-1 and type-2 
DM (Ryan, Williams, Finegold, & Orchard, 1993; Worrall, Moulton, & Briffett, 1993). These 
appear to be more pervasive in older type-2 patients (Croxson & Jagger, 1995; Scott, Kritz, Barrett, 
& Wiederholt, 1998) and those with DM-related health complications (Knopman et al, 2001). 
However, a number of studies have failed to find evidence of cognitive decline in either type-1 
(Deary & Frier, 1996; Kramer et al, 1996) or type-2 patients, especially in cases "uncomplicated" 
by other medical disorders (Cosway, Strachan, Dougall, Frier, & Deary, 2001). Evidence against 
the presence of cognitive changes in type-2 DM includes both case-control studies (Kail, Wolters, 
Yu, & Hagen, 2000; Stewart & Liotitsa, 1999; Strachan, Deary, Ewing, & Frier, 1997) and 
population-based research (Scott, Kritz-Silverstein, Barrett-Connor, & Wiederholt, 1998). In tests 
sensitive to neuropsychological dysfunction (e.g., the Wechsler scale's Digit Symbol test; Crowe et 
al, 1999) the findings in DM are certainly mixed, with the majority of studies not showing 
substantial impairment (see Asimakopoulou, Hampson, & Morrish, 2002, for a review). 
Support for the existence of affected neuropsychological performance in DM includes associations 
between reduced cognitive functioning and each of; glucose intolerance (Kalmijn, Feskens, Launer, 
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Stijnen, & Kromhout, 1995), hyperinsulinaemia (Kalmijn et al, 1995), various cardiovascular risk 
factors related to DM (e.g., hypertension; Knopman et al, 2001), recurrent severe hypoglycaemic 
episodes (Langan, Deary, Hepburn, & Frier, 1991), chronic hyperglycaemia (Northam, Anderson 
Werther, Warne, & Andrewes, 1999; Reaven, Thompson, Nahum, & Haskins, 1990; Ryan & Geckle, 
2000) and each of type-1 and type-2 diabetes per se (Ott et al, 1996; Worrall, Moulton, & Briffett, 
1993). These associations are observed in type-2 patients in both middle-aged adults (Knopman et al, 
2001) and elderly populations, in which the risk and prevalence of dementia is also increased (Ott et 
al, 1996). In older people with type-2 diabetes, "minimal cognitive impairment" was detected after 
controlling for confounding factors (Asimakopoulou et al, 2002, p. 311), including alcohol intake, 
hypertension and cardio/ cerebrovascular conditions. In type-1 DM patients, multiple occurrences of 
serious hypoglycaemic events are believed to substantially contribute towards the cognitive 
dysfunction reported, with "permanent neuropsychological impairment" documented (Wredling, 
Lavender, Adamson, & Lins, 1990, p. 152). 
There is general consensus that the neuropsychological changes associated with DM are due to 
cumulative processes that correlate with the duration of illness (Cosway et al, 2001). Typically, the 
magnitude of intellectual decline is attributed primarily to the total number of- and susceptibility 
towards - acute hypoglycaemic events in type-1 patients (Langan et al, 1991), and to gradual, 
subclinical accretion ofthe effects of discrete events (e.g., ischaemic mini-strokes) resulting in 
diffuse cerebral infarction and other aspects of arteriosclerotic disease, vascular degeneration and 
malfunction (e.g. hypertension) in type-2 patients (Knopman et al, 2001). Since glycaemic control 
in older type-2 patients has lead to improved cognitive functioning (Gradman, Laws, Thompson, & 
Reaven, 1993), it appears that the declines in performance are not necessarily entirely irreversible 
Almost all major indexes of neuropsychological performance have been implicated somewhere 
in the body of research involving cognitive deficits in DM. The most frequently reported, in 
descending order, are speed of information processing (psychomotor slowing) - in both type-1 
(Deary et al, 1992) and type-2 patients (Ryan & Geckle, 2000), memorial functioning, especially 
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short-term verbal memory in type-2 D M (Asimakopoulou et al, 2002; Helkala, Niskanen, Vinamaki, 
Partanen, & Uusitupa, 1995) and attention (U'Ren, Riddle, Lezak, & Bennington-Davis, 1990). 
There is neurophysiological evidence "indicative of abnormal brain function" (Ryan & Geckle, 
2000, p. 1486) in the form of longer P300 latencies in middle aged, type-2 patients (Dey, Mistra, 
Desai, Mahapatra, & Padma, 1997; Kurita, Katayama, & Mochio, 1996). Central nervous system 
involvement is likely (Biessels, 1999; Cerizza et al, 1999), with signs of autonomic neuropathy 
(Zaslavsky, Gross, Chaves, & Machado, 1995) and brain atrophy observed (Pirttila, Jarvenpaa, 
Laippala, & Frey, 1992; Soininen, Puranen, Helkala, Laasko, & Reikkinen, 1992), "consistent 
with subtle compromise of anterior and medial temporal brain regions" (Northey et al, 2001, p. 
pl541). Focal damage of hippocampal structures, as a result of severe, recurrent hypoglycaemic 
events, has been specifically implicated in the memorial deficits documented (Hershey, Craft, 
Bhargava, & White, 1997). Mild impairment of executive functioning reflective of frontal lobe 
involvement has also been documented in elderly type-2 Finish patients (Vanhanen et al, 1999) 
In general, though, abstract reasoning, problem-solving, non-declarative memory functioning and 
learning skills appear to be relatively spared in type-2 DM (Ryan & Geckle, 2000). 
Although cognitive dysfunction in DM is mainly found in older type-2 patients, significant 
psychomotor slowing, but preserved accuracy, has been described in children and adolescents with 
type-1 DM in a large scale U.S. case-control study (Deichmann, 1998) and also in adult patients (Hill, 
1995). In the latter study, "a verbal IQ decrement was found relative to performance IQ" (p. 1700). 
Processing speed, attention, long-term memory and executive skills were all lowered compared to 
community controls in a separate Australian study of children with type-1 DM, six years after disease 
onset (Northam et al, 2001). These deficits were accentuated in children with early-onset DM, 
confirming independent Norwegian findings of reduced psychomotor efficiency and attention in a 
sub-group of young patients also diagnosed early in life (Bjorgaas, Gimse, Vik, & Sand, 1997). 
Overall, the results reviewed suggest that higher cortical functions may remain relatively 
intact, regardless of diabetes type. Conversely, abilities in the areas of processing speed, short-
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term memory and attention/ concentration may be quite susceptible to subtle disruption from early 
in the disease, with greater physical degeneration associated with more pronounced 
neuropsychological dysfunction. 
Quality of Life 
Since DM is an illness with wide-ranging biopsychosocial perturbations and its "management 
depends almost entirely on behavioural self-regulation" (Gonder-Redenick, Cox, & Ritterband, 
2002, p. 611), the quality of life (QOL) of patients is invariably affected at some level or stage of 
the illness. In a review, Luscombe (2000) noted "decrements in virtually all aspects of health-
related QOL due to the disease or its complications" (p. 21). The major emergent themes in a pilot 
study of younger DM patients were "restrictions" (in relation to dietary regimentation/ scheduling 
and social ramifications), "differentness", "negative emotion" and "adaptation", with the latter two 
"expressed most often by participants who had had diabetes for a longer period of time" (Faro, 
1999, p. 247). All four themes were reminiscent of secondary reactions to CD 
Type-2 DM patients without complications had only slightly lower health-related QOL than 
healthy age-matched people in the general community in a recent, large-scale Dutch study, with 
insulin therapy, obesity, and complications all significant determinants of lower life quality 
(Redekop et al, 2002). Comparable results were reported by Glascow, Ruggiero, Eakin, Dryfoos, 
and Chobanian (1997), with lower QOL also associated with femaleness and lower levels of 
physical activity. Self-reported higher QOL by male DM patients and a lower sense of disease 
burden has been reported elsewhere (Rubin & Peyrot, 1999), but is by no means a universal 
finding (Hallert et al, 2002; Wredling et al, 1995). Health-related QOL in newly identified DM 
patients was found to be equivalent to people who did not have DM upon the systematic screening 
of Veterans in a U.S. study (Edelman, Olsen, Dudley, Harris, & Oddone, 2002). Interestingly, 
impaired memory and concentration were cited as the most salient aspects of reduced QOL in 
Chinese DM patients (Fan, Huang, & Li, 1996), confirming that these commonly reported 
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neuropsychological problems may significantly affect daily living. 
According to Watkins et al. (2000), positive QOL outcomes in both type-1 and -2 DM are most 
strongly related to patients' perceptions of control over their illness, as well as their understanding 
of diabetes. However, as in CD, the "health behaviours that comprise up to 99% of disease treatment 
[in DM] are difficult to maintain over time" (Watkins et al, 2000, p. 1511). This was yet another 
likeness between the two illnesses that augured in favour ofthe selection of DM patients as a 
suitable disease control group. 
The Envisaged Chronic Illness Comparison Group - A Summary 
Having made the decision to use DM as the chronic illness comparison group in this thesis, a 
fundamental question was whether to use type-1 or type-2 patients, or a combination of both. 
Hallert et al. (2002) recently reported the use of type-2 DM patients, in their CD case-control 
burden of illness study, as representing "another group.. .in whom the medical treatment is largely 
regulated by the patients themselves by adhering to a diet" (p. 39), two key features shared by CD. 
Another similarity between CD and DM included the fundamental chronicity of illness, as distinct 
from the abrupt or acute pattern of exacerbations and remissions, intermittent symptoms, or 
seasonal variation characterising many other illnesses after diagnosis. Unlike the gradual health 
gains in CD following strict GFD compliance, there is often an eventual marked degeneration in 
health in DM. However, this contrast in outlook was deemed to be more relevant to longitudinal 
considerations than the cross-sectional assessment comprising study 1 ofthe present thesis, in 
which the duration of illness and stage of diabetes in each patient could be monitored during 
recruitment in developing a matched comparison group. 
Nevertheless, a major concession expressed by Hallert et al. (2000) in using DM as a 
comparison group was that, "in clinical terms, diabetes is a more serious condition than being 
coeliac" (Hallert et al, 2002, p. 41). Presumptions of greater disease severity in DM, compared to 
CD, were initially imagined by the writer to especially apply to type-1 patients, but this assumption 
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was not necessarily supported in the D M literature, with "more pronounced psychopathology" not 
infrequently reported in type-2 patients (Herpertz et al, 2000, p. 161; see also Karlsen, Bru, & 
Hanestad, 2002). Differences between various indexes of disease severity in type-1 and -2 DM, 
whether in the physical or psychological domains, are more likely to be attributable to the 
heterogeneity of samples, disease stage and duration, treatment compliance and extent of 
concomitant medical problems, than diabetes type per se. 
Therefore, notwithstanding the etiological distinctions between both major forms of DM, the 
lack of consistent differences in the degree of neuropsychiatric symptomatology between type-1 
and -2 patients paved the way for potential consideration of either or both forms of DM prior to the 
development ofthe chronic illness comparison group. This policy also had the practical benefit of 
reducing restrictions on the potential pool of DM participants considered for recruitment into Study 
I. The impending task of matching groups across demographic variables was consequently made 
easier, given envisaged practical difficulties such as the relative ages of type-1 and -2 patients, 
which were expected to be, respectively, considerably above and below the median age ofthe 
general and adult CD population at the time of (or relatively close to) diagnosis with DM. 
As reviewed in this chapter, the prevalence of Axis I clinical disorders appears to be elevated in 
DM compared to people without a chronic illness, but only to a limited degree in diabetes groups 
uncomplicated by other medical disorders. An increased frequency of subtle to modest 
neuropsychological impairment and somewhat reduced life quality has also been consistently 
reported. For those reasons, DM was regarded as constituting a fair disease comparison group for 
use in the present thesis, in establishing the existence or strength of any differences in the 
psychological fiinctioning of patients with CD, compared to people without a chronic illness and 
against the backdrop ofthe expected effects of a chronic illness in itself, with analogous issues to 
CD. The next chapter outlines the hypotheses proposed in the cross-sectional study of this thesis, 
the methodology used in the selection of CD, DM and healthy participants and the results of 
extensive psychological assessment, followed by a discussion ofthe key findings. 
Chapter 4 — Study 1: 
Cross-Sectional Analysis of Psychological Sequelae in CD 
A review ofthe CD literature in reference to psychological sequelae has revealed a scarcity of 
research throughout most decades ofthe preceding century, punctuated by brief, intense periods of 
interest in discrete areas. Purported associations between CD and schizophrenia (Dohan, 1973, 1983) 
were not supported by epidemiological evidence (Hallert, 1982), while evidence for neurological 
complications in CD (see Morris, Ajdukiewicz, & Read, 1970), and vice versa (Hadjivassiliou et al, 
1996) accumulated (see Cooke & Holmes; Gobbi et al, 1997). 
Goldberg's (1970) observations of an increased prevalence of depression in CD patients have also 
been substantiated (Hallert & Astrom, 1982). Depression may rank with many ofthe more extensively 
researched physical repercussions of CD (e.g., osteoporosis), as a common and debilitating health 
problem preceding the detection of CD (Hallert & Derefeldt, 1982). For many CD patients, depression 
remains post-diagnosis without specialised treatment (Hallert, Astrom, & Walan, 1983), thwarting a 
timely and complete recovery, despite compliance with the GFD (Hallert, 1997). These observations of 
depression as the predominant psychiatric disorder in CD have been corroborated by others (e.g., 
Addolorato et al, 2001). 
The Beck Depression Inventory - Second Edition (BDI-II; Beck, Steer, & Brown, 1996; described 
in this chapter on pp. 130-132) was selected by the author ahead ofthe Zung SDS, due to the 
correspondence of BDI-II items with the criteria used for diagnosing depressive disorders in the DSM-
IV and the opportunity to ascertain the relative contributions of somatic/ affective and cognitive 
dimensions of self-reported depression in CD. These dimensions were based on two mutually 
exclusive sets of BDI-II items identified by Beck et al. (1996) as loading onto two such-named factors 
in a sample of psychiatric outpatients following factor analysis. Exploration of these dimensions in CD 
was considered potentially important in view ofthe prominence of elements of psychomotor 
retardation previously identified in the MMPI profiles of depressed CD patients (Hallert & Astrom, 
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1982), plus discrete (although perhaps additive) aetiological explanations for depression in C D , 
including disruption of monoamine synthesis (Hallert, Astrom, & Sedval, 1982a) and unspecific 
secondary reactions to the implications of having a physical illness. 
Although not a primary focus of previous CD research, many symptoms of anxiety (e.g., restless-
ness and insomnia) often feature in depressive illness (Fawcett & Kravitz, 1983). Anxiety disorders also 
frequently coexist with mood disorders such as major depressive disorder and dysthymia (APA, 1994) 
Reactive (i.e., state, as opposed to trait) anxiety has been identified in CD (Gasbarrini & Addolorato, 
1997), but the sample size was insufficient to draw definitive conclusions. 
Lowered frustration tolerance also commonly occurs in conjunction with mood disorders (APA, 
1994) and extreme examples have long been recognised in children with CD (Gibbons, 1889). In 
adults the period antedating recognition of CD may be onerous and exasperating, and reflections about 
the cumulative health effects associated with undetected CD, due to a belated diagnosis later in life, 
may invoke resentment. As the symptoms of irritability and agitation found in depression - in addition 
to any build up of resentment - are also commonly associated with anger (Spielberger, 1988), it was 
decided to investigate anger, a relatively unknown entity in CD, but not uncommon in other chronic 
illnesses (Grech, 1993). Therefore, both anxiety and anger were independently assessed cross-
sectionally (Study 1) and longitudinally (Study 2) in the current thesis, using the State-Trait Anxiety 
and Anger Expression inventories (Spielberger et al, 1983; Spielberger, 1988; see this chapter's 
description of these measures on pp. 138-140 and 140-142). 
Although changes or decrements in neuropsychological functioning frequently have neurological 
substrates (Kolb & Whishaw, 1990; Lezak, 1983), and these have received increased attention in CD 
(e.g., Gobbi et al, 1997), intellectual ability has been found to be relatively intact in CD patients 
(Hallert & Astrom, 1983), with no deficits peculiar to CD consistently found. However, notwithstand-
ing a sparing of global cognitive capacity, the specific "cognitive functions of CD patients have not 
been extensively studied and large cross-sectional studies are lacking" (Collin, Eerola, & Pirttila, 1997, 
p. 285). This was a principal motivation for systematically assessing the neuropsychological status and 
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indexes of performance in a large group of Australian C D patients. Since there may be a "pernicious 
interplay" (Lezak, p. 127) between any combination of particular neuropsychological functions (e.g., 
memory), depression and brain damage and both ofthe latter have been a cause for concern in CD, the 
concurrent evaluation of mood state and core areas of neuropsychological aptitude in each CD 
participant was also regarded as important. 
Finally, perceived health status and quality of life (QOL) in chronic illness have been increasingly 
researched in the preceding two decades. Reduced life quality during active irritable bowel disease 
was found compared to transient illness controls (Sorenson, Olson, & Binder, 1987) and slightly 
decreased life quality was identified in treated CD patients, especially in females (Hallert et al, 1998; 
Lohiniemi et al, 1998). In view ofthe comprehensive investigation of mood state and cognitive 
functioning in Study 1, an assessment of QOL underpinned by a self-evaluation of behaviours and 
actions, as opposed to affective and cognitive perceptions, was sought. Therefore, the Quality of Life 
Questionnaire (QLQ: Evans & Cope, 1989; see this chapter pp. 145-149), a generic measure based on 
self-reported behaviours as representations of QOL, was selected. The previous findings of mild, 
overall reductions of life quality in CD, rather than a gross impairment in daily living, was another 
factor that influenced the choice ofthe QLQ ahead of disease-specific or illness-related measures. A 
self-rating of general health status, adapted from a scale used in comprehensive Australian health 
surveys (McLennan, 1998), was also administered to the CD, healthy control and diabetes mellitus 
groups, to assist in establishing a reference point of perceived general health measurable against local 
norms. 
M o o d in C D : Primary Hypotheses 
The first goal of Study 1 was to examine the prevalence and nature of depressive symptomatology 
in an Australian CD group of one-hundred patients, compared to demographically matched healthy 
controls and people with diabetes mellitus, a chronic illness in which the prevalence of symptoms of 
depression, has also been found to be elevated (Lustman et al, 1997). Evaluation ofthe symptoms of 
anxiety and anger, which often overlap with depression and other psychiatric diagnoses (APA, 1994), 
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were also measured. Selection ofthe test measures used to assess these areas of functioning were based 
on their specificity, sound psychometric characteristics and, in the case ofthe Beck Depression 
Inventory - II, excellent predictive power (see pp. 126-128). Although the composition of each ofthe 
two disease groups (CD and DM) vis-a-vis respective disease severity, duration of illness or compliance 
with treatment was unknown at the outset of Study 1, six hypotheses were made regarding depression, 
anxiety and anger, in CD participants in relation to two demographically matched comparison groups, 
DM and healthy participants, based on limited prior research: 
1. Levels of depressive symptomatology would be higher in the CD group than the NC group, 
but not the DM group. 
2. Levels of depression would be higher in CD patients who were multisymptomatic, compared to 
oligosymptomatic at diagnosis. 
3. There would be no difference in the prevalence of Cognitive versus Somatic/ Affective 
depression within the CD group, or compared to either comparison group. 
4. State, but not trait, anxiety would be higher in the CD group than the NC group and also higher 
in newly diagnosed, compared to distantly diagnosed, CD patients. 
5. Anxiety levels would be increased in CD patients who were multisymptomatic, compared to 
oligosymptomatic at diagnosis. 
6. State, but not trait anger, would be higher in the CD group relative to the NC, but not DM, 
group. 
Cognitive Hypotheses 
A second aim ofthe thesis was to assess specific indices of performance in neuropsychological 
functioning in CD. This was achieved by selection ofthe Wechsler Adult Intelligence Scale-Ill 
(Wechsler, 1997), enabling the calculation of standard scores across the three experimental groups in 
the areas of verbal comprehension (VC), perceptual organisation (PO), working memory (WM) and 
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processing speed (PS), as well as the full scale intelligence quotient (IQ). Given evidence in support of 
intact overall intellectual ability in CD (De Maria et al, 1997; Hallert & Astrom, 1983) and a lack of 
consistent findings of specific decrements in cognitive functioning, it was hypothesised that: 
7. General intellectual ability (IQ) would not be significantly different in the CD group, compared 
to either the NC or DM group, provided that these groups were matched for age, years of 
education and socioeconomic status (SES). 
It was envisaged that the total mean IQ scores across groups, which were expected to converge on 
comparable figure during the simultaneous development of each ofthe three experimental groups, may 
also be used to assist in matching the groups against a baseline level of functioning, or, as a minimum, 
help define the CD group relative to normative expectations. It was further anticipated that the 
assessment of a large group cross-secfionally would maximise the likelihood of detecting any subtle 
systematic strengths or deficits in performance in the CD group, should they exist. On the balance of 
limited previous research in CD (Hallert & Astrom, 1983; Pavone et al, 1997) and the larger body of 
DM literature (Hershey et al, 1997; Ryan et al, 1993; Worrall et al, 1993) reviewed in the preceding 
chapter, it was hypothesised that: 
8. The DM group would perform at a significantly lower level than the NC but not the CD group 
in the area of Working Memory. 
It was also expected that, depending on the makeup ofthe eventual CD sample, the influence of 
other factors on intellectual performance (e.g., disease intensity and GFD compliance; eg. Pavone et al, 
1997) may also be able to be determined. A dual hypothesis was made regarding these factors on 
neuropsychological performance, in a direct test of Pavone et al's (1997) findings, based on a small 
sample size: 
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9. C D participants non-compliant with the G F D would perform at a significantly lower level than 
participants following the GFD in the Perceptual Organisation and Working Memory Indexes 
ofthe WAIS-III. 
Quality of Life and Health Status Hypotheses 
The third general aim of Study 1 was to undertake a fine grained analysis of self-reported QOL in 
CD patients, compared to healthy controls and people with DM. On the basis of previous research 
(Hallert et al, 1998; Hallert et al, 2002, Lohiniemi et al, 1998) two directional hypotheses were made 
regarding the hypothesised quality of life in CD patients in relation to the comparison groups: 
10. Female, but not male, CD participants would report a significantly lower overall quality of life 
than NC but not DM participants. 
11. General well-being, a major domain ofthe Quality of Life Questionnaire, would be 
significantly lower in participants with CD compared to NC, but not DM, participants 
12. Physical well-being, as subdomain ofthe Quality of Life Questionnaire, would be significantly 
lower in participants with CD compared to NC, but not DM, participants. 
Two hypotheses were made regarding retrospectively self-reported general health status pre- and 
post-CD diagnosis/ GFD implementation, as measured by a modified version of an Australian scale 
used in national community surveys: 
13. Health status would be significantly higher post-diagnosis/ GFD implementation, compared to 
pre-diagnosis, within the CD group. 
14. Patients with CD who were multisymptomatic at CD diagnosis would retrospectively report 
lower health status pre-diagnosis than oligosymptomatic patients. 
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C D Awareness and Multidimensional Health Locus of Control Hypotheses 
Three hypotheses were generated in relation to CD awareness/ knowledge, regarded by Ciacci et al 
1998 and Hallert et al, 2002 as being connected to QOL, and multidimensional health locus of control 
(MHLC), not previously investigated in CD research, but widely used in health-related fields (Wallston 
& Wallston, 1978), including DM (e.g., Wright, 1997). 
15. Increased CD awareness/ knowledge in CD patients, as measured by a new scale developed the 
author, would be positively correlated with greater compliance with the GFD and higher QOL. 
16. Internal MHLC would be positively correlated with greater compliance with the GFD, self-
reported health status and quality of life in CD participants and negatively correlated with 
depression in participants from all three groups. 
17. Internal MHLC would be lower and Chance MHLC higher in CD and DM patients, compared to 
NC participants. 
Development of a Theoretical CD-Specific Damage Quotient 
Ofthe calculable non-demographic factors associated with CD which may influence psychological 
functioning, two static symptom-related and two dynamic dietary variables were selected by the author 
to form a logical quartet of factors comprising a hypothetical risk scale referred to in this thesis as a 
"damage quotient" (DQ). Selection and refinement ofthe four factors was based on previous research 
pertaining to measurable correlates, or perceptions, of physical illness in CD in relation to 
psychological outcomes (e.g., Hallert & Astrom, 1982; Lohiniemi et al, 1998). 
It was hypothesised that each of these factors may have a directional impact on mood state or 
affective functioning, and possibly cognition and life quality in a significant proportion of people with 
CD. Considered simultaneously, these factors were also hypothesised to potentially comprise a DQ 
scale that could explain a large proportion of variance in decrements (or relative improvement) in 
mood, affect, quality of life and cognitive functioning. 
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Increases in magnitude ofthe two symptom-related D Q variables were theorised to increase the 
likelihood or severity of decrements in mood, and possibly cognitive functioning or quality of life. 
Conversely, increases in the two dietary-related variables were presumed to decrease the likelihood or 
severity of decrements in mood or affect, and perhaps decrements in cognitive functioning, should 
these exist. These four factors and their possible impacts on affective and cognitive functioning, or life 
quality, are outlined below. 
Table 2 
Symptom and Dietary-Related Factors Comprising a Hypothetical Damage Quotient (DQ) 
Factor/ Variable Possible Impact 
Number of Symptoms at CD Diagnosis Increased risk of affective disorder/ 
(termed "severity of C D " ) cognitive impairment; decreased life quality 
Total Duration of Symptomatic Increased risk of affective disorder/ 
Period Pre-diagnosis cognitive impairment; decreased life quality 
Compliance with GFD Decreased risk of affective disorder or 
(two measures used) cognitive impairment, should latter exist 
Time Since Diagnosis and Decreased risk of affective disorder or 
Being on G F D cognitive impairment, should latter exist 
These hypothetical effects were partly based on previous findings of increased GFD compliance 
being associated with reduced health complications over time (see Club del Tenue Study Group, 2001) 
and an assumption that the observed amelioration or normalisation of health risks following GFD 
treatment may extend to improvements in mental or psycho-social health. Given the lack of association 
between the duration ofthe GFD and quality of life in a previous study (Lohiniemi et al, 1998) there 
were no specific predictions made in relation to life qualify. Instead, the hypotheses made were limited 
to considerations ofthe predictive power of DQ variables on depression in CD. It was considered 
inappropriate to use the DM group in any comparisons pertaining to the damage quotient factors 
outlined, as these were tailored from the outset to reflect unique aspects of monitoring disease severity 
and progression in CD, with the possibility of better anticipating psychological sequelae in this illness. 
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In summary, there were four unidirectional hypotheses: 
18.a) An increased number of CD-specific symptoms at CD diagnosis (termed "CD severity", 
and assessed retrospectively) were expected to increase depression at assessment in Study 1. 
b) Increased total symptomatic duration pre-diagnosis (also retrospectively assessed) was 
expected to increase the level of depressive symptomatology. 
c) Increased time since diagnosis (assuming GFD compliance) would be negatively correlated 
with depressive symptomatology. 
d) Increased compliance with the GFD would be negatively correlated with depression. 
If significant correlations were found in any ofthe expected directions, it was planned to construct 
an additive model as a basis for discriminating between depressed and non-depressed CD patients 
post-diagnosis (i.e., as assessed at the point of study entry in Study 1). A DQ model could be based of 
any combination ofthe four damage quotient factors. The first two static, symptom-related, variables 
were expected to operate in the opposite direction to the two dynamic dietary variables. 
Due to the heterogeneity of symptom severity in CD, ranging from severe illness to an increasing 
proportion of asymptomatic cases indistinguishable clinically from normal health, it was anticipated 
that inclusion ofthe relatively asymptomatic or oligosymptomatic cases in the full CD group may 
potentially mask any significant differences between the CD group and comparison groups. Therefore, 
as well as defining the first factor for use in the hypothetical DQ, the partitioning process underlying 
subdivision ofthe CD sample - according to number of symptoms at diagnosis - was also undertaken 
to compare CD patients who were symptomatic pre-diagnosis with the other two experimental groups. 
Known or quantifiable disease indices (e.g., symptomatology at diagnosis), compliance with the 
GFD, and second tier parameters (e.g., body mass index) were also systematically recorded. Gauging 
their relevance or potential influence on psychological symptoms in CD, in relation to readily 
identifiable static and dynamic variables such as age at study entry, age and severity of CD at diagnosis, 
time since diagnosis, and compliance with the GFD, were considered important in delineating risk 
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profiles able to discriminate between C D patients with minimal or mild-severe depressive symptom-
atology post-diagnosis, given the greater prevalence of depression in CD. Noting these correlates also 
aided in carefully defining an intensively researched sample, in order to assist in ruling in or out the 
impact of CD-specific and general illness-related factors on psychological fiinctioning. 
A diverse cohort of one-hundred and ten Australians with CD, four out of five with British or Irish 
ancestry and typically of middle-high socio-economic status, was interviewed and clinically evaluated. 
They were demographically representative ofthe adult Australian population in many respects, except 
that about 8% of Australians are of Asian ancestry (ABS, 2001) and there were no participants of 
Asian background in the CD sample. Half of the CD participants were in the third or fourth decade 
of life at study entry and when diagnosed with CD, which, on average, was four years earlier. All 
volunteered without payment to be involved in the study. They were recruited primarily via advertise-
ments in the Victorian supplement ofthe national Coeliac Society magazine (Appendix D) and in 
response to direct marketing ofthe project at local coeliac meetings, conferences and functions. 
Each CD participant was individually interviewed and completed an extensive battery of 
psychological questionnaires and tests during a three-four hour assessment session and received a one 
hour feedback meeting with the author. All sessions in the cross-sectional study occurred during an 
18 month period between June, 1999 and February, 2001, and twenty-seven CD patients (one quarter 
ofthe cross-sectional sample), who were relatively newly diagnosed, were re-assessed 12 months later 
(see Chapter 5 - Study 2: Longitudinal). 
Two well-matched comparison samples were simultaneously developed, one consisting of fifty-
three people with a chronic illness (type-1 or -2 diabetes mellitus) and another comprising sixty-nine 
healthy volunteers, ten of whom participated in Study 2. The final non-CD participants entered the 
Study 1 in January, 2002. The present chapter reviews the methodology, test instruments and 
procedures used in psychologically evaluating the three study groups in Study 1, outlines the statistical 
design utilised and reports the experimental findings. A discussion ofthe key results of Study 1 
completes this chapter. 
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Method 
Coeliac Disease (CD) Participants 
One-hundred and ten people with biopsy-confirmed C D (66 female; 44 male), with a mean age of 
41.0 years (SD = 14.4; range = 16 to 84) living in the state of Victoria, Australia (80% in metropolitan 
Melbourne or Geelong; population 3.8 and 0.2 million respectively), were recruited for the study. 
Half of the remaining 2 0 % of participants were living in the rural city of Ballarat (population: 84,000), 
within proximity to the local university, at which the author was enrolled in clinical psychology 
doctoral studies. Proportions of urban/ rural dwellers in the C D group were equivalent across gender 
(X with continuity correction = 1.21; p = 0.27). 
The full sample had a mean educational level of 12.4 years (SD = 2.6), with the seventh year of 
education corresponding to the first year of high school, twelve years equating to the last year of high 
school and fifteen signifying completion of an undergraduate degree at university. Independent 
samples t-test indicated no significant gender differences (a = .05) across age, educational level or the 
mean age at diagnosis with CD, which was 36.9 years (SD = 15.4; range = 1 to 84). A breakdown of 
age at diagnosis (with number and gender of participants) is displayed in Table 3. 
Table 3 
Diagnosis with CD: Number and Gender of Participants in each Age Group 
Age Range at Diagnosis Number (and gender) of Participants 
Infancy (0-2 years) 4 (Male = 2; Female = 2) 
Childhood (3 -12 years) 2 ( M = 1; F = 1) 
Adolescence (13-19) 8 ( M = 5; F = 3) 
Adulthood; Young (20-34) 33 (F = 23; M = 10) 
Middle (3 5-49) 44 (F = 26; M = 18) 
Mature (50-64) 15 (F = 9; M = 6) 
Senior (65+) 2 ( M = 2) 
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In the great majority of cases the diagnosis of C D had been made in adulthood (20+ years; 87%); 
in eight cases in adolescence (age 13-19 inclusive), and in the remaining six cases in infancy or 
childhood (defined as less than 13 years). In the one age category with sufficient numbers to permit 
meaningful comparisons (young adulthood: age 20-34), there were more than twice as many females 
(23 compared to 10 males) represented. For one quarter of these females (6 out of 23), anaemia 
identified during pregnancy was the principal reason for investigation leading to diagnosis. 
All participants (98% prior to enrolment in study) had received a definitive, biopsy-confirmed 
diagnosis of CD, according to European Society for Pediatric Gastroenterology, Hepatology, and 
Nutrition (ESPGHAN) criteria (Walker-Smith et al, 1990), based on clinical, immunological and 
bioptical features and proven histologic improvement on the GFD. Just under half of all CD 
participants (48%) had received a single upper GI endoscopy in establishing a CD diagnosis, 37% had 
received two, and three or more biopsies had been performed on the remaining 15% in their lifetime at 
the time of study inclusion. People with dermatitis herpetiformis in the absence of villous atrophy or 
inflammatory changes in the small bowel and pregnant or lactating women were not invited to 
participate. All participants, except two people awaiting an appointment with a dietician, had started 
on the gluten-free diet (GFD), with 92%) demonstrating a positive clinical response prior to recruitment 
(or, in the case of those newly diagnosed, within 12 months of inclusion). In a further 4% of 
participants the clinical response was partial or ambiguous, while in the remaining four participants 
(three of whom were asymptomatic at diagnosis and compliant with the GFD) there was no apparent 
improvement. 
Adherence to GFD 
Duration of dietetic restriction for CD participants ranged from one day to 40 years (M = 4.2 
years; SD = 7.9 years). Using two different self-report measures of compliance (frequency of gluten 
consumption in one year and beliefs/ intentions; see pp. 134-135) there was not a significant gender 
difference in adherence to the GFD using independent samples t-test (at .05 confidence level). A strict 
GFD was defined as including no detectable gluten, as opposed to one allowing up to 0.03% protein 
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derived from gluten-containing grains, as determined by the Codex Alimentarius Commission ofthe 
World Health Organization and Food and Agricultural Organization (Selby & Faulkner-Hogg, 1998) 
Consistent maintenance of a strict GFD for a year (preceding inclusion or subsequently, in those 
newly diagnosed) was reported in 68% ofthe sample, as determined at interview, and a further 24% of 
participants were moderately compliant, with their diet most closely - and consistently - following the 
Codex standard, with occasional transgressions. Various degrees of flagrant non-compliance were 
noted in 8% ofthe sample, with seven people keeping to a partial GFD and one highly symptomatic 
participant reporting the inclusion of gluten-containing foods several days per week, including the 
fortnight prior to interview and assessment. No CD participants included in the study typically 
followed, or intended to follow, a regular (non-gluten-free) diet post-diagnosis. 
CD Symptomatology 
Major circumstances and symptomatology retrospective and relevant to the diagnosis of CD were 
recorded in the Questionnaire for Diagnosed Adult Coeliacs designed by the author (see Appendix C). 
Estimated duration of CD symptoms before diagnosis averaged 56 months (SD = 78), with no 
significant gender differences. At interview, each participant nominated the primary reason for referral 
leading to diagnosis. Although a constellation of related symptoms were frequently encountered the 
key reason for each person was categorised (see Table 4, overleaf). Where combinations of apparently 
equally troubling pre-diagnostic symptoms were recorded, the most intense and/ or frequent of these 
just prior to the final referral leading to diagnosis was determined where possible. 
From Table 4, it may be observed that in 50 out of 110 CD participants (45% of cases) GI 
symptoms (most often diarrhoea) were the dominant clinical feature immediately preceding diagnosis. 
In a slight majority of cases, however (60/110, or 55%), the investigation resulting in a diagnosis of 
CD was precipitated primarily by non-GI symptoms, most frequently iron-
deficiency anaemia. Although psychiatric symptoms were not uncommon prior to CD diagnosis, they 
were rarely the primary reason prompting the identification of CD. 
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Table 4 
Primary Reason for Referral Leading to a Diagnosis of Coeliac Disease: Subcategories Indented 
Gastrointestinal (GI) symptoms: 
Diarrhoea 
Nausea; vomiting; abdominal pain1 
Constipation 
Mild steatorrhoea; flatulence 
Equal combination of GI symptoms 
Abnormal blood test results: 
Iron-deficiency anaemia (and/ or low folate/ B12) 
Other 
Screening (blood relatives with C D ) 
Dermatitis herpetiformis 
Weight loss; unable to gain weight (in absence of diarrhoea) 
Lethargy/ fatigue (severe and persistent) 
Psychiatric/ psychological condition: 
One case of major depression; another of dysthymia 
Anxiety (with GI symptoms very minor) 
27% 
11% 
3 % 
2 % 
2 % 
45 % (subtotal) 
19% 
3 % 
22 % (subtotal) 
8% 
8 % 
5 % 
5 % 
2 % 
1% 
3 % (subtotal) 
Migraine (intractable, with mild/ transient GI symptomatology) 2 % 
Other extra-intestinal symptoms (fainting episodes; angina attack) 2 % 
1 0 0 % (Grand total) 
1
 includes other persistent or recurrent upper abdominal (dyspeptic) symptoms (e.g., abdominal bloating, 
heartburn, early satiety, postprandial fullness, belching and regurgitation). 
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In most cases, the nominated key reason leading to referral and ultimate diagnosis with C D did 
not preclude a history of other key symptoms of C D of less prominent intensity, frequency or 
recency. For instance, lethargy of varying degrees was cited by the majority of participants as a 
concomitant symptom, but only occurred in the absence of a more significant reason leading directly 
to referral for diagnosis in five people, each of w h o m had a prior history of other (presumably CD-
related) GI symptoms. 
The majority ofthe total C D sample (81%) reported an unequivocal lifetime history of recurrent 
GI symptoms, typically a combination of diarrhoea, nausea, abdominal pain or cramping (with one 
symptom slightly more frequent) and not uncommonly constipation alternating with diarrhoea. Only 
1 9 % had an anamnesis without GI symptoms. The history or otherwise of GI (and extra-intestinal) 
symptoms noted above needed to be recurrent, persistent and personally troubling to be recorded 
formally for use in statistical analysis in this study, as population studies have shown that more than 
5 0 % ofthe general population experience significant upper GI symptoms (excluding diarrhoea) in 
their lifetime (Heading, 1999). 
Diarrhoea was nominated by 2 7 % of C D participants as the principal reason for referral leading 
to diagnosis, although 5 9 % ofthe sample reported a persistent history of diarrhoea or loose bowels. 
However, for half of these people, another symptom was more prominent and the precursor to 
referral. Overall, the most c o m m o n health conditions reported in the C D sample (as having been 
diagnosed during their lifetime) were iron-deficiency anaemia (72%); hay fever (47%), migraine 
(37% current or previous sufferers), asthma2 (34%), reduced bone mineral density ( B M D ) , typically 
Hay fever and asthma are highly prevalent in Australia (Australian Institute of Health & Welfare, 2000), 
which has the highest child mortality rate for asthma in relation to other developed nations (Peat et al, 1994). 
Self-reported asthma prevalence was 113 per 1,000 people in 1995 (ABS, 1997), peaking in 5-14 year olds 
(192 per 1,000 persons). In the 1995 National Health Survey, 1 4 % of Australians reported that hay fever was 
a long-term health condition (experienced for > 6 months, compared to 1 1 % for asthma); 1 3 % reported that 
headache constituted a recent illness (experienced in fortnight preceding survey). 
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identified via D E X A 3 scanning (32%) of total sample, but 5 8 % of those actually tested) and dental 
enamel hypoplasia (28%). Other health related and second tier demographic variables were recorded in 
the CD and control groups (see Appendix C). 
For each participant a full socio-demographic, bio-medical and psychiatric anamnesis was obtained 
utilizing a general questionnaire (Appendix C) and clinical interview (description on p. 153). The 
majority ofthe CD sample was married or living in a de facto relationship (69% overall; 71%> of 
females [Fs]; 66% of males [Ms]), with 22% ofthe sample single (21% of Fs; 23% of Ms) and the 
remaining 9% divorced, separated or widowed (8% Fs; 11%> Ms). 
Socio-Demographic Profile of CD Group 
Forty percent of participants in the CD sample were employed full-time, 18% worked part-time, 
11% were full-time students, a further 11% were retired (at an earlier than normal age in four cases), 
10% described themselves as being involved full-time in home duties, 5% were receiving the disability 
pension and one person was unemployed when seen by the author. 
The majority of CD participants were of medium-high socioeconomic status (SES), with 59% 
categorised as medium (40 females and 25 males) and 30% high (20 females and 13 males). The SES 
distribution was comparable with those recorded both in the chronic illness comparison (diabetes 
mellitus; DM) and healthy comparison groups, although above local community averages, as detailed 
by the ABS (2001). Different criteria for determining the socioeconomic level were considered during 
data collection, with post code and household income initially utilized. However, the method 
producing the figures reported was based on criteria used by Ciacci et ai. (1998), for whom education 
and work were the key determinants of SES. The author ofthe present study adopted their approach, 
•3 
Ninety-two percent of participants reporting detection of reduced B M D (osteopenia or osteoporosis) at 
interview had received a DEXA (Dual Energy X-ray Absorptiometry) scan in the preceding 5 years; 8% had 
had an earlier scan, measurement using a different technique (e.g., quantitative computerised tomography) or 
could not specify which modality was used, but recalled the diagnosis. 
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with a slight alteration in partitioning years of education to reflect usual Australian community levels 
That only 10% ofthe CD group (12 females; 6 males) was subsequently classified in the low SES range 
reflected the author's general impressions of somewhat above average SES across the full CD group 
Sixty-four percent ofthe CD participants (61%> of Fs; 68% of Ms) had children (94% biological; 
6% adopted or via previous marriage), with 33% ofthe sample having two children, 15% three, 
13% one and 4% having four (which was the maximum number reported). Just over one third ofthe 
sample (36%) had no children. The mean number of children of participants across the full sample 
was 1.36 (SD = 1.22), but for participants older than 30 years the mean increased to 1.75 (SD = 
1.13), with 79%) of women (and 81% of men) over the age of 30 years having at least one child. The 
mean number of children increased further to 1.95 (SD = 1.00) for those participants beyond the age 
of 40 years and to 2.20 (SD = 0.82) for people aged over 50 years. 
Body mass index (BMI), both at diagnosis with CD and at study inclusion, was computed by the 
author, utilizing retrospective and current height and weight data in indoor clothing without shoes 
(minus 1 kg), as supplied by each participant. BMI is a measure ofthe height-weight ratio, obtained 
by dividing weight in kilograms by the square of height in metres (kg/m2). Direct assessment ofthe 
bodily measurements comprising the BMI was not undertaken by the author, these being based on 
participants' knowledge or estimates. The mean BMI for CD participants was 23.5 (SD = 3.6; range 
16.4 to 35.4) at the time when seen by the author and 22.3 (SD = 4.1; 13.7 to 39.0) at the time of 
CD diagnosis, which on average was 4.1 years earlier. The internationally accepted healthy or 
desirable BMI range is 18.5-24.9 (Tierney et al, 2002) with a BMI < 20 (in males, or about a point 
less in females) generally designating underweight status. People with a BMI of between 25 and 30 
are usually classified as overweight, with the threshold for obesity marked by a BMI of > 30. Minor 
adjustments for gender are sometimes advocated (e.g., Heading, 1999). 
All participants were asked to denote their ethnicity or cultural background, with more than one 
category able to be marked (see Appendix C, page 6 of questionnaire). Using these criteria, it was 
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determined that that within the sample of 110 participants with C D , 9 9 % were Caucasian and 1 % 
were of Aboriginal (Koori or indigenous Australian) ancestry. More than 8 out of 10 (83%) ofthe 
sample identified themselves as British/ Irish, with a finer breakdown determining the weightings to 
be 30% English, 20% Irish, 18% Scottish, 7% Welsh and 8% as unspecified British. This result was 
not unexpected, with an Australia-wide observation of CD as most prevalent among Scot-Welsh-
Irish groups previously reported (Barr et al, 1994). Sixteen percent ofthe sample categorised 
themselves as of European ancestry (7% German, 4% Italian, 2% French and 1%> Russian/ 
Scandinavian), with nobody claiming to be of Asian descent. This represents an under-
representation of Asians in the wider Victorian community, who comprise approximately 8% ofthe 
local population (McLennan, 1998). Thirty-eight percent ofthe sample claimed some degree of 
Irish heritage and 36% a proportion of Scottish descent, both relative over-representations 
compared to up-to-date demographic breakdowns of ethnic ancestry (ABS, 2001). 
Screening Protocol for CD Group: Inclusion/ Exclusion Criteria 
The sample was screened for acute illness at study enrolment, any history of previous head 
injury or neurological impairment, medical conditions that may contribute to neuropsychological 
impairment (e.g., known renal failure), English as a second language and severe psychiatric 
disorder. This process was prioritised to reduce the likelihood of participants being excluded after 
significant involvement in the assessment process. 
Criteria for exclusion included a previous head injury requiring hospitalisation for more than 24 
hours or unconsciousness for 5 minutes or longer, a medical condition history (as reported by the 
participant) that was very likely to have contributed to neuropsychological impairment (apart from 
being diagnosed with CD), uncorrected visual impairment or hearing loss, intoxication with illicit 
drugs or alcohol at the time of testing or a history of alcoholism, illicit drug or other substance 
abuse. Four male CD participants reported a history of recreational cannabis use, but three of these 
participants were working - and one was studying - full-time at study entry and none reported 
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cannabis use in the week prior to assessment. Medical/ psychiatric conditions considered 
exclusionary included those with documented neurological or neuropsychiatric sequelae (eg, 
stroke or Alzheimer's dementia) and histories of psychosis or mental disorders other than those in 
the anxiety or mood disorder spectrum. 
Previous or current diagnosis with an anxiety or affective disorder did not preclude inclusion in 
any ofthe three groups used in the study, nor did use of prescribed psychotropic medication at the 
time of recruitment or previously. Five participants in the CD group were prescribed with 
antidepressant medication at study entry, including one male participant undergoing long-term 
treatment for bipolar disorder whose mood was stabilized prior and subsequent to enrolment. Nine 
others had previously used antidepressant medication in their lifetime. Seven participants were 
medicated with anxiolytics or hypnotics (i.e., benzodiazepine class drugs), three primarily for 
anxiety and four to aid sleep, with an addition twelve others having used anxiolytic medication 
previously, typically for night sedative purposes. 
Taking into account concurrent (or a history of either) antidepressant or anxiolytic medication 
use, nine CD participants (8% of sample) were taking psychoactive medication at study entry. An 
additional eighteen (16%) had been medicated previously. This equated to 23%> ofthe CD sample 
having been prescribed with psychoactive or central nervous system (CNS) - relevant medication in 
their lifetime. A record and clinical investigation of these details were kept for each participant. 
Statistical analyses were performed both including and excluding participants prescribed with 
psychotropic medication at the time of assessment. No participants were (or reported having been) 
prescribed with antipsychotic, anticonvulsant or antineoplastic agents, nor had any participant ever 
been an inpatient at a psychiatric facility or received electroconvulsive therapy (ECT). 
Varying proportions ofthe CD sample were taking, or had previously used, a range of other 
mild but CNS-relevant medications. Narcotic analgesics (typically paracetamol and less commonly 
codeine-containing painkillers) were being used on a daily basis by seven participants, were used 
"often" by another twenty-eight (25%), "occasionally' by sixty (55%>) and "never" by only fifteen 
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(14%). Twelve C D participants (nine women) were using medication (typically Ventolin) to assist 
in controlling asthmatic symptoms and six (five women) were taking blood pressure lowering 
agents. Almost one quarter ofthe female CD participants were receiving hormone replacement 
medication, including a 31 year old, and 48% of coeliac women over the age of 45 years. Five 
women reported early onset of menopause (< 40 years) and, in total, twenty-six (39% of female CD 
participants) were post-menopausal Non-steroidal anti-inflammatory (typically aspirin) use was 
commonly reported by male and female CD participants. 
One participant with CD who reported a new diagnosis of diabetes mellitus (Type-2) three 
weeks after participating in the study was not included in the final sample (being excluded from 
statistical analysis). Two CD participants had a history of seizures but neither had a formal 
diagnosis of epilepsy and were included in the sample. 
Thirteen percent of CD participants smoked cigarettes (approximately half the Australian 
community average), although males were twice as likely to smoke as females (18%» cf 9%>). 
Twenty-six percent ofthe CD sample described themselves as previous smokers who had quit (21% 
of Ms; 30%> of Fs) and 60% had never smoked (61% of both Ms and Fs). The sample-wise results 
were comparable to Vazquez et al (2001). 
In relation to alcohol consumption, 46%> of participants best described themselves as social 
drinkers, 24%» typically only drank on special occasions (categorised as less than once per week), 
15% were frequent but not heavy drinkers (less than four standard drinks at least four days weekly), 
13% were lifelong abstainers, and one person best described himself as an occasional binge drinker, 
but there were no indications of associated health problems. People for whom drinking was - or 
used to be - a serious problem (according to WHO criteria; 1993) were not recruited to the study. 
Mindful ofthe positive impact of pyridoxine on depression in CD (Hallert, Astrom, & Walan, 
1983), vitamin/ mineral supplementation was noted, with 26% of CD subjects regularly taking most or 
all ofthe B-group vitamins, 24% being periodic users (or regular recipients of partial formulations, 
e.g., folate/ iron) and 50% never or rarely being in receipt of nutritional therapy apart from the GFD. 
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Recruitment of C D participants 
The majority of CD participants included in the study had initially contacted the author after readini 
advertisements about the project. They were primarily sought and recruited via calls for volunteers in 
the Victorian section ofthe Australian Coeliac Society's national magazine; "The Australian Coeliac" 
(see Appendix D), with the placement of six advertisements over 18 months in consecutive issues. In 
response to a promotion at the 2nd Annual Coeliac Seminar in Melbourne (May 1999), three dozen 
people with CD registered their interest by leaving contact details and were subsequently contacted by 
the author, with twenty-four meeting entry criteria and agreeing to participate. 
Fifteen people relatively newly diagnosed with CD (identified by volunteer staff at the Coeliac 
Support Centre) agreed to be involved in the study after being contacted directly by the author. The 
remaining recruitment occurred via advertisements posted at the Coeliac Support Centre in Melbourne, 
the University of Ballarat and referrals directly from doctors, gastroenterologists and dieticians who 
were aware ofthe project. 
Ninety-eight participants (i.e., 89%> of CD sample) were current members ofthe Victorian branch 
ofthe Australian Coeliac Society, or in the process of joining, as in the case of those very newly 
diagnosed. A further five people were prior members who had not renewed their affiliation and two 
others were not affiliated themselves, but had family members who were diagnosed with CD and who 
were existing members. Seven potential CD participants who had appeared to meet general criteria for 
involvement in the study were excluded immediately prior to assessment on the basis of inadequate 
diagnostic criteria having been satisfied (e.g., serological testing compatible with CD, but endoscopy 
and jejunal biopsy not carried out). Unequivocal diagnosis with CD was essential prior to inclusion in 
the study, with all available medical results verified against Coeliac Society membership database 
records of these details and/ or directly perused by the author with each participant's consent. 
All CD participants were initially seen by the author between June 1999 and April 2001, including 
the longitudinal cohort (n = 27) followed up by the author 12 months after the initial meeting (see 
Chapter 5). 
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Diabetes Mellitus ( D M ) Participants 
Fifty-three people with DM (31 female; 22 male) consented to involvement in the study, serving as 
an age-, gender-, education-, SES- and IQ-matched chronic illness comparison group. Matching with the 
CD group for the four socio-demographic variables was intentional, but the close IQ correspondence 
was incidental. A majority of individuals in this group (77%>) lived in metropolitan Melbourne, with 
another eight living close to the University of Ballarat. Ethnic breakdown was comparable to the CD 
group, the sample being 98%> Caucasian. British or Irish ancestry was predominant (85%). A significant 
minority were of European heritage (13%>), primarily second or third generation 
The mean age of participants with diabetes mellitus (DM) was 44.4 years (SD = 19.3; range = 16 to 
82) and they had a mean educational level of 12.8 years (SD = 2.7). Although not quite statistically 
significant upon t-test, females in the DM group were, on average, about nine years younger than their 
male counterparts (M = 40.7 years; SD = 16.1, versus 49.6; SD = 20.9). The female and male means for 
years of education were identical (M = 12.8; SD = 3.0 and 2.4 respectively) and the SES distribution 
across gender was comparable (medium: 16 Fs; 12 Ms; high: 10 Fs; 8 Ms and low: 5 Fs; 2 Ms). 
Thirty-six people within the DM group had type-1 (previously called insulin-dependent or, more 
distantly, juvenile-onset) diabetes and seventeen had type-2 (previously called non-insulin dependent or 
adult-onset) diabetes. All participants in these subgroups had a previous general practitioner confirmed 
medical diagnosis of DM prior to study entry, based on ketonemia, ketonuria, or both in type-1 DM 
patients and consistently impaired fasting plasma glucose (> 126 mg/dL) in all DM patients prior to 
treatment, the 75-g oral glucose test or other appropriate diagnostic procedures. Each DM participant 
was also receiving ongoing conventional medical assessment, including regular monitoring of glucose 
levels, glycosylated haemoglobin (HbAic), fasting lipid profiles and kidney function and standard 
reviews of individual treatment protocols. Each DM participant's own designation as type-1 or -2 at 
initial recruitment was closely examined at interview, in reference to their medical history and in light of 
current diagnostic and classificatory criteria (Masharani & Karam, 2002) prior to final study inclusion 
In the tvDe-l subgroup, the maioritv of Darticinants had a classic (abrupt and acute) onset of 
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hyperglycaemia in childhood or early adolescence, with proneness to ketoacidosis, insulopaenia and 
immediate dependence on injected insulin. Three participants were best described as having latent 
autoimmune diabetes, having not been initially diagnosed as type-1, but requiring insulin within two 
years of diagnosis. In the type-2 group, seven participants were insulin-assisted at the time of 
involvement in the study, another seven were medicated with oral hypoglycaemic agents and three 
were being treated solely via lifestyle modification (diet combined with aerobic exercise). 
Initial recruitment of DM participants resulted in a preponderance of type-1 (over type-2) volunteers 
who were, on average, about 10 years younger than the CD group, and people with type-2 diabetes who 
were, not surprisingly, about 10-15 years older. Limiting the chronic illness comparison group to either 
type-1 or type-2 DM sufferers was not a fixed initial consideration. Also, matching the chronic illness 
comparison and CD groups on demographic grounds was enhanced by combining people type-1 and -2 
DM. Therefore, this process was undertaken from the onset of recruitment. 
The type-1 and type-2 DM subgroups were therefore combined as the chronic illness comparison 
group (referred to as DM) for the majority of statistical comparisons. These subgroups were also 
considered separately where appropriate. The mean age of participants with each of type-1 and type-2 
DM were 37.44 years (SD = 17.1; range = 16 to 73) and 59.18 years (12.0; 41 to 82) respectively and 
they had a mean educational level of 13.17 (SD = 2.6) and 12.00 years (SD = 3.1). Across the range of 
demographic variables, independent samples t-test demonstrated that only age was significantly 
different between type-1 and -2 DM participants (t = 4.70, p= .000), with equal variance not assumed, 
given that Levene's test for equality of variances was positive (p < .05). 
The mean age at the time of diagnosis with DM was 29.2 years (SD = 19.9; range = 4 to 70). In half 
the cases (51%, including all type-2 cases and nine of type-1) the diagnosis of DM had been made in 
adulthood (20+ years); in sixteen cases (all type-1) in childhood (4-12 years) and in the remaining 
eleven cases (all type-1) in adolescence (age 13-19 inclusive). The mean ages of diagnosis were, for 
type-1, 19.0 years (SD = 14.5; including nine at age 12-13) and, for type-2, 50.8 (SD = 9.8; with all 
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except four first detected in their 40s or 50s). A breakdown of age at diagnosis (with cases numbers, 
gender and diabetes type) is displayed in Table 5 (below). 
The mean duration of D M across the full sample (since diagnosis) was 15.3 years (SD =12.9 years); 
with a mean of 16.34 years (SD = 12.4) for females and 13.75 years (SD = 13.8) for males, a statistically 
non-significant difference. However, the mean duration of illness for the type-1 subgroup was 
significantly higher than for the type-2 subgroup (18.5 years; SD = 13.5 versus 8.5 years; SD = 8.5). 
In addition to recording all socio-demographic factors, the type of diabetes, age at and time since 
diagnosis, the duration of symptoms prior to diagnosis was also noted, calculated or estimated during 
the face-to-face interview in consultation with each participant and all available medical records. 
Following an identical protocol to that used with the CD group to determine the total clinically 
symptomatic period pre-diagnosis, the mean pre-diagnosis symptomatic duration for the full D M was 
computed as 6.8 months (SD = 12.3 months). The type-2 subgroup reported significantly longer pre-
diagnosis symptomatic periods (12.5 months; SD =17.7 versus 3.2 months; SD = 5.0). 
In 50%> of type-1 cases the recalled symptomatic period was less than one month prior to diagnosis. 
Readers should also note that physiological changes may be occurring months and typically years prior 
to initial symptoms, especially in type-2 diabetes (Tierney et al, 2002). 
Table 5 
Diabetes Mellitus (DM) Diagnosis: Participants in Each Age Group by DM Type (i.e., Type-1 or -2) 
Age at Diagnosis 
Childhood: Early (4-9) 
Later (10-12) 
Adolescence: Early(13-14) 
Later(15-19) 
Adulthood: Young (20-34) 
Middle (35-49) 
Mature (50-64) 
Senior (65+) 
Number (and Gender) of Participants 
Type-1 
7(F = 6;M=1) 
8(F = 5;M = 3) 
7(F=5;M = 2) 
4(F = 2;M = 2) 
3 (F = 2; M = 1) 
4 (F= 2; M = 2) 
3 (all M ) 
nil 
Type-2 
nil 
nil 
nil 
nil 
1(M) 
6(F=5;M=1) 
8 (F = 4; M = 4) 
2 (both M ) 
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The major symptoms of ill health experienced and reported by each D M participant at study entry, 
listed from most serious, troubling or uncomfortable were recorded. The top six nominated by all D M 
participants were weighted equally, with breakdowns according to diabetes type (and divided by the 
number in each subgroup to yield a percentage), as listed in Table 6. Three symptoms (anxiety or low 
mood, eye and foot-related complaints) were equally represented at 2 6 % in the full D M sample. These 
are listed from highest to lowest ranked according to respondents' sequential rankings, giving a first-
listed symptom a weighting of 6 down to 1 for the last listed (for those who listed six symptoms) 
Table 6 
Major/ Most Serious Symptoms of III Health Experienced Now, as Nominated by DM Participants, 
According to Diabetes Type (% of subjects) 
Most Serious 
Symptom 
Lethargy/ fatigue 
Hypoglycaemia 
Anxiety/ L o w mood 
Eye 
Foot related 
Memory/ concentration 
Weight1 
Slow wound healing 
Sleep 
problems 
Other psychological 
(Fear of complications/ irritability) 
Type-1 
(n = 36) 
53 
39 
28 
25 
33 
25 
19 
17 
8 
8 
Type-2 
(»=17) 
29 
6 
24 
29 
12 
18 
12 
12 
18 
12 
Total D M Group 
(n = 53) 
45 
28 
26 
26 
26 
23 
17 
15 
11 
9 
Note: Figures are expressed as percentages of participants 
1
 Gaining (or being unable to lose) weight was the key issue for all respondents except one male with 
type-1 diabetes, for whom lost weight was a major concern 
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It is important to note that the percentages reflect the number of people with D M (against 
diabetes type and total group) who themselves perceived the relevant symptoms to be serious, troubling 
or uncomfortable. Some ofthe figures tabulated do not necessarily correlate in a logical sense with other 
measures ofthe symptom in question. For example, a slightly higher proportion of people with type-1 
(versus type-2) DM listed weight as a major symptom of ill health, despite a smaller proportion actually 
being overweight, using objective criteria such as body mass index (BMI) 
Current BMI (kg/m ) was computed from bodily measurement provided by all participants, 
with a mean of 26.3 (SD = 4.0) for the full DM sample, an almost identical figure for males and 
females. People in the type-2 diabetes subgroup had a significantly higher mean BMI than those in the 
type-1 subgroup (29.1; SD = 4.2 versus 25.0; SD = 3.2), with all except three participants with type-2 
DM (82%) having a BMI of > 25 (overweight) and almost half (47%) > 30 (i.e., obese). In the type-1 
subgroup 50%> had a BMI in the normal weight range (20-25), with only three (8%>) with a BMI above 
30. The high proportion of overweight people in the type-2 subgroup was approximately representative 
ofthe community prevalence of overweight status in people with type-2 DM using BMI. 
Medical Parameters at Study Entry 
All except one DM participant (described later) were euglycaemic within an hour of scheduled 
psychological assessment, according to self-administered blood glucose recordings undertaken in front 
of or reported to the author. In addition, the most recent pathology report records of glucose levels, 
glycated haemoglobin (HbAic), fasting lipid profiles, as well as kidney and liver function test results 
(if available), were noted in the interviews of all DM participants where recalled. These details were not 
systematically recorded on a data file or subjected to statistical analysis, but were used primarily to 
exclude DM participants with a consistent recent history of very poor diabetic control, moderate to 
severe nephropathy or indications of serious hepatic complications. According to individual self-report, 
the majority of study participants had good to fair control in relation to HbAic levels, taken as an 
average of their most recently recorded tests in the 12 months immediately prior to study entry. Standard 
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reference intervals used for HbAi c were Normal (non-diabetic): 4.0 - 6.0 %; Good Control: 6.1 - 7.0 % 
and Fair Control 7.1 - 7.9 %. Eleven DM participants reported that their most recently assessed HbA,c 
level was greater than 8.0%> but each of these participants reported at least reasonable short to medium 
term glycaemic control preceding study entry, and an absence of severe DM-related health 
complications. 
Perceived Self-Compliance With Diabetes Treatment 
Each participant also self-rated their level of compliance with diabetic treatment at study entry from 
excellent (I'm doing almost everything I can to stay healthy) to very poor (I am not following my 
treatment plan at all). On this Likert-type scale (see Appendix E), 65% ofthe sample rated their 
treatment compliance as very good (39%) to excellent (26%), 8.7% each as good (I'm doing most things 
I can to stay healthy, but not everything) and fair (I'm doing a lot of things to stay healthy, but missing 
a few things) and 17% as poor (there are a lot of things I should be doing better to stay healthy). 
Reasonable concordance was apparent when perceived self-compliance with diabetes treatment was 
matched on a case by case basis with recent medical parameters (i.e., HbAic, fasting lipid profiles and 
available data regarding nephropathic and hepatic function). A further overall observation, pertinent to 
several cases, was that perceived compliance was excessively self-critical against supplied medical test 
data, especially in the case of those participants rating their compliance as poor. In all such cases, the 
recent test results suggested at least fair control regarding HbAic and an absence of anomalous results 
in other areas. 
Glycaemic Status and Recent Hypoglycaemic Episodes 
Despite variation in self-rated treatment compliance, almost all DM participants were successfully 
maintaining at least reasonable glycaemic control at the time of study inclusion, with a high degree of 
awareness ofthe short and longer-term health protective factors across the sample. Regular glucose 
testing was self-administered by all DM participants, except those with type-2 DM and reliant on diet 
alone. Across the sample, hypoglycaemia preparedness was typically sound. One DM participant who 
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experienced moderate hypoglycaemic symptoms during pre-assessment interviewing stabilized after 
provision of a snack and the passage of time, but cognitive testing was rescheduled. 
A number of distantly diagnosed participants admitted poor or sporadic compliance earlier in life 
There was a positive Pearson correlation between current participant age and diabetes compliance 
(r = 0.48; p = .019) and a negative correlation between compliance and state anger (r = -0.43; 
p_ = .040). Those expressing the greatest difficulty with glycaemic control were typically in new 
medicinal regimes at the time of study involvement. 
Inclusion/ Exclusion Criteria for DM Group 
Akin to the requirements for inclusion into the DM group, exclusionary criteria were strict, given 
the presence of complications, significant morbidity and severe later-state health implications 
encountered in diabetes (Williamson, Thompson, Thun, Flanders, Pamuk, & Byers, 2000). People 
with uncorrected visual impairment, renal or hepatic dysfunction, symptomatic cardiovascular disease 
and amputees were excluded from recruitment to the DM group. Furthermore, the aforementioned 
exclusionary criteria applied to participants in the CD group were also employed. These criteria were 
inclusive of a medical condition history (as reported by the participant) that was unlikely to have 
significantly contributed to neuropsychological impairment, over and above having been diagnosed 
with DM and having a history of mild to moderate complications associated with DM outside ofthe 
categories listed. 
In addition, potential DM inclusions who had a history of classic clinical signs of CD - in 
particular GI symptomatology - and who had not had serologic testing and intestinal biopsy to rule out 
CD, were not included. One person fitting this description and another with a family history of CD 
were excluded, while a third person already recruited to the CD group later informed the author that 
she had been additionally diagnosed with DM after initial assessment. She was omitted from all 
statistical analyses. 
As in the CD sample, psychoactive medication use was not uncommon in the DM group. 
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Combining a history of either antidepressant or anxiolytic medication use (or a concurrent prescription), 
four DM participants (8% of sample) were taking psychoactive medication at the time of assessment 
(one, an antidepressant; three other participants, sedatives). An additional six (11%) had been medicated 
in their lifetime prior to study entry, equating to 19% ofthe DM sample having been prescribed with 
psychoactive medication in their life. No DM participants reported having ever been prescribed with 
antipsychotic, anticonvulsant or antineoplastic agents, had ever been an inpatient at a psychiatric 
facility or been subject to ECT. 
The author was reliant on information provided by each participant in response to detailed 
questionnaire items and discussions of medical histories and records during clinical interviewing, in 
determining the applicability of exclusionary criteria in each case. In a number of cases medical records 
were referred to by participants in the author's presence to clarify diagnostic information. No 
participants in the DM group were direct or distant blood relations (as far as could be ascertained) of 
anyone in either the CD or healthy control (NC) groups. 
Twelve percent ofthe DM participants were cigarette smokers (cf. 13%> of CD sample, 15.5% for 
Australian DM patients in a large scale study [Zimmet & Welborn, 1999] and about half the Australian 
community average, as aforementioned), 24%> were previous smokers who had quit (cf. 26%» of CD 
sample) and 63% had never smoked (60% for CD sample). Regarding alcohol consumption, 23% of 
participants described themselves as social drinkers (cf. 46%> in CD sample), 31% preferred to drink 
on special occasions (i.e., < once per week; cf. 24%> of CD sample), 26% were frequent but not heavy 
drinkers (< 4 drinks > 4 days weekly; cf. 15%> of CD participants) and 21%> were lifelong abstainers 
(13% of CD group), with no DM participants describing themselves as binge or problem drinkers. 
Given that there was a slightly greater proportion of participants in the DM group who were either 
frequent drinkers or abstainers, compared to the CD group, these two samples were viewed as 
approximately balanced overall regarding alcohol consumption. People for whom drinking was, 
or used to be a serious problem, were not recruited to the study. 
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Recruitment of D M Participants 
Diabetes mellitus participants were primarily recruited via five consecutive advertisements 
in the quarterly national "Diabetes Today" magazine (Appendix F), the source of a large proportion of 
participants in older age brackets. From responses to each advertisement, several suitable participants 
(ranging in number from two to six) were selected who met diagnostic requirements and 
all inclusion and exclusion criteria. 
The majority of younger DM participants were recruited via advertisements in a Victorian magazine 
(called "Reality Check"), published from the office of Diabetes Australia targeting the interests of 
teenagers and young adults with DM. An e-mail advertising the study was also sent to all electronic 
subscribers. Finally, the author personally addressed a young diabetic support group, after which several 
adolescent DM sufferers meeting selection criteria consented to involvement. A small proportion of 
middle-aged DM participants were recruited via advertisements posted at the Alfred Hospital in 
Melbourne, the Psychology Department notice board at the University of Ballarat and a mid-week 
advertisement placed in the largest selling Melbourne daily newspaper, the Herald-Sun. In all, eighty-
one percent of DM participants were registered with (i.e., subscribers to) Diabetes Australia. 
People in the DM group were recruited and assessed in the context of two sessions each 
(less than three weeks apart) between March, 2000 and December, 2001. Whilst light snacks and 
beverages were provided, all DM participants assessed away from their own residence were reminded 
ofthe estimated duration of assessment, separate from travel time, the day prior to study participation 
and encouraged to bring refreshments of their choice to ensure sustained glycaemic control 
Healthy Control Participants 
A second control group of 69 age-, gender-, education-, SES- and IQ-matched healthy volunteers 
without a chronic illness (41 females; 28 males) comprised the normal control (NC) group. Selected to 
match the CD group as closely as possible in terms of age, gender, educational level and socio-
economic status (all statistically achieved goals), close matching for full-scale WAIS-IQ incidentally 
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occurred, as happened in the D M sample. There was a comparable with-in group distribution of 
variance in all socio-demographic variables across gender. Most individuals in the NC group lived in 
metropolitan Melbourne (54 out of 69) or Geelong (two people), eight lived in proximity to the 
University of Ballarat, with the remaining five living in other regional locations within Victoria. The 
mean age of NC participants was 41.1 years (SD = 18.7; range of 16 to 81) and they had a mean 
educational level of 12.38 years (SD = 3.0). 
TheNC sample was almost exclusively of Caucasian extraction (99%>), with people of British/ 
Irish background again most highly represented (82%) and European heritage accounting for almost 
for all the remaining variance (17%> overall; Italian 4%, German 3%>, Dutch 1%>). For all NC 
participants, English was spoken at home from an early age. 
No participants in the NC group were direct or distant blood relations of any participants in either 
the CD or DM groups. People with a family history of CD (but not diabetes mellitus) were excluded. 
According to their own reports in the context of answering a specifically designed questionnaire 
identical to the CD Questionnaire, except for the CD material (Appendix L), and clinical interviewing, 
none ofthe healthy volunteers included in the study had previous diagnoses, indications or current 
clinical signs of diabetes mellitus, CD or other gastrointestinal (GI) disorders, such as IBD. For 
example, people with a history of iron-deficiency anaemia who had not undertaken serologic and bioptic 
testing for CD were not included. However, medical testing to rule out CD or other medical conditions 
was not undertaken in asymptomatic volunteers. People with mild asthmatic conditions and minor 
medical ailments (e.g., high cholesterol in absence of symptomatic cardiovascular disease) were 
included, provided that there was not compelling evidence that such conditions may adversely affect 
cognitive functioning. Those with major and disabling or degenerative chronic diseases, other than mild 
cases of common processes (e.g., arthritis), were excluded. All healthy volunteers were also subject to 
the same general exclusionary criteria applied to CD and DM participants, as specified earlier. 
Notwithstanding the clear exclusionary criteria utilised, 19% ofthe NC sample reported a lifetime 
history of occasional or mild GI symptoms. These figures were comparable to or below reported 
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community levels of lifetime upper GI symptomatology (Heading, 1999). The characteristics ofthe GI 
symptoms reported, in conjunction with general health factors, did not arouse suspicion of CD or IBD 
Psychoactive medication use was permitted in all study groups, including the NC sample, 4% of 
whom were prescribed with psychoactive medication at enrolment. Three NC participants were using 
anxiolytic medication (three for night sedation) and one was also using an antidepressant. In total, a 
further ten healthy controls (14%) had been prescribed psychotropic medication in their lifetime, a 
slightly smaller proportion than the DM and CD groups. As was the case in the CD and DM samples, 
no NC participants had ever been treated with antipsychotic, anticonvulsant or antineoplastic 
medications or been an inpatient at a psychiatric facility. 
Various parameters of general health and life quality in the NC sample were in line with 
community norms, but a higher than expected proportion were non-smokers (58%), very similar to 
both the CD and DM groups. Alcohol consumption was also similar to the chronic illness groups. 
Mean BMI, at 24.5 (SD = 3.3), was not significantly different across gender, with 13% underweight 
(range of 17.5 to 19.4), 38% ofthe sample in the healthy range (20 to 24.9), 16% borderline (range of 
25.1 to 25.99), 26% overweight (26 to 29.9) and two NC participants greater than 30 (30.1 and 32). 
There were no strong, pre-existing suspicions of DM in those designated overweight, with the person 
of highest BMI actually a fit young person with very high relative muscle mass and normal 
subcutaneous fat level (12%), as medically assessed. Less pronounced examples of this dynamic 
(relatively high muscle mass/ normal adipose levels) were apparent in a number ofthe NC males with 
a BMI greater than 25. 
The NC participants were sought from three major sources. Recruitment occurred via general 
noticeboard and e-mail advertisements at the University of Ballarat and University of Melbourne, from 
amongst staff serving as correctional officers at Victoria's Port Phillip Prison (and/ or relatives of them) 
and also from general members ofthe public responding to an advertisement placed in the highest 
selling local daily newspaper, the Melbourne "Herald-Sun". The divergent recruitment protocol 
facilitated close matching ofthe NC group with both the CD and DM groups on socio-demographic 
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grounds and also resulted in a good spread of scores in most assessment/ test measures utilized in the 
study. Similar to the two chronic illness groups, the healthy controls, on average, were of medium to 
high SES. 
After fully consenting, a 22 year old male university student was excluded from participating. He 
had scored 32 on the BDI-II, and a concomitant clinical interview established that this person had 
made a serious suicide attempt several days earlier. He voluntarily withdrew from the study and 
accepted a referral to a local psychologist after receiving counselling from the author. 
All NC participants were seen once by the author between the period of June, 1999 and December, 
2001, with a small subgroup accessed before March 2000 (n = 10) followed up for re-assessment one 
year later (see Chapter 5; Longitudinal Study). 
Materials and Measures 
Prior to assessment with a battery of psychological instruments in standardised order (as described 
in the prospective section), each participant read and signed a consent form (Appendix G), tailored 
according to their group (CD, DM or NC), in the presence ofthe author and an independent witness. 
Beck Depression Inventory - 2nd Edition (BDI-H: Beck. Steer & Brown 1996) 
The BDI-II was the first psychological instrument administered to all participants in Study 1 
in the presence ofthe author. It served a joint purpose, being used by the author as both; a) a 
screening test in establishing the likelihood or otherwise in all study participants of signs of a major 
mood disorder, and, b) it comprised the sole psychometric evaluation of depressive symptomatology 
used in Study 1. The Beck Depression Inventory has widespread previous use in screening for clinical 
depression in chronic illness, including diabetes mellitus (e.g., Lustman et al, 1997) and multiple 
sclerosis (De Luca, Barbieri-Berger, & Johnston, 1994), as well as the evaluation of mood in GI 
malabsorption and disturbance (Ledochowski, Widner, Bair, Probst, & Fuchs, 2000). The current BDI-H 
is a 21-item self-report questionnaire for measuring the severity of depression in adults and adolescents 
aged 13 years and older (Beck et al, 1996) and its constituent items were selected by Beck et al. (1996) 
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to correspond with the key criteria used for diagnosing depressive disorders outlined in the American 
Psychiatric Association's (DSM-IV; APA, 1994), 
For each item in the BDI-II, the respondent indicates to what degree a particular depressive 
symptom (e.g., Sadness; Item #1) has been experienced in the past two weeks, including today by 
circling a score from 0 to 3. Each numerical score is self-evaluated as follows (using Sadness as an 
example): 0 = I do not feel sad: 1 = I feel sad much ofthe time: 2 = I am sad all the time: 3 = I am so 
sad or unhappy 1 cannot stand it. Possible total scores range from 0-63. 
The author requested that each subject read the BDI-II instructions out loud in order to broadly 
ascertain the level of reading comprehension and capacity to fill the questionnaire without verbal 
guidance. The inventory took participants approximately 5-10 minutes to complete, as suggested in 
the BDI-II Manual. 
For the purpose of interpreting scores on the BDI-II, the screening protocol advocated in the Manual 
uses a relatively low threshold for detecting depression in order to decrease the likelihood of false 
negatives. The cut score threshold guidelines based on patients diagnosed with major depression (as 
provided on page 11 ofthe Manual) are described by Beck et al (1996) as minimal (total score of 0-13); 
mild (14-19); moderate (20-28) and severe (29-63). These thresholds were considered in relation to 
mean participant scores in each group in the study and the proportion of participants' scores within 
each range in each group. 
The psychometric characteristics ofthe BDI-II, including its reliability and validity, are detailed in 
the BDI-II Manual. In summary, this test instrument is characterised by strong internal consistency, 
with high coefficient alphas and test-retest stability, the latter statistic of special pertinence to the 
longitudinal study ofthe present thesis (Chapter 5). Furthermore, all validity indicators are favourable, 
with clear content, construct and factorial validity. 
Of particular relevance to the cross-sectional study, two major dimensions of self-reported 
depression were identified by Beck et al. (1996) following promax-rotated iterated-principal-factor 
standardised regression analysis using a sample of 500 psychiatric outpatients (see p. 30-31; BDI-H 
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Manual, 1996). Mutually exclusive sets of constituent BDI-H items were found to load onto one of each 
of these dimensions. These factors were described as Somatic/ Affective (Factor 1) and Cognitive 
(Factor 2). Many items on the second half of the inventory map onto Factor 1 (e.g., Tiredness or Fatigue 
and Loss of Energy) and those items appearing mainly on the first half of the inventory loading onto 
Factor 2 (e.g., Past Failure and Worthlessness). The correlation between these factors was 0.66 
The use of a reliable, valid and widely used measure of self-reported depression such as the BDI-II, 
with the capacity to discriminate between somatic/ affective and cognitive dimensions of depression, 
was considered to be of great relevance, especially given that the physical symptoms of depression in 
CD may mimic the somatic symptoms of depression, in addition to other reasons outlined in Chapter 2. 
A final reason the BDI-II was chosen in the present thesis ahead of other measures of depression 
was that it contains just one item of possible direct gastroenteric or dietary significance, namely 18. 
Changes in Appetite. This situation compares favourably with the Zung self-rating depression rating 
scale, used (and modified) by other authors (e.g., Addolorato et al, 2001; Gasbarrini & Addolorato, 
1997), which contained three items evaluating gastroenteric symptoms of depression prior to 
modification by those authors (decreased appetite, weight loss and constipation). 
Coeliac Disease Awareness Screen 
A new scale was developed by the author to measure CD participants' knowledge about CD 
(Appendix H). Ten questions comprising the scale tested awareness of facts about CD across diverse 
areas, including CD symptomatology (Question 4), the gluten-free diet (Question 5) and diagnostic 
criteria (Question 10). The screen was developed and refined over a six month period, involving 
consultation with Victorian Coeliac Society committee and other health care professionals associated 
with the Victorian Coeliac Society. The scale was also administered to society members, who provided 
feedback about item content and clarity. Following administration to a range of people with CD, from 
those newly diagnosed to those on the gluten-free diet for various periods of time, a scoring regime 
was developed (Appendix I), with tentative, preliminary descriptions of various score ranges. 
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For each ofthe ten questions comprising the scale, C D participants were instructed to circle the 
best answer or answers. Please note that in a number of questions more than one answer is preferable. 
Each question had from six to eighteen alternative answers. Every alternative answer to each question 
was given a score by the author. For incorrect answers a negative score was given if the item was 
selected, while for correct answers, positive scores were awarded or in some cases not selecting correct 
answers attracted negative scores. For example, the fifth question asked In the gluten free diet what 
foods can be safely eaten bv people with CD. Of each ofthe 18 alternative answers, several attracted 
positive scores if selected (e.g., circling bananas = 1), selecting gluten-containing foods attracted 
negative scores, while one (correct) item attracted a positive score if selected and a negative score if 
not selected (circling monoglyceride = 2; if not selected = -2). 
Whilst the scoring system was complicated, it was designed to maximise separation of scores (see 
Table 7), based simply on C D participants' knowledge of C D in the context of a brief inventory 
designed to be completed in less than 5 minutes. The author was present at all times during the 
administration ofthe C D Awareness Screen and emphasised the written instructions. 
Table 7 
Score Ranges and Proposed Level of Knowledge in the Coeliac Disease Awareness Screen 
Level of Knowledge Score Range 
Highest possible score = 100 
Excellent Knowledge: >60 
Broad Knowledge (>12 mths diagnosed/updated awareness): 46-60 
Average (Coeliac diagnosed for 12 months): 30-45 
Low Knowledge (Newly diagnosed coeliac): 15-29 
Very L o w < 15 
Lowest possible score = Minus 100 
The Coeliac Disease Awareness Screen was completed by CD participants immediately following 
the administration ofthe BDI-II. Theoretically, possible scores ranged from minus 100 to positive 100, 
with pilot testing suggesting a preliminary scoring range as outlined in Table 7. It was expected that 
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the majority of scores would fall between 0 and 80. The C D Awareness Screen took about 5 minutes to 
complete. 
Health Status 
Participants from each group completed a 6-point self-assessed health status rating in the presence 
ofthe author. They rated their health status (i.e., how good or bad they considered it to be) from very 
poor to excellent (Appendix J), with national community norms available for people with and without 
one or more medical conditions (McLennan, 1998). 
This measure was based on the 5-point rating utilised in the Australian National Health Surveys of 
1989-90 and 1995 (McLennan; Australian Bureau of Statistics; Pocket Year Book, 1998, p.44). In the 
present study an extra rating point ("very poor") was included to better accommodate a finer analysis 
ofthe perceived ill-health of people in the CD and DM groups. 
Each NC participant rated their health on this scale once only, while those participants in the CD 
and DM groups rated their health according to two temporal scales; right now and prior to diagnosis/ 
treatment. Reading the instructions and completing this scale took participants less than 60 seconds. 
Compliance with Treatment in CD and DM Participants 
CD and DM participants rated their compliance with treatment via separate self-report processes, 
also with the author present. Participants with CD estimated how often they ate gluten-containing 
foods, whether deliberately, knowingly or accidentally, by selecting one of six categories based on 
frequency, ranging from Always, i.e.. every day (score = 0) to Never (= 5). 
This self-rating scale was designed by the author (Appendix J) and was intended to reflect actual 
behaviours, as opposed to intentions, beliefs or cognitions about a CD patient's perception of their 
degree of compliance, which are more susceptible to and dependent on temporal, situational, affective 
and memorial factors. Participants with CD were also required to describe recent occasions and 
circumstances when gluten-containing foods were knowingly or accidentally consumed. 
Participants with DM rated their level of compliance with treatment (i.e., "the extent to which you 
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are doing what you can to stay healthy, based on the medical advice you have received") by selecting 
one of six categories from, ranging from Very Poor: i.e.. I am not following mv treatment plan at all: 
I'm not seeking help (score = 0) to Excellent i.e.. I'm doing everything I can to stay healthy (= 5). The 
compliance scale for participants with DM, like its CD counterpart, also emphasized behavioural 
evidence of treatment compliance. The brief CD and DM compliance scales were able to completed 
in less than one minute. 
Compliance with GFD - Second Measure for CD Participants 
The frequency with which CD participants deliberately, knowingly or accidentally ate gluten-
containing foods, as the assessed by the previous scale, was considered the best brief self-report measure 
of compliance with the GFD. However, an alternative scale was also generated from a pool of 18 items 
(Appendix K), with two of four items based on items in a new GFD compliance measure developed by 
Buckfield (1997). The secondary scale subsumed distinct factors related to compliance, as identified by 
that author, including intentions to comply with and difficulty following the GFD, as well as self-
reported compliant and non-compliant behaviours. 
The author's scale was comprised of four compliance-related questions (two positively keyed and 
the other two negatively keyed), each of which yielded five possible scores from 0-4, based on a 5-
point Likert scale (strongly disagree to agree), resulting in a total score of 0-16, with higher scores 
indicating increased dietary compliance. These four questions were selected from a list of 18 
compliance-related questions administered to members ofthe Victorian coeliac society in a pilot 
exercise. They were selected primarily on the basis of encompassing key factors underlying dietary 
compliance with the GFD and were amongst the items that provided the greatest spread of scores 
during pilot testing. The questions were: 
"I have made a firm commitment to follow the GFD" and "I follow the GFD strictly in all 
circumstances" (positively keyed) and "I have not always followed the GFD since being diagnosed" 
and "Because the GFD is difficult, sometimes it is not worth following" (negatively keyed). 
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Demographic and Health Questionnaire for all Participants 
Participants in all groups completed a general 5-6 page pre-test general health and information 
questionnaire designed by the author (see Appendixes C, L and M), which yielded information about 
their socio-demographic profile, family information, medical and psychiatric history, smoking and 
drinking habits, medicinal use and ethnicity/ cultural background. The questionnaire was administered 
in the presence ofthe author and took an average of 15 minutes to complete. It was used conjunction 
with brief pre-assessment clinical interviewing. The screening process also verified each individual's 
inclusion in the study, assisted in matching the groups across key demographic factors and fortified the 
reservoir of background information relevant to the health-related, behavioural, affective and cognitive 
variables being measured. 
The questionnaire was slightly different for each ofthe three groups, with those administered to the 
CD and DM participants including additional information about symptomatology and diagnostic 
details specific to CD and DM. In the CD questionnaire the specific diagnostic trajectory tracing initial 
symptoms to confirmed CD was requested. Primary and secondary reasons for referral leading to 
diagnosis and a retrospective record of which symptoms ameliorated following treatment with the 
GFD were clarified at interview following completion of relevant questions in the questionnaire. 
Four key clinical variables were generated from information elicited via the questionnaire and 
clarified during the interview, these being 1) the precise age at diagnosis; 2) the days since diagnosis 
and being on the GFD; 3) the number oi distinct symptoms at the time of diagnosis (referred to as 
"severity of illness") and 4) the total duration of time that each participant was symptomatic prior to 
diagnosis (persistently recalling experiencing at least one symptom of CD). The first three variables 
(i.e., age at diagnosis, time on GFD and number of symptoms at diagnosis) were able to be ascertained 
with a reasonable degree of confidence in almost all cases. 
Calculating the fourth clinical variable (total duration of time that each participant was 
symptomatic prior to diagnosis) was very difficult in a large minority of cases and subject to many 
potential biases, not the least being how it was specified. The author defined "symptomatic" in the case 
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of this variable as any continuous period of time pre-diagnosis that the participant could recall having 
at least one distinct, unresolved, physical symptom of CD. For example, a participant diagnosed at age 
20 years with definite GI symptoms their entire life (on an unbroken daily basis) prior to diagnosis 
would be designated as having been symptomatic for 20 years. 
In the case of most participants who were diagnosed in adulthood, however, there was a sporadic 
history of CD symptoms experienced, with symptomatic periods often intensifying or increasing in 
length and frequency in the weeks, months and years just prior to diagnosis with CD. For many 
participants diagnosed in adulthood, early adolescence was recalled as being a completely symptom-
free life stage. In the author's definition, if a participant's only symptom prior to diagnosis was, for 
example, anaemia, and this had remained unresolved up to the diagnosis of CD, the entire period 
between identification of anaemia and diagnosis with CD was recorded as the duration of time that that 
participant was symptomatic. In cases where periods of being symptomatic were preceded, broken by 
or alternated with completely asymptomatic stages, the symptom-free and symptomatic periods were 
each appraised and a total symptomatic duration was calculated by adding up each symptomatic period 
prior to diagnosis. Finally, possible non-physical symptoms of CD (e.g., depression) were not included 
in the calculation due to the increased inevitability of error in making retrospective diagnoses of 
psychiatric disorders. 
There were a number of borderline judgements made where the definition of symptomatic was 
problematic. If the only symptom cited by a participant was "fatigue" or "tiredness" the relevant time 
periods were those in which the degree of lassitude clearly exceeded normality and treatment with 
the GFD had significantly increased energy levels. In the case of one participant for whom a history 
of debilitating migraines (which completely resolved after the GFD) and a brief anaemic period pre-
diagnosis were the only distinct symptoms experienced, an estimate ofthe total time period during 
which migraine was experienced outside ofthe anaemic period was added to the duration of 
unresolved anaemia. In every case where a number of symptoms occurred simultaneously the 
continuous time period was only counted once. 
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Using the criteria described, in at least thirty cases out ofthe sample of 110 people with CD, 
converging on a final symptomatic time duration was most accurately described as an estimate with 
error margins that were impossible to quantify. A number of factors impinged on the best estimate able 
to be determined, including each participant's memory and own estimations (encompassing several 
decades in some cases), the clinical judgement ofthe author and the suggestibility of each participant 
in relation to the author's investigation. To guard against the latter source of potential contamination 
each participant completed the demographic health questionnaire prior to any input from the author 
and all available sources of collateral information were utilised. Wherever possible, medical records 
voluntarily supplied by the participant and information provided by family members (parents, siblings 
and spouses) were used to clarify time periods that were difficult or impossible to recall, let alone 
quantify accurately (e.g., infancy). 
Undoubtedly in many cases, time periods excluded from the total symptomatic period may have 
encompassed unidentified symptomatic temporal stages (e.g., being anaemic but undiagnosed and not 
manifested clinically). On the other hand, it was impossible to rule out the inclusion of symptomatic 
periods that may have been attributable to unidentified causes other than CD. All unbroken periods of 
time inclusive of at least one symptom characteristic of CD were included in the calculation unless a 
more likely direct cause could be determined. After a total symptomatic duration pre-diagnosis was 
calculated or estimated for each participant, this variable, as well as the number of days since diagnosis 
and treatment with the GFD, were each partitioned into eight time periods. 
State-Trait Anxiety Inventory (Form Y; Spielberger et al, 1983) 
Participants in all groups completed the State-Trait Anxiety Inventory (STAI) in the presence of 
the author. Referred to as the Self-Evaluation Questionnaire, the S-Anxiety and T-Anxietv scales are 
printed on opposite sides of a single-page test form and are completed consecutively, each taking five 
minutes or less. Prior to administration, care was taken by the author to encourage participants to 
respond candidly, as outlined in the STAI Manual. They were reminded that their results would remain 
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confidential and they were informed that feedback about their test results would be made available, 
Spielberger (1983) describes anxiety states as "characterised by subjective feelings of tension, 
apprehension, nervousness and worry, and by activation or arousal ofthe autonomic nervous system" 
(p. 1; STAI Manual). The S-Anxiety scale (STAI Form Y-l) is designed to measure state (i.e., current) 
anxiety. Consisting of twenty statements (such as I feel worried) 
that evaluate how respondents feel right now... at this moment... with no right or wrong answers. 
participants circled a number reflecting the degree to which each statement described present feelings 
best, from 1 (not at all) to 4 (very much so), in one-point increments. 
Trait anxiety is described by Spielberger as referring to relatively stable individual differences in 
anxiety-proneness (p.l; STAI Manual). The T-Anxiety scale (STAI From Y-2) is also comprised of 20 
statements, similar to those in Y-l, that assess how people generally feel, also rated from 1 (almost 
never) to 4 (almost always). Normative data for Form Y-l and Y-2 ofthe STAI are available for 
working adults and other groups and will be referred to in the Results section of this chapter. The norms 
for working adults are based on a total of 1,838 employees ofthe Federal Aviation Administration 
(1,387 males; 451 females). Reliability data are presented in Table 11 (p. 13) ofthe STAI Manual The 
test-retest correlations for the T-Anxiety scale were reasonably high for college student (ranging from 
.73 to .86) but lower for groups of high school students (.65 to .75). The median reliability coefficient 
for the T-Anxiety scale for college and high school students were .765 and .695 respectively. For the 
S-Anxiety scale, the stability coefficients for college and high school students were relatively low, 
ranging from . 16 and .62, with a median of just .33. However, "relatively low stability coefficients were 
expected for the S-Anxiety scale because a valid measure of state anxiety should reflect the influence 
of unique situational factors that exist at the time of testing" (pl3). The internal consistency ofthe 
S-Anxiety scale, as measured by the alpha coefficient, was quite high, with a median of .93. For the 
T-Anxiety scale, a median coefficient of .90 was also reflective of uniformly high alpha coefficients. 
There is strong evidence of concurrent, convergent, divergent and construct validity ofthe STAI scales, 
as outlined in the STAI Manual 
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Spielberger, Sydeman, Owen, and Marsh (1999) provide a detailed review ofthe underlying 
concepts and use ofthe STAI (and the STAXI; discussed below) for treatment planning and outcomes 
assessment in psychological testing. For a further in-depth review of 816 research articles utilising the 
STAI between 1990 and 2000 please see Barnes, Harp and Jung (2002). 
State-Trait Anger Expression Inventory (STAXI; Spielberger. 1988. 1991) 
The State-Trait Anger Expression Inventory (STAXI) provided a measure ofthe experience, 
expression and control of anger. It conceptualizes anger as having two main components - state and 
trait anger. State anger is defined as an emotional state marked by subjective feelings that vary in 
intensity from mild annoyance or irritation to intense fury and rage. State anger is generally 
accompanied by muscular tension and arousal ofthe autonomic nervous system. Over time, the 
intensity of state anger varies as a function of perceived injustice, attack or unfair treatment by others, 
and frustration resulting from barriers to goal- directed behaviour (Spielberger 1991). The 10 items 
comprising the State Anger scale ("How I feel Right Now") are statements such as "I feel angry" and 
respondents must fill in whether the statement applies to them Very much so (score = 4), Moderately 
so (3), Somewhat (2) or Not at all (1). 
Trait anger is defined as the disposition to perceive a wide range of situations as annoying or 
frustrating, and the tendency to respond to such situations with more frequent elevations in state anger. 
Individuals high in trait anger experience state anger more often and with greater intensity than 
individuals low in trait anger (Spielberger 1991). 
The 10 items comprising the Trait Anger scale (How I Generally Feel) are statements such as lam 
quick tempered and respondents must fill in whether the statement applies to them Almost always 
(score = 4), Often (3), Sometimes (2) or Almost never (1). Trait anger can be further subdivided into 
two subscales, Angry Temperament (T-Anger/T) and Angry Reaction (T-Anger/R). T-Anger/T (made 
up of 4 items) measures a general propensity to experience and express anger without specific 
provocation. T-Anger/R (also 4 items) measures individual difference in the disposition to express 
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anger when criticised or treated unfairly by other individuals. 
Anger expression is conceptualized as having three major components (Spielberger et al, 1985). 
The first component involves the expression of anger toward other people or objects in the 
environment (Anger-Out). The second component of anger expression is anger directed inward - that 
is, holding in or suppressing angry feelings (Anger-In). Individual differences in the extent to which a 
person attempts to control the expression of anger (Anger Control) constitutes the third component of 
anger expression (see also Spielberger 1991). 
Each of those three components of Anger Expression are comprised of eight statements such as "I 
control my anger" or'T express my anger". Respondents must note whether the statement applies to them 
Almost always (score = 4), Often (3), Sometimes (2) or Almost never (1) "when Angry or Furious" 
Finally, when the three anger expression scales (-In, -Out and -Control) are combined a scale exists 
which provides a general index ofthe frequency that anger is expressed, regardless ofthe direction of 
the expression. The STAXI Manual suggests that adolescents and adults can generally complete all 
sections ofthe questionnaire in 10-12 minutes, which was the author's experience. 
Normative data for the STAXI are contained in the Manual and are based on a sample size of 9,293 
United States subjects from adult, adolescent and college student populations (5,521 males; 3,772 
females). The groups represented included managerial, technical, clerical, sales and factory workers, as 
well as senior military officers and civilian personnel One limitation was that normative data for the 
AX/EX and AX/Con scales were not available for females. The mean age ofthe adult sample was 
about 40 years, which was comparable to the mean age of all the groups used in this thesis (CD = 41.0, 
DM = 44.4 and NC = 41.1). 
Age was the most pertinent demographic factor in score variation across all ofthe STAXI scales, 
with additional norms based on three age ranges justified. These were computed for 18-30 year olds, 
31-40 year olds and subjects 41 and older. State anger and, to a lesser extent trait anger, AX/Out, Ax/ 
In and AX/EX decreased with age, while AX/Con increased as a function of age. 
Internal consistency reliabilities ofthe scales were described as satisfactory (p.3) by Spielberger 
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(1991) in the Manual and unaffected by age or gender, with alpha coefficients quite high for all scales 
except the 4-item T-Anger/ R subscale (0.69 for adult males and females). The STAXI author also 
noted that the "distributions ofthe S-Anger and T-Anger/ T scales are skewed in a direction that 
prevents these scales from discriminating among respondents with low scores" (p. 5). 
Correlations existed between the S- and T-Anger scales and their S- and T-Anxiety counterparts 
throughout STAXI scale development. Although in the final items comprising these scales the 
correlations were diminished Spielberger noted "an intrinsic relationship between anger and anxiety 
that may be difficult to eliminate from self-report measures of these constructs" (p.7), and "that 
feelings of anger and irritation were frequently associated with symptoms of anxiety in the subject 
samples (p. 8). Validity studies cited in the Manual referred to "low to moderate correlations between 
S-Anger and T-Anxiety" and "moderately high correlations between S-Anger and S-Anxiety" (p. 12). 
Although gender was not a major factor in difference in S- and T-Anger differences, especially in 
older age groups, "highly significant F-ratios for the AX-In scale indicated that the males had higher 
scores than the females" (p. 11), with no gender differences for the AX/ Out scale score. The Manual 
also noted "moderately high correlations ofthe AX/ Out scores with T-Anger and T-Anger/ T scores, 
suggesting that individuals who experience anger more frequently are more likely to express rather 
than suppress their anger" (p. 13). Correlations between AX/ In and AX/ Out scales were "essentially 
zero" regardless of gender, with a lack of association between Ax/ In and Ax/ Con also. However, Ax/ 
Con and Ax/ Out were highly negatively correlated for both males and females (= -0.59 and -0.58 
respectively). The AX/ EX scale was considered a "research scale" in the Manual (p. 11), with its 
psychometric properties not yet "thoroughly investigated". 
Finally, normative STAXI data for medical and surgical patients (n = 913; 56% male; mean age 50 
years) were included in the STAXI Manual, 71% of whom were "tested shortly before undergoing 
cardiac catheterization procedures" (p. 24). However, the relevance ofthe scores to the CD and DM 
groups in this thesis may be quite limited, given that most ofthe medical/ surgical patients were 
hospitalised, awaiting intrusive medical procedures and possibly sedated with anxiolytic medication. 
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Wechsler Adult Intelligence Scale - HI (Wechsler. 19971 
The Wechsler Adult Intelligence Scale - Third Edition (WAIS-IH; Wechsler 1997) is the current 
version ofthe most widely used general intelligence scale used by mental health clinicians 
internationally (Kaufman, 1990). It consists of fourteen subtests (including one supplementary 
subtest), which each measure distinct, but interrelated, functions of cognition. Four broad aspects of 
intellectual functioning measured by the WAIS-HI include Verbal Comprehension. Working (or 
immediate) Memory. Perceptual Organization (also referred to as analytic processing or non-verbal 
problem solving) and Processing speed. These indexes of general intelligence are made up of (between 
two to three unique) component subtests in the WAIS-III. 
All standard subtests ofthe WAIS-HI (thirteen in all, not including the supplementary Object 
Assembly) were administered to participants in each ofthe three groups ofthe study in the first session, 
if time permitted. In a small number of cases, due to either anticipated or unforseen time restrictions, 
the testing process was divided across two testing sessions (i.e., the first meeting and what normally 
constituted the second, feedback session). In no case was the divided testing process protracted beyond 
two weeks and scores were not pro-rated for any individuals, who all completed the 13 subtests. 
The standardisation sample for the WAIS-III included 2,450 adults aged 16 to 89, divided into 13 
age bands, and was stratified on key demographic variables, including age, sex, educational level and 
geographic region, according to the United States census data (U.S. Bureau of Census, 1995). 
Exclusionary criteria for the standardisation samples included the conditions of exclusion used in 
the selection of participants in the CD, DM and healthy control groups in the present study, with 
additional caveats. These included consumption of more than three alcoholic beverages on more than 
two nights per week, seeing a doctor or other professional for memory problems or problems with 
thinking, additional medical or psychiatric conditions that could affect cognitive functioning (e.g., 
bipolar disorder) and currently taking antidepressant, anti-anxiety or antipsychotic medication. These 
are pertinent considerations when comparisons are made with WAIS-HI norms, because exclusionary 
criteria used in the standardisation sample are slightly stricter than those used in the present study. 
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The psychometric properties ofthe WAIS-HI are described in detail in the WAIS-HI/ WMS-III 
Technical Manual. The average reliability coefficients for WAIS-HI scales and indexes range from 
0.88 to 0.97, whilst coefficients for individual subtests range from 0.7 to 0.9. Confidence intervals at 
the 90%) and 95%> level have been provided for all scale scores and the WAIS-HI was demonstrated to 
possess adequate stability across time for all age groups. In test-retest intervals ranging from 2 to 12 
weeks, 2.0 to 3.2 point increases in full-scale IQ were observed. Test-retest results across a 12 month 
period were not attempted by the authors ofthe WAIS-HI, as conducted in the present study for newly 
diagnosed CD participants (n = 27) and a small NC subgroup group (n = 10; see Chapter 5). 
There was a high magnitude of intercorrelations amongst the majority ofthe subtests ofthe WAIS-
III, supporting the premise that these components are measuring general intelligence or intellectual 
functioning. Furthermore, there were intercorrelations between subtests comprising the indexes, verbal 
and non-verbal scales. 
In line with expectations noted in the Manual, the WAIS-III took approximately ninety minutes to 
administer to the majority of participants in all three groups, including about 5-10 minutes of breaks, 
but the assessment of elderly participants, on average, tended to take about 20 minutes longer overall 
All participants were informed ofthe expected length of assessment (and time involved in pre-
assessment interviewing and questionnaire completion processes) at study entry and reminded the day 
before being seen. As testing generally occurred outside of their homes, they were encouraged to bring 
food/ snacks with them. Basic food (gluten-free and regular biscuits, rice cakes, cheese and fruit) and 
beverages (tea/ coffee, juice and water) were provided. 
Given the overall length of interviewing and assessment prior to cognitive appraisal and significant 
travelling time for some participants, those with DM were encouraged to carefully self-monitor their 
blood sugar levels, including just prior to cognitive assessment, to allow the testing process to 
accommodate breaks for snacks. Although exact records of pre-test blood sugar levels were not 
systematically tabulated for every participant, all except one DM participants reported good glycaemic 
control just prior to (and throughout) cognitive assessment. One male experienced moderate 
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hypoglycaemia before testing occurred. Although he recovered sufficiently following the provision of 
a snack to comfortably complete the clinical interview, cognitive assessment was rescheduled. No 
other participants appeared distressed or adversely affected by any acute effects of DM, other medical 
conditions or preceding emotional events during intellectual assessment. 
A standard administration and scoring protocol, as outlined in the Manual, was closely followed 
Particular care was taken to avoid providing or alluding to correct answers after administration of 
items and subtests or during subsequent feedback sessions. Despite adherence to standard procedures, 
a number of participants expressed interest in knowing the answers to particular items, in particular 
word definitions and general knowledge questions, or whether their answers were correct. However, 
all participants, including those in the CD group pre-selected for longitudinal follow-up, were gently 
discouraged from endeavouring to seek answers to any test questions, in deference to prescribed 
administration procedures and also in view of test-retest validity. 
Comprehensive reviews of test-retest research using the Wechsler scales are available (e.g., 
Kaufman, 1990; Matarazzo, Carmody, & Jacobs, 1980; Shatz, 1981; see also Sirois et al, 2002), 
although not in regard to the third version used in the present thesis. In the previous version, the 
WAIS-R, "gains for normal people... over a 1- to 2-month interval average 3 points in V-IQ, 8'A points 
for P-IQ, and six points in FS-IQ" (Kaufman, 1990, p. 298). Average IQ gains generally taper 
downwards over longer re-test intervals, to "4 points for a 4-month interval" (Kaufman, 1999, p. 106), 
and so a one year interval, as used in Study 2 ofthe present thesis, may be expected to equate with an 
even smaller practice effect of several points or less. 
Quality of Life Questionnaire (Evans & Cope. 1989) 
The Quality of Life Questionnaire (QLQ) was developed to provide "a direct measure of life 
quality based on an individual's actions and behaviour in response to particular environmental 
domains", as opposed to other measures that "emphasize affective and cognitive perceptions of life 
quality" (Evans & Cope, QLQ Manual, p.l). It has been used in studies of many issues relevant to life 
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quality, including personality, marital, and occupational factors (Evans, Pellizzari, Culbert, & Metzen, 
1993) and cognitive impairment in the elderly (Pilon, Arsenault, & Pare, 1997), as well as life quality 
in relation to proposed or actual medical interventions (e.g., prior to in vitro fertilization; Hearn, 
Yuzpe, Brown, & Casper, 1987, and after liver transplantation; Grant et al, 1987). 
Fifteen content scales, or subdomains, of life quality (consisting of 12 statements each) are 
measured by the QLQ, which are subsumed within five major domains displayed below: 
5 Domains 15 Scales/ Subdomains Description of Scales 
General Well-being: 
Material Weil-Being 
Physical Weil-Being 
Personal Growth 
Interpersonal Relations: 
Marital Relations 
Parent-Child Relations 
Extended Family Relations 
Extramarital Relations 
Organizational Activity: 
Occupational Activity: 
Altruistic Behaviour 
Political Behaviour 
Job Characteristics 
Occupational Relations 
Job Satisfiers 
Leisure/ Recreation Activity: 
Creative/ Aesthetic Behaviour 
Sports Activity 
Vacation Behaviour 
Income/ living environment 
Health seeking/ protective behaviours 
Goals/ characteristics/ problem solving 
Communication/ activities with partner 
Quality of involvement 
Interactions with relatives 
Social interaction/ friendships 
Orientation towards helping others 
Current events/ electoral engagement 
Work challenging/ varied/ interesting 
Communication at work 
Salary/ benefits/ training/ opportunities 
Cultural activity/ hobbies 
Participation/ attendance/ interest 
Relaxing/ flexible holidays 
Emphasis on a behavioural measure of life quality was preferred by the author ofthe present thesis, 
given the use of a battery of inventories already assessing mood and cognition, self-assessed perceptions 
of health status and cognitions regarding locus of control. The QLQ was designed to be suitable for self-
administration, with minimal supervision, in surveys and in both individual and group settings. It 
consists of 192 statements, each answered as either true (if the respondents agrees or finds it descriptive 
of themselves) or false, at the present time. Items that are not applicable to current life circumstances 
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(e.g., having children living with you) are not filled. 
A total Qualify of Life score is calculated by adding all valid individual scale (i.e., subdomain) 
scores and dividing by the number of valid scales. A scale is designated as invalid if > 9 out of 12 items 
making up the scale are unmarked (i.e., missing), as a result of being irrelevant to the person filling the 
QLQ. For example, if a person has no children then all 12 items of Parent-Child Relations scale would 
not apply. Similarly, for an unemployed person the three Occupational Activity scales would typically 
be irrelevant, unless a person involved in voluntary work (for example) perceived items in these scales 
as personally applicable. The scale Marital Relations was pertinent to people in de facto relationships, 
but respondents in less committed intimate relationships may interpret the majority of items from the 
perspective of being single and therefore not applicable 
The QLQ also includes a Social Desirability scale. Although the authors ofthe QLQ do not stipulate 
a cut-score regarding valid and invalid test results, they do suggest that very high social desirability 
scale scores may suggest stereotypical responding intended to hide true feelings, attempts to please the 
investigator and otherwise faking good. Nevertheless, a key strength ofthe QLQ is that actions and 
behaviours are being self-assessed, as opposed to mood, affect, cognitions or intentions in relation to life 
quality, presumably minimising the likelihood of response sets susceptible to dissimulation. 
The normative data for the QLQ (p. 21; QLQ Manual) are based on two samples of individuals 
(N=163 and N=274) selected to represent the population of London, Ontario (Canada), collected during 
the summers of 1980-81. The total sample of 437 (60%> female; 85%> married) was aged 18 years or 
older and was determined to be highly representative ofthe population sampled. In 1980, London was a 
city of approximately 300,000 people and is situated south west of Toronto and Niagara Falls. Of 
primarily British background and middle-upper socio-economic status (compared to the Canadian 
population) the normative sample ofthe QLQ is highly comparable to all three groups ofthe present 
thesis, notwithstanding the twenty-year historical difference in data collection. 
The psychometric properties ofthe QLQ, as outlined in the QLQ Manual, indicate good reliability 
and validity. Internal consistency, as measured by the Kuder-Richardson-20 coefficient, was generally 
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high and stable, ranging from .61 for Physical Well-Being to .96 for Occupational Relations in the item 
selection sample and from .55 for Physical Well-Being to .97 for Occupational Relations in the cross-
validation sample. 
Test-retest reliability for the QLQ, as assessed over a two week period by the authors, was 
acceptable, with reliability coefficients ranging from between .77 and .89. Furthermore, inter-
correlations among the scales, their factor structure and cross-validation data are clearly presented in the 
QLQ Manual. 
Using the interpretive guidelines for T-scores used by Evans and Cope (1989), the percentage of 
participants in each group falling into nine narrow ranges of QOL (from very much below to very much 
above average) may be calculated. For clarity, these nine intervals of QOL were collapsed by the author 
ofthe thesis into three broad ranges (i.e., below average - average - above average) so that 
the percentages of cases falling into different ranges of QOL could be ascertained. 
The QLQ was completed by participants in each group ofthe study in their own time and mailed to 
the author, prior to the second, follow-up meeting. During the first meeting each participant was 
instructed to complete the questionnaire independently from the influence of family members and in an 
environment with minimal distractions. The purpose ofthe instrument was briefly described and the 
instructions about the QLQ booklet read to each participant. At that time a discussion of each 
individual's results was scheduled to be undertaken at the subsequent follow-up meeting, generally 
within a fortnight ofthe first meeting. Particular reference was made to scales that were not applicable 
to certain participants, such as Parent-Child Relations, which was most relevant to those participants 
with children living at home. 
A subset of participants with below average literacy, as established during pre-test interviewing and 
the completion of preceding questionnaires, completed the QLQ in the presence ofthe author, who was 
available in person to answer any questions arising and verify that the correct response set was being 
adhered to. Those completing the QLQ in their own time were provided with a contact phone number of 
the author, should any difficulties arise. 
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At the time ofthe follow-up meeting, the Q L Q answer booklet was checked by the author to ensure 
that all relevant questions were answered and the correct response set had been adhered to. Feedback 
from participants indicated that the scale took approximately half an hour to complete. Details, 
discussion and life quality inferences pertaining to each participants' scores ensued in the feedback 
session in general terms, with more specific details provided verbally on request to CD and NC 
participants not participating in the longitudinal study. 
Multidimensional Health Locus of Control Scale (Becker & Rosenstock. 1984) 
Form A ofthe Health Beliefs Questionnaire (Appendix N) was administered to gauge the extent to 
which participants in the three groups perceived their health to mediated by their own internal resources, 
by other people central to their lives, such as health professionals and family (powerful others) and by 
chance factors. 
Scores for each ofthe three scales (internal, powerful others and chance health locus of control; I, P 
and C HLC) pertaining to these dimensions had ranges from 1 to 36. They were based on responses to 
six statements each, with respondents circling a number reflecting the extent to which they agreed or 
disagreed with each statement. There were six choices from disagree strongly (scored as one) to agree 
strongly (= six). Items from each ofthe three scales (totalling 18, i.e., 3x6) were interspersed through 
the questionnaire and unmarked regarding which subscale they belonged to. 
The development ofthe multidimensional health locus of control (MHLC) scales (including Form 
A), normative data, internal consistency, reliability and validity indicators appear in Wallston, Wallston 
and DeVellis (1978). 
Normative data was based on 115 returned and adequately filled questionnaires of 282 handed out to 
people over age 16 at a metropolitan airport near Nashville, Tennessee, in the United States. The sample 
corresponding to returned booklets was 51% female, 74% had "at least some college education" (p. 163, 
Wallston et al, 1978) and the mean sample age was 42 years, similar in most respects to the groups 
studied in this thesis, especially in regard to age. 
Psychological Sequelae in C D 150 
Internal consistencies ofthe three constituent scales of Form A were reasonable at 0.77 (Internal 
HLC), 0.67 (Powerful Others HLC) and 0.75 (Chance HLC). From correlational matrices provided in 
Wallston et al. (1978) it is evident that, in Form A, the Internal HLC scale is essentially statistically 
independent from the powerful others HLC scale (r = 0.15; p > .05) but negatively correlated with 
Chance HLC (r = -0.34; p < 0.001). Furthermore, on Form A (used in the present thesis) Powerful 
Others HLC is independent of Chance HLC (r = 0.06; p > 0.05). Powerful Others HLC (in Form A) 
had a statistically significant positive correlation with age (r = .198, p < .05) and negative correlation 
with educational level (r = - .222; p < .05), where r 0.05 = . 183 for the sample size used. 
Wallston et al. (1978) described the scales as "three separate theoretically and empirically 
differentiated dimensions" (p. 167) intended for use with adults with an eighth grade reading level The 
author ofthe present thesis observed no difficulty in participants' understanding ofthe questionnaire, 
which took less than 5 minutes to complete for almost all respondents. 
Procedure 
Ethical Approval, Consent Process, Participation and Protocol 
Ethical approval for the project (study design/ subject recruitment) was granted by the Human 
Research Ethics Committees ofthe University of Ballarat (June, 1999) and by Ballarat Health Services 
(August 1999). In addition, the executive committees of Victorian branches ofthe Australian Coeliac 
Society and Diabetes Australia sanctioned advertising for participants at their office premises, via their 
quarterly magazines, at associated conferences and workshops and through direct communication with 
health care practitioners recommended by the societies. 
All newly admitted members ofthe Coeliac Society were informed ofthe project via their new 
membership kits. In addition, direct monitoring by the author of newly admitted members ofthe 
Victorian Coeliac membership register (and perusal ofthe recorded log of people making initial phone 
inquiries) was permitted from July, 2000, in order to increase the likelihood of adding newly diagnosed 
participants with CD to the study sample. A number of people very recently diagnosed with CD or 
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awaiting confirmation of biopsy results were directly contacted by phone, with details ofthe project 
mailed out if those contacted were receptive to possible involvement. In total, approximately one quarter 
of participants in the CD sample (and the majority of those newly diagnosed) were recruited via this 
procedure. 
Other participants in the CD group, and those in the DM groups, contacted the author by phone, via 
the Coeliac Society of Victoria or Diabetes Australia in response to advertising requesting volunteers for 
the study, placed in quarterly national magazines. Details about each volunteer's potential involvement, 
participation and inclusion/ diagnostic requirements were explained by the author via telephone or e-
mail (and in writing). First meetings with the author (for those meeting the study's selection criteria) 
were arranged via telephone for individuals who verbally consented. Prior to meeting with the author for 
the first time, the length ofthe assessment protocol was outlined and all participants were encouraged to 
ensure adequate sleep. On a few occasions participants fell ill or were otherwise inconvenienced prior to 
the first meeting, which was rescheduled in each case. 
At the beginning ofthe first meeting the consent process and details of participation were again 
described in detail. People still wishing to participate read (and signed) a consent form attached to a 
plain language statement (Appendix G) in the presence ofthe author and an independent third person 
where possible. 
Participants who lived in Ballarat were interviewed and assessed individually in rooms within the 
psychology department at the University of Ballarat, while those in Melbourne met the author at the 
Victorian Coeliac Society state office, which was relocated mid-way during testing (February 2000). An 
office was made available to the author for research/ interviewing purposes, at each venue, seven days 
per week, upon request. 
People wishing to participate who were unable to attend these venues were also seen by the author in 
their own homes, if suitably lit rooms were available. In several cases, the author met participants at 
their place of employment during or after work hours. Meeting times and locations were at the mutual 
convenience ofthe participants involved and the author. Up to four participants were seen on several 
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occasions in back-to-back bookings, but in the majority of cases one participant was seen on a given 
day. In most cases (for those participants in the cross-sectional study) all interviewing, assessing and 
testing was completed in one session of approximately three and a half to four hours duration, including 
breaks. For about 20% of participants interviewing and assessment was spread across two meetings with 
the author, due to time constraints. These meetings generally occurred within one week of one another 
and never more than a fortnight apart. The same testing protocol was followed, regardless of whether 
assessment occurred in one or two sessions and irrespective ofthe venue. 
The offices used for assessment at the University of Ballarat and Victorian Coeliac Society were 
well lit and ventilated, with drink/ snack facilities and lavatories in close proximity to the assessment 
venue. These features were minimum requirements ofthe alternative venues used by the author, 
including participants' homes, and were discussed prior to meetings being arranged. 
As aforementioned, all participants were informed ofthe expected length of assessment (and time 
involved in pre-assessment interviewing and questionnaire completion processes) at study entry and 
reminded the day before being seen. If testing occurred outside of their homes, participants were 
encouraged to bring food/ snacks with them, but basic food provided by the author at all venues 
included gluten-free and regular biscuits, rice cakes, cheese and fruit, and standard beverages (tea/ 
coffee, juice and water). 
Of those people visited by the author, one person with CD chose to withdraw from the study shortly 
after providing written consent. Another person newly diagnosed with CD who was visited at home had 
fallen asleep. He contacted the author two days later to inform that he had been hospitalised as a result 
of extreme exhaustion and - pending further medical investigation - chose to withdraw from 
participation. 
Clinical Interview, Assessment and FoUow-up Meeting 
The eleven questionnaires and scales described in the preceding section, beginning in each case with 
the Beck Depression Inventory - H, were administered to each participant in each group in the exact 
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order in which they have been described, in the first of two meetings with the author. Participants in the 
healthy control group were not required to complete the compliance with treatment scales and only CD 
participants completed the Coeliac Disease Awareness Screen. The Quality of Life Questionnaire was 
completed (and mailed to the author in the self-stamped envelope provided) by the majority of 
participants between meetings. 
During and following completion ofthe Demographic/ Health Questionnaire by participants in each 
ofthe three groups (Appendixes C, L and M), the author perused all information pertaining to the recent 
and retrospective symptomatology history (on p.2 of that questionnaire) and medical information (p. 3 to 
5 or 6), with particular reference to any history of anxiety or mood disorders. 
In subsequent interviewing by the author it was explored and recorded whether each participant had 
been previously diagnosed with or treated for any type of mental disorder. Any history of treatment with 
psychotropic medication of any kind or visits to a mental health practitioner, including presenting 
symptoms, were noted retrospectively back to childhood. If a firm history of symptom clusters 
synonymous with anxiety or mood spectrum disorders was noted, a retrospective diagnosis with 
reference to DSM-IV criteria was attempted if sufficient information existed and the participant had an 
acceptable recollection of contemporaneous behaviours and events (e.g., being unable to work for a 
protracted period due to a traumatic experience, long-lasting sleeping problems, visits to general 
practitioner, etc.). 
If sufficient criteria were fulfilled to justify diagnosis with a mood or anxiety spectrum disorder the 
applicable (albeit tentative and retrospective) diagnosis or diagnoses according to DSM-IV criteria were 
made by the author and included in the participant's data file. Borderline diagnoses were rejected. 
Participants were encouraged to take a break of a minimum duration of 10 minutes per hour and a 
fifteen minute break and snack, if desired, prior to assessment with the WAIS-HI. As part ofthe normal 
assessment protocol with the WAIS-HI, participants were also encouraged to take breaks between 
subtests, as needed, throughout. The majority of participants chose to take one five minute break close 
to the middle of testing, effectively dividing the WAIS-ffl assessment into two consecutive sessions of 
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approximately forty minutes duration each. 
Feedback about performance on the WAIS-HI was provided either at the completion ofthe first 
meeting with the author if time permitted or during the follow-up session, within a fortnight ofthe first 
meeting. If time allowed, scoring ofthe WAIS-HI was undertaken whilst participants completed the 
Multidimensional Health Locus of Control and started the Quality of Life Questionnaire, to allow for 
initial feedback. 
The feedback session consisted ofthe discussion of questionnaire and test results, as well as any 
questions arising from the research. In a small number of cases, WAIS-III testing was completed in the 
follow-up session with the author, due to time constraints in the initial meeting. The feedback sessions 
were conducted in person with the author, generally at the same venue as the original meeting, except 
for a small percentage of feedback sessions for healthy controls that were conducted by telephone at the 
request and convenience ofthe participant. 
Statistical Design 
Group variables are generally expressed as a mean (M), with accompanying standard deviation 
(SD), unless otherwise indicated. For continuous variables, ranges are provided if applicable. The 
statistical software system SPSS for Windows (Version 10; 1999; Illinois, U.S. A) was used exclusively 
in all data analysis. 
Since the CD, DM and NC group sample sizes all exceeded 50 cases (with group-wise matching 
across demographic variables successful) and the majority of statistical procedures were based upon 
group difference hypothesis-testing, parametric analyses of variance were utilized where applicable. 
Prior to all computations, assumptions of normality and homoscedasticity were assessed, using a variety 
of procedures. These included the Kolmogorov-Smirnov statistic for all data and the Shapiro-Wilk test 
prior to performing within group gender (or other) comparisons if case numbers were less than 50. 
Normal probability and detrended normal probability plots were also examined to test normality, with 
the Levene test used to determine the validity of assumptions of homogeneity of variance. 
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The unpaired (independent samples) t-test was computed for within-group comparisons between 
various subgroups of participants (e.g., males versus females, or type-1 versus type-2 participants in the 
DM group) and in several other analyses across groups (e.g., newly diagnosed CD patients versus 
healthy controls). Levene's test for equality of variances was computed in each analysis, with tests for 
unequal variance utilised in positive (significant) cases (i.e., p < 0.05). Differences between proportions, 
clinically more meaningful than comparing means in certain instances, were assessed via chi-square 
Primary comparisons between the CD, DM and NC groups were undertaken using parametric one-
way analyses of variance (ANOVA) and a highly conservative, but flexible, post-hoc procedure, the 
Scheffe method (Scheffe, 1953), which provided protection for tests of every linear combination of 
means, including pair-wise differences between the three groups. 
The dependent variables were demographic data and total scores and sub-scores on each ofthe 
questionnaires assessing mood and affect (i.e., the BDI-II, STAI and STAXI), cognition (WAIS-III), 
quality of life (QLQ), health status, the CD Awareness Screen and MHLC scales. This statistical 
paradigm was very similar to that utilised in a recent study which investigated depressive symptoms in 
adult CD (Ciacci et al, 1998) and most closely resembled the present thesis, in terms ofthe composition 
of comparison groups and the absolute and relative number of participants within each group. In Ciacci 
et al's, study, two clinical groups (92 CD patients and 48 Hepatitis C patients) and 100 normal controls 
were compared on the Zung Self-Rating Depression Scale. The statistical methodology used in that 
study and in the present thesis is regarded as appropriate, if not optimal, in the conventional evaluation 
of between-group effects and group-wise differences entailing group sizes ofthe absolute and relative 
magnitudes used in these studies (see Keppel, 1973; Tabachnick & Fidell, 1989), especially if prior 
research is lacking. 
Following post-hoc analysis using the Scheffe method, a third procedure was applied to all results 
presented within the key domains studied (affect, cognitive functioning and quality of life), to further 
guard against inflated Type I error in the event of multiple testing within domains. These procedures are 
outlined by Tabachnick and Fidell (1989). Put simply, all results following post-hoc analysis were 
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recognised as significant only after falling within stringently set alpha (a) levels, appropriate to the 
number of comparisons made. These were decided on a Bonferroni basis where multiple comparisons 
between groups were made using several tests (or subscales within tests). 
As a general rule, the .05 level was divided by the number of comparisons performed, unless there 
were compelling reasons not to do so. For example, if a single measure was used to assess functioning in 
a distinct area (e.g., quality of life), total mean group scores were compared without setting a levels 
below .05. Finally, confidence intervals (C.I.s) were noted wherever statistically significant differences 
in means were reported. Confidence interval sizes of 95% were reported throughout the thesis, unless 
otherwise indicated. 
An alternative analytic approach to the three-step procedure (i.e., ANOVA => Scheffe post-hoc 
comparisons => indicated Bonferroni adjustments) outlined was the use of planned comparisons in the 
ANOVA. However, this approach was not considered suitable at the present time, given an absence of 
previous research with CD patients across several ofthe domains investigated, especially state and trait 
anger, and, to a lesser degree cognition, including neuropsychological functioning, and locus of control. 
Furthermore, the exploratory nature ofthe research increased the likelihood of unexpected findings and 
a very high number of comparisons between each primary group, and subgroups of CD participants with 
the comparison groups, were anticipated. Therefore, a systematic and conservative, but flexible, 
approach, best served by the three-step procedure outlined, was regarded as the most appropriate. 
Since many components ofthe present study were exploratory, bivariate Pearson correlational 
analyses were also performed on all data, in order to establish the strength of any statistically significant 
and clinically relevant or important associations between variables. Significant correlations were also 
examined in order to assist in the process of ruling in or out the effects of within group factors (e.g., 
age, mood state, or compliance with diet in the CD group) if particular between group differences 
(e.g., neuropsychological functioning) were observed. Whilst attenuation of point-biserial significance 
has been described in cases where the proportion of individuals sampled in each category ofthe 
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dichotomous variable deviate markedly from 5 0 % (see Day, Kane & Roberts, 2000), for gender the 
proportions of individuals within the smaller category (i.e., male) did not drop below 40%. In the 
development of all categorical variables or interval data, binary scales were avoided in preference to 
multiple gradation (e.g., number of symptoms at diagnosis), to maximise their predictive value. 
Finally, discriminate function analysis was undertaken to determine the utility of combining static 
and dynamic clinical correlates (e.g., symptom number/ duration at diagnosis and dietary compliance) 
in predicting clinical outcomes (e.g., CD participants who were depressed or not at study entry). 
Partitioning of CD Participants 
As well as performing between-group analyses using the full CD group of 110 participants, the CD 
sample was subdivided according to the severity of CD at diagnosis, to assess whether this within-group 
factor impacted on mood, cognition and life quality in people with CD. Specifically, it was investigated 
whether CD participants who had numerous (2+), distinct symptoms at diagnosis (as opposed to being 
asymptomatic or having only one symptom) and classified as having moderate to severe symptoms -
could be better understood as a distinct group. This was achieved by partitioning the CD sample 
according to the number of CD symptoms at diagnosis. The arbitrary criteria used by the author to 
determine the severity of CD at diagnosis was simply the number of observable clinical symptoms at the 
time of diagnosis, which were retrospectively recorded by each participant. The sample was partitioned 
as follows: 
Severity of C D at Diagnosis... .# Cases: 
Asymptomatic 
Monosymptomatic 
6 (M=5, F=l) 
31 (M=17,F=14) ... Oligosymptomatic 37 
2-3 symptoms 35 (M=10, F=25) 
>3 symptoms 38 (M=12, F=26) ...Multisymptomatic 73 
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Using these criteria, approximately one third ofthe C D sample was designated oligosymptomatic 
(those CD participants with one or no symptoms at diagnosis) and the remaining two thirds (n = 71) 
multisymptomatic (> 2 symptoms at diagnosis). In a minority of borderline cases quantitative 
assessment of symptomatology was problematic. 
Where the author was hindered by conflicting information, limitations in participants' recall of 
their diagnosis (e.g., those diagnosed in infancy) or data incongruous with the apparent severity of CD 
according to all other indicators as provided by the participant, clinical judgment and discretion was 
exercised in categorising the severity of CD. The method used to partition CD participants was the 
simplest available and congruent with the author's estimates of individual's severity of 
symptomatology, based on clinical data, in the majority of cases. 
Classic symptoms (e.g., diarrhoea) were historically used in investigating and diagnosing CD 
Partitioning was undertaken as it has become evident during the preceding decade that a growing 
percentage of newly diagnosed CD patients are relatively asymptomatic. With increased awareness of 
CD, a greater proportion of patients with minor or few, if any, symptoms are being identified 
It was suspected inclusion of oligosymptomatic cases in all statistical analyses may mask clinically 
important group differences, by weakening such effects. Preliminary analyses indeed demonstrated 
that CD participants in the oligosymptomatic subgroup were closer to NC participants than 
multisymptomatic CD participants, where group differences in affect were emerging. Other key within 
group factors were used in statistical analyses with the CD sample, including GFD compliance and the 
period of dietetic restriction, which was equivalent to the time since diagnosis in almost all cases. 
Results of Study 1 
Socio-Demographic Variables - Group Comparison 
Age, years of education, general intelligence (WAIS-IQ), gender and socioeconomic status 
(SES) were comparable across the CD, DM and NC groups, with univariate analysis of variance 
(ANOVA) demonstrating no significant group differences (for age, education and IQ) and both gender 
and SES proportionately distributed group-wise. These demographic variables, with body mass index 
(BMI) at study entry, are summarized in Table 8. Age at and time since diagnosis (each in years) are 
also tabulated for the CD and DM groups. 
Table 8 
Demographic and Biomedical Characteristics of CD, Diabetes Mellitus (DM) and Healthy Control 
(NC) Groups; Means and Standard Deviations (SDs) for Age, Education, WAIS- IQ, Age At and Time 
Since Diagnosis and BMI; Percentages for SES and Group Numbers for Sex 
Variable 
Group number (n) 
Age (yrs; SD) 
Education (yrs; SD) 
WAIS-IQ (full scale; SD) 
Sex (male/ female) 
SES (% low/ med/ high) 
Age at Diagnosis (yrs; SD) 
Years since Diagnosis (SD) 
BMI(kg/m2;SD) 
CD 
110 
41.0(14.3) 
12.6 (2.4) 
112.2(13.2) 
(n=108) 
66/44 
(11/59/30) 
36.9a(15.4) 
4.3b(8.2) 
23.5°(3.6) 
DM 
53 
44.4 (18.6) 
12.8 (2.8) 
112.7(12.6) 
(n = 51) 
31/22 
(13/53/34) 
29.2a(19.9) 
15.3b(12.9) 
26.3d (4.0) 
NC 
69 
41.1(18.7) 
12.4(3.0) 
112.7(13.8) 
(n = 62) 
41/28 
(13/61/26) 
n.a. 
n.a. 
24.5e(3.3) 
a
 Sig. difference at .01 level; C D > D M ; b Sig. difference at .001 level; C D < D M ; 
c,d
-
e
 Sig. grp. difference at .001 level; Post-hoc Scheffe test: cd CD < D M (p < .001); 4e N C < D M (p < .05) 
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The aim of matching the three groups of study participants across key demographic variables (age, 
education, SES and gender) was clearly achieved, with the almost identical WAIS-IQ mean scores 
somewhat fortuitous, but also a product ofthe close matching across other variables, especially 
education, as confirmed by the highly significant positive Pearson correlation (r [232] = .424, p = 
,000) between years of education and WAIS-IQ. 
With regard to their defining illness, participants in the CD group had clearly been diagnosed at a 
significantly older age than DM patients (t = 2.50, degrees of freedom [dfj = 82.92, p = .015, mean 
difference [m.d.] = 7.74, 95%, confidence interval [CL] = 1.57, 13.91) and had been diagnosed for 
significantly longer at study entry (t = 5.64, df = 72.76, p < .001, m.d. = 10.94, 96% C.I. = 7.07, 
14.81), using t-test, with equal variances not assumed in either analysis. Levene's test for equality of 
variances was highly significant in both cases, especially in relation to the years since diagnosis 
analysis (F = 19.1, p < .001), in which the SD was almost double the size ofthe respective mean in the 
CD group. Table 8 shows that, on average, DM patients had been diagnosed for 15.3 years, compared 
to an average of 4.3 years for the CD group, The CD-DM differences in age at and time since 
diagnosis arose because the majority of CD patients (85%) were diagnosed in adulthood (> 20 years), 
while two thirds ofthe DM group were type-1 patients, of whom the majority (72%>) had been 
diagnosed in childhood or adolescence (< 20 years). 
Univariate ANOVA showed that there was a significant difference in BMI across the CD, DM and 
NC groups (F (2,229) = 10.394; p = .000). Post-hoc Scheffe testing was conducted to compare BMI 
between each pair of groups, with DM participants having a significantly higher BMI compared to both 
CD participants (p = .000) and, to a lesser extent, healthy controls (p = .025). The higher proportion of 
type-1 patients comprising the DM group may have limited the significantly elevated mean BMI 
compared to the two other groups, given that mean BMI is often higher in studies of type-2 patients. 
Participants with CD did not have a significantly different BMI to healthy controls (p_ = .235). However, 
a subgroup 27 relatively newly identified CD patients (diagnosed within ten weeks of study entry) had a 
significantly lower BMI than the NC group; t = 3.254, df = 94, p = .002, m.d. = 2.43, CI. = .94, 3.9). 
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Coeliac Disease Awareness 
Scores on a new scale developed by the author to measure CD participants' knowledge about the 
illness were compared against the four levels of severity of CD, as shown in Table 9. A favourable 
spread of scores was observed. There were no differences across C D subgroups, including when the 
four subgroups were collapsed into oligosymptomatic and multisymptomatic subgroups. 
Table 9 
Means, Standard Deviations (SDs) andRanges of CD Awareness Scores Across CD Subgroups* 
Asymptomatic Mild Moderate Severe 
(n = 6) (n = 31) (n = 35) (n = 38) 
Number of C D Symptoms: 
N 
Mean (SD) 
Range 
0 1 
Oligosymptomatic 
6 31 
23.50(17.9) 38.48(18.8) 
2 to 49 -4 to 70 
2-3 4+ 
Multisymptomatic 
35 38 
41.11(15.2) 41.47(15.3) 
10 to 74 -4 to 74 
* Asymptomatic = no symptoms at C D diagnosis; Mild = single symptom at C D diagnosis; 
Moderate = 2 symptoms at C D diagnosis; Severe = 3 or more symptoms at C D diagnosis 
When C D awareness scores were correlated against key demographic and test outcome measures, 
positive bivariate Pearson correlations were identified with years of education (r [110] = .25 (p < 
.01), WAIS-III IQ (r [110] = .41 (p < .01) and two measures of dietary compliance (p < .05), as 
hypothesised, but not depression or quality of life, with close to zero association observed. 
Affective Functioning 
Depressive Symptomatology: Group Comparisons 
The Beck Depression Inventory - 2nd Edition (BDI-H) was used to measure various components of 
depressive symptomatology in the three experimental groups in Study 1. In addition to total BDI-H 
scores, individual item and Factor 1 (i.e., Somatic/ Affective) and Factor 2 (i.e., Cognitive) sub-scores 
were tabulated for each group. Univariate analysis of variance ( A N O V A ) , with post-hoc Scheffe testing 
in the event of a significant effect across groups, was computed to compare scores pair-wise. 
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Full BDI-II score was the first dependent measure compared. Alpha level was fixed at p = .05, with 
no Bonferroni adjustment required, given that only one measure of depression was utilised in Study 1. 
ANOVA demonstrated that there were no significant differences across groups (F [2, 229] = 1.86, g = 
.158). Descriptive statistics for total BDI-H scores across groups are reported in Table 10. 
Table 10 
Means, Standard Deviations (SDs) and Ranges of the BDI-II Scores in the CD, DM and NC 
Groups* 
N 
Mean (SD) 
Range 
CD 
110 
8.92(7.13) 
0-34 
DM 
53 
9.36 (8.03) 
0-32 
NC 
69 
7.09 (6.82) 
0-27 
* C D = coeliac disease; D M = diabetes mellitus; N C = normal controls 
Notwithstanding a slight gender disparity between mean BDI-II scores across all study participants 
(9.01 for females [n = 138]; 7,70 for males [n = 94]), in the direction ofthe trend towards mood 
disorders being identified more often in females, the difference was not significant overall, or within any 
ofthe three groups, including the CD group, in which the female mean (9.58, SD = 7.34) was 1.64 
points higher than the male mean (7.93, SD = 6.77), also negligible from a clinical perspective. 
The proportion of participants in each group falling into the four ranges of depression outlined in 
the BDI-H Manual are displayed overleaf. It was evident that about four fifths ofthe full cross-sectional 
CD group (78.2%) did not show substantial signs of depression according to BDI-H cut score criteria, 
compared with about three out of four DM participants (75.5%) and almost nine out often NC partici-
pants (87%>). In the CD group, 21.8% were in the mildly to severely depressed range at assessment 
(compared to 24.5% of DM and 13% of NC participants) and 10% of CD participants (compared to 
15.1% of DM and 4.3% of NC participants) were in the moderately to severely depressed range. 
None ofthe group-wise proportional comparisons were statistically significant, using the Crosstabs 
function of SPSS to perform chi-square tests using pairs of groups or all three groups in the analysis 
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(asymptotic significance > .05 using each ofthe Pearson chi-square, continuity correction, likelihood 
ratio and Fisher's exact test). As noted earlier, one potential NC participant who was assessed to be in 
the severely depressed range did not continue in the study due to concerns about his high degree of 
suicidal ideation and recent behaviour. Symptoms of suicidality were not features ofthe ofthe CD or 
DM participant in the elevated ranges of depression who participated in Study 1. 
Table 11 
Number (and Percentages) of Participants with Full BDI-II Scores in the Four Ranges of 
Depression (Absent/Minimum to Severe) Across the Three Groups 
CD DM NC 
Total BDI-II 
Score 
0-13 
14-19 
20-28 
29-63 
Range of 
Depression 
Absent/ Minimal 
Mild 
Moderate 
Severe 
86 (78.2%) 
13(11.8%) 
10 (9.1%) 
1 (0.9%) 
40(75.5%) 
5 (9.4%) 
7 (13.2%>) 
1 (1.9%) 
60 (87.0%) 
6 (8.7%) 
3 (4.3%) 
Nil 
Totals: 110 (100%) 53 (100%) 69 (100%) 
In summary, the categorisation in Table 11 indicates that 24 out of 110 (or about one in five) C D 
participants were depressed at the time of assessment, using cut score criteria used by the BDI-n 
authors to screen for major depression, compared to one in four people with DM and just under one in 
eight NC subjects. All except one CD participant categorised as depressed fell within the mild to 
moderate depression range, an interval of depression that may be broadly referred to as dysthymic 
Beck etal. (1996). 
Following the comparison ofthe three groups using all participants in Study 1, the CD sample was 
subdivided on the basis ofthe number of CD-related symptoms at CD diagnosis (severity of illness), 
as outlined in the previous chapter. This subdivision resulted in the initial partitioning ofthe full CD 
sample into four subgroups, for which mean BDI-H scores were calculated (see Table 12 overleaf). 
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Table 12. Means, SDs andRanges ofthe BDI-II Scores Across the Four CD Subgroups* 
Asymptomatic Mild Moderate Severe 
(n = 6) (n = 31) (n = 35) (n = 38) 
Number of C D Symptoms 
N 
Mean (SD) 
Range 
0 1 
Oligosymptomatic 
6 
5.17(7.7) 
0-20 
31 
5.03(4.1) 
0-13 
2-3 
Multisympt< 
35 
8.34 (6.5) 
0-26 
4+ 
jmatic 
38 
13.21 (7.4) 
0-34 
* Asymptomatic = no symptoms at C D diagnosis; Mild = single symptom at C D diagnosis; 
Moderate = 2 symptoms at C D diagnosis; Severe = 3 or more symptoms at C D diagnosis 
There was a significant Pearson correlation (r [110] = .458, g = .000) between the severity of C D 
(i.e., across the four C D subgroups) and BDI-II depression. Figure 3 (overleaf) graphically illustrates 
the increased proportion of depressed patients in the moderately (compared to mildly) symptomatic sub-
group and especially in those severely symptomatic at diagnosis. In the latter subgroup, 18 out of 38 
patients (i.e., 47%>) were in the clinically depressed range, with 1 8 % moderately or severely depressed 
This result prompted consideration ofthe possibility that a less symptomatic proportion ofthe full C D 
group may have substantially contributed to a "normalisation" ofthe mean overall level of depression in 
the full C D group, masking statistically and perhaps clinically relevant differences bet-ween the more 
symptomatic portion ofthe C D group and healthy controls, if not the D M group as well. 
The small number of asymptomatic cases precluded their inclusion as a separate subgroup in any 
justifiable parametric statistical analysis. They were instead combined with the monosymptomatic cases 
to create an oligosymptomatic subgroup (of 6 + 3 1 = 3 7 cases), an amalgamation also defendable on 
clinical grounds. Notwithstanding the immediate creation of three similarly sized subgroups (oligosymp-
tomatic, moderately and severely symptomatic) highly suitable for subsequent comparison from a 
statistical viewpoint, there were minimal differences from a clinical perspective between C D patients 
with at least two CD-related symptoms at diagnosis and those participants with three or more. 
Therefore, these groups were also combined to form a multisymptomatic subgroup (of 35 + 38 = 73 
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cases). Mean BDI-II scores were tabulated for these two subgroups, as reported below. 
Table 13 
Means, Standard Deviations (SDs) andRanges ofthe BDI-II Scores Across Primary CD Subgroups 
Oligosymptomatic Multisymptomatic 
BDI-II (21 items) 
N 37 73 
Mean (SD) 5.05 (4.72) 10.88 (7.36) 
Range 0-20 0-34 
An independent samples t-test was computed in order to compare the BDI-II mean scores between 
the oligosymptomatic and multisymptomatic subgroups, setting alpha at .05, given the single procedure 
undertaken. A significant difference occurred between these subgroups, t = 4.37, df = 101.93, g = .000; 
m.d. = 5.82, 95%» C.I. = 3.18, 8.46). Since Levene's test was positive (F = 6.61, g = .011), equal 
variances were not assumed. 
Furthermore, it was revealed that, in the oligosymptomatic subgroup, only one C D participant out 
of 27 (= 2.7%o of that subgroup) had a total BDI-II score above 13, the cut-point of absent/ minimal 
depression, compared to 22 out of 73 (= 30%) participants in the multisymptomatic subgroup, who had 
full BDI-H scores ranging from 14 to 34. 
Given the significant difference between oligosymptomatic and multisymptomatic subgroups in the 
mean level of BDI-II depression (underpinned by the substantially higher proportion of mildly and 
moderately depressed participants who were multisymptomatic), a second A N O V A comparing the full 
D M and N C groups with the multisymptomatic C D subgroup was undertaken. This re-analysis, 
omitting oligosymptomatic C D participants, did not require a Bonferroni adjustment, with alpha again 
set at .05. Results showed a significant difference between the three groups (F [2, 192] = 4.733, g = 
010). Post hoc Scheffe testing revealed only one pair-wise difference, with the multisymptomatic C D 
subgroup mean BDI-II score significantly higher than the mean N C score (g = .010; m.d. = 3.79, 9 5 % 
C.I. = .739, 6.841). 
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The 21 items ofthe BDI-II may be subdivided into two factors. As noted in the preceding chapter, 
twelve load onto a Somatic/ Affective dimension and the other nine onto a Cognitive dimension (p. 31; 
Beck et al, 1996). Table 14 lists the means and standard deviations ofthe nine Cognitive dimension 
items, with symptomatic percentages for each item (i.e., percent of participants endorsing a 1, 2 or 3 
point response, as opposed to a zero response). 
Table 14 
Means (SDs) of Item Scores and Percent (%) Symptomatic (Item score of> 1) for Each BDI-II Item 
in the Cognitive Dimension Across the Three Groups 
Symptom (Item) 
Sadness 
Pessimism 
Past Failure 
Guilty Feelings 
Punishment Feelings 
Self-Dislike 
Self-Criticalness 
Suicidal Thoughts/ Wishes 
Worthlessness1 
(»=110) 
M(SD) 
0.17(0.4) 
0.28 (0.5) 
0.33 (0.6) 
0.30 (0.5) 
0.12(0.4) 
0.34 (0.6) 
0.39 (0.7) 
0.06 (0.2) 
0.15(0.4) 
% 
17 
27 
26 
29 
10 
29 
29 
6 
15 
(n = 53) 
M(SD) 
0.23 (0.4) 
0.51 (0.7) 
0.49 (0.7) 
0.38 (0.5) 
0.20 (0.6) 
0.49 (0.8) 
0.38(0.6) 
0.23 (0.4) 
0.43 (0.8) 
Significant differences across groups (g < .01); D M > C D and N C 
% 
23 
43 
36 
38 
13 
34 
32 
23 
30 
(N=69) 
M(SD) 
0.20 (0.4) 
0.33 (0.5) 
0.39 (0.6) 
0.39 (0.6) 
0.23 (0.5) 
0.29 (0.5) 
0.43 (0.6) 
0.13(0.3) 
0.13(0.4) 
% 
20 
32 
32 
35 
20 
28 
38 
13 
12 
Univariate analysis of variance was computed to compare BDI-H item scores across the three 
groups, with the alpha level pre-adjusted to g = .01, due to the multiple comparisons. A N O V A 
demonstrated that the only significant differences at this alpha level across groups was on Worthlessness 
(F [2, 229] = 6.870, g = .001). Post hoc Scheffe testing showed that the DM group mean score on this 
item was significantly higher than the mean score of both the CD group (g = .004; m.d. = .28, 95%, C.I 
= .07, .49) and the NC group (g = .005, m.d. = .30, 95% C.I. = .08, .53). 
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Table 15 lists the means and standard deviations ofthe twelve Somatic/ Affective dimension items. 
with symptomatic percentages for each item (i.e., percent of participants endorsing a 1, 2 or 3 point 
response). Univariate analysis of variance was computed to compare BDI-H item scores across the 
three groups, with the alpha level again pre-adjusted to g = .01, due to the multiple comparisons. 
ANOVA demonstrated that the only significant differences at this alpha level across groups was on 
Changes in Appetite (F [2, 229] = 9.162, p = .000). Post hoc Scheffe testing showed that the CD group 
mean score on this item was significantly higher than the mean score of both the DM group (g = .006; 
m.d. = .41, 95% C.I. = .10, .71) and theNC group (p = .001, m.d. = .43, 95% C.I. = .15, ,71). 
Table 15 
Means (SDs) of Item Scores and Percent (%) Symptomatic for Each BDI-II Item in the Somatic/ 
Affective Dimension Across the Three Groups 
CD~ DM NC 
(«=110) (n=53) (N=69) 
Symptom (Item) M(SD) % M(SD) % M(SD) % 
Loss of Pleasure 
Crying 
Agitation 
Loss of interest 
Indecisiveness 
Loss of Energy 
Sleeping Pattern Changes 
Irritability 
Changes in Appetite1 
Concentration Difficulty 
Tiredness or Fatigue 
Loss of Interest in Sex 
0.44 (0.6) 
0.33 (0.7) 
0.50 (0.8) 
0.40 (0.6) 
0.43 (0.8) 
0.80(0.7) 
0.85 (0.9) 
0.45 (0.7) 
0.76 (0.9) 
0.63 (0.8) 
0.71 (0.7) 
0.45 (0.8) 
40 
25 
37 
36 
32 
64 
56 
35 
55 
46 
56 
30 
0.34 (0.5) 
0.25 (0.6) 
0.34 (0.6) 
0.36 (0.7) 
0.30 (0.6) 
0.83 (0.6) 
1.02(1.0) 
0.28 (0.5) 
0.36 (0.7) 
0.55 (0.6) 
0.79 (0.7) 
0.70(1.0) 
32 
17 
30 
27 
25 
70 
62 
26 
28 
47 
68 
40 
0.21 (0.5) 
0.23 (0.5) 
0.41 (0.6) 
0.30 (0.6) 
0.30 (0.6) 
0.58 (0.6) 
0.58 (0.9) 
0.33 (0.6) 
0.33 (0.6) 
0.33 (0.5) 
0.52 (0.6) 
0.45 (0.8) 
20 
19 
36 
28 
26 
54 
38 
28 
28 
33 
46 
29 
Significant differences across groups (g < .01); C D > D M and N C 
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Following perusal of individual item means across the three groups, each ofthe twelve BDI-II items 
loading onto factor 1 (i.e., the Somatic/ Affective dimension) and the nine items loading onto Factor 2 
(i.e., the Cognitive) were averaged to create mean sub-scores pertaining to the Somatic/ Affective 
dimension and Cognitive dimensions, as outlined Table 16. 
Table 16 
Means, Standard Deviations (SDs) and Ranges of the BDI-II Somatic/ Affective and Cognitive 
Factor Scores Across the Three Groups 
Somatic (12 items) 
Mean (SD) 
Range 
Cognitive (9 items) 
Mean (SD) 
Range 
Univariate analy 
CD 
(«=110) 
0.56 (0.47) 
0-2.08 
0.24 (0.26) 
0-1.11 
sis of variance was undertaken to 
DM 
(n = 53) 
0.51 (0.40) 
0 - 1.50 
0.37 (0.40) 
0-1.56 
compare the mean 
NC 
(N=69) 
0.38 (0.37) 
0-1.50 
0.28 (0.33) 
0-1.22 
Somatic/ Affective dimensi 
and Cognitive dimension factor scores across the three groups. The alpha level was set at g = .025, in 
relation to two comparisons being performed, but also acknowledging that this was a conservative 
perspective, given that these factors were composite scores based on the averages of 12 and 9 BDI-H 
items respectively, each individually having strong, built-in reliability coefficients. ANOVA 
demonstrated that there was a significant differences across groups on the Somatic/ Affective factor 
scores (F [2, 229] = 3.782, g = .024). Post hoc Scheffe testing showed that this overall difference could 
be attributed to the CD group mean score being significantly higher than the mean score of NC group 
(g= .025, m.d. = .18, 95% C.I. = .02, .34). 
Psychological Sequelae of C D 169 
There was not a significant difference across the three groups relative to the Cognitive dimension. 
Since there was a significant positive Pearson correlation (r [110] = .356, g = .000) between the severity 
of CD and the Cognitive dimension of BDI-II depression, consecutive ANOVA was conducted across 
the NC, DM and increasingly severely symptomatic CD subgroups groups to determine if a significant 
difference emerged between groups. It was interesting to note that even when the severely symptomatic 
CD subgroup (> 3 symptoms at CD diagnosis; n = 38) was used in the ANOVA there was not a 
significant difference across groups (F [2, 157] = 1.376, g = .256). This result clearly demonstrated that 
depression underpinned by Cognitive, as opposed to Somatic/ Affective factors, was not significantly 
more prevalent in the CD sample than either ofthe control groups used in Study 1, even amongst the 
most symptomatic third ofthe CD group. 
State and Trait Anxiety: Group Comparisons 
The State-Trait Anxiety Inventory (STAI) was used to measure the levels of state and trait anxiety in 
the three groups. Univariate analysis of variance (ANOVA) was undertaken, with post-hoc Scheffe 
testing performed if significant group effects were identified. Mean state STAI scores, standard 
deviations and ranges across groups are reported below in Table 17. 
Table 17 
Means, Standard Deviations (SDs) andRanges of State Anxiety in the CD, DMandNC Groups 
N 
Mean (SD) 
Range* 
CD 
110 
35.79 (12.5) 
20-76 
DM 
53 
32.81 (10.0) 
20-64 
NC 
69 
30.04 (9.2) 
20-57 
* Possible score range of 20-80, with individual scores > 40 indicating elevated state anxiety 
There was a significant effect across groups on state anxiety (F [2, 229] = 5.814, p = .003), with 
Scheffe testing showing that the CD group reported significantly greater state anxiety than the NC group 
(g = .004; m.d. = 5.74, 95% C.I. = 1.56, 9.94). There were no other pair-wise differences. Upon gender 
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partitioning, statistical significance across groups was only maintained among female C D patients 
(F [2, 135] = 3.40, g = .036), with the CD -NC pair-wise difference also maintained (g = .037, m.d. = 
5.67, 95% C.I. = .27, 11.06). If only multisymptomatic CD cases were considered, the same significant 
group effect was maintained regardless of gender, with the mean multi-symptomatic CD state anxiety 
score rising to 39.15 (SD = 13.2) - near the cut-off of 40 designating elevated state anxiety - from 35.79 
(12.5) in the fill CD group. Using this cut score criteria, corresponding to the 70-85* percentile, 
depending on age (Spielberger et al, 1983), 28% ofthe CD sample scored greater than 40, compared 
with 18.9%o of DM patients and 14.5% of NC participants. There was not a statistical difference between 
male and female CD patients regarding state anxiety upon t-testing. 
There was not a significant difference across groups in trait anxiety, mean scores for which are 
displayed in Table 18, Using equivalent cut score criteria, corresponding to the 72-88* percentile, again 
depending on age (Spielberger et al, 1983), 38% ofthe CD sample scored greater than 40, compared 
with 37.7%i of DM patients and 30.4% of NC participants. 
Table 18 
Means, Standard Deviations (SDs) andRanges of Trait Anxiety in the CD, DMandNC Groups 
N 
Mean (SD) 
Range* 
CD 
110 
38.39(10.79) 
20-71 
DM 
53 
37.04 (10.9) 
20-62 
NC 
69 
34.61 (10.76) 
20-63 
* Possible score range of 20-80, with individual scores > 40 indicating elevated trait anxiety 
When the previously mentioned multisymptomatic C D subgroup was substituted for the full C D 
sample in the ANOVA, a significant difference across groups arose (F [2, 192] = 7.88, g = .001), with 
only the CD - NC pair-wise difference significant (g = .001; m.d. = 7.12, 95% C.I. = 2.62, 11.61). Upon 
t-testing, a slight statistical differences emerged between male and female CD patients in trait anxiety (F 
[108] = .06, g = .041, m.d. = 4.29, CL = .19, 8.4); female CD patients mean = 40.11, versus male CD 
patients = 35.82), with the assumption of equal variance made as Levene's test was negative. 
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State and Trait Anger: Group Comparisons 
The State-Trait Anger Expression Inventory (STAXI) was used to evaluate various aspects of anger 
in each ofthe three groups. Mean state anger levels are shown in Table 19. There were no differences 
across groups, but a small significant difference occurred when the multisymptomatic subgroup was 
used (F [2, 192] = 4.08, g = .018), with only the CD -NC pair-wise difference significant (g = .019; 
m.d. = 1.79, 95% C.I. = .23, 3.35). It is doubtful, however, whether this small statistical difference -
approaching two points in a range of possible scores between 10 and 40 - is clinically meaningful 
Table 19 
Means, Standard Deviations (SDs) andRanges of State Anger in the CD, DMandNC Groups 
N 
Mean (SD) 
Range* 
CD 
110 
11.91 (4.2) 
10-31 
DM 
53 
11.57(2.8) 
10-22 
NC 
69 
10.85 (2.8) 
10-30 
* Possible score range of 10-40, with individual scores > 20 indicating elevated state anger 
Neither Angry Temperament nor Angry Reaction (each subscales of state anger) were 
significantly different across groups, even after consideration of only multisymptomatic CD 
patients, a result repeated in relation to trait anger, which is reported in Table 20 below. 
Table 20 
Means, Standard Deviations (SDs) andRanges of Trait Anger in the CD, DMandNC Groups 
N 
Mean (SD) 
Range* 
CD 
110 
17.65 (5.8) 
10-31 
DM 
53 
17.32 (4.46) 
10-29 
NC 
69 
17.22 (5.0) 
10-33 
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Other Anger Functions: S T A X I Anger-In, -Out, Control and Expression 
Four other functions of anger assessed by the STAXI, namely Anger - In (often abbreviated to 
Ax-ln when reported), Anger - Out (Ax-Out), Anger Control (Ax-Con) and Anger Expression (Ax 
Ex). These are displayed in Table 21, with possible score ranges footnoted. 
Table 21 
Means, Standard Deviations (SDs) andRanges of Anger - In, Anger - Out, Anger Control and 
Anger Expression on the STAXI in the CD, DMandNC Groups 
Anger - In 
Mean (SD) 
Range1 
Anger - Out 
Mean (SD) 
Range2 
Anger Control 
Mean (SD) 
Range3 
Anger Expression 
Mean (SD) 
Range4 
CD 
16.92 (3.7) 
9-26 
14.08 (3.2) 
8-25 
22.92 (4.7) 
14-32 
24.08 (7.9) 
6-41 
DM 
16.45 (4.4) 
9-29 
13.42(2.7) 
8-32 
24.21 (4.7) 
8-32 
21.66(7.1) 
6-39 
NC 
14.53 (3.5) 
8-22 
14.4 (3.4) 
9-28 
24.71 (5.0) 
12-32 
20.24 (7.9) 
2-46 
P^ossible score range of 8-32; ^Possible score range of 8-32; 
Possible score range of 8-32; theoretical range of 0-72 (derived from Ax-In/ -Out/ -Con.) 
The only significant effect across groups occurred for Anger - In (F [2, 228] = 3.82, g = .023), with 
only the D M - N C pair-wise difference significant (g = .026; m.d. = 1.92, 9 5 % C.I. = . 18, 3.66). Given 
the possible range of scores of 7-30, the difference was regarded as clinically irrelevant. If alpha level 
was adjusted to g = .007, decided on a Bonferroni basis by considering an overall .05 level for each 
score divided by the five STAXI sub-scores compared across groups, this difference also disappeared. 
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When the multisymptomatic C D subgroup was used in the A N O V A the significant effect across 
groups was stronger (F [2, 191] = 7.45, g = .001), with a significant difference involving the CD-NC 
comparison, as well as DM - NC pairing (p = .001 and p = .025 respectively). However, the m.d. of 
2.38 (C.I. = .74, 2.07) between the multisymptomatic CD and NC group remained clinically 
unremarkable. 
A somewhat more notable affect across groups occurred in Anger Expression, with multisympto-
matic CD patients expressing anger (regardless ofthe direction of expression) significantly more often 
than NC participants (F [2, 191] = 4.26, p = .016), with only the DM - NC pair-wise difference 
significant (g = .017; m.d. = 3.85, 95% C.I. = .56, 7.13), 
Using the t-test, there was only one significant gender difference (at an a level of .05) in any ofthe 
seven functions of anger within the CD group, with Anger - In higher in female CD patients, but only 
marginally (t [108] = 2.08, g = .04, m.d. = 1.52, C.I. = .07, 2.98). In view ofthe small mean difference -
and multitude of comparisons undertaken increasing the likelihood of type 1 error - this result was not 
viewed as particularly clinically important. 
Cognitive Functioning 
Neuropsychological Assessment: Group Comparisons 
The WAIS-3 was used to measure various components of cognitive functioning in the cross-
sectional study. Univariate ANOVA with post-hoc Scheffe testing was computed to compare 
performance across the three groups. The dependent measures consisted ofthe seven major scores on 
the WAIS-3. These were full-scale IQ, verbal IQ, performance IQ and the four index scales; verbal 
comprehension, perceptual organisation, working memory and processing speed. 
Alpha level was fixed at g = .007, decided on a Bonferroni basis by considering an overall .05 level 
for each score divided by the seven WAIS-3 scores compared across groups, to markedly reduce the 
likelihood of Type 1 errors. 
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There were no significant differences across groups on the WAIS-3 full-scale, verbal and 
performance IQ scores (F [2, 218] = .04, .607 and 2.617 respectively and g > .05 in each case). Mean 
scores, SDs and ranges for these measures across groups are reported below in Table 22. 
Table 22 
Means, Standard Deviations (SDs) and Ranges of Full Scale, Verbal and Performance IQ Scores 
Across the Three Groups 
WAIS-IO (Full Scale) 
Mean (SD) 
Range 
Verbal IO 
Mean (SD) 
Range 
Performance 10 
Mean (SD) 
Range 
CD 
112.19 (13.2) 
75-145 
109.56(12.1) 
72-138 
113.30(15.0) 
76-153 
DM 
112.71(12.6) 
81-143 
111.45(12.5) 
88-147 
112.33(12.6) 
77-140 
NC 
112.69(13.8) 
72-145 
111.53(14.1) 
75-140 
111.96(15.4) 
73-155 
Neuropsychological Index Performance 
Regarding the four WAIS-IQ index performance scores, no significant differences occurred across 
groups on the WAIS-3 Verbal Comprehension (VC) or Perceptual Organisation (PO) indexes (F [2, 
218] = .61 and 2.62 respectively, g > .007 in each case), despite the mean PO score in the CD group 
being 5.4 points higher than the mean NC PO score. 
However, significant differences occurred across groups for the two other WAIS-IQ indexes; 
Working Memory (F [2, 218] = 9.13, g = .000) and Processing Speed (F [2, 218] = 14.60, p = .000. 
The mean scores, standard deviations and ranges for the four WAIS-3 index scores across groups are 
reported overleaf in Table 23. 
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Table 23 
Mean, Standard Deviation (SDs) and Ranges of IQ Index scores; Verbal Comprehension, 
Perceptual Organisation, Working Memory and Processing Speed, Across the Three Groups 
WAIS-III Index 
Verbal Comprehension 
Mean (SD) 
Range 
Perceptual Organisation 
Mean (SD) 
Range 
Working Memory 
Mean (SD) 
Range 
Processing Speed 
Mean (SD) 
Range 
CD 
(n=108) 
112.4(12.2) 
76-138 
116.4(15.1) 
76-150 
101.7 (13.3) a 
71-144 
99.6(13.5)° 
69-137 
DM 
(n=51) 
113.2(11.9) 
84-136 
113.3(13.3) 
72-142 
104.3 (12.8) b 
69-150 
104.1 (12.8)d 
76-137 
NC 
(n = 60) 
110.7(13.8) 
80-140 ' 
111.0(16.7) 
69-150 
110.9 (14.6) ^  
71-144 
110.8 (12.7) c'd 
81-148 
aCD<NC(g<.001); b D M < N C ( g < . 0 5 ) ; C C D < N C (g< .001); d D M < N C (g< .05) 
For Working Memory (WM), CD participants performed at a significantly lower level than healthy 
controls (g = .000; m.d. = -9.20, 95% CL = -14.52, -3.88). Participants in the DM group also performed 
at an inferior level to NCs (g<.05), but not significantly so after a Bonferroni adjustment (g > .007). 
In the Processing Speed (PS) index, there was a similar, but even more salient result (F = 14.60, 
g = .000), with CD participants again performing at a significantly lower level than NCs (g = .000, m.d. 
= -11.28, C.I. = -16.43, -6.13). The performance of DM participants was not significantly different to 
NCs following the Bonferroni adjustment. Across the four IQ indexes, the performance of CD and DM 
participants was not significantly different. The strength of already clear WM and PS results increased 
slightly when the multisymptomatic CD group was used in the ANOVA, with the mean WM and PS 
scores in the CD group dropping a further 2.17 and .65 points respectively. Statistical significance held 
when the CD sample was subdivided into low, medium or high subgroups, based on total IQ, age at 
study entry, age or number of symptoms at CD diagnosis and time on or compliance with the GFD. 
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In regard to gender, the PS difference was slightly accentuated in male, compared to female, C D 
participants, using the independent samples t-test, with equal variance assumed (t = 2.08, g = .040, m.d. 
= 1.52, 95% C.I. = .07, 3.0). 
Finally, covariate ANOVA was performed using a number of dependent variables (measuring 
indices of mood and other psychological factors) that may impact on memorial functioning and speed of 
information processing. When total BDI-II scores were used as the covariate, significant differences 
across groups remained for WM (F [2, 218] = 7.68 [cf. 9.13], g = .001 [cf. .000]) and PS (F [2, 218] = 
12.97 [cf. 14.60], g = .000 [no change to third decimal point]). Similar results were obtained when state 
anxiety was the covariate for WM (F [2, 218] = 6.85 [cf. 9.13], g = .001 [cf. .000]) and PS (F [2, 218] = 
11.50 [cf 14.60], g = .000 [no change]). Although space does not permit the reporting of all covariate 
analyses undertaken, none using other measures of mood or quality of life changed the existence of 
significance pertaining to the WM and PS group differences. 
Index Performance: Discrepancy Analysis in CD Group 
Given the significant mean decrements in the WM and PS indexes ofthe WAIS-3 in the CD group 
compared to the NC (but not DM) group, further analysis was undertaken to determine in what 
percentages ofthe three groups these indexes were significantly low - or high - compared to the VC and 
PO indexes. Table 24 (overleaf) displays these percentages. The cut score criteria used were those 
published in the WAIS-HI Administration and Scoring Manual. Differences required for statistical 
significance are based on the standard errors of measurement of each Index at each age and calculated 
using the following formula: 
Difference Score: Z V SEMa2 + SEMb 2, 
where Z is the normal curve value associated with the desired significance level and SEMaand SE Mb 
are the standard errors of measurement ofthe two scales (Wechsler, 1997). In practice, the required 
magnitude of difference that is statistically significant at the .05 level varies by several points, being 
between 9 and 11 points for the VC-WM comparison and 11-14 points for the PO-PS comparison. 
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Table 24 
WAIS-III Index Score Differences for VC-WM and PO-PS Pairings Across Groups: Percentage of 
Cases Involving a Significant Difference at. 05 Level (Each Direction) and No Statistical Difference 
Index Pairine 
VC-WM 
% VC < W M 
% N o statistical difference 
% VC > W M 
PO-PS 
% PO < PS 
% N o statistical difference 
% PO > PS 
CD 
(n=108) 
13.0% 
33.3 % 
53.7% 
3.7 % 
37.0 % 
59.3 % 
DM 
(n = 51) 
3.9 % 
47.1% 
49.0 % 
7.8 % 
49.0 % 
43.1% 
NC 
(n = 60) 
30.6 % 
46.8 % 
22.6 % 
17,7 % 
56.5 % 
25.8 % 
According to the WAIS-III Technical Manual, significant differences between Index scores are 
expected to occur in approximately 40-60%) of people, depending on the full-scale IQ range. The 
direction of these differences is balanced. Therefore, examining Table 24, it is evident that, in both the 
CD and DM groups there are a greater than expected number of cases in which WM < VC (53.7 % and 
49.0 %) and in which PS < PO (59.3 % and 43.1 %), compared to the NC group (22.6 % and 25.8 % 
respectively). These proportions are congruent with the significant mean index score differences found 
in the CD compared to the NC, but DM, group. 
One again, the PS index result was the most pronounced in the CD group, with PS < PO in more 
than half of all cases (59.3 %) versus the converse (i.e., PO > PS) in only four cases out of 108 (= 3.7 
%). These results confirm that there are relative weaknesses in both the WM and PS indexes in CD, 
relative to the two other core indexes, and that this result is especially salient in the case of Processing 
Speed. It was interesting to note that the CD result did not vary according to CD severity, as determined 
by the number of symptoms at diagnosis. For the multisymptomatic subgroup the VC-WM difference 
percentages were 8.3 (VC < WM)/ 33.3 (no difference)/ 58.3 (VC > WM), versus 22.2/ 33.3/ 44.4 for 
the oligosymptomatic subgroup, whilst for the PO-PS pairing the respective results were 2.8/ 34.7/ 62.5 
versus 5.6/38.9/52.8. 
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Neuropsychological Subtest Performance: Descending Order 
The reliability coefficients ofthe WAIS-HI IQ and Index scores (ranging from .88 to .97) are 
consistently higher than those ofthe 14 subtests, which ranges from .70 (Object Assembly - not used in 
thesis) and .74 (Picture Arrangement) to .93 (Vocabulary. Digit Span, and Information). Therefore, the 
analyses of discrepancies in performance between groups focussed on differences between Index 
Scores. However, having identified the deficits in WM and PS in the CD group, a straightforward 
exercise undertaken was listing the descending order of performance in each ofthe three groups. These 
orders are displayed in Table 25. 
Table 25 
Means and SDs of Subtest Scores, in Descending Numerical Order of Performance Across Groups 
Best 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
Worst 
CD(n=108) 
W A I S Subtest (Mean. SD) 
Vocabulary (13.51, 2.7) 
MatrixReas. (13.32,2.7) 
Picture Comp. (12.57, 2.8) 
Comprehension (12.16, 2.9) 
Block Design (12.01, 2.8) 
Information (11.93, 2.5) 
Picture Arr. (11.78,2.8) 
Similarities (11.39, 2.4) 
Arithmetic (10.52, 2.6) 
L-N Sequenc. (10.43, 2.6) 
Digit Span (10.14, 2.9) 
Symbol Search (10.00, 2.5) 
Digit Sym. Cod. (9.94, 2.8) 
D M ( n = 51) 
W A I S Subtest (Mean. SD) 
Matrix Reas. (13.14, 2.9) 
Information (12.96, 2.1) 
Vocabulary (12.84, 2.5) 
Comprehension (12.51, 2.4) 
Block Design (11.92, 2.5) 
Picture Arr, (11.63,2.4) 
Picture Comp. (11.49,2.1) 
Similarities (11.47, 2.4) 
Arithmetic (11.23, 28) 
L-N Sequenc. (10.96, 2.3) 
Digit Sym. Cod. (10.84, 2.4) 
Symbol Search (10.73, 2.8) 
Digit Span (10.23, 2.9) 
N C (n = 60) 
W A I S Subtest (Mean. SD) 
Vocabulary (12.19, 2.6) 
Information (12.16, 2.7) 
Digit Sym. Cod. (12.13, 2.3) 
Matrix Reas. (12.13, 3.0) 
Comprehension (12.02, 2.7) 
L-N Sequenc. (11.97, 2.6) 
Arithmetic (11.95, 2.7) 
Picture Comp. (11.74, 2.6) 
Symbol Search (11.76, 2.8) 
Digit Span (11.65, 3.0) 
Similarities (11.50, 2.8) 
Block Design (11.45, 3.0) 
Picture Arr. (11.14,2.4) 
It is apparent from Table 25 that in the C D group, the five numerically lowest mean scores were the 
two PS subtests, followed by the three WM subtests. In terms of statistical significance, the mean scores 
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for the C D group's two worst performed (PS Index) subtests, Digit Symbol-Coding (= 9,94) and 
Symbol Search (=10.00) were each statistically different (g < .05) from the mean scores in both 
Vocabulary (m.d.'s = 3.57 and 3.51; required differences at .05 level = 2.80 and 3.20 respectively) and 
Matrix Reasoning (m.d. = 3.38 and 3.32, required difference = 3.01 and 3.39). 
The next three numerically lowest subtest scores in the CD group (Digit Span. Letter-Number 
Sequencing and Arithmetic, comprising the WM Index) were also significantly lower than performance 
on Vocabulary (m.d.'s = 3.37, 3.08, and 2.99; with the respective required differences at the .05 level 
being 2.48, 2.98, and 2.57). Mean scores on two out ofthe three, Digit Span and Arithmetic, were also 
significantly lower than performance on Matrix Reasoning (m.d.'s = 3.18 and 2.80; with the respective 
required differences being 2.64 and 2.80). 
A similar pattern of results (WM and PS Index subtests comprising bottom five) was found in the 
DM group, but statistical significance only occurred in regard to the pairing of Digit-Span with the 
highest three DM subtest scores. Within the NC group there were no significant discrepancies in mean 
performance between any pairs of subtests, even at the .15%) level of significance, with the m.d. between 
the highest and lowest subtest performance scarcely one point and the next greatest m.d. = .74. 
Furthermore, the PS and WM Index subtests were evenly distributed regarding descending numerical 
mean score order, occupying ranks equal third through to tenth. These comparative NC results underline 
the significance ofthe CD findings. 
Health Status and Life Quality 
Comparisons of Health Status Across Groups 
Self-assessed health status was recorded at study entry for all participants. In the case of CD and DM 
participants, health status was rated retrospectively in relation to two time periods; prior to and after 
diagnosis/ treatment with either CD or DM. For the NC group, the health status rating corresponded to 
the exact time of study entry. Since the ratings corresponding to the CD and DM groups relate to 
different temporal durations and points than the NC ratings, statistical comparisons were limited to the 
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C D and D M groups. However, the N C ratings provide a useful background perspective. The percentages 
of participants in all three groups rating their health according to one of six rating categories (from very 
poor to excellent), are displayed in Table 26. The only missing data involved two CD participants who 
were unable to rate their health status after diagnosis with CD as they had not received confirmation of 
CD at study entry. 
Table 26 
Health Status Before/After Diagnosis with CD or DM and at Study Entry for NC Participants (%) 
Rating (% of Si 
1: Very Poor 
2: Poor 
3: Fair 
4. Good 
5: Very Good 
6: Excellent 
ample) 
CD 
Before/ After 
25.5% - 0% 
28.2% - 0.9% 
22.7% - 19.4% 
9.1%-38.9% 
11.8%-25.9% 
2.7% - 14.8% 
DM 
Before/ After 
0 % - 3 . 8 % 
2.0% - 9.4% 
18.0%- 11.3% 
52.0% - 54.7% 
22.0% - 17.0% 
6.0% - 3.8% 
NC 
Study Entry 
0% 
2.9% 
8.7% 
30.4% 
36.2% 
21.7% 
From Table 26, it is evident that three-quarters (76.4%) ofthe C D sample rated their health as 
very poor to fair prior to diagnosis, where as four-fifths (79.6%>) rated their health as good to 
excellent after diagnosis and treatment with the GFD. The shift towards an improved health rating 
pre-post diagnosis in the CD group was exemplified by the observation that no CD participants rated 
their health in the period since diagnosis as very poor, compared to one-quarter ofthe CD sample 
(25.5%) pre-diagnosis. Those rating their health as poor also fell from 28.2% to 0.9% (i.e., just one 
case). Health ratings in the very good to excellent categories increased from 14.5% to 40.7%. 
In contrast, about half of the DM group rated their health status as good both prior to and after 
diagnosis with DM (52% and 54.7% respectively). More DM patients rated their health as poor to very 
poor post diagnosis (13.2%, compared to 2%> pre-diagnosis) and fewer DM patients rated their health 
as very good to excellent after diagnosis (20.8% compared to 28% pre-diagnosis). Unlike in the CD 
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group, where there was a marked increase in the percentage of participants who reported increases in 
health pre-post diagnosis, the opposite trend occurred in the D M group, although to a lesser degree 
In both the CD and DM groups there was a greater percentage of participants who rated their 
health, both pre- and post-diagnosis, in the lower three categories (very poor to fair) compared to the 
N C group at study entry. These percentages were, for the C D group, 76.3% and 20.3% (pre-post 
diagnosis), for the D M group, 2 0 % and 24.5% (pre-post) and 11.6% at study entry for the N C group 
These results were comparable to Australian National Health Survey data (McLennan, 1998, 2000), 
in which 3.3% of people without a medical condition surveyed rated their health as poor to fair and 
1 8 % of people with one or more medical conditions (recent and/ or long-term) were in the same 
range. However, a 5- rather than 6-point scale was used in the National Health Surveys of 1989-90 
and 1995, with the scale used in this thesis including an additional category (very poor) in view ofthe 
focus on people with at least one medical condition (CD or D M ) . Therefore, comparisons are 
somewhat limited, although the differences between people with and without a medical condition 
were notable. In both the National Health Surveys and the D M and N C groups in the present thesis, 
there were no gender differences in health status. However, in the C D group, females rated their 
health status as lower than males, as shown in Table 27. 
Table 27 
Means and Standard Deviations (SDs) of Self-Assessed Health Status Prior to and Since Diagnosis 
in Male and Female CD Participants 
Male CD Female CD 
Health Status Prior to Diagnosis 
Mean (SD) 2.86 (1.5) 2.45 (1.3) 
Health Status Since Diagnosis 
_Mean (SD) 4.67 (1.0) 4.14(1.0) 
Independent samples t-test showed that the difference in health status was only significant in 
relation to the period since diagnosis, with t = 2.81, p = .006, m.d. = .53, 95% C.I. = 15, .90). 
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Table 28 displays the mean health status scores prior to and since diagnosis for the C D and D M 
participants and the NC scores at study entry. 
Table 28 
Means, Standard Deviations (SDs) and Ranges of Self-Assessed Health Status Prior to and Since 
Diagnosis in relation to CD and DM Patients and at Study Entry for NC Participants 
CD DM NC 
Health Status Prior to Diagnosis 
Mean(SD) 2.62(1.4) 4.12 (.8) 
Range 1-6 2-6 
Health Status Since Diagnosis 
Mean(SD) 4.34(1.0) 3.83(1.1) 
Range 2-6 1-6 
Health Rating Score Range Key: 
1: Very Poor 2: Poor 3: Fair: 4: Good 5: Very Good 6: Excellent 
Using ANOVA with retrospectively reported pre- and post-diagnosis CD and DM scores, and 
with NC health status scores at study entry in each analysis, there was a difference across groups in 
health status both pre-diagnosis; F [2, 226] = 68.86, g = .000) and post-diagnosis F [2, 227] = 9.91, 
g = .000). Post-hoc Scheffe testing showed that pre-diagnosis CD health status scores were 
significantly lower than pre-diagnosis DM scores (g = .000, m.d. = 1.50, 95% C.I. 1.00, 2.00) and 
NC scores (g = .000, m.d. = 2.03, 95%. C.I. = 1.58, 2.48). Post-diagnosis, DM scores were 
significantly lower than both NC scores (g = .000, m.d. = .82, 95% C.I. = .37, 1.28) and, to a lesser 
degree, CD scores (g = .012, m.d. = .51, 95% CL = .09, .93). 
There was not a significant difference between the CD and NC scores, although when the multi-
symptomatic CD subgroup was used in the ANOVA, a significant effect still occurred across groups 
(F = 11.596, p = .000) and the multisymptomatic subgroup's score was significantly lower than the NC 
score (g = .003, m.d. = .58, 95%> C.I. = .17, .99). Upon gender partitioning, statistical significance only 
held in the analysis isolating female participants (g = .022, m.d. = .57, 95%> C.I. = .07,1.08). 
Mean(SD) 4.65(1.0) 
Range 2-6 
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Within-group analyses were also undertaken. Using paired samples t-test, there was a 
significant increase pre- to post-diagnosis in CD scores (t [107] = 13.12, g = .000) and a smaller 
although still significant, decrease pre- to post-diagnosis in D M scores (t [49] = 2.13, g = .038). 
The lack of perceived health improvement in the chronic illness comparison group pre- to post-
diagnosis was attributed to the almost inevitable, eventual deterioration of health associated with 
D M , as distinct from C D , in which a remission of health problems is generally observed following 
consistent adherence to the GFD. 
Further analysis of the increase in health status in the CD group (pre- post-diagnosis) showed 
that this result was significant in both the multisymptomatic participants, with an average increase 
of 1.85 points (or almost two categories) in that subgroup (t [71] = 11.35, g = .000, m.d. = 1.85, 
9 5 % C.I. = 1.52, 2.17) compared to 1,58 points in the oligosymptomatic group (t [35] = 6.68, g = 
.000, m.d. = 1.58, 9 5 % C.I. = 1.10, 2.06), These results are shown in Table 29. 
Table 29 
Means, Standard Deviations (SDs) andRanges of Self-Assessed Health Status Prior to and Since 
Diagnosis in the Multisymptomatic and Oligosymptomatic CD Subgroups. 
Multisymptomatic CD Oligosymptomatic CD 
Health Status Prior to Diagnosis 
Mean(SD) 2.23(1.1) 3.31(1.5) 
Range 
Health Status Since Diagnosis 
Mean (SD) 4.07 (0.9) 4.89 (0.9) 
Range 
There was not a significant difference in health status between the oligosymptomatic CD 
subgroup and NC participants. 
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Quality of Life 
Quality of life (QOL) was assessed using the Quality of Life Questionnaire. Table 30 displays 
the mean QOL and major domain scores across the three groups. Using ANOVA, there was no 
difference in overall QOL between groups. 
Table 30 
Means, Standard Deviations (SDs) and Ranges of Quality of Life (QOL) and Major QOL Domain 
Scores Across the Three Groups 
O O L (Total score) 
N 
Mean (SD) 
Range 
General Well-being 
N 
Mean (SD) 
Interpersonal Relations 
N 
Mean (SD) 
Organisational Activity 
N 
Mean (SD) 
Occupational Activity 
N 
Mean (SD) 
CD 
107 
104.76 (22.6) 
54-162 
107 
7.96 (1.7) 
69 
7.78 (2.0) 
105 
5.92 (2.0) 
78 
6.68 (2.6) 
Leisure and Recreation Activitv 
N 106 
Mean (SD) 6.04 (2.2) 
DM 
53 
103.83 (22.8) 
30-153 
53 
7.55(1.8) 
23 
7.55(1.8) 
53 
6.11(2.3) 
34 
7.05 (2.4) 
53 
6.17(1.9) 
NC 
60 
111.28(21.0) 
49-158 
60 
8.28 (1.6) 
28 
7.67(1.6) 
60 
5.54(2.1) 
49 
7.33 (2.2) 
60 
7.54 (2.2) 
Major domains 
General Well-being 
Interpersonal Relations 
Organisational Activity 
Occupational Activity 
Leisure/ Recreation Activity 
Subdomains 
= Means of Material & Physical Well-being & Personal Growth 
= Means of Marital, Parent-Child, Extended Family & Extramarital Relations 
= Means of Altruistic & Political Behaviour 
= Means of Job Characteristics, Occupational Relations & Job Satisfiers 
= Means of Creative/ Aesthetic Behaviour, Sports Activity & Vacation Behaviour 
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In the subsequent analyses of variance involving the five major Q O L domain scores, alpha level 
was fixed at g = .01, decided on a Bonferroni basis by dividing the standard alpha level of .05 by 
five - corresponding the five major domain scores - to limit Type 1 errors. The only significant 
difference across groups occurred in Leisure/ Recreation Activity (F [2, 216] = 10.59, g = .000), 
with both the mean CD group score significantly lower than NC group score (g = ,000, m.d. = 1.50, 
95% C.I. = .67, 2.34) and the DM group score also lower than NCs (g = .003, m.d. = 1.37, 95% C.I 
= .40, 2.35). 
Further perusal ofthe subdomain scores comprising this major domain (i.e., Creative/ Aesthetic 
Behaviour, Sports Activity and Vacation Behaviour) showed that there was a significant effect 
across groups (F [2, 217] = 11.77, g =.000), with the NC group significantly more involved in 
sporting activity than both the CD group (g = .000, m.d. = 2.60, 95% C.I. = 1.25, 3.94) and the DM 
group (g = .004, m.d. = 2.17, 95% C.I. = .60, 3.75). 
In the consideration of subdomain score differences, which involved 15 analyses, a further 
Bonferroni adjustment was made by dividing alpha by 15 (= .003), with only significant differences 
below this level reported. Using this adjustment, only one other significant subdomain difference 
was detected between groups, namely Parent/ Child Relations (F [2, 127] = 6.46, g = .002). Post-
hoc analysis showed only one pair-wise difference between the CD and DM group, with CD 
participants reporting significantly better Parent/ Child Relations (g = .004, m.d. = 2.10, 95% C.I. = 
.54, 3.49). No difference across groups occurred on the Social Desirability scale, and the mean 
scores in each group were well within acceptable limits, indicating that responses were not biased 
towards social desirability. 
There were no significant male-female differences in any ofthe three groups using the 
Bonferroni adjustments, except for Sporting Activity in the CD group, where males (M = 6,35, SD 
= 3.7) were significantly more involved than females (M = 4.02, SD = 2.7) with CD (t [70.69] = 
3.58, g = 001, m.d. = 2.33, 95% C.I. = 1.12, 3.55). Equality of variances could not be assumed, as 
Levene's test was significant. 
Psychological Sequelae of C D 186 
Life Quality Lower in Multisymptomatic C D 
When the multisymptomatic CD subgroup was used in an ANOVA using the DM and NC 
groups, a significant difference emerged across groups (F [2, 181] = 5.91, g = .003). Post-hoc 
Scheffe analysis showed that the multisymptomatic CD subgroup reported significantly lower QOL 
than the NC group (g = .003, m.d. = 13.10, 95% C.I. = 3.69, 22.51). In another ANOVA using the 
oligosymptomatic CD subgroup with the DM and NC groups, there was also a significant 
differences across groups (F [2, 146] = 4.71, g = .010). Post-hoc Scheffe analysis showed that the 
oligosymptomatic CD subgroup reported significantly higher QOL than the DM group (g =012, 
m.d. = 13.89, 95% CL = 2.54, 25.24), but not the NC group. Mean scores for the multisymptomatic 
and oligosymptomatic subgroups are shown with DM and NC group scores in Table 31. 
Table 31 
Mean, Standard Deviations (SDs) andRanges of Quality of Life QOL in the Multisymptomatic and 
Oligosymptomatic CD Sub-Groups, DMandNC Groups 
Multisymptomatic CD Oligosymptomatic CD DM NC 
N 71 36 53 60 
Mean(SD) 98.18(21.5) 117.72(19.1) 103.83(22.84) 111.28(21.0) 
Range 54-146 69-162 30-153 49-158 
High versus Low Scorers on the Quality of Life Questionnaire 
Another approach to examining possible group differences in QOL was to consider the 
percentages of cases falling info different ranges of QOL using the T-scores published in the QOL 
Manual Using the interpretive guidelines for T-scores used by Evans and Cope (1989), the 
percentage of participants in each group falling into nine narrow ranges of QOL (from very much 
below to very much above average) were able to be calculated. For clarity, these nine intervals of 
QOL were collapsed into three broad ranges (i.e., below average - average - above average) and are 
shown overleaf in Table 32, with the multisymptomatic CD subgroup added to demonstrate the 
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relative increase in cases at the lower Q O L range within the C D group. 
Table 32 
Percentage of QOL Scores in the Low, Average and High Ranges for the Multisymptomatic CD 
Subgroup, the Full CD Group and the DMandNC Groups, Using T-Scores 
Multisymptomatic CD Full CD Group DM NC 
N 71 107 53 60 
High QOL 
(T>61) 5.6% 7.5% 5.7%, 8.3% 
Average QOL 
(T = 41 to 60) 55% 63.5% 66% 78,7% 
Low QOL 
(T < 40) 39.4% 29% 28.3% 13% 
From Table 32 it is evident that the percentage of participants reporting average to high QOL are 
roughly equivalent across groups. However, more than twice as many CD and DM participants 
reported low QOL than NC participants and this increased to three times in the multisymptomatic CD 
group. These results are reminiscent ofthe depression results reported earlier, in which there are no 
mean score differences across groups (unless the multisymptomatic CD subgroup is isolated), but a 
greater proportion of low scorers are found within the CD group compared to the NC group. 
Unlike the data sets used in preceding analyses, in which missing data was minimal, several ofthe 
major QOL domains (especially Interpersonal Relations and Occupational Activity) involved the 
measurement of aspects of QOL inapplicable to a large minority of participants in each group (e.g., 
marital relations for those who were single and job characteristics for the retired, unemployed or 
females with full-time home duties). As a result of close matching across demographic factors, though, 
equivalent proportions ofthe three groups were affected. Also, standard adjustments to the scoring 
regime ofthe QOL questionnaire in cases of missing data are described in the Manual (Evans & Cope, 
1989). Power was nevertheless reduced where lower sample sizes were used. 
It was notable that the mean QOL score for the NC group (111.28, SD = 21.0) and oligosymp-
Psychological Sequelae of C D 188 
tomatic C D subgroup (117.72, S D = 19.1) were comparable to the mean normative total score for 
the QOL Questionnaire (113.15, SD = 20.4), especially in view ofthe fact that the demographic 
characteristics of all three groups were similar, notwithstanding historical and geographic differences 
Multidimensional Health Locus of Control 
No significant differences were found between groups in the three Multidimensional Health 
Locus of Control sub-scales, which are displayed in Table 33. 
Table 33 
Mean, Standard Deviations (SDs) andRanges of Multidimensional Health Locus of Control Scores 
(Internal Powerful Others and Chance) Across the Three Groups 
Internal H L O C 
Mean (SD) 
Range 
Powerful Others H L O C 
Mean (SD) 
Range 
Chance H L O C 
Mean (SD) 
Range 
CD 
24.98 (4.7) 
12-36 
16.29 (4.9) 
6-34 
16.39(4.5) 
7-26 
DM 
24.36(5.1) 
14-35 
18.08 (5.2) 
6-33 
16.36(5.1) 
6-31 
NC 
25.51(4.8) 
8-34 
16.06(6.1) 
6-34 
16.81 (5.0) 
8-29 
There were also no significant differences between the mean scores for any ofthe three groups and 
normative data published by Wallston, Wallston and DeVellis (1978), although the CD and NC group 
scores on Powerful Others HLOC were a few points lower than two decade old United States 
community levels. As hypothesised, internal HLOC was negatively correlated with BDI-H depression in 
the CD, DM and NC groups (r [110] = -. 192, g < .05, r [53] = -.331, g < .05, and r [68] = -.317, g < ,01 
respectively) and positively correlated with health status since diagnosis (r [110] = .277, g < .01) and 
qualify of life (r [107] = .251, g < .01. However, Internal HLOC was not correlated with GFD 
compliance, reminiscent ofthe lack of association between CD awareness and GFD compliance. 
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Correlation Matrices Within C D Group 
A selection of bivariate Pearson correlational analyses are displayed in Table 34. These highlight 
numerous positive correlations between the test measures used in Study 1 and two important 
demographic variables, age and educational status. 
Table 34. 
Bivariate Pearson Correlations Within CD Group Between the Variables Age, Education and Test 
Scores 
Variable 
Age 
Education 
BDI-II 
Anxiety (State) 
Anxiety (Trait) 
Anger (State) 
Anger (Trait) 
WAIS-IQ 
QOL 
Age : 
-
-.11 
-.13 
-.20 
-.20* 
-.24* 
-.25** 
.11 
.17 
Education 
-.11 
-
-.22* 
-.20 
-.10 
-.04 
-.20* 
.46** 
.29** 
BDI-II 
-.125 
-.22* 
-
.61** 
.63** 
A'J** 
40** 
-.20* 
-.53** 
Anx.(S) 
-.20* 
-.20* 
-.61** 
-
.73** 
.52** 
.54** 
-.24* 
-.60** 
Anx.(T) 
-.20* 
-.10 
.63** 
.73** 
-
.42** 
.51** 
.19* 
-.60** 
Ang.(S) 
-.24* 
-.04 
.47** 
.52** 
.42** 
-
.66** 
-.16 
-.38** 
Ang.(T) 
-.25* 
-.20 
40** 
.54** 
.51** 
.66** 
-
-.23* 
-.41** 
WAIS-IQ 
.11 
45** 
-.20* 
-.24* 
-.19 
,16 
,54** 
-
.22* 
QOL 
.17 
29** 
-.53** 
,60** 
-.60** 
-.60** 
-.41** 
.22* 
-
Note: N = 110, except in case of WAIS-IQ (N = 108) and Q O L (N=107) and IQ/ Q O L (N = 105) 
Correlation are statistically significant at * g < 0 5 and ** g < .01. 
The highly significant positive correlations between measures of affect (e.g., the BDI-H, STAI and 
STAXI) were expected, given the clinical overlap in the mood and anxiety spectrum disorders and 
anger functions, as described in Chapter Two. There was a modest positive correlation between WAIS-
III IQ and BDI-H depression (r [108] = -.203, g < .05). Further analysis isolating the four WAIS-HI 
Index scores showed that just one ofthe four indexes, Working Memory, was negatively correlated 
with BDI-H depression (r [108] = -.22, g < .05). As noted earlier, however, Working Memory was still 
reduced in the C D group compared to the N C group even after controlling for the effects of depression, 
the overall level of which was not significantly different across each full group. Table 34 shows that 
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lowered mood, increased anxiety and anger are all negatively correlated with quality of life. Finally, 
self-rated Health Status (not in Table) was significantly negatively correlated with BDI-II depression 
in participants across all three groups (r [230] = -.54, g < .001), and within each group (g < .001 in 
each case), indicating a robust association between poor general health and depression. The effects of 
demographic variables, including age, years of education and gender, have been tested and generally 
noted within preceding sections. There was no correlation, nor trend towards an association, between 
gender and either ofthe two measures of dietary compliance. 
As a prelude to discriminant function analysis, the four DQ variables, described earlier in Study 1, 
were used in a correlational analysis with BDI-II scores for all CD participants, as shown in Table 35 
Each ofthe four DQ variables had been proposed to have a directional association with the 
hypothetical level of depression. 
Table 35 
Bivariate Pearson Correlations Within CD Group Between BDI-II Depression and the DQ Variables 
Variable BDI-II CD Symptoms Time Symptomatic Time Since GFD Compliance1: 
Score at Diagnosis Pre-Diagnosis Diagnosis Measure 1 Measure 2 
(0-64) (1-4+) (# Months) (Days) (1-5) (1-16) 
BDI-II Score 
Time Since 
Diagnosis -.12 
GFD Compliance1: 
Measure 1 -.13 
(Freq. gluten) 
Measure 2 -.11 
(Questionnaire) 
.46** 
40** 
.02 
-.05 
.07 
.43** -.12 
.40** .02 
-.02 
-.02 
-.15 0.05 
.07 -.08 
-.13 -.11 
-.05 .07 
-.15 .07 
.05 .08 
.50** 
.50** 
C D Symptoms 
At Diagnosis .46** 
Time Symptomatic 
Pre-Diagnosis .43 * * 
A higher score = greater compliance; Results statistically significant at * p <05 and ** g < 01 
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The two greatest correlations (g < .01) occurred between BDI-H depression and each of two static 
disease correlates; CD Symptoms Pre-diagnosis and Time Symptomatic Pre-diagnosis. A strong 
significant correlation between the latter two variables indicates that, in the CD group used in Study 
1, people who retrospectively reported a higher number of CD-related symptoms at diagnosis also 
tended report having experienced a greater duration of symptoms pre-diagnosis. These two variables 
were unrelated to the elapsed time period since diagnosis with CD and GFD duration. Dietary 
compliance, as measured by two separate scales, was not significantly related, overall, to any other 
variables, except one another. The hypothesis that higher dietary compliance would be associated 
with lower levels of depression was not confirmed, although the trend in each case was in the 
expected direction. Although only two out of four DQ variables were significantly associated with 
BDI-II depression, each ofthe others were in expected directions and so the DQ model incorporating 
combinations of all four variables was tested via discriminant function analysis. 
Discriminant Function Analysis 
Utility of Theorised Damage Quotient Model in Predicting Depression in CD 
A systematic series of discriminant function analyses were performed using combinations of all, 
and subsequently three, ofthe within-CD group hypothetical damage quotient (DQ) variables, as 
equally weighted predictors of membership of two outcome groups, namely 1) absent/ minimal 
depression (BDI-II < 13), and 2) at least mild depression (BDI-H > 13). Prior to analysis, each of four 
DQ variables were converted to standard scores, as outlined. There were pragmatic and actuarial 
motivations for subdivision ofthe CD group using static clinical parameters (i.e., disease severity) and 
dynamic behavioural and temporal correlates (e.g., dietary compliance and time since diagnosis), as a 
prelude to discriminant analysis. As well as Study l's observation that the prevalence of depression in 
CD was higher in multisymptomatic than oligosymtomatic CD patients, previous reports in the 
literature support the view that non-demographic, CD-related factors may predispose to the 
development of both physical and psychological sequelae. 
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These findings justified the pooling of all readily obtainable clinical information underpinning the 
DQ, to determine whether this information had clinical utility in predicting which CD patients may be 
expected to be at risk of suffering from clinically significant depression post-diagnosis. Given the 
increasingly heterogeneous spectrum of CD worldwide (Fasano & Catassi, 2001) and exposure ofthe 
less symptomatic portion ofthe CD iceberg, plus Study l's finding of unremarkable levels of depressive 
symptomatology in oligosymptomatic cases, it was also considered important to be able to determine in 
which circumstances screening for depression in CD is actually justified. With shrinkage of affordable 
health care proportionate to the ageing of western populations and rising competition for these resources 
due to increased awareness of mental health issues in many chronic illnesses (e.g., DM), specification of 
risk profiles within the greater CD population was deemed important in justifying which CD patients 
may warrant and potentially benefit from early specialist intervention in the area of mental health 
All 110 CD participants were used in a series of direct discriminant function analyses (DFAs), with 
a selection of four ofthe most accurate analyses (regarding predicted group membership) reported, in 
order to highlight which DQ variables were most clinically useful in predicting significant levels of 
depression in CD. 
How Accurately Did the DQ Variables Identify Depressed CD Patients? 
The first DFA used each ofthe four DQ predictor variables previously described and all CD 
participants were included. Depressed and non-depressed CD participants on the BDI-II were the two 
groups used. There were 86 CD patients in the non-depressed group and the 24 remaining CD patients 
constituted the depressed group. The first measure of dietary compliance was used (i.e., frequency of 
gluten intake). No items were removed as a result of missing data. The Mahalanobis distance method 
(Coakes & Steed, 1999; Tabachnick & Fidell, 1996) was applied to probe for multivariate outliers, but 
none were identified. 
Relationships between predictor variables within groups were examined for linearity and serious 
violations were not observed. Since significant correlations were observed between several 
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independent variables, the possible effects of multicollinearity were monitored, but did not prove to be 
problematic. Box's M test was used to assess equality of covariance and was found to be non-
significant (M = 6.92, p > .001), verifying homogeneity of variance-covariance matrices. Finally, DFA 
"is quite sensitive to the ratio of sample size to the number of predictor variables", with "a ratio of 20 
observations for each predictor variable" suggested (Hair, Anderson, Tatham, & Black, 1992, p. 106) 
Clearly, this recommendation was met. 
The first DFA was significant; %2 (4, n = 110) = 24.40, p = .000, accounting for 20.6% of between-
group variability. It was noted that, in testing "the null hypothesis that the means of all the variables 
across groups are equal" Lambda "provides little information regarding the success ofthe model for 
classifying cases" (The SPSS Base 10.0 Application Guide, 1999, p. 255). This was certainly the case, 
as three-quarters of CD patients (75.5%) were correctly classified, exceeding at a statistically 
significant level the classification accuracy expected by chance. This was determined by using Press's 
Q statistic, calculated using a standard formula1 (Hair et al, 1992, p. 104), with Q = 28.51, where the 
critical value at the .01 significance level = 6.63. 
Closer inspection revealed that, in the larger, non-depressed CD subgroup, 73.3%> of cases were 
correctly classified and, in the depressed subgroup, 83.3%> of cases were grouped correctly. Together, 
the results indicated that that the DFA used demonstrated a reasonable degree of specificity and high 
sensitivity in correctly identifying depression, as assessed by the BDI-H. 
Further examination the standardised canonical discrimination function coefficients shown in 
Table 36 (overleaf) demonstrate that the number of symptoms at diagnosis was most influential in 
discriminating depressed from non-depressed CD patients and that the measure of dietary compliance 
appeared irrelevant. 
1
 Press's 0= FN-(n*K)l2 
N(K-1) 
N = total sample size, n = number of observations correctly classified, K = number of groups (Hair at al, 1992). 
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Table 36 
Discriminant Function Analysis using Four DQ Variables, as Predictors of Depression 
Predictor (independent) Canonical Discrimination Tests of Equality of Group Means 
Variable Function Coefficients Univariate F Sig. 
CD Symptoms 
At Diagnosis 1.07 19.01 .000 
Time Symptomatic 
Pre-Diagnosis -.23 3.58 .061 
Time Since 
Diagnosis .535 3.13 .080 
GFD Compliance 
Measure 1 .125 .81 .310 
The second DFA was identical except that the alternate measure of dietary compliance (i.e., the brief 
questionnaire) was substituted to determine whether either ofthe two key goals of classification, 
specificity and sensitivity to depression, could be improved. This DFA was also significant; % (4, n = 
110) = 27.04, p = .000, accounting for 22.5% ofbetween-group variability and all assumptions ofthe 
analysis were again met. Not surprisingly, the standardised canonical discrimination function 
coefficients were very similar. Overall, the classification rate improved numerically, by two cases, to 
77.3% (from 75.5%), as did the classification accuracy pertaining to he non-depressed group (up to 
76.7%, from 73.3%, an improvement of three cases), but the correctly predicted depressed patients fell 
marginally to 79.2% (from 83.3%, equivalent to one case). Since both dietary compliance measures had 
almost negligible discriminant function coefficients, this DQ was removed from the next analysis. 
It has been previously noted that "often a model with fewer variables is more useful for classifying 
new cases than one with more variables" (The SPSS Base 10.0 Application Guide, 1999, p. 260). In the 
third DFA, three DQ variables (excluding either measure of dietary compliance) and all 110 cases were 
used. This DFA was significant, with %2 (3, n = 110) = 24.18, g = .000, accounted for 20.3%> ofthe 
between-group variability and 74.5% of cases were correctly classified. The best predictor for 
distinguishing between depressed and non-depressed CD patients at study entry was again the number 
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of CD-related symptoms at diagnosis. The three D Q variables used in the final D F A were not only 
successful in grouping about three-quarters of CD patients correctly, but seven out often non-depressed 
CD participants (70.9%) were correctly classified in this DFA (a slight decrease), almost nine out often 
(87.5%) patients who were depressed were identified. This was a very important finding. 
Can the DQ Model Still Discriminate at Lower Thresholds of Depression? 
A fourth DFA was computed, identical in its use ofthe three DQ variables used in the preceding 
DFA, except that the cut score criteria for depression was lowered from > 14 to > 8, which may be 
regarded as a subthreshold or subclinical level of depression. The new subgroup (n = 59), inclusive of 
subthreshold levels of depression, outnumbered the non-depressed group (n = 51). In the final DFA (x2 
(3, n = 110) = 32.91, g = .000, accounting for 26.6%> ofthe between-group variability) the same 74.5% 
overall classification rate was achieved. Press's Q statistic was significant (Q = 26.51, g < .01). The 
correct predicted group membership percentages for non-depressed and depressed patients were 70.6% 
and 78%. These figures demonstrated that a comparable degree of accuracy was maintained via the use 
ofthe sameDQ model at lower, subclinical levels of depression. 
Discussion of Study 1: Key Results 
Study 1 was a cross-sectional analysis of mood, intellectual functioning, health status and quality of 
life in a large CD sample, compared to people with DM, who served as a chronic illness comparison 
group, and a sample of healthy people without a significant chronic medical condition. The comparison 
groups were gender balanced and closely matched to the CD group socio-demographically, in regard to 
age, years of education, SES, general intelligence, occupational status and urban versus rural habitation. 
Each group was principally of Anglo-Celtic ethnicity. Participants recruited to the CD group primarily 
included Coeliac Society members (all with biopsy-confirmed CD using ESPHAGN criteria) who 
volunteered on the basis of successive magazine advertisements and interest generated at local 
conference proceedings. Several consequent idiosyncrasies were observed in the CD and matched 
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samples. Notably, age, SES and general intelligence were each slightly above general community levels, 
notwithstanding considerable ranges. A relatively high degree of compliance with the GFD was also 
noted among CD participants. 
In other respects, the CD sample developed over two years was decidedly heterogenous, which was 
a primary goal. The CD group's heterogeneity enabled arbitrary partitioning ofthe full CD group on the 
basis ofthe number of CD-related symptoms at diagnosis, with separation into multisymptomatic and 
oligosymptomatic subgroups undertaken prior to many ofthe statistical procedures. This subdivision 
hinged on the assumption that CD patients with few, if any, symptoms of illness may be indistin-
guishable from a self-perceived health perspective and other respects from the NC group, and potential 
between-group differences using the full CD group may be masked or weakened by the presence of 
oligosymptomatic patients. This supposition seemed justified, given that in many analyses of variance 
using the three groups and test scores as dependent variables, significant between-group differences 
were only found after the oligosymptomatic CD cases were omitted. Further evidence was supplied by 
the DFA results, in which the number of symptoms at diagnosis was the most important predictor 
variable in discriminating depressed from non-depressed patients at study enrolment. 
Two thirds ofthe DM sample had type-1 diabetes, with the remaining third classified as early-
middle stage type-2 patients on the basis of previous general practitioner confirmed medical diagnoses 
of DM prior to study entry and status reviews, based on self-reported, up-to-date medical information at 
study entry in the context of current diagnostic criteria (Masharani & Karam, 2002). Overall, the DM 
participants were generally compliant with their medical treatment regimes, euglycaemic prior to study 
entry and free from debilitating diabetic complications. The choice of a suitable chronic illness 
comparison group was made on the basis of shared similarities with key features of CD and approximate 
equivalence regarding severity of disease. 
Most ofthe hypotheses about psychological functioning in CD were contingent on expectations of 
differences with healthy people - who provided a baseline against which to evaluate changes in CD -
but not necessarily in relation to patients with DM, who served as a yardstick in evaluating the strength 
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of any identified changes, over and above the affects of having a serious, but treatable, chronic illness, 
and in identifying any changes unique to the coeliac condition. The three groups were assessed across 
three primary domains of psychological functioning, namely clinical symptomatology (mood, anxiety 
and anger), life quality and neuropsychological aptitude. 
Cognition: Neuropsychological Performance 
The hypothesis that general intellectual ability would not be significantly different across groups 
was confirmed, supporting previous findings (De Maria et al, 1997; Hallert & Astrom, 1983). However, 
the most salient result of Study 1 was the identification of a modest, but consistent, neuropsychological 
test performance pattern. This was evident in both DM and CD patients, but, in several respects, 
statistically different to healthy controls only in the CD group. 
Fortuitously close and chiefly incidental matching in general intelligence permitted the direct 
comparison of WAIS-III Index profiles across groups, in addition to the Wechsler scale's well-
elaborated test norms. During early data collection a trend was observed in the CD group indicative of 
relative decrements in performance on subtests in the Working Memory (WM) and Processing Speed 
(PS) Indexes, compared to normative expectations after test scores were standardised, as previously 
reported (Grech et al, 2000). This tendency was sustained throughout data collection, with sixty-four 
out of one-hundred and eight CD participants (i.e., 59%, compared to 43.1% of DM and 25.8% of NC 
participants) having a discrepancy in Index performance consisting of their PO Index score significantly 
exceeding their PS Index score in the Performance Scale. The converse (PS > PO) was true in only four 
CD cases (i.e., 3.7% ofthe CD group). 
Similarly, the WM Index score was lower than the VC Index score in 53.7% of CD participants 
(compared to 49.0% of DM and 22.6% of NC participants), with the opposite occurring in only 13% of 
CD patients. This result provided evidence in support of Pavone et al. (1997). Conversely, though, in 
relation to those authors' findings of impaired visual discrimination, especially in patients non-
compliant with the GFD, the CD performance in Perceptual Organisation was certainly not inferior to 
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that of N C or D M patients in the present study. Furthermore, no evidence was found that dietary 
compliance significantly affected overall intellectual functioning or specific Index performance. 
Comparable lack of diminution in the PO Index in DM compared to NCs was also consistent with 
previous DM research (Ryan & Geckle, 2000). 
Deficits in the CD group, compared to NC but not DM patients, in the areas of WM and PS, 
as highlighted by the proportions of CD patients with VC-WM and PO-PS discrepancies, were not 
predicted. This outcome was also more prominent than could be expected on the basis of Pavone 
et al's (1997) suggestive, but inconclusive, findings. 
Advantages ofthe present study were use of a sensitive, reliable, and well-standardised cognitive 
assessment measure and the generation of large sample sizes, each defining aspects which permitted 
elaboration ofthe distinct neuropsychological profile which emerged. With a much smaller sample 
size of less than about twenty cases per group (which characterises almost all other studies in this area), 
simulated testing using random samples of cases drawn from the present study's full participant pool 
showed that the mean aforesaid WM/ PS differences lost statistical significance at the .05 level, 
even assuming homogeneity of variance and similarly sized comparison groups. In less ideal control 
conditions, upwards of thirty cases would be required to elicit statistical significance, based on trial ling 
incremental analyses using arbitrarily sized samples comprised of real, randomly selected test results. 
Initially, it seemed conceivable that elevations in the level of depression and/ or state anxiety, as 
observed in the CD group, and which may be associated with psychomotor slowing, distractibility and 
reduced output under time pressure (Kaufman, 1990), may have influenced the observed WM and PS 
results. However, when BDI-II depression and STAI state anxiety scores were made covariates in 
analyses of variance, between-group significance remained in relation to the WM/ PS differences, with 
only a slight diminution of F values. Corresponding relative differences in WM and PS between the CD 
and NC groups were only fractionally reduced. Using a range of other covariates (e.g., quality of life) 
also resulted in small F value decrements and marginal changes in the relative WM and PS means, but 
in every case the between-group statistical significance was unchanged. 
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The PS Index result was accentuated in male, compared to female C D patients. This result was in 
agreement with others' general observations of neurological impairment in both CD (e.g., Ciclitira, 
2001) and temporal lobe epilepsy (Briellmann, Berkovic, & Jackson, 2000). Frodl et al. (2002) found 
that hippocampal changes in patients with a first episode of major depression were "more pronounced in 
male patients" (p. 1112), further noting that "a substantial number of brain disease seem to affect male 
patients more severely than female patients" (p. 1115). Explanations of these gender differences include 
the finding that "estrogen protects while testosterone exacerbates" neurotoxic processes (Nishino et al, 
1998, p. 303). 
These distinctive patterns of performance were also evident in DM patients, although not to quite the 
same degree. The WM and PS results translated into lowered mean scores in those indexes in both CD 
and DM compared to healthy controls but, while the CD-NC result was unequivocal (g < .000), the DM-
NC result was statistically marginal. In broad terms, the DM performance was approximately mid-way 
between the CD and NC scores. The hypothesis that the DM group would perform at a significantly 
lower level than the NC but not the CD group in the WM Index was confirmed. 
Although the results pertaining to WM may have neurological underpinnings related to a subtle 
degradation in hippocampal structure in DM (Hershey et al, 1997), connecting the neuropsychological 
findings of reduced immediate memory and psychomotor slowing in CD to brain structure is neither 
straightforward, nor justified on the basis of what is presently known. Unlike in DM, cerebral atrophy, 
where found in CD, has been more diffuse (Gobbi et al, 1998), although generalised, mild damage to 
multiple sites has been implicated in psychomotor slowing in a number of other disease processes (Kolb 
& Whishaw, 1990; Lezac, 1983). Furthermore, the Digit-Symbol subtest ofthe WAIS-HI, on which the 
CD patients performed especially poorly, is sensitive to mild, generalized deficits (Crowe et al, 1999). 
More research is needed in this area. 
As noted, a plausible alternative explanation for the pattern of neuropsychological results observed 
in the CD and DM, compared to the NC group, was that higher levels of depression or anxiety, each 
known to be related to psychomotor slowing, distractibility and reduced output undertime pressure 
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(Kaufman, 1990), may have caused or contributed to the observed W M and PS results. However, given 
that a significant difference in performance between the CD and NC groups remained after the minimal 
effect of depression was controlled, alternative explanations must be sought to determine the cause of 
these subtle, but consistent, neuropsychological changes, which, at least statistically, impinged on about 
half of the CD sample to at least a mild degree. It may be premature to speculate on the clinical 
significance of these findings until such time as they are replicated by others, but for a significant 
minority ofthe CD sample, the gap between general intellept and WM or PS (or both) was large by any 
criteria. This result was reflected in anecdotal observations of a somewhat increased frequency of 
apprehension or general concern expressed to the author about cognitive performance in relation to 
memorial functioning by CD and DM patients during testing compared to NC participants. 
Affective Functioning: Depressive Symptomatology, Anxiety and Anger 
The general hypothesis that levels of depression would be higher in CD patients than in people 
without a chronic illness received qualified support. Across the full CD sample, mean BDI-II depression 
was not significantly different to healthy participants or people with DM. However, the level of 
depressive symptomatology was higher in the multisymptomatic CD subgroup than in the NC group. 
The related hypothesis that depression would be higher in CD patients who were multisymptomatic, 
compared to oligosymptomatic at diagnosis, was also confirmed. An even finer-grained analysis, after 
further subdivision ofthe CD sample, showed that about half of the CD participants who were severely 
symptomatic at diagnosis (> 3 symptoms) were clinically depressed using BDI-n cut criteria at study 
entry. In around one in five of this highly symptomatic subgroup the level of depression was moderate 
to severe in intensity. 
In contrast to the reports of others (Holmes, 1997; Nielsen et al, 1985; Pellergrino, 1995), symptoms 
of suicidal ideation or behaviour were not prominent features ofthe CD or comparison participants in 
the elevated ranges of depression who participated in Study 1. During participant recruitment, however, 
the author was contacted by three people displaying varying degrees of suicidality. One person was a 
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young man without any chronic physical illnesses, w h o reported a very recent suicide attempt by 
hanging, but had not come to the attention of a general practitioner or mental health care professional. 
He received immediate - and ongoing - counselling and was not included in the healthy comparison 
group, due to more immediate, serious concerns for his personal safety. 
The other two people referred to above were CD patients. They consisted of a middle-aged woman 
with longstanding health problems - possibly CD-related - who was included in Study 1, and a young 
man who had been diagnosed with CD within days of contacting the author. This man was asleep at the 
time of his initial meeting regarding study participation and it was not possible to reschedule an 
appointment. The author was later contacted by his housemate, who had driven the young man to 
hospital several days later following a disclosure of suicidal intent and detailed plans. Follow-up, 
involving psychiatric outpatient care arranged at the hospital and provision of information from the 
Coeliac Society by the author, was implemented, but this man was not subsequently contactable. 
Although each ofthe three cases involve isolated examples of apparently severe depression in CD, 
the final case is notable in that the CD statistics pertaining to Study 1 do not include his information, as 
he was unable or uninclined to participate, with his immediate health obviously of paramount concern. 
However, he is by no means the first example to come to the author's direct attention of troubled young 
men with CD who fail to avail themselves to support mechanisms such as the Coeliac Society. It is the 
author's belief that single men, in particular, are over-representative of people with CD who fail to 
undertake or maintain treatment with the GFD, let alone commit themselves to medical follow-up. Their 
subsequent invisibility may also lead to underestimates of psychological difficulties amongst males with 
CD, with their problems less discernible given increased female representation in diagnoses of both 
mood disorders and CD. 
The hypothesis that there would be no difference in the prevalence of Cognitive versus Somatic/ 
Affective depression within the CD group, or compared to either comparison group, was rejected. It was 
instead found that the increase in depression in the multisymptomatic CD subgroup was due to an 
increase in the Somatic/ Affective, as opposed to the Cognitive dimension, of self-reported depression. 
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This result contrasted with other suggestions (Ciacci et al, 1998), but was in partial support of a 
previous study's findings of increased subjective depression (Dl), psychomotor retardation (D2) and 
Physical Malfunctioning (D3) in the elevation of Scale 2 on the MMPI, using the Harris subscales 
(Hallert & Astrom, 1982). 
The present study's finding of an increased level of somatic rather than cognitive symptoms of 
depression in those affected and an escalating proportion of depressed patients among those increasingly 
affected by CD-related symptoms, may help to explain moderate variation in the reported prevalence of 
depression in groups of CD patients worldwide, over and above the impact of idiosyncratic differences 
in the choice of measures and local protocols used in data collection. Carefully defining background 
parameters of CD-related symptomatology and correlates of general health is especially important in CD 
research given the protean clinical picture and possible diffusion ofthe significance or strength of future 
results owing, inevitably, to greater inclusion of minimal-symptomatic cases corresponding to the 
CD iceberg floating higher in the water. A potential danger is that patients whose health and well-being 
is complicated by genuine depressive processes - related to CD or otherwise - may not receive 
specialised clinical attention commensurate with the intensity, chronicity or specificity of mental health 
difficulties. 
Anxiety levels were higher in multisymptomatic, compared to oligosymptomatic, CD patients, as 
well as NC participants, but neither state nor trait anxiety was higher in the full CD group, compared to 
NCs. Support for the hypothesis that state, but not trait, anxiety would be greater in the CD group was 
provided by the observation of an increase in state anxiety in the multisymptomatic CD group compared 
to NCs, which held after gender partitioning. This result differed somewhat from Addolorato et al's 
(2001) findings of normalised state anxiety following one year's GFD intervention, although a 
comparison of mean STAI scores (not provided by Addolorato et al.) between the two studies would be 
useful. However, the present thesis' sample of CD patients was more heterogenous regarding time since 
diagnosis, so direct comparisons with Addolorato et al's longitudinal group may be limited by cross-
study variations in the duration of illness. 
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State, but not trait, anger was also higher in the multisymptomatic C D subgroup in the present thesis 
compared to the NC group. Considered together, the findings of elevated state, as distinct from trait, 
anxiety and anger in the multisymptomatic CD subgroup, support Gasbarrini and Addolorato's (1997) 
suggestion that differences in affective functioning in CD may be attributed to reactive processes, rather 
than personality traits. 
Health Status and Quality of Life 
No difference in overall QOL was found between groups. Conforming to a familiar pattern, though, 
QOL was significantly lower in the multisymptomatic CD group compared to NCs. Furthermore, the 
oligosymptomatic CD subgroup reported significantly higher QOL than the DM group, but not the NC 
group. A significant difference also occurred across groups occurred in Leisure/ Recreation Activity, 
with both the mean CD and DM group scores significantly lower than the NC group score. Further 
inspection ofthe subdomain sub-scores comprising this major domain revealed a significant effect 
across groups, with the NC group significantly more involved in Sports Activity than both the CD and 
DM groups. Given the utility of regular, vigorous and/ or weight bearing physical activity in the treating 
both depression and osteoporosis, each major concerns in CD, it would seem prudent to encourage 
inactive CD patients to participate in sport or exercise suitable to their needs, preferences and capacity. 
In the consideration of other subdomain score differences, CD participants reported significantly 
better Parent/ Child Relations than DM patients. There were no significant male-female differences 
within any ofthe three groups, except for Sports Activity in the CD group, in which males reported 
significantly more involvement, activity and interest than females. 
The percentage of participants reporting average to high QOL was equivalent across groups, yet 
more than twice as many CD and DM participants reported low QOL than NC participants. There was a 
threefold increase in low QOL in the multisymptomatic CD subgroup, compared to the NC group. These 
results were similar to the aforementioned depression results, in which there were no mean score 
differences across groups unless the multisymptomatic CD subgroup was isolated. The hypotheses that a 
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major domain of Q O L , General Well-Being, and a sub-domain, Physical Well-Being, would be 
decreased in CD, compared to the NC group, was not supported. 
In results paralleling the QOL findings, retrospectively self-reported health status was reduced in the 
multisymptomatic CD subgroup, compared to the NC group, as hypothesised. Across the full CD 
sample, health status was markedly lower prior to diagnosis in relation to each comparison group. 
Unlike participants with DM, whose self-rated health status declined slightly pre- to post-diagnosis, a 
significant increase in subjective health status was reported in the CD group following diagnosis. 
Nevertheless, the multisymptomatic subgroup still rated their health status following diagnosis (i.e., at 
study enrolment) as below healthy control levels. Upon gender partitioning, statistical significance only 
held for females, supporting Hallert et al's (2002) findings. The lack of perceived health improvement 
in the chronic illness comparison group pre- to post-diagnosis was attributed to the almost inevitable, 
eventual deterioration of health associated with DM, as distinct from CD, in which a remission of health 
problems is typically observed following consistent adherence to the GFD. 
CD Awareness, GFD Compliance and Health Locus of Control 
The hypothesis that increased CD awareness and knowledge in CD patients would be positively 
correlated with greater compliance with the GFD was confirmed, but the scores on the awareness 
screen developed by the author were not meaningfully associated with depression or self-reported 
QOL. Ciacci et al. (1998) observed a trend towards an inverse correlation between depression and 
their patients' level of knowledge about CD, prompting those authors to reasonably propose that 
"depressive symptoms may prevent patients from reaching a high level of knowledge ofthe disease 
or, conversely, that a good level of knowledge about the disease could play a role in reducing the 
depression level" (p. 249-250). The present study's results do not discount Ciacci et al's hypothesis, 
since a proportion of highly depressed CD patients may have an unusually in-depth awareness of 
their illness, or vice versa, a result which, if superimposed upon the result corresponding to Ciacci et 
al's hypothesis, would tend to cancel any correlation between CD awareness/ knowledge and 
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depression across the full C D group. 
A possible mix of inter-relationships such as these, which may underpin both direct and circuitous 
associations between variables, could help to explain the lack of association - overall - between GFD 
compliance and several variables of interest in the present study. As well as pointing to complex 
relationships, the lack of correlation between dietary adherence and other key indices also highlights the 
reality of individual variation and fluctuations in attitudinal beliefs at different stages of CD. 
There were no differences between the mean MHLOC sub-scores across any ofthe three groups or in 
relation to normative data published by Wallston, Wallston and DeVellis (1978). As hypothesised, 
Internal MHLOC was negatively correlated with BDI-II depression in the CD, DM and NC groups and 
positively associated with health status since diagnosis and quality of life, but not GFD compliance The 
hypothesis that Internal MHLC would be lower and Chance MHLC higher in CD and DM patients, 
compared to NC participants, was not confirmed. 
Depression Prediction Using Discriminant Analysis 
Using equally weighted static and dynamic diagnostic, dietary and temporal correlates as predictor 
variables, DFA was undertaken to determine if a combination of readily available or obtainable clinical 
information was useful in forecasting depression in CD. This process correctly predicted group member-
ship of three in four CD participants, each classified beforehand as either non-depressed or above the 
minimum cut score denoting BDI-H depression at study entry. The same result was replicated at sub-
threshold levels of depression. 
Of major clinical relevance was the high sensitivity and reasonable specificity of this straightforward 
procedure. Seven out often non-depressed CD participants were correctly classified, with identification 
of more than eight out often CD patients who were depressed at study enrolment. Basic clinical 
information, obtainable without difficulty, was utilised. False positives - comprising just under one third 
of those assessed as not depressed at study entry - could be screened via psychometric assessment or 
clinical interviewing and need not pose a serious problem in the use of this system. Therefore, this 
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accurate, brief, cost-effective procedure, used to identify C D patients most likely to experience clinical 
depression post-diagnosis, would appear to have significant practical utility as an adjunct in mental 
health intervention considerations in CD patient care. 
In the next chapter, a subset of one-quarter ofthe cross-sectional CD group - who were newly 
diagnosed at entry into Study 1 (i.e., at Ti) - are tracked and re-assessed one year later (at T2), in order 
to evaluate the nature of changes in psychological functioning, including depression, intellectual ability 
and QOL over time in response to the GFD. 
Chapter 5 — Study 2: Longitudinal One-Year Follow-Up 
A major goal ofthe thesis was to re-evaluate any newly diagnosed CD participants, willing to 
continue their involvement beyond the cross-sectional study (i.e., at Ti) one year later (T2), using the 
full assessment protocol. The purpose of re-assessment was to determine if any ofthe major domains of 
psychological functioning that were the subject ofthe thesis changed over time (from Ti to T2) in 
people with CD, whether in response to GFD treatment, or as a result of other factors, such as changes 
in mood state. 
It was conceded from the outset of data collection in Study 1 that any changes in functioning 
detected at T2 in newly diagnosed CD participants already on the GFD at Tj would not be able to be 
attributed to the GFD alone, regardless ofthe degree of detail kept regarding dietary compliance, 
Furthermore, it was evident that the capacity to ascribe any observed changes to the GFD would 
proportionately diminish in relation to the elapsed period of treatment with the GFD at Tt. In view of 
the further anticipated difficulty of capturing CD participants yet to begin the GFD at Ti within the 
limitations ofthe planned recruitment protocol and period of data collection, a large window was 
initially maintained regarding suitability for inclusion in Study 2 in reference to time elapsed since CD 
diagnosis and beginning the GFD. This period was subsequently set at nine weeks or less, in response 
to balancing the needs of an early capture of newly diagnosed CD participants in Study 1 with the 
practical requirement of developing a longitudinal cohort of sufficient size. 
Hypotheses 
Ten primary hypotheses, pertaining to the longitudinal cohort regarding psychological functioning 
one year post-diagnosis and GFD implementation, were made on the basis of limited previous 
longitudinal research, principally four key studies discussed in Chapter 2 (Addolorato et al, 2001; 
Hallert & Astrom, 1982; Hallert, Astrom, & Walan, 1983; and Lohiniemi et al 1998). The major 
hypotheses were: 
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1. Levels of depression, as measured by the BDI-H, would not change significantly within the 
CD group between Ti to T2 in the absence of any specific interventions other than the GFD. 
2. State, but not trait anxiety, on the STAI, would decrease significantly within the CD group 
between Ti and T2 in response to compliance with the GFD. 
3. State, but not trait anger, on the STAXI, would decrease significantly within the CD group 
between Ti and T2 in response to compliance with the GFD (an exploratory hypothesis, as 
no prior research was available). 
The preceding hypothesis was made on the basis of overlap between the constructs of anger, 
anxiety and depression, as well as anecdotal reports of irritability reported in the early stages of CD at or 
immediately following diagnosis. The expectation was that the level of several measures of mood state, 
as opposed to traits, would change across several domains. The Profile of Mood States (McNair, Lorr, & 
Droppleman, 1971; described on pp. 218-220 of this chapter) was used to assess specific dimensions of 
mood state, namely Tension-Anxiety, Depression-Dejection, Anger-Hostility, Vigor-Activity, Fatigue-
Inertia and Confusion-Bewilderment. It was hypothesised that: 
4. Tension-Anxiety, Anger-Hostility, Fatigue-Inertia and Confusion-Bewilderment would 
decrease significantly within the CD group between Ti and T2 in response to compliance 
with the GFD. 
5. Vigor-Activity would significantly increase within the CD group between Ti and T2 in 
response to compliance with the GFD. 
6
 Depression-Dejection would not change within the CD group between Ti and T2 in the 
absence of any specific interventions other than the GFD. 
Collin et al (1997) concluded their investigation of dementia and CD with a call for a "cross-
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sectional study ofthe intellectual ability of new and earlier diagnosed C D patients" (p. 288), an 
exercise undertaken in Study 1. Those authors further noted that "the impact ofthe gluten-free diet 
on intellectual ability must be evaluated" (Gobbi et al, 1997, p. 288). In order to monitor retesting 
effects in the Wechsler Adult Intelligence Scale (at T2, compared to Ti) the re-assessment of a 
demographically matched subgroup of healthy controls (drawn from Study 1) was also planned. 
Although comprehensive reviews were available regarding test-retest findings using previous 
Wechsler scales (e.g., Matarazzaro, Carmody, & Jacobs, 1980; Shatz, 1981) and findings pertaining 
to 1-year intervals using previous versions (e.g., Sirois et al, 2002) and other measures of cognition 
(e.g., Ivnik et al, 1999), there were no studies available regarding one-year follow-up testing using the 
Wechsler Adult Intelligence Scale - Third Edition. The possibility of a small increase in IQ due to a 
practice effect, especially in the Performance Scale, was anticipated on the basis of previous research, 
Therefore, a small group of NC participants was also re-assessed to monitor the magnitude of any 
changes due to a practice effect. Given the stability ofthe construct of global intelligence it was 
hypothesised that: 
7. General intelligence, as measured by the WAIS-HI, would not change significantly within 
the CD group between Tito T2 regardless of compliance with the GFD, over and above a 
practice effect, if the latter occurred. 
8. Mean WAIS-IH Index scores would not change, in absolute or relative terms, within the CD 
group between Ti and T2. 
On the basis of Lohiniemi et al's (1998) findings regarding quality of life, and the author's 
observations of retrospectively reported changes in perceived health status, it was hypothesised that: 
9. Health status would increase within the CD group in response to compliance with the GFD. 
10- Total QOL would increase in response to compliance with the GFD. 
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Method 
Selection of Newly Diagnosed CD Participants from Cross-Sectional Pool 
Twenty-seven people (14 females, 13 males), who had been diagnosed with CD within nine weeks 
of enrolment in Study 1 (i.e., first time point: Ti), were selected for assessment at 12 month follow-up 
(second time point: T2). These relatively newly diagnosed patients formed the longitudinal CD (LCD) 
group, who were the focus of Study 2. Although a much shorter duration than nine weeks between CD 
diagnosis and initial assessment at Ti was preferable, this generous arbitrary cut-off was established 
with the practical consideration of generating an adequate longitudinal sample size, given that very few 
ofthe first fifty CD participants enrolled cross-sectionally had been diagnosed with CD within a few 
weeks of Study 1 entry (Ti). Another consideration was the number of Ti entrants willing and available 
to be re-assessed. 
The proactive recruitment of very newly diagnosed CD participants from mid-2000 was facilitated 
by immediate identification of new member applications via the Victorian Coeliac Society. This 
process continued until March, 2001 (final Ti study entrant). From September 2000, the cut-off point of 
nine weeks since diagnosis at Ti had been determined to be inclusive of sufficient CD participants 
already seen and permitted the development ofthe eventual longitudinal group of twenty-seven, with 
the addition of an increasingly greater proportion of newly diagnosed CD participants to the cross-
sectional pool, from which the LCD patients were chosen. 
Newly Diagnosed CD Group: Demographic Characteristics 
For the 13 males and 14 females comprising the longitudinal group, the mean age was 39.0 years 
(SD = 16.7; range 16-84), only two years younger, on average, than that ofthe full CD sample and not 
significantly different according to independent samples t-test at .05 level. Longitudinally tracked 
females (mean age of 34.4; SD = 12.6; range 18-56) were somewhat younger than their male 
counterparts (42.5; SD = 19.6), although not significantly so (t = 1.28, g > .05). Mean years of 
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education for the longitudinal group was 12.3 (SD = 2.4), equivalent to the full C D sample. Females 
in the L C D group had, on average, completed an extra year and a half of formal education (13.1 year: 
SD = 2.7) than L C D males (11.5; S D = 1.9), but this was not a significant difference. As noted in the 
previous chapter, the seventh year of education corresponds to the first year of high school, 12 = the 
last year of high school and 15 = completion of an undergraduate degree at university. 
The extent of matching across all demographic variables within the L C D group by sex and in 
comparison to the full C D sample was entirely incidental, the overriding consideration being to 
maximize the L C D sample size via recruitment of newly diagnosed C D participants. Nevertheless, 
the original consideration given to matching the cross-sectional group, which spawned the L C D 
subgroup, conferred sex-wise equivalence to the latter subgroup across all demographic variables 
apart from the minor differences in age and years of education. These are summarized in Table 37, 
with general intelligence (full-scale W A I S IQ) and body mass index (BMI) at the time of initial 
inclusion in the study (Ti). 
Table 37 
Demographic Characteristics (Means/ SDs) at Tj of Newly Diagnosed CD group (n = 27), the 
Remaining CD participants (n = 831) and Full CD sample (n = 110) 
TiCD Other C D at Ti Full Sample at Ti 
Demographic (n = 27) (n = 831) (n=110) 
Age (Yrs/SD) 
Male 
Female 
Gender (Male - Female) 
Education (Yrs/SD) 
38.3 (16.6) 
42.5 (19.6) 
34.4 (12.6) 
13 - 14 
12.3 (2.5) 
41.9(13.5) 
42.5 (13.7) 
41.6(13.4) 
31 - 52 
12.7 (2.5) 
41.0(14.3) 
42.5 (15.4) 
40.1(13.5) 
44 - 66 
12.6 (2.4) 
Male 11.5(1.9) 12.7(2.6) 12.3(2.5) 
Female 13.1(2.7) 12.6(2.4) 12.7(2.4) 
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Table 37 (Cont.) 
TiCD Other C D at Ti Full Sample at T, 
Demographic 
SES: Low-Med-High (%) 
Male 
Female 
WAIS-IQ (full scale/ SD) 
Male 
Female 
BMI (in kg/ m2/ SD) 
Male 
Female 
(a = 27) 
15-63-22 
15-62-23 
15-64-21 
108.1(15.5) 
107.0 (14.6) 
109.1 (16.8) 
22.1 (3.3) 
22.1 (1.6) 
22.0 (4.3) 
(n = 831) 
10-58-33 
13-55-32 
8-60-33 
113.6(12.2) 
115.4(12.1) 
112.5(12.1) 
24.0(3.6) 
24.4(3.2) 
23.8(3.9) 
(n=110) 
11-59-30 
14-57-30 
9-61-30 
112.2(13.2) 
112.8(13.3) 
111.8(13.2) 
23.5(3.6) 
23.7(3.0) 
23.4 (4.0) 
1
 Includes female participant diagnosed with C D 8 weeks prior to being initially seen (T,) who had 
moved interstate at time of follow-up 12 months later (T2) and could not be contacted 
All except one participant in the newly diagnosed group were urban dwellers, residing in 
metropolitan Melbourne or - in two cases - in the city of Geelong. The socioeconomic status (SES) 
ofthe C D subgroup longitudinally tracked was comparable to the full C D sample from which it was 
drawn, with four participants (2 M ; 2 F) classed as low, seventeen as middle (8 M ; 9 F) and six of 
high SES (3 M ; 3 F). In addition to almost identical matching for SES by sex, fortuitously close 
correspondence was observed regarding general intelligence, with newly diagnosed males equivalent 
to new females (mean male WAIS-IQ being 107.0, S D = 14.6, versus 109.1, S D = 16.8 for females). 
The mean number of days since C D diagnosis at Ti was 31.3 (SD = 23.2), with six participants 
having been diagnosed with C D for a week or less, another three between 8-14 days and a further five 
between 15-30 days. The remaining participants included in the longitudinal study had been diagnosed 
with C D between 31-63 days inclusive when initially interviewed and assessed, as shown in Table 38. 
Psychological Sequelae of C D 213 
Table 38 
Number of Days Since CD Diagnosis for LCD Group at Tj: Number and Percentage of Group 
N 
% 
3 days or Less 
3 
11.1% 
Days since Diagnosis with C D 
4-7 Days Inclusive 
3 
11.1% 
8-14 Days Inc. 15-30 days Inc. 
3 5 
11.1% 18.5% 
31-63 Days 
13 
48% 
These newly diagnosed C D participants (designated "TiCD" at time of first assessment and distinct 
from the full CD group at Ti) represented about one quarter ofthe full CD sample. They were re-
assessed using all test measures and interview procedures within 11-13 months of initial assessment 
(at that point designated "T2CD", denoting 2nd time assessed). 
The greatest deviation from 12 month follow-up was a participant seen 12 months and three weeks 
after his first assessment, due to difficulties contacting him and scheduling a follow-up appointment. 
All other participants were re-interviewed and re-assessed within a fortnight of exactly 12 months later 
Two participants pre-selected as longitudinal study inclusions, having been diagnosed with CD 
within nine weeks of being first seen, were not re-assessed. One woman diagnosed for two weeks at T 
contacted the author three weeks later, informing that she had subsequently been diagnosed with 
diabetes mellitus, in addition to CD. She was removed from the CD sample and her results deleted from 
the database, being excluded from all analyses in Study 1. 
Another female participant who had been diagnosed with CD eight weeks after being first seen by 
the author had moved interstate within Australia during the subsequent 12 month period. She was 
unable to be contacted and could therefore not be included in the follow-up study. 
All TiCD participants received a definitive, biopsy-confirmed diagnosis of CD - 93% prior 
to initial recruitment into study - according to European Society for Pediatric Gastroenterology, 
Hepatology, and Nutrition (ESPGHAN) criteria (1990), based on clinical, immunological and 
bioptical features, as outlined in Study 1. In the case of two TiCD participants, diagnostic confirmation 
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occurred within several days of study involvement, with prior serological testing having being highly 
suggestive of CD at the point these participants were initially assessed. 
Histologic normalisation or improvement on the GFD was proven within eight months of dietary 
intervention in all TiCD cases included in data analysis, although clinical improvement was unable to 
be accurately gauged in two people who were asymptomatic at diagnosis. All TiCD participants were 
also re-interviewed at 12-month follow-up regarding their response to the GFD and any miscellaneous 
diagnostic developments. In summary, all TiCD participants selected for follow-up and included in 
statistical analysis remained medically confirmed CD patients at T2. 
A breakdown ofthe number of CD symptoms at diagnosis and pre-diagnosis symptomatic duration 
in the TiCD subgroup, compared to the both the remaining CD participants in the full CD sample and 
the total sample, are shown in Table 39. 
Table 39 
Number and Duration of Symptoms at CD Diagnosis (as recalled at Tj) of Newly Diagnosed CD 
Group Who Were Followed Up (n~ 27), the Remaining CD Participants (n = 83) and Full CD 
Sample (n = 110) 
Symptom number at diagnosis 
# Cases in each category 
nil (= Asymptomatic) 
1 (=Mild) 
2-3 (= Moderate) 
4 (= Severe) 
Symptomatic Duration 
(Months/SD) 
TiCD 
(n = 27) 
!; 
1(1M) 
9 (6 M, 3 F) 
8 (3 M, 5 F) 
9 (3 M, 6 F) 
66.4 (79.7) 
Other C D at Ti 
(n = 83) 
5 (4 M, 1 F) 
22(11M, 11 F) 
27 (7 M, 20 F) 
29 (9 M, 20 F) 
52.1 (78.2) 
Full Sample at Ti 
(n=110) 
6 (5 M, 1 F) 
31 (17 M, 16 F) 
35 (10 M, 25 F) 
38 (12 M, 26 F) 
55.6 (78.4) 
Male 69.2(98.4) 43.0(82.7) 50.7(87.3) 
Female 63.9(61.3) 57.6(75.6) 58.9(72.4) 
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Although symptomatic duration in the T i C D subgroup was not remarkably different from the full 
CD sample, the proportion of asymptomatic cases was smaller. The author's explanation of this 
difference was based on a simple, anecdotal observation noted during recruitment. Rather than 
representing any trend related to contemporary or local CD diagnosis practices, the newly diagnosed 
CD participants directly invited to participate in the study who actually agreed to involvement were 
more likely to believe their participation may be personally valuable if they had endured more CD-
related symptoms prior to diagnosis. Volunteers at the Victorian Coeliac Society and the author 
himself observed that people recently diagnosed who were asymptomatic typically perceived there to 
be less value, including personal benefit, in study participation and generally declined involvement 
All TiCD participants were re-screened for head injury or neurological impairment and any new 
medical conditions emerging in the preceding year that may have contributed to neuropsychological 
impairment or the development of severe psychiatric disorders. None ofthe TiCD participants were 
excluded on the basis of these criteria. 
Two CD participants in the longitudinal group were using psychoactive medication at both Ti 
and T2. One male in the longitudinal group had been undergoing long-term treatment for bipolar 
disorder and was of stabilized mood at Study 1 entry (Ti). His medication regime had changed four 
months prior to follow-up (antidepressant medication discontinued; replaced with Epilim, also known 
generically as sodium valproate). A female LCD participant had been prescribed with benzodiazepine 
medication to assist sleep at initial assessment (Ti) but reported reduced dosage and intermittent use at 
T2. Two other TiCD participants had reported previous use of psychotropic medication at initial 
assessment, but did not report any use in the year preceding follow-up. 
The author re-assessed all TiCD participants between July 2000 and March 2002. Throughout 
this chapter, the group of 27 people with CD who were subsequently re-assessed are referred to as 
either the LCD group, or as "TiCD" participants when the time point is initial study entry (i.e., first 
assessment) and "T2CD" participants when the time point is one year later. 
Psychological Sequelae of CD 216 
Healthy Control Participants 
Ten healthy control participants were re-interviewed and re-assessed with the BDI-H, the WAIS-III 
and Q O L Questionnaire within 11-13 months of initial participation in the study. These normal controls 
followed up (TiNC participants) were selected from the full sample of 69 healthy volunteers without a 
chronic illness to match the TiCD participants as closely as possible across key demographic factors, as 
displayed in Table 40, 
Table 40 
Demographic Characteristics (Means, SDs & Ranges) at Tj of Healthy Controls Followed 
Longitudinally (n = 10), Compared with Newly Diagnosed CD Group (n = 27) 
Gender (Male - Female) 
Age (Yrs/SD) 
Male 
Female 
Education (Yrs/ SD) 
Male 
Female 
SES: Low-High (# cases) 
(Male, Female) 
WAIS-IQ (full scale/SD) 
Male 
Female 
BM[kg/m2]/SD 
Male 
Female 
TiNC 
(n=10) 
4 M - 6F 
39.2 (21.9); Range 18-82 
37.3 (14.2); Range 23-55 
40.5 (27.1); Range 18-82 
11.9 (2.8); Range 7-15 
12.3 (2.1); Range 10-15 
11.7 (3.4); Range 7-15 
L=2; Med.= 6; High=2 
(2F); (3M, 3F); (IM, IF) 
109.5 (11.0); Range 86-125 
112.3 (5.7); Range 104-116 
107.7 (13.8); Range 86-125 
22.7 (2.9); Range 17.7-26.0 
24.5 (1.2); Range 23.2-26.0 
21.5 (3.2); Range 17.7-25.5 
TiCD 
(n = 27) 
13 M - 14 F 
38.3 (16.6); Range 16-84 
42.5 (19.6); Range 16-84 
34.4 (12.6); Range 18-56 
12.3 (2.5); Range 9-18 
11.5 (1.9); Range 9-16 
13.1 (2.7); Range 9-18 
L=4; Med.=17; High=6 
(2M, 2F); (8M, 9F); (3M, 3F) 
108.1 (15.5); Range 75-145 
107.0 (14.6); Range 75-131 
109.1 (16.8); Range 88-145 
22.1 (3.3); Range 18.0-31.1 
22.1 (1.6); Range 18.8-24.3 
22.0 (4.3); Range 18.0-31.1 
Data collected from the TiNC participants at Ti and T2 was compared using single sample (i.e., 
dependent) t-test to help establish whether practice effects impacted on the re-assessment results ofthe 
TiCD participants, in particular in the case of full scale, index and subtest WAIS-HI scores. Although 
slight increases in IQ upon re-testing are reported in the WAIS-HI Manual (p.56), these are in reference 
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to follow-up periods of 2-12 weeks, much briefer than the 12 month follow-up pertaining to Study 2 
The NC group also completed the BDI-H, which served as a check to monitor and guard against any 
significant changes in mood across the group, or individuals, between Tiand T2, in order to ensure that 
any changes in the NC WAIS-IQ profile could indeed be assumed to be related to a practice effect, 
rather than mood changes. Finally, the QOL questionnaire was re-administered as normative data 
regarding re-assessment with this measure was not available. Using a healthy comparison group, albeit 
one of limited size, also helped control for any other intangible factors, unrelated to CD or practice 
effects, that may have impacted on changes between Tiand T2 in the LCD group. 
Consent Process, Materials and Measures 
Prior to initial assessment with a battery of psychological instruments, and cognitive assessment, 
each participant in the study read and signed a consent form (Appendix G) in the presence ofthe 
author and an independent witness. In addition, participants who had been diagnosed with CD 
within one-hundred days of being seen by the author were also asked if they were willing to be 
contacted 12 months later with a view to being re-interviewed and re-assessed, according to exactly 
the same protocol as outlined in Study 1. All TiCD participants who were asked about follow-up 
participation expressed a willingness to be contacted one year from the time of initial assessment. 
All participants in the NC group were also asked at the time of their initial inclusion in the study 
whether they were willing to be contacted one year later with a view to being re-interviewed and re-
assessed. Those who expressed willingness had their files marked as potential follow-up candidates. 
Twelve out of sixty-nine NC participants, well matched demographically to the emerging TiCD sample, 
were subsequently contacted and ten were available or obliged to be re-assessed. The twenty-seven 
TiCD and ten NC participants re-tested at T2 were subject to the same battery of measures used at Ti, as 
described in Chapter 4. These were the demographic and health questionnaire, BDI-H, WAIS-HI and 
QLQ, and, for the TiCD sample, the CD Awareness Screen, STAI, STAXI, Multidimensional Health 
Locus of Control Scale (Form A) and an additional measure, unique to Study 2, described overleaf 
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Profile of M o o d States ( P O M S ) 
The Profile of Mood States (POMS; McNair, Lorr, & Droppleman, 1971) is a psychometrically 
sound, easy to understand, self-response inventory. It has longstanding acceptance as a reliable measure 
of transient mood state (Peterson & Headen, 1984). From the outset of cross-sectional data collection, 
the POMS was administered to all CD participants considered eligible for future inclusion in the 
longitudinal study, by virtue of having been diagnosed with CD for less than one year when first seen. 
After September 2000, when a cut-off point of nine weeks since diagnosis at Ti was determined to be 
the longitudinal entry criteria, administration ofthe POMS was limited to CD participants in this 
category. All 27 participants diagnosed with CD for less than nine weeks at Ti who were included in the 
longitudinal sample completed the POMS for a second time at follow-up one year later (T2). 
At both Ti and T2, CD participants used a 5-point Likert scale to rate the degree to which each of 65 
adjectives comprising the POMS described their mood in the preceding week, including the day of 
assessment. Non-overlapping combinations of these adjectives contribute to six separate factors or mood 
scales. These scales are Tension-Anxiety (T), Depression-Dejection (D), Anger-Hostility (A), Vigor-
Activity (V), Fatigue-Inertia (F) and Confusion-Bewilderment (C). The dimensions consist of between 
seven (scale F) and fifteen (scale D) unique questions. 
According to the POMS' authors, factor T is "defined by adjective scales descriptive of heightened 
musculoskeletal tension" and factor D "appears to represent a mood of depression accompanied by a 
sense of personal inadequacy". Anger-Hostility (factor A) represents "a mood of anger and antipathy 
towards others" (POMS Manual, p.7). 
Vigor-Activity (V) is "defined by adjectives suggesting a mood of vigorousness, ebullience and high 
energy". Conversely, fatigue-Inertia (F) represents a "mood of weariness, inertia and low energy level", 
classically typical of people with undiagnosed CD. Finally, Confusion-Bewilderment (C) appears 
"characterized by bewilderment and muddleheadedness" (POMS Manual, p.7). 
Summing the scores across all six factors (and weighting Vigor-Activity negatively) provides a 
single global estimate of affective state, known as the Total Mood Disturbance (TMD) score. Norms and 
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validity data are unavailable for T M D , but the authors ofthe P O M S Manual encourage research into this 
variable, which was calculated by the author ofthe present study. 
Different time-periods for ratings have been used in various applications ofthe POMS. As 
aforementioned, the author ofthe present study used the standard one-week reference frame. Reasons 
for using a one-week period were twofold; 1) to be able to compare the longitudinal CD group 
experimental data against POMS normative data and 2) because one week was judged to be most 
appropriate in capturing a consistent picture of mood state soon after and 12 months post-diagnosis 
Norms have been developed for two groups by McNair et al (1971); mixed gender psychiatric 
outpatients (n = 1,000; 65% female) and undergraduate college students (n = 856; 60.3% female). 
Correlations between scales ranged from -.49 (F versus V) to .76 (D vs. T, in both cases among female 
psychiatric outpatients). Most correlations were in the vicinity of .50 to .70, ignoring V, which is 
negatively weighted when considered in conjunction with total mood scores. McNair et al (1971) note 
that "correlations between Tension-Anxiety (T) and the other mood scales fend to be lower in the 
normal group than in the outpatient group, suggesting a clearer distinction between T and other moods 
in normals" (POMS Manual, p. 9). Internal consistency reliabilities (K-R
 20) ofthe POMS, measuring 
the extent to which individual items within the six mood scales measure the same factor, were 
consistently high. Using psychiatric outpatient normative data, K-R
 2o indices ranged from ,87 (factor C) 
to .95 (factor D). 
Test-retest reliability was measured using a sub-sample ofthe normative psychiatric outpatient 
group (n = 100; approximately two-thirds female) accepted for treatment at a university medical center 
psychiatry clinic. They were reassessed on the POMS immediately prior to their first therapy session 
(with a median time of 20 days; range 3-110 having elapsed since intake) and after six weeks after 
treatment. The reliability estimates for these periods across the six scales ranged from .66 to .74 (20 day 
period) and from .43 to .53 (6 week period). McNair et al (1971) noted that the first time frame involved 
seeking and finding a source of psychiatric treatment for these patients, in itself probably associated 
with change in emotional states, and that the correlations are therefore "probably lower-bound estimates 
Psychological Sequelae of C D 220 
of reliability" ( P O M S Manual, p. 10). 
According to McNair et al (1971), the six factor analytic replications in the development ofthe 
POMS may be taken as evidence ofthe factorial validity ofthe six mood factors. The results were 
indeed very consistent for the various patient and non-clinical samples and across the different ratine 
time periods. 
Using the psychiatric outpatient norms, correlations were reported in the POMS Manual between 
demographic variables and scale scores. In summary, all POMS factors except A were significantly 
related to sex, with female outpatients obtaining significantly higher scores than males on T, D, F and C, 
and males reporting significantly higher V scores. Correlations with age were small, with older patients 
(primarily those > 40 years) scoring lower on A and C. In female patients, small positive correlations 
existed between education and each of T, D, V and C, while for males there was a slight but significant 
positive correlation between education and F. The POMS took participants approximately 10-15 
minutes to complete. 
Participation Procedures and Protocol 
The TiCD participants were originally interviewed and assessed in accordance with exactly the same 
procedures as all members ofthe full CD sample. At the time of follow-up (T2) twelve months after the 
initial meeting with the author, precisely the same protocol was adhered to in re-interviewing and re-
assessing each participant selected and contacted to be a member ofthe longitudinal study. A second 
consent form was signed by all TiCD participants according to the same procedures used at the time of 
their original participation. If practicable, re-interviewing and testing was scheduled for the same venue 
and time of day as occurred at the original session one year earlier. 
In view ofthe relatively small sample size ofthe longitudinal group, a particularly detailed record at 
initial and follow-up testing was kept in relation to situational factors that may have impacted on mood 
state and test results. Foe example, one participant reported being "a bit sadder than normal", having 
attended a funeral of a relative five days prior to re-assessment, but she was included in statistical 
analysis. 
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The ten healthy control (TiNC) participants w h o were matched demographically to the TiCD 
participants were re-interviewed and re-assessed 12 months following their original inclusion in Study 1 
and were also subject to the same protocols. They re-rated their health status and completed all sections 
ofthe demographic and health questionnaire except static information (e.g., date of birth). However, 
these participants were only re-tested with a subset ofthe full battery of psychological inventories, 
namely the BDI-II, WAIS-III and QOL Questionnaire. 
Statistical Design 
In the case ofthe BDI-II, WAIS-III and QOL measures, in which both the LCD and NC groups were 
re-assessed, a standard between and within-subject repeated measures ANOVA was used to determine 
whether changes between Ti and T2 in the LCD group were able to be attributed to being on the GFD 
(or other possible CD-related factors), or whether the change was due to chance or systematic factors 
unrelated to CD (e.g., re-testing or practice effects). Using this model, the test scores at Ti and T2 
comprised the within-subjects factor and group (CD or NC) was the between-subjects factor, with the 
interaction between group and the series of within-subject factors of primary interest. 
Where the NC group was not re-assessed, within-group comparisons ofthe CD participants 
between Ti and T2 were conducted using a paired comparison (or dependent) t-test. Test scores and 
measures used in the cross-sectional study, plus POMS scores, served as dependent variables. These 
included various demographic data and major scores on the STAI and STAXI, Health Status, the 
Multidimensional Health Locus of Control scale (Form A) and the Coeliac Disease Awareness Screen. 
Where multiple testing occurred within domains, suitable Bonferroni adjustments were undertaken 
(i.e., division of alpha by tests executed), as in Study 1. Standard tests of normality and equality of 
variance (Levene's test) were undertaken prior to each analysis. In some instances, case by case 
observations about - and feedback from - individual patients were made, where these elucidated any of 
the findings reported. Finally, several cases were described highlighting the marked improvement in 
general well-being observed in a number of patients who had been highly symptomatic at diagnosis. 
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Results of Study 2 
Nutritional Considerations: Compliance with GFD and Orthomolecular Findings 
In general, the longitudinal LCD group reported initial GFD compliance, which had been sustained 
at reassessment. Using both scales of G F D compliance (frequency of gluten intake and the brief 
questionnaire of beliefs, intentions and behaviours), there were no significant changes across the L C D 
group between Ti and T2. 
There were also no significant changes in vitamin and mineral supplementation, with 33.3% ofthe 
L C D group regular B-group vitamin users at Ti (and 25.9% at T2), another quarter being periodic users 
or regular recipients of partial formulations, such as folate/ iron (25.9% at Ti and 29.6% at T2) and half 
never or rarely being in receipt of nutritional therapy apart from the G F D (40.7% at T! and 44.5% at T2) 
In summary, there were no systematic changes in supplement use, whether prescribed by a health care 
professional or initiated by L C D participants. 
Coeliac Disease Awareness 
The mean scores in the questionnaire reflecting knowledge of C D increased significantly between 
between Ti and T2in the L C D group (t = 4.93, g = .000; m.d. = 8.36, S D = 5.1, 9 5 % C.I. = 4.69, 12.02). 
These results are shown in Table 41. Since the measure was a new scale developed by the author, it was 
impossible to determine the extent to which this was due to a practice effect. 
Table 41 
Means, Standard Deviations (SDs) andRanges ofthe CD Awareness Screen at Tj and T2 
LCDTi L C D T 2 
N 27 27 
Mean (SD) 34.93 (14.7) 43.29 (12.9) 
Range 4-60 16-65 
The first year of diagnosis with CD involves a great deal of new learning about the GFD and so this 
result was not unexpected, but the magnitude of change seemed modest, perhaps suggesting that key 
knowledge about C D and the G F D is acquired between the lead up to confirmation of diagnosis and the 
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first few weeks post-diagnosis, at the time of a limited series of dietetic sessions for many patients. 
Affective Functioning 
Minimal Change in Depressive Symptomatology at 1-Year Follow U p 
Using a between and within-subject repeated measures A N O V A , there was an insignificant trend 
towards reduction in BDI-II depression in the C D group between Ti and T2(F [1, 35] = 2.96, g = .094) 
Mean BDI-II scores for the two groups at Ti and T 2 are shown in Table 42. 
Table 42 
Means, Standard Deviations (SDs) and Ranges for BDI-II Scores Across Groups 
Ti 
CD 
T2 Ti 
NC 
T2 
N 27 27 10 10 
BDI-II 
Mean(SD) 11.04(6.4) 7.81(6.2) 8.20(4.5) 8.0(3.9) 
Range 0-25 0-21 1-14 0-13 
Notwithstanding the lack of a significant mean decrease in BDI-H in the L C D group, there was a 
numerical decrease in BDI-II from Ti to T2in 70.4%, or about seven in ten participants. The decrease 
equalled or exceeded 6 points in one third, as shown in Table 43. Ofthe eight L C D participants whose 
BDI-H score increased, the rise was limited to < 3 points in all but one case. 
Table 43 
Magnitude of BDI-II Change in LCD Group Between Tj and T2 
N 
Percent 
Increase1 
8 
29.6% 
Decrease of 1-2 
5 
18.5% 
Decrease of 3-5 
5 
18.5% 
Decrease of 6-10 
9 
33.3% 
of any magnitude (ranged from 1 to 6 points) 
Although the BDI-H score decreased in seven out often L C D participants, only 29.6% ofthe sample 
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(eight participants) registered an actual shift in their depression rating, using the 4 range cut score scale 
(i.e., Minimal to Severe, outlined in Study 1 on p. 131). For 22.2% (6 participants out of 27) a downward 
shift of one rating occurred, from Mild to Minimal in 5 cases, and Moderate to Mild in the remaining 
case. During interviewing, each of these L C D participants corroborated their improvement in mood at 
re-assessment, attributing the change at least in part to positive improvements in their general health and 
wellbeing as a result of proper diagnosis of their C D and adoption ofthe GFD. Four of these patients 
believed their improved mood state was entirely a result of diagnosis and G F D treatment. In two L C D 
participants, an upwards shift in depression from Mild-Moderate occurred. In one case, there were 
several ongoing GI symptoms and frustration was also expressed at the restrictions and pre-planning 
involved in following the GFD, while in the other, relationship difficulties were being experienced. 
Somatic/ Affective - Cognitive Difference 
Further analysis ofthe numerical decrease in mean BDI-II scores in the L C D group indicated that 
the changes was predominantly underpinned by a decrease in the Somatic/ Affective, as opposed to the 
Cognitive, dimension of self-reported depression, as shown in Table 44. 
Table 44 
Means, Standard Deviations (SDs) and Ranges of the BDI-II Somatic/ Affective and Cognitive 
Factor Scores Across the LCD Groups at Tj and T2 
LCDTi LCDT2 
N 27 27 
Somatic (12 items) 
Mean (SD) 0.72 (0.43) 0.48 (0.41) 
Range 0-1.50 0-1.42 
Cognitive (9 items) 
Mean (SD) 0.26 (0.28) 0.23 (0.24) 
Range 0-1.11 0-0.67 
Psychological Sequelae of C D 225 
State and Trait Anxiety at Follow U p 
Both state and trait anxiety, as measured by the STAI, decreased significantly between Ti and T2 in 
the LCD group. The change in state anxiety was greater (t = 3.27, g =.003, m.d. = 6.30, 95% C.I. = 2.34, 
10.25), being significant in both male and female LCD participants after gender partitioning, where as 
the change in trait anger (t = 2.41, g =.023, m.d. = 3.00, 95%o CL = .44, 5.56) was only significant 
across the full LCD group. Table 45 shows the mean scores at Ti and T2 
Table 45 
Means, Standard Deviations (SDs) andRanges of State and Trait STAI Scores at Ti and T2 
LCDTj LCDT2 
State Anxiety 
Mean(SD) 40.30(12.7) 34.00(10.2) 
Range 24-69 20-55 
Trait Anxiety 
Mean(SD) 41.78(10.8) 38.78(11.3) 
Range 24-62 20-61 
State and Trait Anger at Follow Up 
Both state and trait anger were lower at T2 compared to Ti in the LCD group (t = 2.08, g = 047, 
m.d. = 1.37, 95% CL = .02, 2.72 and t = 2.63, g = 014, m.d. = 2.07, 95% C.I. = .45, 3.70). The 
results are shown in Table 46. 
Table 46 
Means, Standard Deviations (SDs) andRanges of State and Trait STAXI Scores at Tj and T2 
LCD Ti LCD T2 
State Anger 
Mean (SD) 
Range 
Trait Anger 
Mean (SD) 
Range 
13.19(5.5) 
10 - 26 
20. 37 (6.5) 
10-32 
11.81(3.2) 
10-22 
18.3(6.1) 
10-31 
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Other anger functions measured by the STAXI, namely Angry Temperament. Angry Reaction. 
Anger-In, -Out, -Control and Anger Expression were also re-assessed in the LCD group at T2. No 
significant differences were found at T2 compared to Ti, following application of a Bonferroni 
adjustment, setting alpha at .01, to compensate for the five STAXI sub-scores and corresponding tests. 
Profile of Mood States 
Scores on each ofthe six POMS scales, as well as a Total Mood Disturbance (TMD) score were 
computed, as exhibited in Table 47, with negative scores possible on TMD, as occurred. 
Table 47 
Means, Standard Deviations (SDs) andRanges of POMS Scores in the LCD Group at Tj and T2 
N 
Total Mood Disturbance ( T M D ) 
Mean (SD) 
Range 
Tension- Anxiety (T) 
Mean (SD) 
Range 
Depression-Dejection (D) 
Mean (SD) 
Range 
Anger-Hostilitv (A) 
Mean (SD) 
Range 
Vieor-Activitv (V) 
Mean (SD) 
Range 
Fatigue-Inertia (F) 
Mean (SD) 
Range 
Confusion-Bewilderment 
Mean (SD) 
Range 
OQ 
There was a significant decrease 
LCDTi 
27 
41.63(34.3) 
-23 to 118 
11.03(6.4) 
0-32 
11.03(6.4) 
0-40 
11.03(6.4) 
0-38 
11.03(6.4) 
5-30 
11.03(6.4) 
0-22 
11.03(6.4) 
2-23 
L C D T 2 
27 
27.81(35.54) 
-19 to 132 
7.81 (6.17) 
0-34 
7.81(6.17) 
0-43 
7.81 (6.17) 
0-31 
7.81 (6.17) 
8-25 
7.81(6.17) 
0-24 
7.81 (6.17) 
2-21 
in Total Mood Disturbance (TMD) score between Ti and T2 in t 
LCD group (t [26] = 3.31, g = .004; m.d. = 13.81, SD = 22.9, 9 5 % C.I. = 4.76, 22.86. Caution was taken 
in interpreting this result, given its status as an experimental variable according to the POMS authors 
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and the size ofthe SD. Nonetheless, since T M D is an additive, composite score based on all mood 
scales, a significant decrease in general mood state was considered notable. 
Prior to analysis of results in the six standard POMS scales, alpha level was adjusted to g = .008, 
decided on a Bonferroni basis by considering an overall .05 level for each score divided by the six scale 
scores. Notwithstanding this conservative approach, there was a significant change between Ti and T2 
in three ofthe six scales, namely Anger-Hostility (t = 2.90, g = .008), Confusion-Bewilderment (t = 3.14, 
g = .004) and Fatigue-Inertia (t = 3.59, g = .001), the only scale in which the change held across gender. 
There was not a significant change in Tension-Anxiety (T), Depression-Deiection (D) or, 
interestingly, Vigor-Activity (V), which may, in a sense, be considered the converse of Fatigue-Inertia 
The lack of significant change in Depression-Dejection (D) corroborated the only other previous 
longitudinal findings involving depression levels after GFD implementation (Addolorato et al, 2001; 
Hallert & Astrom, 1982; Hallert, Astrom, & Walan, 1983). 
Cognitive Functioning 
The means, SDs and ranges of full scale, Verbal and Performance IQ at Ti and T2, in both the LCD 
and NC groups, are displayed in Table 48. 
Table 48 
Means, Standard Deviations (SDs) andRanges of Full Scale, Verbal and Performance IQ Scores 
Across the LCD andNC Groups at Tj and T2 
L C D T i L C D T 2 N C T 2 N C T2 
N 27 27 10 10 
WAIS-IQ (Full Scale) 
Mean(SD) 108.11(15.5) 111.07(16.2) 109.50(11.0) 111.20(11.7) 
Range 75-145 77-143 86-125 87-126 
Verbal-IQ 
Mean(SD) 106.30(13.6) 108.19(14.0) 109.40(13.4) 110.00(13.1) 
Range 72-133 74-133 87-133 88-131 
Performance-IQ 
Mean(SD) 109.33(17.6) 112.11(17.6) 108.50(12.3) 110.90(14.0) 
Range 81-153 84-146 86-127 87-134 
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Using a paired comparison (dependent) t-test, there was a significant increase in WAIS-IQ between 
Ti and T 2 in the L C D group (t = 2.80, g = .010; m.d. = 2.96, S D = 5.5, 9 5 % C L = .78, 5.14), equating to 
2.96 IQ points (SD = 5.5), but not in the NC group, in which the numerical increase in IQ was 1.7 points 
(SD = 3.1) and t = 1.76, g > .10). Importantly, the WAIS-IQ difference between Ti and T2 across the 
LCD and NC groups was not significant (t_= .68, g = .499), demonstrating that the increase in mean IQ 
in the L C D , although statistically significant, was certainly not above a level that could be accounted for 
by a practice effect, assuming that this was the cause of change in the N C group 
Use ofthe standard between and within-subject repeated measures ANOVA of course yielded the 
identical insignificant result (F [1, 35] = .467, g = .499), but the relatively cumbersome, multiple-step 
alternative approach to the same problem, as outlined above, was undertaken simply to show that 
longitudinal changes may appear to be significant in the absence of a control group, but change may not 
be able to be attributed to effects specific to the group of interest, in this case the C D group. Clearly, a 
practice effect would seem to have contributed to the slight numerical increase in IQ observed in the 
L C D group. The mean scores, SDs and ranges of change in WAIS-IQ from Tj to T2for both groups are 
shown in Table 49. 
Table 49 
Means, Standard Deviations (SDs) andRanges of Change in WAIS-IQ Across Groups from Ti to T2 
LCD NC 
Mean Difference (SD) 2.96 (5.5) 1.7 (3.1) 
Range -10 to 13 -3 to 7 
Furthermore, there was no correlation between dietary compliance and variation in WAIS-IQ. It 
therefore appeared that one year ofthe GFD, following CD diagnosis, had no impact on overall intellect. 
Significant increases in performance in the CD group between Ti and T2 were observed in Verbal IQ 
(t [26] = 2.47, p =.020), Working Memory t [26] = 5.81, g =.000 and Processing Speed (t [26] = 2.47, 
P. =.002). Further analyses were undertaken to determine if any ofthe mean changes in the WAIS-IQ 
Verbal, Performance or Index scores in the LCD group (ranging from .92 to 4.52 point increases) 
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differed significantly from the small increases observed in the N C group. Only one marginally 
significant difference was recorded in Working Memory, in which the LCD group change of 4.52 (SD = 
4.0) differed from the NC group (t = 2.03, g = .050, m.d. = 2.92, 95% CL = .00, 5.84). Following a 
Bonferroni adjustment, however, this result was no longer considered significant. 
Health Status and Life Quality One Year Post-GFD Implementation 
In analysing any change in perceived health status between Ti and T2 it was evident that statistical 
comparisons concurrently involving the LCD and NC groups were not possible since health was being 
rated from different perspectives and this was complicated further by the longitudinal protocol. 
Therefore, a paired comparison t-test was used to compare the CD ratings between Ti and T2. 
Using this approach, health status "since diagnosis" increased significantly from Ti to T2 (t [24] = 
2.14, g = .043, m.d. = .48, 9 5 % C.I. = .02, .94). From Table 50 it is also evident that the L C D group 
mean for retrospectively rated health status "prior to diagnosis" at Ti and T2 was identical 
Notwithstanding the fact that a number of individual ratings changed slightly, the same result at Ti and 
T2 possibly validates the scale to a certain extent, given that the same time period was being evaluated, 
albeit from a different time point. 
Table 50 
Mean, Standard Deviations (SDs) and Ranges of Self-Assessed Health Status Prior to and Since 
Diagnosis in the LCD Groups at Tj and T2 
LCDTj LCDT2 
Health Status Prior to Diagnosis 
Mean(SD) 2.56(1.5) 2.56(1.5) 
Range 1-6 1-6 
Health Status Since Diagnosis 
Mean(SD) 4.04(1.1) 4.51(0.9) 
Range 2-6 3-6 
Using between and within-subject repeated measures ANOVA, there was not a significant change in 
QOL between Ti and T2in the CD group (F [1, 35] = 3.757, g = .061), but a trend was evident. 
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Mean Q O L increased numerically by an average of 6.15 points, which did not quite equate to a 
meaningful clinical increment within the slightly below average range in which the LCD QOL 
scores fell, on the basis of Evan and Cope's (1989) interpretative guidelines provided in the QOL 
Manual There was no mean numerical change in QOL in the NC group. Total QOL scores in the 
LCD group at Ti and T2 are shown in table 51. 
Table 51 
Means, Standard Deviations (SDs) andRanges of Quality of Life (QOL) in LCD Group (Tj to Tz) 
LCD Ti LCD T2 
QOL (Total score) 
N 
Mean (SD) 
Range 
The number of LCD participants exhibiting high, medium or low QOL from Ti to T2 in the 
LCD was ascertained using T-scores, as shown in Table 52. Chi-square testing showed that the 
proportions of LCD participants in each of these ranges of QOL was not statistically different at Ti 
and T2, although it was noted that one-third ofthe longitudinal cohort still exhibited low life quality 
and less than one ten recorded high life quality on the QOL Questionnaire at one year follow-up. 
Table 52 
Number (and Percentage) of QOL Scores in the Low, Average and High Ranges for the LCD 
Subgroup at Tj and T2 Using T-Scores 
27 
94.48 (25.7) 
54-145 
27 
100.63 (24.4) 
58-140 
L C D Ti LCD T2 
High QOL 
(T>61) 1(3.7%) 2(7.4%) 
Average QOL 
(T = 41 to 60) 15 (55.56%) 12 (44.4%) 
Lo_v_QOL 
(T<40) 11(44.4%) 7(33.3%) 
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In the five major domains of Q O L there were no significant changes between Ti to T 2 in the 
LCD group, with only trends towards an increase observed in General Well-Being and Leisure/ 
Recreation (g = .075 in both cases). 
Multidimensional Health Locus of Control 
A significant decrease occurred in Powerful Others HLOC between Ti to T2 in the LCD group 
(t = 2.46, g = .023, m.d. = 1.82, 95% C.I. = .28, 3.36). There was no change in either ofthe other 
two HLOC scales; Internal and Control. 
BriefCase Reports 
The recent history and pre-post results of three highly symptomatic LCD participants are succinctly 
reported, with their kind permission (but names changed), to illustrate the impact ofthe GFD where 
unequivocal improvement was observed. Coincidentally, each person had an initial BDI-II score of 15, 
placing them in the mild range of depression when first seen in Study 1. 
Case 1. Jade, an 18 year old student living at home with her parents and younger brother, was the 
fifty-third CD participant in Study 1 and the fifth person followed up in Study 2. Her grandparents 
were all of Welsh lineage. When first assessed, she had been on the GFD for 63 days. At 168 cm and 52 
kg, her BMI of 18.4 reflected her slightly underweight status, although this had already improved 
significantly from 44 kg at CD diagnosis 10 weeks earlier (BMI =15.6), which Jade recognized as 
extremely underweight. Although quite slim her entire life, a three-day bout of food poisoning preceded 
a distinct 12 month symptomatic period pre-CD diagnosis, during which she was subsequently found 
to be anaemic. The development of GI symptoms, menstrual irregularities, anaemia and gradual 
weight loss lead to the investigation of CD, after many other medical conditions were ruled out. 
Jade presented as shy, somewhat hesitant, and was interviewed while her father browsed for more 
than two hours in the foyer ofthe Victorian Coeliac Society Office. She reported feeling much better 
physically on the GFD, including far less irritable, "jittery" and "edgy", with all GI symptoms having 
subsided within a few weeks. However, her mild level of BDI-II depression was congruent with a 
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gloomy demeanour, with an equal endorsement of cognitive and somatic/ affective items. The only 
question on the BDI-II fully endorsed (Indecision) partly reflected Jade's uncertainty about what she 
would be doing the following year, as she was awaiting course offers, having just finished high school. 
Her FSIQ fell within the average range, although WM and PS were each low-average. Self-reported 
QOL was in the average range and her levels of state and trait anxiety and trait anger were elevated. She 
rated her health status as "fair" at assessment, compared to "poor" prior to diagnosis. 
At one-year follow-up, there was a stark contrast in Jade's deportment; she appeared brighter, 
healthier-looking, and full of spirit. This was partially reflected in her BDI-II score, which had fallen to 
9, placing her in the non-clinical range. Throughout interviewing, a new found sense of joy and humour 
was also evident which had been absent at the first meeting. Her weight had increased slightly to 56 kg, 
with no change in height (BMI = 19.8), although Jade expressed discontent with this minor increase 
Given that her BMI placed her at the lower fringe of normality and she still appeared very slim, this was 
concerning. However, she now rated her health status as "very good" (up two increments from "fair") 
and retrospectively rated her health as "poor" prior to CD diagnosis, the same self-rating noted a year 
previously. Her trait anxiety score was almost unchanged, trait anger dropped marginally, but her state 
anxiety and anger scores were significantly lower, now placing her in the lowest percentile compared to 
normative data, a major shift. Her total POMS mood disturbance score had also halved in value. On the 
WAIS-HI, FSIQ was identical at follow-up, WM had increased 2 points but was still in the low-average 
range and PS had increased 4 points, moving from the low-average to average range, with neither shift 
in excess of what may be able to be attributed to a practice effect. 
Jade was studying in her chosen field and reported having the energy to work part-time and lead an 
active social life. She reported strict GFD adherence and felt well supported by her family. Jade said that 
two inadvertent transgressions had lead to a noticeable reaction within hours of gluten ingestion. This 
had consisted of abdominal cramping, with loose bowel motions on the first occasion and a headache on 
the second. Jade had received medical follow-up since CD diagnosis via her general practitioner. Her 
haematological parameters and menstrual cycle had normalised, but she had not been referred for a 
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D E X A scan to assess bone mineral density at or post-diagnosis. 
Case 2. Len was a diminutive but sinewy 46 year old, self-employed wood carver, born in Scotland, 
who was married with two adult children. He lived rurally, but met with the author on several occasions 
while on weekend business trips to Melbourne. He had been on the GFD for 25 days when first seen, but 
stated that his weight had increased dramatically from 50 to 61 kg in just under one month, with his 
BMI rising from a gaunt 18.4 to 22.4 (within the recommended range). He had a history of moderate to 
severe, but unrecognised, CD-related symptoms spanning his entire life and had always been 
underweight until diagnosis. However, his GI symptoms had intensified in the preceding 12 months, 
during which he had experienced stress related to legal and financial problems. His was mildly 
depressed according to the BDI-H, but the elevation was limited to and therefore accentuated in the 
somatic dimension, with reflecting agitation, increased appetite, tiredness, reduced sexual interest, poor 
sleep and concentration strongly endorsed. Len also exhibited high scores on the STAI (state anxiety 
only) and STAXI (state and trait). His FSIQ and all Index scores were in the average range, except his 
Perceptual Organisation score, which placed him in the superior range. 
His QOL score was "much below average", being about three standard deviations below the 
normative mean, while his POMS total mood disturbance score was highly elevated, being the fourth 
highest ofthe LCD group of 27. This seemed to truly reflect his level of distress across multiple 
psychological/ emotional domains, including Anger-Hostility, Fatigue-Inertia, Confusion-Bewilderment 
and Tension-Anxiety, in that descending order. 
At one year follow-up, Len's appearance had changed noticeably; he had put on another 14 kg 
(BMI = 27.5), which was significant in the context of his previously lean frame. Like Jade, he expressed 
a concern regarding his now overweight status, which had the potential to introduce a range of new 
health problems, especially at his age. On all measures of mood, Len had scores placing him in the 
normal range compared to significant elevation on most measures a year earlier. There was minimal 
change in FSIQ and pronounced relative decrements in WM remained. 
Case 3. Full-time employed and living in a de facto relationship without children, Jocelyn presented as a 
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striking but worn-out looking 28 year old woman, with a placid temperament, when first assessed. She 
had been on the GFD for 25 days and had just returned to work following a three week rest after her CD 
diagnosis. This had been made following a continuous two year symptomatic period, marked by low 
iron levels, frequent headaches and self-reported depressive symptoms. Jocelyn indicated that her 
depression had "lifted" appreciably and her headaches had subsided in the last few weeks but she still 
felt "exhausted". Her BDI-II score placed her in the mild range of depression, with the somatic items 
preferentially endorsed, in particular those corresponding to reduced energy, sleep and concentration 
and increased tiredness. Her weight was 48 kg at diagnosis (BMI = 17.9) and had risen to 50 kg (BMI = 
18.6) when first seen by the author. Jocelyn reported elevated mood disturbance, "poor" health status 
pre-diagnosis ("fair" at study enrolment) and average QOL. Anxiety levels were in the average range, 
while anger levels were very low. All WAIS-III scores were in the average range. 
At one-year follow-up, Jocelyn, reminiscent of Jade, appeared in much better physical shape, rating 
her health status as "very good", compared with "very poor" pre-diagnosis (a decrease of one increment 
from her retrospective rating at study entry). Her full BDI-II score fell to just 3 and total QOL rose sig-
nificantly to "above average". There were no changes in anxiety or anger levels (still average-low), but 
her total POMS mood disturbance score had fallen markedly. A small rise on FSIQ was of a magnitude 
attributable to a practice effect, but Jocelyn believed that her clarity of thought had improved greatly. 
Each ofthe three cases presented as severely symptomatic prior to diagnosis, but only Len could be 
considered a classic CD case, in the sense he reported GI symptoms throughout his entire life. For two 
people, post-diagnosis weight gain was somewhat disconcerting, a common anecdotal finding observed 
by the author and often reported by dietitians and general practitioners. Extensive interviewing revealed 
that each person perceived their CD diagnosis as a relief and life changing event, providing them with 
the physical energy and motivation to be actively involved in life. However, there were other 
participants in the LCD cohort who felt that their lives had hardly altered, or who felt burdened by the 
GFD, or had become aware of new CD-related health problems. The overall impression was one of 
great individual variation in acceptance and adjustment to life post-CD diagnosis. 
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Discussion of Study 2: Key Results 
Study 2 was a longitudinal analysis, at twelve month follow-up, of affective functioning, cognition 
and quality of life in a subset ofthe cross-sectional CD sample used in Study 1. These participants had 
been diagnosed with CD and taking the GFD for less than nine weeks at Ti (Study 1 entry) and for 
about one year at their second assessment (T2). A small group (n = 10) of NC participants were also re-
assessed twelve months after Study 1 enrolment, principally to monitor WAIS-HI re-testing effects. 
Affective Functioning and Mood States Profile at Follow-Up 
There was a trend, but not a significant decrease in BDI-H depression between Ti and T2 in the LCD 
group, which supported previous findings (Addolorato et al, 2001; Hallert & Astrom, 1982; Hallert, 
Astrom, & Walan, 1983). Although a numerical decrease occurred in BDI-II from Ti to T2 in the 
majority of CD participants, which equalled or exceeded six points in one third, only 29.6%> ofthe 
sample registered an actual shift in their clinical depression rating, using the standard four point cut 
score scale (i.e., Minimal to Severe) specified by Beck et al (1996). For 22.2%, a downward shift of one 
rating occurred, from mild to minimal in five cases, and moderate to mild in the remaining participant. 
Further analysis of change in mean BDI-II scores indicated that it was underpinned by a decrease in the 
Somatic/ Affective, as opposed to the Cognitive, dimension of self-reported depression. 
During interviewing, each ofthe LCD participants whose depression score fell subjectively believed 
that their mood had improved at re-assessment, invariably attributing increased well-being to proper 
diagnosis of their CD and adoption ofthe GFD. In two LCD participants, an upwards shift in depression 
from Mild-Moderate occurred. The restrictions and demands imposed by the GFD and lack of 
significant health improvements were cited as explanations for their higher level of depression. 
Anxiety, as measured by the STAI, decreased significantly between Ti and T2 in the LCD group. 
The change in state anxiety was more pronounced, being significant in both male and female LCD 
participants after gender partitioning, whereas the change in trait anger was only significant across the 
full LCD groun. Each of state and trait anger were lower at T2 compared to Ti in the LCD group, but no 
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significant differences were found at T 2 compared to Ti in any ofthe other anger functions measured by 
the STAXI (i.e., Angrv Temperament, Angry Reaction. Anger-In. -Out Control and Anger Expression! 
Using the Profile of Mood States (POMS) inventory, there was a significant decrease in Total Mood 
Disturbance (TMD) score between Ti and T2 in the LCD group. Caution was taken in interpreting this 
result, given its status as an experimental variable by the POMS authors. Nevertheless, given that it was 
an additive, composite score based on all mood scales, a significant decrease in general mood state was 
considered notable. There was a significant decrease between Ti and T2 in three ofthe six scales, 
namely Anger-Hostility, Confusion-Bewilderment and Fatigue-Inertia, the only scale in which the 
change held across gender. There was not a significant change in Tension-Anxiety (T), Depression-
Deiection (D) or, interestingly, Vigor-Activity (V). The latter may be considered the converse of 
Fatigue-Inertia, in which the greatest change was observed. 
Neuropsychological Re-Assessment 
An increase in mean IQ in the LCD, although statistically significant, was certainly not above a 
level that could be accounted for by a practice effect, assuming that this was the cause of change in the 
NC group. Furthermore, as previously noted by Matarazzo et al. (1980), "Wechsler has consistently 
cautioned that a gain in IQ of about 5 points from test to retest generally should be considered a 
practice or retest effect rather than a clinically meaningful change in actual IQ" (p. 95; see also 
Kaufman, 1990, pp. 107-112, 204-206, and 297-299; Matarazzo, 1972, pp. 241-242; Wechsler, 1997, 
Technical Manual, pp. 56-61; Zimmerman & Woo-Sam, 1973, pp. 14-19). 
There was also no correlation between dietary compliance and increase in FSIQ. It appears, then, 
that a diagnosis of CD and one year ofthe GFD, following CD diagnosis, had no impact on overall 
(i.e., global) intellectual ability. This result is consistent with, and extends, Study l's results and Hallert 
and Astrom's (1983) finding of "intact intellectual ability in adults after lifelong intestinal malabsorp-
tion due to CD" (p. 87) at diagnosis. 
The index-specific weaknesses in WM and PS, compared to the NC group, observed in Study 1, 
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had not resolved at follow-up. These results mirror neurological findings in C D (Hadjivassiliou et al, 
1998), in which relatively common neurophysiological manifestations of CD, such as idiopathic ataxia, 
"may be progressive" (p. 1582) and "reflect chronic irreversible damage to the cerebellum triggered by 
continuous ingestion of gluten in a gluten-sensitive individual" (p. 1585). On the other hand, those 
authors' noted that some patients with neurological signs "have shown improvement of ataxia and 
peripheral neuropathy on a GFD" (p. 1584; see Beversdorf, Moses, Reeves, & Dunn, 1996; Ward, 
Murphy, & Greenberg, 1985), while "some of our patients in whom the diagnosis of gluten ataxia was 
prompt have experienced complete resolution of their symptoms after strict adherence to a GFD" (p. 
1585). In the present research, there were several LCD cases in which either the WM or PS Index 
scores, or both, improved significantly between Ti and T2, but a systematic increase across the LCD 
group in excess of a practice effect or relatively greater than the small increases in other Indexes was 
not observed. Individual scrutiny ofthe few cases in which significant increases in WM or PS occurred, 
against demographic or biomedical data and mood state, did not provide any clues as to why isolated 
increases occurred. They may be attributed to random processes associated with retesting such as a 
practice effect, chance variation and perhaps unidentified factors. 
It may be suspected that in a number ofthe participants in Study 2, whose CD diagnosis was 
precipitated by an onset of symptoms soon before gastroenterological referral, adherence to the GFD 
may protect neural (and consequently neuropsychological) function in those susceptible to gluten-
related neuropathic damage. Therefore, a holding of neuropsychological performance could be 
regarded as a satisfactory outcome. 
These results highlight the essence of early detection of CD, even prior to the emergence of 
characteristic physical signs and symptoms. In this regard, neuropsychological assessment may play a 
role in cases where cryptic gluten sensitivity may be "an important cause of neurological illness" 
(Hadjivassiliou et al, 1998, p. 369). Those authors "showed that 57% of patients with neurological 
dysfunction of unknown cause had serological evidence of gluten sensitivity, compared with 12% of 
healthy blood donors" (Hadjivassiliou et al, 1996, p. 1582). If Study 1 and 2's results are replicated, it 
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is proposed that in instances where a neuropsychological test profile includes unexplained relative 
deficits in WM or PS combined with signs of malabsorption or inexplicable, chronic ill health, 
investigation of CD should be considered. Whereas in the small number of stadies detailing 
neurodegenerative changes in CD, often the "neurological symptoms came before the diagnosis of 
gluten sensitivity and CD" (Hadjivassiliou et al, 1998, 1582), in the present thesis GI symptoms were 
the principal reason preceding referral for investigation of CD. 
Health Status, Quality of Life (QOL), and Health Locus of Control 
Perceived health status "since diagnosis" increased significantly from Ti to T2, while the LCD 
group mean for retrospectively rated health status "prior to diagnosis" at Ti and T2 was identical. 
Notwithstanding the fact that a number of individual ratings changed slightly, the same result at Ti and 
T2 possibly validates the scale to a certain extent, given that the same time period was being evaluated, 
although from a different time point. 
Neither total QOL, nor the proportion of LCD participants in each ofthe three ranges of QOL (low, 
average, high), changed significantly between Ti and T2. In addition, one-third ofthe longitudinal 
cohort still exhibited low life quality and less than one in ten recorded high QOL at one year follow-up. 
In the five major domains of QOL there were no significant changes between Ti and T2 in CD patients. 
The final chapter discusses key outcomes and clinical implications of Study 1 and 2 in relation to 
previous research, the strengths and limitations ofthe thesis, the interface with clinical and health 
psychology, future directions in CD research and suggestions for further study. 
Chapter 6: General Discussion 
In the past few decades, Italian, Swedish, Finnish and British investigators have traversed the brain-
gut frontier in research on C D , with contributions from gastroenterology (see Fasano et al, 2000), and 
the perspective ofthe psyche, including psychiatry (e.g., Carta et al, 2002; Pynnonen et al, 2002), 
neurology (Alaedini et al, 2002; Cooke & Smith, 1966; Gobbi et al, 1998; Hadjivassiliou et al, 1996; 
Luostarinen, Collin, Peraaho, Maki, & Pirttila, 2001), functional neuropharmacology (e.g., Hallert & 
Sedvall, 1983; Hernanz, & Polanco, 1991), mood (Addolorato et al, 2001, Ciacci et al, 1998; Hallert 
et al, 1982), nutrition and orthomolecular medicine (e.g., Hallert, Astrom, & Walan, 1983; Reinken, 
Zieglauer, & Berger, 1976), personality (Hallert and Astrom, 1982), cognition (Hallert & Astrom, 
1983; Pavone et al, 1997), and psycho-social permutations, including quality of life (e.g., Hallert et 
al, 1998; Lohiniemi et al, 1998) and burden of illness (Hallert et al, 2002). 
Few research projects concerning the mental aspects of C D have involved the concurrent study of 
diverse facets of psychological functioning - across affective, cognitive and behavioural domains. 
The primary goal of this thesis was to assess these distinct, albeit connected, features of psychological 
life among adults with C D and tentatively calibrate any results against those to be expected in either 
people with or without a chronic illness involving some parallels (e.g., self-management of diet). A 
review ofthe cross-sectional and longitudinal assessment and analysis of these factors, as assessed in 
Study 1 and 2, is discussed in the current chapter in reference to previous research and implications 
for future study. 
Major Outcomes of Study 1 and 2 
The C D sample in Study 1 was heterogenous in terms of clinical severity at diagnosis, with 37 
patients best described as oligosymptomatic (one or no symptoms at diagnosis) and 73 designated 
multisymptomatic (two or more distinct CD-related symptoms). M e a n age at diagnosis was 36.9 years 
(range 1-84, S D = 15.4), occurring after the age of 19 years in 8 7 % of cases, and the mean duration of 
dietetic restriction was 4.2 years; S D = 7.9 years). The estimated total duration of C D symptoms before 
Psychological Sequelae in C D 240 
diagnosis averaged 56 months (SD = 78), with no significant gender differences. Symptomless periods 
were excluded in this calculation, as described in Chapter 4. Most CD participants were decidedly 
compliant with the GFD. The sample was 99% Caucasian, and, using weightings based on family 
lineage, 30% English, 20% Irish, 18% Scottish, 16% European (7% German, 4% Italian), 8% 
unspecified British and 7%» Welsh. There was a high lifetime prevalence of comorbid health problems 
in the CD sample, compared to the NC group, including headache, migraine (37%> of CD sample, 
leading directly to eventual CD diagnosis in two cases), hay fever (47%), asthma (34%>), reduced bone 
mineral density (32% overall, but 58% of those actually tested) and dental enamel hypoplasia (28%). 
Previous observations that depressive symptomatology is more prevalent in CD were generally 
supported - if oligosymptomatic cases were omitted - than in people without a chronic illness, even 
after diagnosis and implementation ofthe GFD. Overall depression, using the BDI-II (but not the 
POMS), was higher in the proportion ofthe CD group clinically multisymptomatic pre-diagnosis, with 
statistical significance attributed to the contribution of somatic, rather than cognitive, factors. 
A trend towards reduced BDI-H depression was observed at one year follow-up in the group tracked 
in Study 2, with change underpinned by a lowering ofthe Somatic/ Affective, as opposed to the 
Cognitive, dimension of self-reported depression. This result, although statistically weak and clinically 
marginal, may be partly considered in the context of two distinct (but perhaps additive) explanations; 
the recession of symptoms of physical illness post-diagnosis and the universal observation in depression 
that "physical symptoms become more prominent as depression becomes more severe" (Glenmullen, 
2000, p. 271), but also tend to ebb prior to the resolution of underlying psychological symptoms. 
Using the STAXI, state, but not trait, anger was higher in the multisymptomatic CD subgroup 
compared to the NC group. State anxiety (on the STAI) was higher in the multisymptomatic CD sub-
group in Study 1 than in both the DM and NC comparison groups, but significantly decreased within 
the longitudinal cohort after one year of GFD intervention. Trait anxiety was significantly higher in the 
CD group compared to the healthy (but not the chronic illness) comparison group. At one year follow-
up, a decrease occurred in the longitudinal cohort in fatigue-inertia (which held across gender), 
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confusion-bewilderment and anger-hostility. A total mood disturbance score, based on the summation 
of all six POMS subscales, was also found to significantly decrease after one year on the GFD. 
At study entry, life quality was significantly reduced in multisymptomatic CD patients compared 
to the NC (but not the DM) group. Retrospectively self-reported health status was markedly lower 
prior to diagnosis in relation to each comparison group, across the full CD sample. Unlike participants 
with DM, whose self-rated health status declined slightly pre-to post-diagnosis, a significant increase 
in subjective health status was reported in the CD group following diagnosis. 
In Study 2, perceived health status increased at one year follow-up (compared to Study 1 entry), 
verifying the similar retrospective finding in Study 1. However, the multisymptomatic subgroup in 
Study 1 still rated their health status following diagnosis (i.e., at study enrolment) as below healthy 
control levels. Upon gender partitioning, statistical significance only held for females. The lack of 
perceived health improvement in the DM comparison group pre- to post-diagnosis was attributed to 
the almost inevitable, eventual deterioration of health associated with DM, compared to the remission 
of health problems generally observed in CD following consistent GFD adherence. 
Quality of life scores did not rise appreciably at follow up in the LCD group and one third still 
exhibited low QOL. Given the somewhat above-average socioeconomic status (SES) ofthe CD group 
as a whole, this would appear especially disconcerting if extrapolated to less well resourced patients. 
A full intellectual assessment ofthe CD group, whose mean IQ was in the above-average range, 
leads to new observations about relative cognitive strengths and weaknesses in CD compared to 
normative expectations. Reduced working memory and processing speed index scores were observed 
in the CD group compared to the NC group at neuropsychological assessment, regardless of SES, 
total IQ, age at study entry, age or number of symptoms at CD diagnosis, time on or compliance 
with the GFD and mood state. The processing speed deficit was greater in male, compared to female, 
participants with CD. A mean 3-point improvement in full IQ, not above a level that could be 
accounted for by a practice effect, occurred within the longitudinal CD group, with residual index-
specific weaknesses in working memory and processing speed compared to normal controls. 
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Discriminant function analysis, using a three and four factor hypothetical damage quotient, was 
used to establish whether readily obtainable clinical data had utility in distinguishing depressed from 
non-depressed CD patients. This process correctly predicted group membership of three quarters ofthe 
CD group, each classified prior to analysis as either non-depressed or above the minimum cut-score 
conferring BDI-II depression at enrolment into Study 1. Seven out often non-depressed CD participants 
were correctly classified, with identification of more than eight out often who were depressed. The 
high sensitivity and reasonable specificity of this straightforward procedure may be of major clinical 
relevance. Since only easily procurable clinical information was utilised and false positives could be 
screened via psychometric assessment or clinical interviewing, this rapid, inexpensive approach may 
be applicable in mental health interventions in the care of CD patients. 
Relation of Study 1 and 2 Results to Previous CD Research: Clinical Issues 
A considerable occurrence of associated health conditions - as found in the CD sample - was not 
unexpected, but direct comparisons with other cohorts of CD patients was not undertaken due to 
differences in disease definitional criteria and participant sampling methods. In the present thesis, 
determination ofthe existence of most recorded general health conditions was by marking categories 
(via self-report). Inclusion criteria were broad or open-ended, in all probability inflating cited 
prevalence figures, which were tabulated for completeness, rather than specific study. Nevertheless, 
the high prevalence of headache and/ or migraine (just over one in three) was comparable to figures 
pertaining to a similarly sized, randomly selected Spanish CD sample (Roche Herrero et al, 2001). 
The high incidence of bronchial conditions (hay fever and asthma) in the present study must be 
additionally considered in the context of sharply rising worldwide rates, especially in Australia, as 
noted almost a decade earlier (Peat et al, 1994). In relation to health-related behaviours, cigarette 
smoking was reduced by about half in the CD sample compared to Australian community averages, 
with only 13% CD participants (18% of males; 9% of females) being current smokers and 60% having 
never smoked (61% of both genders). These results agreed with several recent studies (e.g., Austin, 
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Logan, Thomason, & Holmes, 2002). Alcohol consumption and vitamin-mineral supplement use in 
the CD group was unremarkable compared to both the comparison groups and community levels 
Almost one in three participants who were multisymptomatic at CD diagnosis reported at least 
mild depressive symptomatology at Study 1 entry, an almost identical finding to that reported by 
Ciacci et al. (1998). Depending on the criteria and cut points used to define depression, a figure of 
about one in three also appears congruent with other previous reports (see Hallert, 1997, for a 
review). In relation to Goldberg's (1970) series, Hallert and Astrom (1982) reported that the 
"demonstration of depressive traits in 42% seemed high" (p. 23), but a third of that sample did not 
follow a strict GFD, in contrast to the group studied in the present research. At one-year follow-up, 
almost one-quarter ofthe longitudinal cohort remained at least mildly depressed. These results 
support the generally held view of an increased prevalence of depression in CD, compared to 
expected community levels, but are markedly lower than the 57% figure reported by Addolorato 
et al. (2001) in a newly diagnosed group at diagnosis and at one-year follow-up. 
In the present thesis, the mean level of depression and proportion of depressed patients was 
comparable to the DM group, in contrast to Ciacci et al's (1998) findings of 1 in 10 hepatitis C virus-
related chronic persistent hepatitis patients experiencing depressive symptoms. This disparity between 
studies underlines the impact of one's choice of a chronic illness comparison group in CD research, as 
much as the apparent commonality of levels of depressive symptomatology. Ciacci et al. (1998) 
concluded "that symptoms are better related to the characteristics of CD than to a general chronic 
illness condition" (p. 249), in direct response to a statistically higher mean score in their CD group on 
the Zung Self-Rating Depression Scale (31.8 versus 28.7 in chronic persistent hepatitis patients), and a 
greater proportion of depressed CD patients. Alternatively, the current research found no evidence for 
increased depression, other than that which may be attributed to having a chronic illness. Of course, it 
has also been established that there is a high prevalence of depression in DM (Gavard et al, 1993), 
with an occurrence at least three times higher than in the general population (Lustman, Clouse, 
Alrakawi, et al, 1997) and major depression affecting one in five DM patients (Lustman, Clouse, 
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Griffith, et al, 1997). It may be that some ofthe mechanisms leading to depression in C D are different 
than those in DM, but that the end result is a comparably high level of depression in each illness 
That the elevated level of depressive symptomatology observed in the CD group was able to be 
attributed to the contribution of somatic-affective, rather than cognitive, factors was also contrary to 
Ciacci et al's interpretation that psychological, rather than biologic, mechanisms were "probably.. in 
our sample, predominant" (p. 250). As in Addolorato et al's (2001) group of newly diagnosed CD 
patients, the level of depression, as measured by both the BDI-H and the POMS, did not markedly 
decrease at one year follow-up in the group tracked in Study 2. Minimal changes were underpinned 
by a lowering ofthe Somatic/ Affective, as opposed to the Cognitive, dimension of self-reported 
depression. The distinction between somatic-affective and cognitive factors, in relation to CD and the 
findings ofthe present thesis, has several clinical implications. 
The spectrum of mood disorders described in the DSM-IV and ICD-10 include a number of 
categories potentially applicable to the depressive features observed in CD. Hallert and Derefeldt's 
(1982) observation that 19% of CD patients attended a psychiatric clinic in the decade prior to CD 
diagnosis and that "depression was the principal diagnosis and neurotic disorders as a whole.. the 
commonest reason for the granting of a disability pension in the entire celiac series" (Hallert, 1984, p. 
98-99), proves that "psychiatric illness may be severe in undiagnosed [CD]" (Hallert & Derefeldt, 
1982, p. 17). Findings of refractory depression in CD post-diagnosis (Addolorato et ai, 2001; Hallert 
& Astrom, 1982) were also confirmed in the present research, albeit to a lesser degree in a sample 
of comparatively greater than average SES. 
With individual exceptions, the general clinical impression garnered by the specific results 
obtained at interview in both Study 1 and 2 were of a group of features in the CD group that, at study 
entry, most often resembled Neurasthenia (ICD-10; WHO, 1993), Dysthymic Disorder (DSM-IV; 
APA, 1994) or the DSM-IV research criteria for minor depressive disorder (p. 719), recurrent brief 
depressive disorder (p. 721) or mixed anxiety-depressive disorder (p. 723). The criteria for these 
proposed categories of psychiatric disorder are tentatively based on thresholds and durations of 
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symptoms that do not quite reach requisite criteria for M D D , or which do meet the requirements for 
Anxiety Disorder Not Otherwise Specified. In the case of mixed anxiety-depressive disorder, the 
dysphoric mood symptoms in this thesis' CD group that most frequently presented - from the 
pool of 10 (see list on p. 724-725) - were the first four, namely: (1) difficulty concentrating or mind 
going blank, (2) sleep disturbance, (3) fatigue or low energy, and (4) irritability. These observations 
were verified by the individual BDI-II item results discussed in Chapter 4. It was noted that all four 
symptoms were somatic in nature. Exclusionary criteria for the three research disorders included the 
symptoms not being due "to the direct physiological effects.. of a general medical condition" (DSM-
IV, p. 725) and criteria "never" having been met for MDD, Dysthymic Disorder, Panic Disorder, or 
Generalized Anxiety disorder, nor "currently.. .for any other Anxiety or Mood Disorder" (p. 725). 
The case of a medical condition disqualifying the mixed anxiety-depression criteria needs 
consideration in light of Carta et al's (2002) implication of subclinical thyroid disease as a 
"significant risk factor" (p. 789) for psychiatric disorders in CD, as well as the unresolved question 
of whether CD itself may qualify as a medical illness directly responsible for depression, via the 
range of possible mechanisms outlined in Chapter 2. Although associations between CD and thyroid 
dysfunction are believed to have immunological underpinnings, selenium deficiency is not uncom-
mon in CD pre- and post-diagnosis (Cortigiani et al, 1989; Hinks et al, 1984; Kalita et al, 2002; 
Ward et al, 1984), so its role in thyroid function (Sher, 2001) in CD should not be overlooked. This 
is an example ofthe breadth of subtle consequences of CD that may ultimately manifest in mood 
disturbance, with the effect of another single nutrient - pyridoxine - on depression in CD previously 
proven (Hallert, Astrom, & Walan, 1983). 
As noted in Chapter 2, Carta et al. (2002) found an increased prevalence of Major Depressive 
Disorder, Dysthymic Disorder, Panic Disorder and Adjustment Disorder, using DSM-IV criteria and 
the Italian version ofthe composite international diagnostic interview. In the present thesis, 
sufficient criteria for current Major Depressive Disorder (MDD; DSM-IV) was lacking in most 
cases at Study 1 entry. However, based on background information gathered at interview, a case for 
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retrospective lifetime diagnoses of either M D D or Dysthymia could be made in about four out often 
CD participants across the full sample. One CD patient had a prior diagnosis of Bipolar Disorder 
(DSM-IV). The question of whether the DSM-IV category "Mood Disorder Due to a General 
Medical Condition" was applicable to CD was considered, given the increased prevalence of 
depression in certain neurological, metabolic, endocrine and autoimmune conditions, as well as CD, 
which may involve multi-systemic degeneration if untreated. However, evidence suggesting the 
utility of that category was not compelling, primarily due to lack of clarity of a "direct physiological 
effect", especially in retrospective attempts at diagnosis. 
Clinical levels of current BDI-II depression were identified in 21.8% ofthe CD group (i.e., about 
one in five people). This figure increased to 22 out of 73 (i.e., 30%>) of CD participants when the 
multisymptomatic subgroup was isolated. Their BDI-II scores ranged from 14 to 34. Of great concern, 
47% of those severely symptomatic at diagnosis were clinically depressed. No evidence existed that the 
Somatic/ Affective dimension of depression was more prominent than the Cognitive dimension in the 
CD patients whose total scores placed them above the minimum BDI-II cut score, with both or either 
dimension equally likely to be elevated. However, as noted earlier, the Somatic/ Affective dimension 
of depression was more prominent than the Cognitive dimension across the CD group as a whole. 
Correlational and discriminant function analysis clearly demonstrated that depression in the CD 
group was strongly associated with static diagnostic factors, especially the number and duration of CD 
symptoms pre-diagnosis. Although Hallert (1984) noted that in a previous study of psychic disturbances 
in adult CD (Hallert & Astrom, 1982) the "depressive attitudes were not explained by the somatic 
complaints" (p. 99) a significant correlation was identified between MMPI depression and daily fat 
excretion (u = .66) by those authors. Similarly, Lohiniemi et al. (2000) found that "poorer psychological 
well-being was associated with abdominal symptoms in coeliac patients" (p. 947). In the present thesis, 
it was clearly evident that both a greater severity and duration of (untreated) illness is associated with a 
poorer psychological outcome, to the extent that the likelihood of depressive symptomatology post-
diagnosis could be predicted in more than eight often CD patients (identified as depressed at study 
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entry), using the aforementioned variables in conjunction with time since diagnosis. 
The significantly high level of state anxiety observed in multisymptomatic CD patients in Study 
1 (compared to both comparison groups), which decreased within the CD group at one year follow-
up, supported the findings of Addolorato et al. (2001). However, it was notable that significance 
disappeared if the full CD group was used in Study 1 (i.e., if oligosymptomatic CD patients were 
included). The dissipation of significance upon addition of minimal symptomatic cases may merely 
reflect sample selection differences, in that it is realistic to expect that the CD patients who 
volunteered to participate in the present thesis were, overall, less likely to be severely ill as a group, 
on average, than a series of successive CD patients presenting at a gastroenterology clinic, even if 
only due to the passage of time since diagnosis. 
As reported, trait anxiety was significantly higher in the CD group compared to the healthy 
(but not the chronic illness) comparison group in Study 1, with the result less pronounced than for 
state anxiety, again supporting Addolorato et al's observations. Overall, 8%> of both the CD and DM 
groups, compared to 4%> ofthe NC group, were using psychotropic (anxiolytic or antidepressant) 
medication at study entry. Lifetime use was similar across the three groups, varying from 23% for 
participants with CD, 19% for the DM group and 18%> for the NC group. Across the full CD sample, 
on the basis of clinical interviewing, retrospective lifetime diagnoses of an anxiety disorder sufficient 
to meet DSM-IV criteria could be made in just over two out often CD participants across the full 
sample, with 14% ofthe sample retrospectively meeting DSM-IV criteria for a panic attack within 
the preceding two years. The decrease in fatigue-inertia (significant regardless of gender), confusion-
bewilderment and anger-hostility within the CD group at one year follow-up, was reflected in the 
decreased total mood disturbance score. This result was consistent with anecdotal decreases in 
irritability and apathy, and increases in energy, reported after GFD treatment. 
Neuropsychological findings observed in this thesis partially agreed with limited previous research, 
in that there were no differences between groups regarding overall intellectual ability (Hallert & 
Astrom, 1983). The comparable level of perceptual organisation ability in the CD and NC groups 
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contrasted with Pavone et al's (1997) and Incorpa et al's (1997) findings of reduced visual discrim-
ination ability, a key component, with abstract reasoning, ofthe WAIS-3 Perceptual Organisation 
Index. Verbal Comprehension was not significantly different across the three groups of people 
comprising Study 1. No evidence was found that GFD compliance significantly affected overall 
intellectual functioning or specific Index performance. The lack of decrements in the PO Index in 
DM compared to NCs was also consistent with previous studies in DM (e.g., Ryan & Geckle, 2000). 
An unexpected result was a reduction of working memory and processing speed (PS) in CD, 
compared to NCs and normative expectations, but not DM, in which a similar pattern, but less salient 
deficits were also identified. The CD result was congruent with Pavone et al's (1997) and Incorpa et 
al's (1997) conditional findings of relatively lowered short-term memory in children with CD (1997), 
based on patients non-compliant with the GFD and small sample sizes. A concomitant reduction in PS 
seen in the CD group in this thesis has been found previously in other degenerative or neuropsychiatric 
disorders (Wechsler, 1997), but was not noticeable in Hallert and Astrom's (1982) consecutive series 
of 19 CD patients in two tests of reaction time. No other studies were available for comparison. 
The PS result was accentuated in male, compared to female CD patients. This result was in 
agreement with others' general observations of neurological impairment in both CD (Ciclitira, 2001; 
Hadjivassiliou et al, 1998) and temporal lobe epilepsy (Briellmann, Berkovic, & Jackson, 2000). 
Frodl et al. (2002) found that hippocampal changes in patients with a first episode of major 
depression were "more pronounced in male patients" (p. 1112), further noting that "a substantial 
number of brain disease seem to affect male patients more severely than female patients" (p. Ill 5). 
Potential explanations of these gender differences include the finding that "estrogen protects while 
testosterone exacerbates" neurotoxic processes (Nishino et al, 1998, p. 303). 
Although the results pertaining to working memory may have neurological underpinnings related 
to a subtle degradation in hippocampal structure in DM (Hershey et al, 1997), connecting the 
neuropsychological findings of reduced immediate memory and psychomotor slowing in CD to brain 
structure is not straightforward. Federico et al. (1997) reviewed the neuropathological picture in CD. 
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Those authors described "a cerebellar syndrome characterized by ataxia, marked by speech impair-
ment (associated in some cases with memory loss), myoclonus, fibrillation and hypoareflexia" (p. 
266), with "the most consistent neuropathologic changes...in the cerebellum, deep-grey and brain-
stem nuclei, and spinal cord" (p. 266). A contrast with the pattern observed in alcoholic and nutritional 
cerebellar degeneration was noted. They pinpointed the "focal neuronal loss and/ or gliosis in deep-
grey and brain stem nuclei" as "mainly involving [the] thalamus, caudate nucleus, globus pallidus, 
putamen, amygdala, anterior hypothalamic nuclei, periaqueductal grey, corpora quadrigemina, 
substantia nigra, red nuclei, and motor and sensory cranial nerve nuclei..." and "demyelination of 
posterior columns" (p. 266). These brain structures are all involved, to a greater or lesser degree, 
in memory, emotional tone and fine motor movement (Kolb & Whishaw, 1990). 
A multi-faceted model of neuroaxonal degeneration in psuedoglutaric aciduria II (see Federico 
et al, 1997, p. 268-269), inclusive of concepts of nutrient malabsorption, as well as immunological 
abnormalities, toxins, environmental stress and genetic background, may have utility in discerning the 
pathologic mechanism in CD-related neurological and neuropsychological impairment. It is feasible 
that each mechanism may play a role in isolation or in coalition, with "immunologically mediated 
neural damage" (Hadjivassiliou et al, 1998, p. 1584) perhaps most pertinent - but other factors additive 
- to the final manifestation. Diffuse, mild damage to multiple sites has been implicated in psychomotor 
slowing in a number of other disease processes (Kolb & Whishaw, 1990; Lezac, 1983) and the Digit-
Symbol subtest ofthe WAIS-III, on which the CD patients performed especially poorly, is sensitive 
to subtle, generalized deficits (Crowe et al, 1999). More research is needed in this area. 
A plausible alternative explanation for the pattern of neuropsychological results observed in the CD 
and DM, compared to the NC group, is that higher levels of depression or anxiety, each known to be 
related to psychomotor slowing, distractibility and reduced output under time pressure (Kaufman, 1990), 
may have caused or contributed to the observed results. When the effect of depression and state anxiety 
were independently controlled via covariate analysis, the neuropsychological deficits diminished 
slightly, but a significant difference in performance between the CD and NC groups remained. 
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Strengths and Limitations of Thesis 
Considered in its entirety, the present study of psychological sequelae in CD is unique regarding 
cross-sectional sample size, Study l's use of two comparison groups, 1-year follow-up of a longitudinal 
cohort and the range of assessments undertaken in both studies. Few stadies of neuropsychiatric 
functioning CD have utilised sample sizes of beyond two dozen cases. Only one of comparable size in 
this regard also used two comparison groups (Ciacci et al, 1998). Prospective stadies are also scarce, 
with only Addolorato et al. (2001) using an equivalent number of CD patients. The present cross-
sectional study's use of large sample sizes, and close matching across demographic variables, permitted 
the use of parametric statistical procedures, using a similar protocol to Ciacci et al. (1998). 
Employment of two comparison groups in Study 1, that is people with DM and people without a 
definitive chronic illness, was a distinguishing feature ofthe thesis. The selection of DM patients was 
motivated on similar grounds to Hallert et al (2002), although those authors used exclusively type-2 
patients. Ciacci et al. (1998) utilised hepatitis C virus-related chronic persistent hepatitis patients as 
their chronic control condition. Close matching with the CD group across age, gender, education, 
SES and IQ was achieved in both comparison groups in the present thesis. The CD group was 
heterogeneous in relation to age at and time since diagnosis, as well as the duration and intensity of 
CD symptomatology pre-diagnosis, permitting a wide range of intra-group comparisons based on these 
distinctions. Recruiting a sufficient number or proportion of males has been an issue in previous CD 
research, but a reasonable gender balance was achieved in the present thesis, with 40% ofthe sample 
male, compared to 24%» in Ciacci et al's sample. Finally, a large number and diversity of 
psychometric psychological measures were used in each participant's assessment, resulting in a 
carefully defined and extensively studied CD sample. 
Limitations ofthe present thesis are also acknowledged. A primary consideration is the middle-
upper SES ofthe CD groups in both Study 1 and 2 and, as a consequence of close matching, similar 
demographics in each comparison group. Unlike Ciacci et al's (1998) sample, in which 42% and 11% 
of patients were of low and high SES respectively, the opposite demographic trend was observed in the 
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present research, with 11%> and 3 0 % the corresponding proportions. The moderately elevated SES ofthe 
CD group as a whole was, not surprisingly, accompanied by a somewhat above-average mean IQ score 
(= 112), which may have been expected to be closer to 100 in truly unselected community samples, 
notwithstanding the unavailability of Australian norms for the current version ofthe Wechsler Adult 
Intelligence Scale. However, it must also be noted that, unlike the U.S. normative sample, the group of 
patients comprising the CD sample in present thesis was 99% Caucasian and English was the first or 
predominant language used in all cases. It was presumed that the demographic aspects ofthe CD group, 
including slightly above-average mean intelligence (equating to about three-quarters of a SD above the 
U.S. normative mean of 100), also reflected the method by which the sample was drawn. 
Self-selection into Study 1, largely via advertisements in the national Coeliac Society magazine, 
invitations to participate at a local conference and direct phone solicitation of newly diagnosed CD 
patients, was neither a systematic, nor necessarily representative process. Unlike other studies which 
have used consecutive series of CD patients presenting at university or hospital-based gastroenterology 
clinics (e.g., Ciacci et al, 1998; Hallert and Astrom, 1982), selection of CD patients in the present 
research was comparatively varied and expansive. This was necessary to generate a large sample size 
within planned timelines and also enabled the development of a relatively heterogeneous group. There 
was a strong bias towards selection of current Coeliac Society members, who may be assumed 
to be more conscientious regarding dietary adherence (and health in general) than non-members. 
By virtue of volunteering to be involved in the study, the Coeliac Society members who 
participated may be further hypothesised to have formed an especially conscientious subgroup 
compared to members who declined. These biases perhaps underpinned several ofthe aforementioned 
demographic patterns. Although tight inclusion and exclusion criteria were applied in order to ensure 
the integrity ofthe CD and comparison groups, it is possible that, as a result ofthe recruitment 
methodology utilised, the CD group is not as representative of CD patients in the local community as 
may otherwise have been the case if successive patients from a large gastroenterology clinic had been 
used. The higher than average mean IQ score may provide an indication of this. 
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Realistically, it is uncertain what effect the selection biases and ultimate composition of this 
study's CD group (in relation to IQ, SES, etc.) had on key outcome variables such as the proportion of 
the group who were clinically depressed. It may be speculated that if a greater proportion of low SES 
participants (as in Ciacci et al's 1998 sample) had been included, the frequency or severity of 
depression may have been greater across the full CD group. However, selection factors unique to this 
thesis may have had this effect. For instance, people who are more troubled by CD or psychological 
difficulties, including depression, may have been more likely to volunteer to participate in response to 
advertisements mentioning "coping" and "quality of life", which were phrases used. Certainly, it was 
anecdotally observed that the less symptomatic Coeliac Society Members did not appear to avail 
themselves as often for study participation when directly invited. Ultimately, though, these intangible 
effects are unquantifiable unless people declining participation are also thoroughly assessed. 
What constitutes an appropriate chronic illness comparison group in CD research - or for that 
matter studies involving many multifactorial illnesses - remains open to debate. A non-GI illness 
with as many other similarities to CD was preferred. The use of DM patients in the present study was 
considered a suitable choice based on several commonalities, such as the degree of responsibility on 
the patient's part in treatment management and the fundamental role of dietary awareness and 
restrictions. However, DM may certainly be considered "a more serious condition" than CD (Hallert 
et al, 2002, p. 41). For this reason, people in the early to moderate stages of DM were recruited, with 
very poorly managed cases or those involving end-state complications deliberately screened out. 
The admixture of type-1 and type-2 DM patients in the chronic illness comparison group, 
although based on both clinical and pragmatic grounds, may also be considered a contentious matter 
by some observers. Although the reasons underlying this decision have been outlined in earlier 
chapters, it is conceded that, in spite of clinical similarities and significant overlap across each entity, 
type-1 and type-2 DM could be viewed as separate disease processes with somewhat different 
medical, practical and psychological implications. In the present research, though, there were minimal 
apparent differences between the type-1 and -2 subgroups on the psychological measures employed. 
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In the end, this justified their combination into one group, enabling parametric statistical comparisons 
with the CD and NC groups. 
An acknowledged flaw is the use of different testing venues (e.g., home versus office), for conven-
ience, in participant assessment. However, minimal biases were identified across groups in this regard, 
with equivalent proportions of participants from each group assessed at either type of venue. Only one 
examiner, the author, was involved in recruiting, as well as assessing and interviewing all participants, 
and was therefore not blind to participants' disease (or health) status. 
Finally, it is also acknowledged that neither the DM nor the NC participants were systematically 
medically screened for CD - or the CD patients for DM - at or following study enrolment. An increased 
prevalence of CD in DM and vice versa raises the possibility that a very small number of participants 
with either CD or DM may have been undiagnosed with the other illness, as was discovered in the case 
of a person subsequently excluded from statistical analysis. Nevertheless, it should be remembered that 
participants with existing symptoms ofthe alternate illness were excluded prior to study entry. Also, a 
significant proportion had been subject to medical investigations of DM or CD as part of their previous 
treatment, conceivably reducing the likelihood of any participants having both diseases to a very low 
level. 
Implications for Interface with Clinical/ Health Psychology 
Hadjivassiliou et al. (1999) portrayed the spectrum of gluten sensitivity as a "many headed hydra" 
(p. 1710), while Greco (1997) remarked that new cases of CD are increasingly "found by obstetricians, 
neurologists, psychiatrists, dental surgeons, dermatologists, rheumatologists and endocrinologists" (p. 
13). Similar observations were made in previous decades, initially by Barry, Baker, and Read (1974), as 
cited by Hallert (1984), who noted initial hospital enquiries or admissions by undetected CD sufferers 
were often in departments other than Gastroenterology or Medicine. These included Neurology, Ear, 
Nose and Throat or Dentistry, Orthopaedics, Gynaecology, Psychiatry and Dermatology in the Swedish 
experience. Clearly, adult patients may present for CD-related illnesses in a variety of medical/ health 
settings and at almost any hospital department, with "psychiatric morbidity a leading cause of disability 
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among adult coeliacs" (Hallert, 1987, p. 127). 
Clinical and health psychologists are therefore likely to directly encounter untreated, newly or 
distantly detected CD patients in private practice, public hospitals and community health settings, 
or incidentally in population based research and health promotion campaigns. Behavioural medicine 
approaches to CD have been proposed by Manikam (2000), who conceptualised the illness as a 
biopsychosocial disorder, a justifiably all-encompassing description applied in treatment models 
pertaining to other multifactorial conditions, such as DM (Jacobson, 1996; Jenkins, 1995), GI 
illnesses in general (Drossman, 1998) and irritable bowel syndrome in particular (Camilleri, 2001). 
Increased CD awareness among mental health care professionals would assist the case-finding 
process, greatly reducing unnecessary and seemingly inexplicable suffering in individual instances, 
given that mood changes, including depression, appear to be common even in screening-detected, 
otherwise asymptomatic patients (Catassi, 1997). Since these screening studies demonstrate that CD is 
considerably under-diagnosed, and disabling psychiatric illness may antedate recognition by years or 
decades (Hallert, 1984), psychologists should be cognizant that untreated cases may masquerade as 
apparently refractory depression, anxiety or other psychological conditions during different life stages. 
Given the latency of CD in many cases, previous exclusion of CD early in life should not preclude 
re-testing, given that serious complications of CD, such as osteoporosis, have emerged after the disease 
was "wrongly excluded in childhood" (Barnes & Catto-Smith, 2002, p. 983). 
An undiagnosed CD sufferer who is depressed may not improve upon psychiatric or psychological 
intervention, regardless ofthe therapy undertaken, if the depressive disturbance is underpinned by 
gluten sensitivity. Lack of responsiveness to antidepressant medication or, for that matter, other drug 
resistant psychiatric or neurological conditions (e.g., intractable epilepsy) should prompt investigations 
of CD as a key element of further enquiry (see Corvaglia, Catamo, Pepe, Lazzari, & Corvaglia, 1999). 
Serotonin, a key neurotransmitter long known to be implicated in depressive illness (Asberg & 
Bertilsson, 1979), is synthesised in a series of steps that are heavily dependent on micronutrient 
precursors supplied in the diet (Wurtman, 1979). In untreated CD patients, depression may be secondary 
Psychological Sequelae in C D 255 
to a reduced neuronal production of monoamines (serotonin, dopamine and noradrenalin), related to the 
characteristic malabsorption of nutrients essential to neurotransmitter regulation (Addolorato et al, 
2001; Challacombe & Wheeler, 1987; Hallert, Astrom, & Sedval, 1982; see also Hallert, Martensson, 
& Allgen, 1982; Hallert & Sedvall, 1983). In these circumstances, appropriate treatment obviously 
hinges on awareness ofthe nature and possibility of underlying physical illness. On the other hand, the 
languor and apathy characteristic of CD pre-diagnosis may resemble depressive symptomatology, but 
psychiatric/ psychological interventions will not correct the somatogenic causes of impaired general 
health and diminished sense of psychophysical well-being (see Marziani & Pianaroli, 2000). 
In either case, suspicion of CD should lead straight to serologic testing by a general practitioner, 
followed by biopsy in the case of suggestive results. Strong suspicion on clinical grounds, regardless of 
serology, also necessitates specialist referral, via a general practitioner, for endoscopic, duodenal biopsy 
(Fasano & Catassi, 2001). Hallert (1997) "recommended that adults seeking care for depression who 
give a history of unexplained nutritional deficiencies should be routinely screened" for CD (p. 216). 
Detection of CD and treatment with the GFD usually improves physical health - often remarkably 
- if gluten is strictly excluded, as highlighted by the significant increase in health status from pre to 
post diagnosis noted in Study 1. However, acceptance of and compliance with the dietary restrictions, 
or even the diagnosis of CD itself, may be difficult for children and require primary parental 
supervision (Anson, Weizman, & Zeevi, 1990). Parents' understanding of CD, the GFD and young 
patients' need for follow-up may be enhanced by psychological, as well as medical and dietetic, 
intervention (Bardella et al, 1990; Jackson, Glasgow, & Thorn, 1985). 
Primary difficulties stemming from a reluctance to accept a child's CD diagnosis among parents 
should not be underestimated, given the "disconcerting finding" raised by Hill et al (2000) that half of 
the parents in their epidemiological study whose children were identified with a positive serologic 
result "were unwilling to allow their children to undergo intestinal biopsy" (p. 89). Those authors 
acknowledged that a general lack of awareness of CD, and, in many cases, symptoms, may have 
influenced the pervasive disinclination to "accept the concept of a GFD" (p. 89), yet embracing the 
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GFD is difficult even for very unwell patients in high CD-awareness nations. 
In adolescents, and adults as well, such self-regulated regimes are difficult to implement, and 
adhere to lifelong, without considerable psychologic resources and interpersonal support, as observed 
or surmised in CD (Barr et al, 1993; Ciacci et al, 1998; Kokkonen, Viitanen, & Simila, 1989), other 
illnesses (e.g., DM; Hanson et al, 1996) and general medical conditions (e.g., hypertension; Richardson, 
Simons-Morton, & Annegers, 1993). Peer group pressure is a strong force in adolescence (Barr et al, 
1993) and "socialisation may expose the coeliac patient to many potential sources of gluten" (Ryan, 
2000, p. 837), with beer consumption in teenage CD patients "often denied" but a common example of 
either unknowing or "deliberate inattention to dietary guidelines" (p. 837). Unfortunately, beer, pasta 
and pizza are typically favourite - and socially endorsed - former choices, as noted by Lohiniemi 
(2001). Ciacci et al. (1998) speculated that the "main psychopathologic dimension of depression (that is, 
the 'reactiveness') could be related to a restricted lifestyle" (p. 250), which may well sustain depression 
in CD post-treatment, but does not explain its initial existence. 
The GFD may also be especially difficult to subjectively justify and maintain if CD has been 
identified via screening, rather than on clinical grounds (Fabiani et al, 2000). An absence, mildness or 
delay of physical symptoms in following an unrestricted or partially GFD is certainly not conducive to 
adolescent or even adult GFD compliance (Kumar et al, 1988; Mayer, Greco, Troncone, Auricchio, & 
Marsh, 1991), which depends most strongly on the perceived utility of dietary restriction (Buckfield, 
1997). This may partially underlie the reduced retention of new Australian Coeliac members detected 
via family screening or incidental detection - one year after joining - compared to an increased rate of 
overall, annual membership renewal (G. Price, personal communication, July 9, 2002). 
An interesting result in the present thesis was the unsubstantiated hypothesis that a lower GFD 
compliance would be associated with greater depression (or, equally, that depressed patients would 
be less compliant). This was expected to be one ofthe key damage quotient variables, but its 
contribution to variance in the prediction of depression was negligible. Although there were numerous 
individual cases in which poor dietary adherence and lowered mood were observed, there were almost 
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as many cases in which the opposite trend was observed (i.e., high compliance comorbid with 
significant depression). A close, case-by-case, perusal ofthe database suggested that the frequency of 
the latter coupling (i.e., high GFD compliance + elevated depression) statistically negated any 
systematic association in the expected direction, based on hypothesised underlying relationships (i.e., 
high compliance => lower depression, and vice versa). Given that there was a strong inverse 
association between perceived health status and depression in this study, it is not inconceivable that 
people who were mildly to moderately depressed were more conscientious about following the GFD in 
an effort to improve their health. Depression not infrequently involves ruminative and obsessional 
qualities, with the possibility in some patients of increased vigilance in relation to avoiding gluten and 
strict dietary adherence. Indeed, there were individual cases in which poor health and/ or elevated 
depression appeared to be channelled towards an almost fanatical adherence to the GFD. 
Clearly, the level and type of depressive symptomatology must be individually evaluated. Health 
care professionals must differentiate between a lack of- or lapses - in motivation, in relation to GFD 
adherence, versus excessively strict compliance, in terms of a potentially distressing tendency of some 
patients to be hypervigilant. A fixation with dietary restrictions in the GFD may be disadvantageous in 
regard to social integration and interaction, leading to or exacerbating social avoidance. Fortunately, 
the restrictions characteristic of CD may be not be as detrimental to social functioning in adolescence 
as the effects observed in IBD and chronic liver diseases (Calsbeek et al, 2002). 
It would seem constructive to be able to declare, unequivocally, that greater dietary compliance in 
CD automatically lowers the risk of depression, or that lowering depression in CD results in greater 
GFD compliance, leading to better health outcomes. However, the results of this thesis suggest that 
the relationship between depression and GFD compliance is a complex one, perhaps most 
appropriately assessed and managed clinically on a case-by-case basis. 
Depression and other psychological disorders in CD often persist in spite of dietary intervention, 
for many reasons. These may include later feelings of inferiority and increased vulnerability stemming 
from early events of undiagnosed CD (Hallert, 1982) and secondary psychological reactions to the 
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dietary and social restrictions peculiar to the illness (Ciacci & D e Rosa, 1996), as distinct from the 
consequence of having a chronic illness per se (Addolorato et al, 2001). Gasbarrini and Addolorato 
(1997) speculated that the elevated ('reactive' type) state anxiety and depression found in a very small 
central Italian CD series compared to healthy controls - at levels indistinguishable from irritable 
bowel patients - could indeed be secondary "to the emotional reaction to the symptoms of disease" 
(p. 353), additional to reduced neurotransmitter activity. 
Residual nutritional deficiencies in CD (Hallert, Astrom, & Walan, 1983), possible nutritional 
inadequacies ofthe GFD itself (Hallert, Lilliecreutz, et al, 1999), apprehension of irretrievable loss of 
physical health, and risk or fear of complications, which increase with age at diagnosis and duration 
of gluten exposure (Lanzarotto et al, 2000), may all contribute to psychological morbidity after 
diagnosis. Depression "left unrecognised may complicate the clinical course and contribute to 
persistent feelings of ill-health despite [GFD] adherence" (Hallert, 1997, p. 216) 
Conversely, unintentional gluten ingestion is an important consideration in cases of enduring 
mental as well as physical ill-health in those apparently adhering to the GFD (Fasano & Catassi, 
2001), with even the trace amounts detectable in "gluten-free" diets defined traditionally by the 
World Health Organisation's Codex Alimentarius standard possibly responsible for the continuing 
symptoms seen in some CD patients (Faulkner-Hogg, Selby, & Loblay, 1999). 
Resentment or bitterness at not being diagnosed earlier in life (e.g., in short stature men), or simply 
being different, plus the perceived burden of illness, can be other explanations for reduced subjective 
health and life quality in CD, perhaps especially so in young children (Kolsterman, Koopman, 
Schalekamp, & Mearin, 2001) and female, compared to male, CD patients, with social context 
especially germane (Hallert et al, 2002). Simply feeling different was recently found to be positively 
correlated with a cluster of negative emotions (sadness, anger and fear) in Italian CD patients (Ciacci 
et al, 2002). Another gender- and GFD compliance-related issue worthy of exploration following 
dietary treatment, intestinal restitution and restored absorptive function, is greater than desired weight 
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gain (Barr et al, 1993), especially in female C D patients, and different aspects of body image, which 
may be pertinent in both males and females. 
An irrepressible appetite or the capacity to consume unlimited portions of food, but an inability to 
put on weight, may be replaced pre-post diagnosis by an unintended, rapid or unmanageable increase 
in body mass index (BMI) and novel GI symptoms (e.g., constipation). Reckless abandon regarding 
caloric intake may be superseded by hypervigilance regarding the presence of gluten. Thus, some 
preconditions conducive to the development of eating disorders, which, like CD, are under-diagnosed 
(Jones, Lawson, Daneman, Olmsted, & Rodin, 2000) may exist. Indeed, the "cycle of weight loss at 
disease onset and subsequent weight gain" with treatment and "trend towards a higher BMI, and 
dietary restraints" (Snoek & Skinner, 2002, p. 266), seen in DM, is also applicable to CD. At present, 
though, the coexistence of eating disorders and CD is a relatively unexplored area of research, 
In the present thesis, mean BMI was comparable across the three groups of participants, at 23.5 
for the CD group, 24.5 for the NCs, and, not surprisingly, slightly higher at 26.3 for the DM patients. 
In the CD group, BMI had increased just over one point from the time of diagnosis, so the average 
change was minimal This is reflective ofthe contemporary rarity of severe weight loss as a symptom 
of CD pre-diagnosis, especially in adult-detected CD patients, unlike "in the early days", when 
emaciation was a "cardinal sign" (Hallert, 1984, p. 92). 
Bulimia was one ofthe "main neuropsychiatric complaints taken into consideration" by Bottaro et 
al. (1997, p. 353), in a retrospective clinical study of all 550 paediatric CD patients (aged 7 months to 
17 years at diagnosis; mode around second year), detected in their department from 1985-94. However, 
it was a primary or associated "psychic complaint" (p. 354) in only two and five cases respectively, 
among all patients in that series. Furthermore, it was unclear whether the neuropsychiatric complaints 
were considered only at the time of diagnosis and also how the assessment was undertaken. 
References in the CD literature to anorexia (said by Bottaro et al. to be present in 50% of CD 
cases) typically relate to unintentional weight loss due to malabsorption in untreated CD, and perhaps 
occasionally apathy, rather than deliberate food restriction in the sense of anorexia nervosa (AN). 
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However, C D diagnoses prior to and following the onset of A N have been reported in Italian women 
(Ricca, Mannucci, Calabro, Bernardo, Cabras, & Rotella, 2000). Those authors discussed two case 
studies illustrating the "complex relationships" between CD and AN, proposing that "the onset of CD 
could have exacerbated the clinical symptoms of AN' where CD was identified after AN onset and that 
"the dietary restriction could act as trigger for the eating disorder" in the patient in which AN was 
identified after CD diagnosis (p. 119). Heightened susceptibility to the development of eating disorders 
in CD cannot be ruled out in the absence of epidemiological research. Several circumstances certainly 
appear ripe for the evolution of underlying emotional factors associated with an obsessive concern 
with food consumption and one's weight, which is subject to various dynamics pre-post diagnosis 
Recent reports of a marginally increased incidence of cosmetic surgery in CD patients pre-
diagnosis versus controls (Ciacci et al, 2001), which those authors related to an "impaired 
psychological profile" (p. 2206), perhaps also point to the possibility of disturbed body image in CD 
It may be hypothesised that in men with CD, underweight status prior to diagnosis may lead to a 
disturbed body image, whereas in women, problems are more likely to emerge following diagnosis 
as a result of increased weight or overweight status, because of enhanced caloric retention. 
Ideally, psychologists should be alert to different types of psychological complications which may 
be attributable to underlying physical conditions such as CD, even after diagnosis, and mindful ofthe 
importance of timely specialist medical intervention and management if doubt exists about the source 
of a particular health-related problem. Evidence is accumulating that having CD may activate 
disordered adjustment to life stressors, potentiating reactive processes in depression or anxiety 
stemming from unrelated causes or events, over and above the changes expected in people without a 
chronic illness, and possibly specific to the pattern of psychological sequelae in CD (Carta et al, 2002; 
Gasbarrini & Addolorato, 1998). Making these distinctions in treating a depressed patient, who also 
happens to have CD, or vice versa, should be contingent on the evaluation of clinical, histological, 
dietary and nutritional parameters, as well as psychosocial, cognitive-behavioural or psychodynamic 
considerations. 
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Future Directions 
The prevalence and impact of CD on the physical and mental health of Australians needs 
systematic investigation. In Italy, a high CD-awareness nation, the cost of long-term complications of 
CD and malignancies clearly exceed diagnostic expenditure (Greco & Percopo, 1996). A recent study 
(Sandler ef al, 2002) highlighted the cost burden of GI and hepatic illness in the United States, with 
the direct estimated cost of all digestive disease in that nation equal to a fifth ofthe Australian gross 
domestic product. It was concluded that establishing the prevalence of these diseases was a key task. 
Fasano (2003) recently reiterated that the CD prevalence is approaching 1%> in general populations 
worldwide. He argued a strong case for screening Europeans and North Americans for CD, based on 
CD meeting all five WHO mass screening recommendations. These criteria include the target disease 
being common and causing significant morbidity, early clinical detection difficulties, the existence of 
highly specific/ sensitive screening tests, available treatment (i.e., GFD), and lack of recognition 
resulting in severe, difficult to manage complications (e.g., osteoporosis, lymphoma). In 1996, 
Australia's federal government, in consultation with each State, identified national health priorities 
(Wall, Wood, & Holman, 1999). These were determined on the basis ofthe major existing and 
projected medical and public health problems. The inclusion criteria included morbidity, mortality 
and the cost, at different levels, to the Australian community. The original list of five was: 
(1) Cardiovascular Health 
(2) Cancer Control (4) Mental Health 
(3) Injury Prevention and Control (5) Diabetes Mellitus 
After intense lobbying by many community groups for the inclusion of a number of other disease 
entities or systemic health problems, Asthma/ Respiratory Health and Arthritis/ Musculoskeletal 
Disease were recently added. Stated goals ofthe National Health Priority Initiative are "reducing the 
burden of illness", focussing on "common health determinants" (Wall, Wood, & Holman, 1999, p. 
47) and supporting "early detection" (p. 48). 
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With these goals in mind, a quick inspection ofthe dynamic priority list (of seven categories) is of 
great relevance in connection with CD. A strong case can be made that, in four out of seven disease 
entities, the prevalence of C D is significantly increased, the exceptions possibly being Injury Preven-
tion/ Control, Asthma/ Respiratory Health and Cardio-Vascular Disease, notwithstanding Hallert et 
al's (1999/ 2002) observations of increased blood homocysteine in C D , a major risk factor for cardio-
vascular disease, an increased risk for C D in end-state heart failure (Prati et al, 2002) and the author's 
observations of one third ofthe C D group in Study 1 having a lifetime history of asthmatic symptoms. 
As discussed in Chapter 1, where C D is undetected and consequently untreated with the G F D - or 
not optimally managed - the prevalence ofthe four other associated health problems increase further 
The risk of C D in association with the seven disease entities identified in the ongoing National Health 
Priority Initiative is displayed in Table 53. 
Table 53 
Risk of CD in Relation to Health Priority Areas and Documented Association 
Risk Priority C D Association 
X (1) Cardiovascular & Stroke Raised homocysteine (Hallert et al, 1999/ 2001) 
X X (2) Cancer Control Upper GI lymphoma risk increased 
X X (3) Diabetes Mellitus Proven association (Holmes, 2002) 
X (4) Asthma/ Respiratory Disease History in 3 4 % of C D patients in Study 1 
X X (5) Mental Health Depression/ anxiety elevated; Life quality lower 
(6) Injury Prevention & Control Nil 
X X X (7) Arthritis/ Musculoskeletal Osteopaenia present in most new C D diagnoses 
XXX Strong Association 
X X Increased Prevalence 
X Weak, Hypothetical or Unconfirmed Association 
It should also be recalled from Chapter 1 that CD is frequently implicated in occult cases of 
neurological impairment, as well as gynaecological and obstetric disorders, including unexplained 
infertility, which collectively impact on the quality of life of hundreds of thousands of Australians. 
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Conclusion 
The present thesis is unique in CD research in its concurrent use of a very wide range of 
psychological assessments, a large, well-defined and gender balanced adult CD sample, the utilisation 
of two comparison groups and a combination of cross-sectional and longitudinal protocols. For each 
of these reasons, a number of important results were calculable and firm conclusions were able to be 
drawn. Having established that the prevalence of depression in this thesis' CD sample was only 
greater than in healthy controls when CD cases physically oligosymptomatic pre-diagnosis were 
omitted, four disease correlates were identified that were hypothesised to collectively form a quartet 
of factors expected to impinge on a CD patient's trajectory to depression post-diagnosis. 
A damage quotient model was tested in a series of discriminant function analyses. The most 
successful function was able to identify more than eight out often CD patients who were depressed 
at study entry, regardless of whether a clinical or sub-threshold level of depression was set as the 
independent variable, based on three readily procurable items of information. These were the 
severity of illness, duration of CD symptomatology pre-diagnosis and, to a lesser degree, time since 
diagnosis. This actuarial approach to detecting the risk of depression in CD would appear to be 
highly relevant at the time of diagnosis, in conjunction with other standard interventions. The 
timely diagnosis and treatment of depression requires the expertise of a mental health professional, 
whose involvement may be ideally considered close to the time of diagnosis. 
Detection of subtle, but systematic, neuropsychological deficits in working memory and 
processing speed in CD highlighted the need for highly sensitive assessment tools in clinical practice 
and sufficient sample sizes to ensure adequate power in quantitative research, in identifying these 
deficits. A similar pattern of relative neuropsychological decrements were also found in DM, with 
different mechanisms (e.g., chronic hyperglycaemia and acute hypoglycaemic episodes) possibly 
involved. In both the CD and DM groups, a higher level of each of depressive and CD or DM-related 
symptomatology, while not changing the significance of these results if factored out, exacerbated 
the extent of psychomotor slowing and impaired verbal memory. 
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Each of these deficits, whilst often mild from a clinical perspective, were acutely felt by 
individuals, with complaints about memory the most commonly expressed misgiving during 
neuropsychological testing in the CD group. It must be remembered that the CD group utilised was 
of above average intellect and SES, factors which may, in the present thesis - and previous studies -
have served to mask rather than accentuate findings of specific neuropsychological deficits, including 
the distinct pattern found identified in Study 1. Each study detailed in this thesis highlighted that the 
psychological sequelae observed in CD are typically juxtaposed with markers of clinical severity at 
diagnosis and physical symptomatology post-diagnosis. For the majority - but not all - of those 
newly diagnosed, mood state ameliorates in concert with recession of physical symptoms in response 
to a strict GFD sustained over the passage of time. However, the specific neuropsychological 
weaknesses - once established - may be relatively refractory to dietary change. 
Increased symptomatic duration prior to diagnosis significantly impacted on the degree of 
impairment, underlining the essence of early detection. In Study 1, there was typically a lag of many 
years from patients' recollections of initial CD-related symptoms to the time of diagnosis. 
Furthermore, self-reported depression affected about one third of multisymptomatic CD participants 
at study enrolment and remained elevated in almost one-quarter of all newly diagnosed CD study 
entrants at one year follow-up. Finally, multisymptomatic members of this longitudinal group did 
not quite attain, on average, the same qualify of life as healthy comparison participants, with a 
significantly greater proportion reporting low life quality. These results reinforce the earlier 
proposition that psychological intervention should be considered following CD diagnosis, in 
conjunction with ongoing specialist medical advice and expert dietary assistance. 
If epidemiological considerations of CD are illuminated by conceptualisations of an iceberg 
model, awareness of general well-being, including the psychological sequelae, may be likened to 
the notion of an undiagnosed patient floating on their back in ocean waves, obscured by spray. The 
spine would be submerged and situated at the deepest point, perhaps symbolic of reduced bone 
density, one ofthe most common but regularly undetected, underlying physical problems at 
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diagnosis. In cases of moderately severe illness, the distended gut is likely to be visible from the 
water surface, even through the haze. The face may lie at the same level as the body, but appear 
pallid, and is susceptible to descending below the water's surface and out of view without constant 
arm movement, just as psychological concerns often go unnoticed. In rougher seas, some patients 
must paddle with their legs and flail their arms to avoid total submersion, yet even their spirited 
activity is often unseen from above and their desperate calls for help frequently unheard. When 
depression is the major sign of ill health in CD, the potential for health care practitioners to 
overlook the underlying physical cause of illness is ever present. Even after diagnosis, clinically 
noticeable depression often remains an obstinate problem. The modest, but consistent, pattern of 
neuropsychological test performance decrements identified in this thesis requires further 
exploration, whilst the quality of life of patients is of great importance in considerations of their 
immediate and long term well-being. For the entire person to remain buoyant and thrive, catching 
sight of, recognising and attending to parallel aspects of health - the physical and the psychological 
- is indispensable in CD. 
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